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Abstract
This thesis describes cerebral hemodynamic monitoring with the optical techniques of diffuse optical
spectroscopy (DOS) and diffuse correlation spectroscopy (DCS). DOS and DCS both employ near-infrared
light to investigate tissue physiology millimeters to centimeters below the tissue surface. DOS is a static
technique that analyzes multispectral tissue-scattered light intensity signals with a photon diffusion approach
(Chapter 2) or a Modified Beer-Lambert law approach (Chapter 3) to derive tissue oxy- and deoxy-
hemoglobin concentrations, which are in turn used to compute tissue oxygen saturation and blood volume
(Section 2.13). DCS is a qualitatively different dynamic technique that analyzes rapid temporal fluctuations in
tissue-scattered light with a correlation diffusion approach to derive tissue blood flow (Chapter 4). Further, in
combination these measurements of blood flow and blood oxygenation provide access to tissue oxygen
metabolism (Section 7.6).
The new contributions of my thesis to the diffuse optics field are a novel analysis technique for the DCS signal
(Chapter 5), and a novel approach for separating cerebral hemodynamic signals from extra-cerebral artifacts
(Chapter 6). The DCS analysis technique extends the Modified Beer-Lambert approach for DOS to the DCS
measurement. This new technique has some useful advantages compared to the correlation diffusion
approach. It facilitates real-time flow monitoring in complex tissue geometries, provides a novel route for
increasing DCS measurement speed, and can be used to probe tissues wherein light transport is non-diffusive
(Chapter 5). It also can be used to filter signals from superficial tissues. For separation of cerebral
hemodynamic signals from extra-cerebral artifacts, the Modified Beer-Lambert approach is employed in a
pressure modulation scheme, which determines subject-specific contributions of extra-cerebral and cerebral
tissues to the DCS/DOS signals by utilizing probe pressure modulation to induce variations in extra-cerebral
hemodynamics while cerebral hemodynamics remain constant (Chapter 6).
In another novel contribution, I used optical techniques to characterize neurovascular coupling at several
levels of cerebral ischemia in a rat model (Chapter 7). Neurovascular coupling refers to the relationship
between increased blood flow and oxygen metabolism and increased neuronal activity in the brain. In the rat,
localized neuronal activity was increased from functional forepaw stimulation. Under normal flow levels, I
(and others) observed that the increase in cerebral blood flow (surrogate for oxygen delivery) from forepaw
stimulation exceeded the increase in cerebral oxygen metabolism by about a factor of 2. My measurements
indicate that this mismatch between oxygen delivery and consumption are more balanced during ischemia
(Chapter 7).
In Chapters 2 and 3, I review the underlying theory for the photon diffusion model and the Modified Beer-
Lambert law for DOS analysis. I also review the correlation diffusion approach for analyzing DCS signals in
Chapter 4. My hope is that readers new to the field will find these background chapters helpful.
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ABSTRACT
OPTICAL CEREBRAL BLOOD FLOW MONITORING OF MICE TO
MEN
Wesley Boehs Baker
Arjun G. Yodh
This thesis describes cerebral hemodynamic monitoring with the optical techniques of diffuse
optical spectroscopy (DOS) and diffuse correlation spectroscopy (DCS). DOS and DCS both
employ near-infrared light to investigate tissue physiology millimeters to centimeters below the
tissue surface. DOS is a static technique that analyzes multispectral tissue-scattered light in-
tensity signals with a photon diffusion approach (Chapter 2) or a Modified Beer-Lambert law
approach (Chapter 3) to derive tissue oxy- and deoxy-hemoglobin concentrations, which are in
turn used to compute tissue oxygen saturation and blood volume (Section 2.13). DCS is a quali-
tatively different dynamic technique that analyzes rapid temporal fluctuations in tissue-scattered
light with a correlation diffusion approach to derive tissue blood flow (Chapter 4). Further, in
combination these measurements of blood flow and blood oxygenation provide access to tissue
oxygen metabolism (Section 7.6).
The new contributions of my thesis to the diffuse optics field are a novel analysis technique
for the DCS signal (Chapter 5), and a novel approach for separating cerebral hemodynamic sig-
nals from extra-cerebral artifacts (Chapter 6). The DCS analysis technique extends the Modified
Beer-Lambert approach for DOS to the DCS measurement. This new technique has some useful
advantages compared to the correlation diffusion approach. It facilitates real-time flow monitor-
ing in complex tissue geometries, provides a novel route for increasing DCS measurement speed,
and can be used to probe tissues wherein light transport is non-diffusive (Chapter 5). It also can
be used to filter signals from superficial tissues. For separation of cerebral hemodynamic signals
from extra-cerebral artifacts, the Modified Beer-Lambert approach is employed in a pressure
modulation scheme, which determines subject-specific contributions of extra-cerebral and cere-
bral tissues to the DCS/DOS signals by utilizing probe pressure modulation to induce variations
v
in extra-cerebral hemodynamics while cerebral hemodynamics remain constant (Chapter 6).
In another novel contribution, I used optical techniques to characterize neurovascular cou-
pling at several levels of cerebral ischemia in a rat model (Chapter 7). Neurovascular coupling
refers to the relationship between increased blood flow and oxygen metabolism and increased
neuronal activity in the brain. In the rat, localized neuronal activity was increased from func-
tional forepaw stimulation. Under normal flow levels, I (and others) observed that the increase
in cerebral blood flow (surrogate for oxygen delivery) from forepaw stimulation exceeded the
increase in cerebral oxygen metabolism by about a factor of 2. My measurements indicate that
this mismatch between oxygen delivery and consumption are more balanced during ischemia
(Chapter 7).
In Chapters 2 and 3, I review the underlying theory for the photon diffusion model and the
Modified Beer-Lambert law for DOS analysis. I also review the correlation diffusion approach
for analyzing DCS signals in Chapter 4. My hope is that readers new to the field will find these
background chapters helpful.
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Chapter 1
Introduction
Diffuse correlation spectroscopy [37, 79, 84, 182, 269] (DCS) and diffuse optical spectroscopy
[99, 115, 166, 175, 193, 219, 231, 248] (DOS) are optical techniques that employ near-infrared
light (NIR) to monitor cerebral blood flow, oxygen saturation, and blood volume continuously
and non-invasively at the bedside. In adults, the surface of the cerebral cortex is about 1-1.5 cm
below the surface of the scalp, which is optically deep tissue. To investigate tissue physiology
centimeters below the tissue surface, DCS/DOS relies on the NIR spectral window (∼ 650−950
nm) wherein light absorption from water and hemoglobin is relatively low (Figure 1.1). Although
the overall low light absorption enables NIR photons to travel deep in tissue, the spectra of
dominant NIR tissue chromophores, i.e., oxy-hemoglobin (HbO or HbO2), deoxy-hemoglobin
(HbR or Hb), and water, still differ significantly across the spectral window (Figure 1.1). Thus,
these tissue chromophore concentrations can be separated from one another and quantitatively
resolved with multi-spectral spectroscopy measurements.
Conversely, tissue scattering is high in the NIR window, and photons will scatter thousands of
times before they are absorbed. While most traditional optical spectroscopy techniques sample
optically thin media where photons scatter no more than once, cerebral tissue measurements
are in the opposite, optically thick regime. In the high multiple scattering limit, light transport
through tissue is very well approximated as a diffusive process (Chapter 2). The photon diffusion
model of light makes the inverse problem of determining tissue absorption, scattering, and blood
flow from measurements of light intensity tractable (Chapters 2, 4).
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Figure 1.1: Absorption (µa) spectra of main tissue chromophores over a large wavelength range.
The inset shows the so-called “physiological window” in the near-infrared where water and
hemoglobin absorption are relatively low. Notice in the inset that the water and lipid absorption
are not multiplied by 100. In this NIR spectral window, light can penetrate several centimeters
into tissue. Furthermore, there are clear features in the spectra which enable estimation of chro-
mophore concentration from diffuse optical measurements at several wavelengths. This figure is
a reprint of [79, Figure 1]
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Figure 1.2: A single DCS/DOS source-detector pair (separation ρ = 3 cm) in the remission
geometry for brain tissue measurements.
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A very basic DCS/DOS cerebral measurement with a single source-detector pair is depicted
in Figure 1.2. NIR light delivered to a point on the scalp diffuses through tissue randomly
in all directions. A fraction of this diffusing light emerges at the light detector located a few
centimeters away from the source point. This detected light has probed (i.e., interacted with) a
“banana shaped” volume of tissue that spans millimeters to a couple centimeters below the scalp
surface (Section 2.12).
The DOS and DCS techniques use the same measurement geometry, but they measure the
detected light intensity on different time scales (Figure 1.3). DOS is a static technique that mea-
sures slow (0.1− 1 s) variations in the detected light intensity induced by tissue absorption (µa)
and scatttering (µ′s) changes. DCS is a qualitatively different dynamic technique that measures
the rapid (microsecond scale) speckle light intesity fluctuations induced by blood flow (F ). Tis-
sue absorption in the NIR spectral window depends predominantly on HbO2, Hb, water, and
lipids. Multispectral DOS measurements can quantitatively resolve the concentrations of these
chromophores through using the photon diffusion model to separate absorption from scatter-
ing (Section 2.13). The primary chromophores of interest are oxy- and deoxy-hemoglobin, from
which the tissue oxygen saturation, i.e., StO2 = HbO2/(HbO2+Hb), and tissue blood volume,
i.e., BV ∝ (HbO2 +Hb), can be calculated (see Section 2.13).
DCS obtains a tissue blood flow index, F , that is directly proportional to tissue blood flow,
from the decay of the intensity autocorrelation function of the speckle intensity fluctuations
(Section 4.9). Further, a tissue compartment model (Section 7.6) can be employed to compute
an index of tissue oxygen metabolism (or oxygen consumption rate) from measurements of F
and StO2.
As might be anticipated, this information about cerebral blood flow, blood oxygenation and
oxygen metabolism has clinical value. All three parameters, for example, are important biomark-
ers for brain diseases such as ischemic stroke [127, 229].
1.1 Ischemic Stroke
Ischemic stroke is among the leading causes of death and morbidity, and occurs in ˜700 thousand
people each year in the U.S. alone [110]. In an ischemic stroke, a blood clot blocks a cerebral
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Figure 1.3: (A) Schematic for a homogeneous tissue model of the head with a blood flow index,
absorption coefficient, and reduced scattering coefficient of F , µa, and µ′s, respectively. The
incident source intensity, Is, remains constant over time. Blood cell motion (e.g., red disks at
time t and light-red disks at time t+ τ ) induces fast temporal fluctuations (i.e., speckle intensity
fluctuations) in the detected light intensity on the time scale of µs, while absorption and scat-
tering changes modify mean light intensities (e.g., averaged on time scales of ms or greater).
(B) Schematic of detected intensity fluctuations for a baseline tissue state (red curve) and a per-
turbed state from baseline with higher blood flow and absorption (blue curve). The horizontal
black lines are the mean intensities for the two states, denoted as I0 and I .
artery (e.g., middle cerebral artery (MCA)), causing an interruption in blood flow supply to
a localized region of the brain (Figure 1.4). The stroke lesion is comprised of a core and a
penumbra [11, 127, 229]. The core is almost entirely dependent on the blocked artery for blood
flow supply, and consequentially, blood flow in the core is very low (< 20% of normal flow).
This tissue region does not remain viable long, and is usually doomed. Surrounding the core is
the penumbra, which is partially dependent on the blocked artery for blood flow supply. Thus,
blood flow in the penumbra is low (< 50% of normal flow), but substantially higher than the
core due to perfusion from collateral vessels. Therefore, the penumbra remains viable on a
longer time scale than the core.
The volume of stroke-related dead tissue is the infarct. On short time scales, the infarct
mostly consists of the core, but on longer time scales, the penumbra will also succumb to low
blood flow conditions (Figure 1.4). Importantly, the penumbra tissue does not die all at once,
but is recruited in a complex infarction process that results in gradual infarct growth until well
perfused tissue is encountered (Figure 1.4).
Since the recruitment of penumbra tissue into the infarct takes time, an acute therapeutic
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Figure 1.4: Exemplar schematic of acute ischemic stroke progression. Blood flow supply is
interrupted to a localized region of the brain (i.e., the stroke lesion) by occlusion of the middle
cerebral artery (MCA) (left). The ischemic stroke lesion consists of a core that depends almost
entirely on the MCA for blood flow supply, and a surrounding penumbra that is partially perfused
by collateral vessels. On short time scales, the infarct largely consists of the core. At longer time
scales, the infarct expands into the penumbra until well perfused tissue is encountered. Since the
recruitment of penumbra tissue into the infarct takes time, there is an acute therapeutic window
in which interventions can be prescribed to reduce the infarct growth by maximizing perfusion.
DCS is a promising technique for determining the efficacy of an intervention’s ability to increase
penumbra blood flow. This figure is courtesy of Turgut Durduran.
window should exist where effective treatment interventions can halt infarct growth. Thus, treat-
ments for acute ischemic stroke aim to minimize neurological damage by maximizing perfusion
to the brain lesion [86,97,259]. Of course, the most obvious way restore blood flow is to remove
the clot blocking the cerebral artery. Indeed, on short time scales within a few hours of stroke
onset, rtPA infusion is typically prescribed, which is a drug that dissolves the clot.
However, on longer time scales after stroke onset, rtPA infusion can be harmful. If the core
has been dead long enough, the vasculature in the core is often no longer intact. In these cases,
a sudden restoration of blood flow to the core results in heavy bleeding that leads to death.
Paradoxically, restoration of blood flow to the core hours after stroke onset can also exacerbate
tissue damage through mechanisms such as increased edema (e.g., brain swelling from a leaky
vasculature) and the production of injurious free oxygen radicals [229]. Thus, on time scales of
several hours to days following stroke onset, the treatment strategy is to maximize perfusion to
the penumbra to halt infarct growth without restoring flow to the core.
Numerous acute treatment interventions for stroke are available, but variability in response-
to-treatment has been observed [86, 97, 155], and an effective treatment for one patient may be
ineffective, or even harmful, for another patient. Thus, a promising clinical application for DCS
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and DOS is rapid patient-specific assessment of treatment efficacy. An effective treatment will
increase perfusion to the penumbra, which DCS and DOS/NIRS can measure in real time. In-
deed, DCS and DOS enable detection of hemodynamic changes before new neurological symp-
toms emerge [84, 192, 277]. Crucially, DCS and DOS/NIRS can detect an ineffective treatment
on a faster time scale than the time it takes for new neurological symptoms from an ineffective
treatment to develop.
1.2 Thesis organization
Although DCS and DOS show strong potential for ischemic stroke treatment management, a
well-known drawback for optical monitoring of cerebral tissue is its significant sensitivity to
blood flow and oxygenation in the extra-cerebral tissues (scalp and skull) [26, 184, 221, 237,
238]. Traditional diffuse optics analyses approximate the head as a homogeneous medium (Fig-
ure 1.3A). The homogenous model is simple and does not require a priori anatomical informa-
tion, but it ignores differences between extra-cerebral hemodynamics and cerebral hemodynam-
ics in the brain. Because extra-cerebral blood flow and blood oxygenation are non-negligible,
their responses contaminate the DCS and DOS signals. Specifically, extra-cerebral contributions
can lead experimenters to incorrectly assign cerebral physiological responses [64, 237, 239],
which raises questions about the accuracy of optical cerebral monitoring.
A big part of my thesis was the development of a new analysis approach for filtering extra-
cerebral contamination in the DCS measurements of cerebral blood flow. This approach utilizes
a novel DCS Modified Beer-Lambert law for analysis of DCS signals (Chapter 5), and employs a
two-layer model of the head with pressure modulation to separate the cerebral and extra-cerebral
contributions to the DCS signal (Chapter 6). Importantly, this algorithm does not require a priori
anatomical information (though it’s helpful if available), and can be implemented in real-time.
Further, this algorithm extends to the DOS measurement of cerebral blood oxygenation and
blood volume (Chapter 6). My hope is that this algorithm when implemented in clinical settings
will lead to more reliable cerebral hemodynamic monitoring.
In another major part of my thesis, I utilized optical techniques to assess neurovascular cou-
pling at different levels of cerebral ischemia, including penumbral levels and core levels, in a
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rat model (Chapter 7). Neurovascular coupling is the quantification of hemodynamics due to
increase neuronal activity. To increase neuronal activity, the forepaw of the rat was stimulated.
For normal flow, this resulted in a localized blood flow increase (which is a surrogate for oxy-
gen delivery) that substantially exceeded the localized oxygen consumption increase by about
a factor of 2 (Chapter 7). If forepaw stimulation continues to increase oxygen delivery more
than oxygen consumption during ischemia, then stimulation could be an effective treatment for
locally increasing oxygen to the penumbral region of the stroke region. The oxygen delivery and
consumption increases from functional stimulation are more balanced at the penumbral levels of
ischemia, but the oxygen delivery increase is still slightly higher. This suggests that functional
stimulation may be neuroprotective in the penumbra.
Additionally, I have extensively reviewed the underlying theory for the photon diffusion
and Modified Beer-Lambert law approaches for analyzing DOS signals in Chapters 2 and 3,
respectively. I also have reviewed the underlying theory for the correlation diffusion approach
for analyzing DCS signals in Chapter 4. My hope is that readers new to the field will find these
background chapters helpful.
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Chapter 2
Diffuse Optical Spectroscopy (DOS):
Photon Diffusion Approach
2.1 Introduction
Light in the near-infrared (NIR) spectral window ( 650-950 nm) interacts with tissue via two
fundamental processes: absorption and scattering (Figure 2.1). Absorption is the light interaction
with matter resulting in the conversion of light energy to other forms of energy (e.g., thermal
energy). Thus, absorption irretrievably removes light from tissue via the destruction of photons.
The energy of these vanished photons is not lost, but transferred to tissue in the form of heat.
Scattering is the light interaction with matter where light is taken up by matter and re-emitted.
The re-emitted, or scattered, light may have both a different energy and momentum than the
original light. As illustrated in Figure 2.1B, ki = 2π/λikˆi and ks = 2π/λskˆs are the wave
vectors and λi and λs are the wavelengths of the incident and scattered light, respectively. The
scattering interaction in principle could impart both an energy change (~ω = ~v(|ks| − |ki|); v
is the speed of light through matter) and a momentum change (~q = ~(ks − ki)) between the
scattered and incident light.
Elastic (or Rayleigh) scattering is a commonly used term describing scattering interactions
where light energy is conserved (i.e., λs = λi), but light momentum is not necessary conserved
(i.e., the directions of ki and ks are different). In Raman scattering and fluorescence, the energy
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Figure 2.1: Photon absorption (A) and scattering (B) interactions within tissue. A tissue absorber
completely transforms the photon’s energy into internal thermal energy, thus halting any further
propagation of the photon through tissue. A tissue scatterer takes up the incident photon with
wave vector ki and reemits a scattered photon with wave vector ks. The scattering interaction
can induce changes in both the magnitude and direction between ks and ki.
of the scattered light is different from the incident light. The energy shifts in Raman scattering
are caused by photon interactions with vibrational and rotational degrees of freedom in matter,
while the energy shifts in fluorescence are caused by photon interactions with electronic degrees
of freedom in matter. Energy shifts in fluorescense are typically much larger, and thus easier to
detect, than energy shifts in Raman scattering. For near-infrared light propagating in endogenous
tissue, elastic scattering is dominant. However, if exogenous contrast agents such as fluorescent
dyes (e.g., Indocyanine Green) are added to tissue to improve contrast, fluorescent scattering
will obviously need to be considered as well [59].
Elastic light scattering in tissue reveals structural information about cells and surrounding
fluids [74, 189, 248]. This is because light scattering originates from spatial variations in the re-
fractive index on the length scale of the light wavelength [18]. In most cases, the refractive index
is directly proportional to the molecule number density [100], and light scattering measurements
therefore provide information on the spatial heterogeneity of molecule density. Pure water is
a non-scattering medium because the number density of water molecules is homogeneous on
the length scale of λ. Tissue, in contrast, is a highly scattering medium for near-infrared light
because it has heterogeneous regions of greater and lesser density on a length scale comparable
to NIR wavelengths. Examples of these heterogeneous regions include interfaces between cells
and extracellular space and interfaces between cellular cytoplasm and cellular organelles.
Tissue light absorption measurements provide complementary information on the concen-
trations of various tissue chromophores. In the near-infrared spectral region, the strongest
9
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Figure 2.2: A single DOS source-detector pair (separation ρ = 3 cm) in the remission geometry
for brain tissue measurements. Detected light travels over a distribution of pathlengths between
source and detector to probe a “banana shaped” volume of tissue [200]. As a rough rule of
thumb, the mean penetration depth is of order ρ/3 = 1 cm.
absorbing endogeneous tissue chromophores are oxy- and deoxy-hemoglobin and water (Fig-
ure 2.20) [144]. From using the well-known spectra of these chromophores [207], tissue absorp-
tion measurements at multiple wavelengths permits the direct calculation of the chromophore
concentrations (Section 2.13) [79, Section 2.8].
Diffuse optical spectroscopy (DOS) uses near-infrared light to measure absorption and scat-
tering in tissue. For example, a very basic DOS measurement probing brain tissue is depicted
in Figure 2.2. Near-infrared source light is delivered to a point on the scalp surface via an opti-
cal fiber. Another optical fiber is employed to detect the backscattered component of the source
light emerging from tissue at a different point on the scalp surface. This detected light has probed
(i.e., interacted with) a “banana shaped” volume of tissue that spans millimeters to a couple cen-
timeters below the scalp surface (Section 2.12) [200]. It is important to recognize, though, that
the attenuation in the detected light relative to the source depends on both the absorption and
scattering properties of tissue. In order to separate scattering effects from absorption effects in
the detected light signals, a quantitative model of light transport through tissue is required.
In this chapter, I will first show that light transport over long distances in tissue is well
approximated as a diffusive process [123, 266]. Then, I will discuss in detail how to use the
diffusion model of light transport in practice to separate tissue absorption from tissue scattering
in DOS measurements [10, 79].
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Figure 2.3: The light radiance L is defined such that the radiant power transported across an
element of area dσ at position r and time t in directions confined to an element of solid angle
dΩ centered around the Ωˆ direction is L(r, Ωˆ, t, λ) cos θdσdΩ.
2.2 Radiative Transport Theory
Maxwell’s equations correctly describe light transport through all media, including tissue. How-
ever, because of their complexity, solving Maxwell’s equations over long distances in tissue
is an intractable problem that must be addressed numerically. From numerical solutions, it is
very difficult to gain physical insight on light transport through tissue. For these reasons, I will
use radiative transport theory as the starting point for the theoretical description of diffuse op-
tics, which is an excellent approximation of Maxwell’s equations for describing light transport
through tissue [46, 51, 142]. The notation for important light transport parameters is shown in
Table 2.1.
In radiative transport theory, light with wavelength λ propagating through tissue with refrac-
tive index n is characterized by its light radiance, L(r, Ωˆ, t, λ) [Wcm−2sr−1], which is the light
power per unit area traveling in the Ωˆ direction at position r and time t. The amount of radiant
power, W (Ωˆ) [W], which is transported across an element of area dσ in directions confined to
an element of solid angle dΩ (see Figure 2.3) is
W (Ωˆ) = L cos θdσdΩ, (2.1)
where θ is the angle between Ωˆ and the area element’s normal vector, nˆ.
The interactions of light with tissue are in turn characterized by an absorption coefficient,
µa(Ωˆ, r, t, λ) [1/cm], and a scattering phase function, p(Ωˆ, Ωˆ′, r, t, λ) [1/cm]. These parameters
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are wavelength-dependent probability densities for light absorption in the Ωˆ direction and for
light scattering into the direction Ωˆ given the incident direction Ωˆ′ at (r, t), respectively. To
understand their physical meanings, consider a radiance L(r, Ωˆ, t, λ) incident on an infinitesimal
spherical volume of diameter |dr| (Figure 2.4). The amount of the incident radiance absorbed by
this volume is µa(Ωˆ, r, t, λ)L(r, Ωˆ, t, λ)|dr|, and the amount of the incident radiance scattered
into the Ωˆ′ direction is p(Ωˆ′, Ωˆ, r, t, λ)L(r, Ωˆ, t, λ)|dr|.
Often of interest is the total amount of incident radiance scattered by the tissue volume in all
directions. This is determined by a tissue scattering coefficient, µs(Ωˆ, r, t, λ) [1/cm], which is
simply the integral of the scattering phase function over all 4π steradians of space1:
µs(Ωˆ, r, t, λ) =
∫
4π
p(Ωˆ′, Ωˆ, r, t, λ)dΩ′. (2.2)
From the definition of the scattering phase function p, µs(Ωˆ, r, t, λ)L(r, Ωˆ, t, λ)|dr| is the total
amount of incident radiance scattered by the infinitesimal tissue volume, and µs is the probability
density for tissue scattering in any direction2.
The typical light transport length scales between absorption and scattering events are the
multiplicative inverses of µa and µs, respectively. To understand why, let us use the particle
description of light as a packet of N0 photons propagating through a homogeneous medium. Let
N(r) be the number of photons that have not been scattered after traveling a distance r inside the
medium. The probability of a single photon being scattered in distance dr is µsdr. Therefore,
since N(r + dr) is less than N(r) by the number of photons that have scattered in dr, we have
the equation
N(r + dr) = N(r)−N(r)µsdr,
which is a differential equation:
dN(r)
dr
= −µsN(r).
The above equation describes exponential decay, and has the well known solution [100, Section
1In spherical coordinates,
∫
4π
f(Ωˆ)dΩ =
∫ π
0
∫ 2π
0
f(θ, φ) sin θdθdφ [240, Section 14.4].
2If the tissue volume consists of discrete scattering particles with number density ̺ and a scattering cross section
of σs [cm2], then µs = ̺σs [240, Section 14.2]. Here, the total scattered light power from a single particle is the
product of σs and the incident radiance on the particle. Thus, a particle occupies an effective area σs where light
impinging on this area is scattered. Similarly, the scattering phase function, p, is related to the particle differential
scattering cross-section, σD , via p = ̺σD [240, Section 14.4]
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Figure 2.4: The radiance L(r + dr, Ωˆ, t + dt, λ) emerging from an infinitesimal spherical vol-
ume of tissue is different from the radiance L(r, Ωˆ, t, λ) incident on the volume because of the
interactions between light and tissue. The portion of the incident radiance absorbed by the tissue
volume is µa(Ωˆ, r, t, λ)L(r, Ωˆ, t, λ)|dr|. The portion of the incident radiance scattered by the
tissue volume into the Ωˆ′ direction is p(Ωˆ′, Ωˆ, r, t, λ)L(r, Ωˆ, t, λ)|dr|. Here, |dr| denotes the
magnitude of the vector dr, i.e., |dr| = vdt, where v = c/n is the speed of light through the
volume element.
43-1]
N(r) = N0 exp[−µsr] = N0 exp[−r/ℓs],
where ℓs ≡ 1/µs is the scattering length. Note that the probability density function for a photon
to scatter after traveling a distance r without scattering, i.e., Ps(r)dr, is equal to the probability
that a photon travels a distance r without scattering (i.e., N(r)/N0) multiplied by the probability
of scattering in distance dr (i.e., µsdr):
Ps(r)dr =
N(r)
N0
µsdr = µs exp[−µsr]dr.
Consequentially, the mean distance a photon travels between scattering events is the scattering
length, i.e.,
〈r〉 =
∫ ∞
0
rPs(r)dr =
∫ ∞
0
rµs exp[−µsr]dr = 1
µs
= ℓs. (2.3)
Using exactly the same logic, the absorption length, ℓa ≡ 1/µa, is the mean distance photons
travel before they are absorbed.
Transport theory is valid when the characteristic scattering and absorption lengths, ℓs and
ℓa, are much greater than the light wavelength. In other words, photons travel distances of many
wavelengths between interactions with tissue. This is true for near-infrared light, where typical
values for ℓs and ℓa are on the order of 0.1 and 10 cm, respectively. Under these conditions,
light transport is adequately described by the geometrical optics (or small wavelength) limit of
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Table 2.1: Parameters affecting light transport through tissue
Quantity Symbol Units
Light radiance (Equation 2.4) L W cm−2 sr−1
Scattering phase function (Figure 2.4) p 1/cm
Absorption coefficient (Figure 2.4) µa 1/cm
Absorption length ℓa ≡ 1/µa cm
Scattering coefficient (Equation 2.2) µs 1/cm
Scattering length ℓs ≡ 1/µs cm
Total transport coefficient µt ≡ µa + µs 1/cm
Normalized scattering phase function f ≡ p/µs dimensionless
Refractive index n dimensionless
Speed of light in tissue v = c/n cm/s
Radiant source power per volume (Equation 2.7) Q W cm−3 sr−1
Maxwell’s equations [31, Chapter 3], where the light electric field propagates in straight lines
between tissue interactions as a local quasi plane wave. The light radiance in terms of these
propagating electric fields is3 [116, Section 9.3.1]:
L(r, Ωˆ, t) =


∣∣∣E‖(r, Ωˆ, t)∣∣∣2 + ∣∣∣E⊥(r, Ωˆ, t)∣∣∣2 , unpolarized light∣∣∣E(r, Ωˆ, t)∣∣∣2 , polarized light, (2.4)
where E(r, Ωˆ, t) is the complex representation of the electric field at (r, t) that is transported as
a quasi plane wave with wave vector kΩ = (2πn/λ)Ωˆ, amplitude E0, and angular frequency ω,
i.e.,
E(r, Ωˆ, t) = E0(r, t) exp [i(kΩ · r− ωt)] . (2.5)
For unpolarized light, the light radiance is the sum over the intensities of the two orthogonal
polarization components, i.e., |E‖|2 = E‖E∗‖ and |E⊥|2 = E⊥E∗⊥. Another key result from
geometrical optics is that light interference effects are negligible, which results in additive light
intensities.
Changes in the light radiance are described by the radiative transport equation, which is a
conservation equation for the radiance in each infinitesimal volume element within the tissue.
Referring again to Figure 2.4, the change in radiance as it moves across an infinitesimal tis-
sue volume element in the Ωˆ direction is given by a convective (or material) derivative of the
3Here and in some of the remaining equations, the λ dependence of L is implict to make the notation less
cumbersome.
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radiance [240, Section 16.12]:
dL ≡ L(r+ dr, Ωˆ, t+ dt)− L(r, Ωˆ, t) = ∂L(r, Ωˆ, t)
∂t
dt+ dr · ∇L(r, Ωˆ, t)
=
∂L(r, Ωˆ, t)
∂t
dt+ vdtΩˆ · ∇L(r, Ωˆ, t). (2.6)
Because interference effects are negligible, this change in radiance dL also must be equal to
dL = −µa(Ωˆ, r, t)L(r, Ωˆ, t)|dr| − L(r, Ωˆ, t)
∫
Ωˆ′ 6=Ωˆ
p(Ωˆ′, Ωˆ, r, t)dΩ′|dr|+
∫
Ωˆ′ 6=Ωˆ
p(Ωˆ, Ωˆ′, r, t)L(r, Ωˆ′, t)dΩ′|dr|+Q(r, Ωˆ, t)vdt. (2.7)
Here, Q(r, Ωˆ, t) [Wcm−3sr−1] is the light power per volume emitted by sources at position r
and time t in the Ωˆ direction with wavelength λ. The change in radiance dL is decreased by the
losses in the incident radiance due to absorption (first term, right-hand side) and due to scattering
in all directions Ωˆ′ different than Ωˆ (second term, right-hand side). dL is also increased by the
gains in radiance scattered into Ωˆ from all incident directions Ωˆ′ different than Ωˆ (third term,
right-hand side) and the gains from light sources inside the volume element (fourth term, right-
hand side)4. Substituting vdt for |dr|, and adding zero, i.e., −p(Ωˆ, Ωˆ, r, t, λ)L(r, Ωˆ, t, λ)|dr| +
p(Ωˆ, Ωˆ, r, t, λ)L(r, Ωˆ, t, λ)|dr|, to the right-hand side of Equation 2.7, we obtain
dL = −
[
µa(Ωˆ, r, t) + µs(Ωˆ, r, t)
]
L(r, Ωˆ, t)vdt+∫
4π
p(Ωˆ, Ωˆ′, r, t)L(r, Ωˆ′, t)dΩ′vdt+Q(r, Ωˆ, t)vdt, (2.8)
where µs is given by Equation 2.2. Combining Equations 2.6 and 2.8 results in the radiative
transport equation (RTE) [46, Section 1.3],
1
v
∂L(r, Ωˆ, t, λ)
∂t
= −Ωˆ · ∇L(r, Ωˆ, t, λ) − µt(Ωˆ, r, t, λ)L(r, Ωˆ, t, λ) +Q(r, Ωˆ, t, λ)+
µs(Ωˆ, r, t, λ)
∫
4π
L(r, Ωˆ′, t)f(Ωˆ, Ωˆ′, r, t, λ)dΩ′. (2.9)
4To understand the gain in radiance from light sources, note that Q(r, Ωˆ, t, λ)dt is the light energy per volume
generated in time dt that is propagating in the Ωˆ direction. The increase in the light radiance emerging from the
volume element due to sources is then the product of this generated light energy with the speed of light through the
volume element.
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Here, I have introduced a total transport coefficient, µt [1/cm], and a normalized scattering
phase function, f , which are defined as:
µt(Ωˆ, r, t, λ) ≡ µa(Ωˆ, r, t, λ) + µs(Ωˆ, r, t, λ) (2.10)
f(Ωˆ, Ωˆ′, r, t, λ) =
p(Ωˆ, Ωˆ′, r, t, λ)
µs(Ωˆ, r, t, λ)
. (2.11)
Note from Equations 2.2 and 2.11 that
∫
4π
f(Ωˆ, Ωˆ′, r, t, λ)dΩ′ = 1. (2.12)
The RTE (Equation 2.9) is the main result of this section, which I derived using the geo-
metrical optics limit of Maxwell’s equations5. A hidden assumption in this derivation of the
RTE is that the radiation field propagating through matter is unpolarized. In principle, both
the absorption coefficient and scattering phase function depend on the polarization state of the
radiation field, and a vector radiative transport equation is required to account for polarization
effects [188]. In the vector RTE, L is replaced by a 4 × 1 vector of the four Stokes parameters
describing the intensity and polarization of the light field, i.e.,
L˜ =


L
pEL
ǫ〈−E‖E∗⊥ − E⊥E∗‖〉
ǫ〈i(E⊥E∗‖ − E‖E∗⊥)〉


,
where pE is the degree of polarization, ǫ is a proportionality constant, E‖ and E⊥ denote the or-
thogonal polarization states of the electric field (see Equation 2.4), and the angle brackets denote
time averages [51, 188]. Additionally, µt, µs, and f are replaced by 4 × 4 tensors. The vector
RTE simplifies to the scalar RTE (Equation 2.9) when the light field is completely unpolarized,
i.e., pE = 0. In many practical DOS tissue measurements, the light field is unpolarized because
of the rapid depolarization of light via multiple scattering [18, Chapter 14].
To summarize, the scalar RTE is valid when
5In a more rigorous approach, Jorge Ripoll also recently presented a step by step derivation of the RTE directly
from Maxwell’s equations [211].
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• The characteristic scattering length, ℓs ≡ 1/µs, and the characteristic absorption length,
ℓa ≡ 1/µa, are both much greater than the light wavelength λ. The photon propagation
distances within the medium also need to be much greater than λ.
• The light field propagating through tissue is unpolarized.
• The tissue refractive index is homogeneous, meaning that between tissue interactions,
the light field travels with constant velocity v = c/n. This condition can be relaxed by
replacing v with v(r, Ωˆ, t, λ) in the RTE (Equation 2.9).
Though it is considerably simpler than Maxwell’s equations, the RTE is still complex enough
that it must be solved numerically in most cases of interest [9, 162]. Numerical schemes to
solve the RTE are computationally time consuming and difficult to implement in data fitting
algorithms. Fortunately, for many cases of practical importance, near-infrared light transport
through tissue is well approximated as a diffusive process, which reduces the complexity of the
RTE significantly.
2.3 Photon Diffusion Equation
Under diffusive light transport, individual photons execute random walks through tissue, wan-
dering about in all directions without having a preferential direction of travel. As with Brownian
motion of diffusing particles in general, the net movement of large numbers of photons through
tissue is driven by the concentration gradient of these photons. Macroscopically, the concen-
tration of photons is directly proportional to the photon energy concentration (also called the
light energy density), Γ(r, t) [Jcm−3], which is the light energy per volume at (r, t). The photon
energy concentration is in turn dependent on the light radiance, L (Table 2.1).6 To understand
how, note that L(r, Ωˆ, t)/v, where v is the speed of light, is the component of the photon en-
ergy concentration traveling in the Ωˆ direction [100, Section 43-5]. The total photon energy
6To make the notation less cumbersome in this section, I will no longer explicitly label the wavelength dependence
(i.e., λ) in L, µa, µs, and f . The wavelength dependence is not important in the derivation of the photon diffusion
equation, but it will be very important later on when I discuss diffuse optical spectroscopy.
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concentration is thus the integral of L/v over all solid angles, i.e.,
Γ(r, t) =
1
v
∫
4π
L(r, Ωˆ, t)dΩ =
1
v
Φ(r, t). (2.13)
In Equation 2.13, I have introduced the photon fluence rate, Φ(r, t) [Wcm−2], which is defined
as the total light power per area moving radially outward from the infinitesimal volume element
centered at (r, t):
Φ(r, t) ≡
∫
4π
L(r, Ωˆ, t)dΩ. (2.14)
Clearly, the photon energy concentration and fluence rate are directly proportional to each other
(Equation 2.13). The rest of this section presents a detailed derivation of the diffusion model
for the photon fluence rate (Equation 2.46). A summary of important optical parameters in this
diffusion model are given in Table 2.2.
2.3.1 Continuity relation between the photon fluence rate and the photon flux
The transport of the fluence rate through tissue is described by a continuity equation obtained
from integrating the radiative transport equation (Equation 2.9) over all solid angles:7
1
v
∂
∂t
∫
4π
L(r, Ωˆ, t)dΩ = −
∫
4π
∇ ·
(
L(r, Ωˆ, t)Ωˆ
)
dΩ−
∫
4π
µt(Ωˆ, r, t)L(r, Ωˆ, t)dΩ +
∫
4π
Q(r, Ωˆ, t)dΩ+
∫
4π
µs(Ωˆ, r, t)
∫
4π
L(r, Ωˆ′, t)f(Ωˆ, Ωˆ′, r, t)dΩ′dΩ. (2.15)
The photon diffusion model is only applicable in isotropic media, wherein the scattering and
absorption coefficients do not depend on the direction of light travel:
assumption 1: µs(Ωˆ, r, t) = µs(r, t), µa(Ωˆ, r, t) = µa(r, t). (2.16)
Physically, Equation 2.16 means that on both the scattering and absorption length scales, ℓs ≡
1/µs and ℓa ≡ 1/µa, respectively, the medium looks the same to incident photons from every
7Because Ωˆ is a constant direction vector, Ωˆ · ∇L(r, Ωˆ, t) = ∇ ·
(
L(r, Ωˆ, t)Ωˆ
)
[116, Section 1.2.6]
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direction. Under this condition, Equation 2.15 simplifies to
1
v
∂Φ(r, t)
∂t
= −∇ ·
∫
4π
L(r, Ωˆ, t)ΩˆdΩ− µt(r, t)Φ(r, t) + S(r, t)+
µs(r, t)
∫
4π

∫
4π
f(Ωˆ, Ωˆ′, r, t)dΩ

L(r, Ωˆ′, t)dΩ′. (2.17)
Here, S(r, t) [Wcm−3] is the concentration of radiant source power, or the total power per
volume emitted radially outward from position r at time t, i.e.,
S(r, t) ≡
∫
4π
Q(r, Ωˆ, t)dΩ. (2.18)
Another assumption of photon diffusion theory is that the normalized scattering phase func-
tion, f , is rotationally symmetric. Mathematically, this means that f depends only on the angle
between incident and outgoing scattering wave vectors:
assumption 2: f(Ωˆ, Ωˆ′, r, t) = f(Ωˆ′, Ωˆ, r, t) = f(Ωˆ · Ωˆ′, r, t). (2.19)
Assumptions 1 (Equation 2.16) and 2 (Equation 2.19) go hand in hand in that they are generally
either both true or both false. Applying Equations 2.10 and 2.12 to Equation 2.17, along with
using assumption 2, results in a continuity equation for the fluence rate,
1
v
∂Φ(r, t)
∂t
+∇ · J(r, t) + µa(r, t)Φ(r, t) = S(r, t), (2.20)
where the photon flux, J(r, t) [Wcm−2], is the vector sum of the radiance emerging from the
infinitesimal volume element centered at (r, t), i.e.,
J(r, t) ≡
∫
4π
L(r, Ωˆ, t)ΩˆdΩ. (2.21)
Note that J(r, t) · nˆdσ [W] is the net light power crossing an element of area dσ (with
normal vector nˆ) in the nˆ direction (see Figure 2.3). This physical meaning of the photon flux is
understood from the definition of the light radiance (Equation 2.1). The light power crossing the
area element dσ from light traveling in the Ωˆ direction is
W (Ωˆ) = L(r, Ωˆ, t)dΩdσ cos θ = L(r, Ωˆ, t)Ωˆ · nˆdσdΩ.
Thus, the total net light power crossing dσ, i.e.,
∫
4πW (Ωˆ)dΩ, is J(r, t) · nˆdσ.
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2.3.2 Fick’s law relation between the photon fluence rate and the photon flux
Another relation between the photon fluence rate and the photon flux is derived from approxi-
mating the light radiance, L, as a series expansion of spherical harmonics, Yℓm (with coefficients
φ˜ℓm), truncated at ℓ = N :
L(r, Ωˆ, t) =
N∑
ℓ=0
ℓ∑
m=−ℓ
√
2ℓ+ 1
4π
φ˜ℓm(r, t)Yℓm(Ωˆ). (2.22)
Equation 2.22 is the so-called PN approximation of the light radiance [46,134,142]. Substituting
Equation 2.22 into Equation 2.14, and noting that spherical harmonics form an orthonormal set,
we obtain
Φ(r, t) =
N∑
ℓ=0
ℓ∑
m=−ℓ
φ˜ℓm(r, t)
∫
4π
√
2ℓ+ 1
4π
Yℓm(Ωˆ)dΩ
=
N∑
ℓ=0
ℓ∑
m=−ℓ
√
2ℓ+ 1φ˜ℓm(r, t)
∫
4π
Y ∗00(Ωˆ)Yℓm(Ωˆ)dΩ
= φ˜00(r, t). (2.23)
Similarly, substituting Equation 2.22 into Equation 2.21 results in8
J(r, t) =
N∑
ℓ=0
ℓ∑
m=−ℓ
√
2ℓ+ 1
4π
φ˜ℓm(r, t)
∫
4π
Yℓm(Ωˆ) [sin θ cosφxˆ+ sin θ sinφyˆ + cos θzˆ] dΩ
=
√
4π
3
N∑
ℓ=0
ℓ∑
m=−ℓ
√
2ℓ+ 1
4π
φ˜ℓm(r, t)
∫
4π
Yℓm(Ωˆ)
[√
1
2
(
Y ∗1−1(Ωˆ)− Y ∗11(Ωˆ)
)
xˆ−
i
√
1
2
(
Y ∗1−1(Ωˆ) + Y
∗
11(Ωˆ)
)
yˆ + Y ∗10(Ωˆ)zˆ
]
dΩ
=
√
1
2
(
φ˜1−1(r, t)− φ˜11(r, t)
)
xˆ− i
√
1
2
(
φ˜1−1(r, t) + φ˜11(r, t)
)
yˆ + φ˜10(r, t)zˆ
(2.24)
8I wrote Ωˆ in terms of the Cartesian unit vectors (i.e., xˆ, yˆ, and zˆ), where θ and φ (not to be confused with φ˜ℓm)
are the polar angle and azimuthal angle, respectively, in the spherical coordinate system [116, Section 1.4.1].
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In terms of the coefficients φ˜ℓm, the net power per area traveling in the Ωˆ direction is
J · Ωˆ = Jx sin θ cosφ+ Jy sin θ sinφ+ Jz cos θ
=
1√
2
(
φ˜1−1 − φ˜11
)
sin θ cosφ− i√
2
(
φ˜1−1 + φ˜11
)
sin θ sinφ+ φ˜10 cos θ
= φ˜10 cos θ +
sin θ√
2
(cosφ− i sin φ)φ˜1−1 − sin θ√
2
(cosφ+ i sin φ)φ˜11
= φ˜10 cos θ +
1√
2
sin θe−iφφ˜1−1 − 1√
2
sin θeiφφ˜11
=
√
4π
3
(
φ˜10Y10(Ωˆ) + φ˜1−1Y1−1(Ωˆ) + φ˜11Y11(Ωˆ)
)
, (2.25)
In Equation 2.25, there is still implicit position and time dependence in the coefficients φ˜ℓm and
J.
For diffusive light transport, L is accurately described by the P1 approximation, wherein the
series expansion in Equation 2.22 is truncated at N = 1:
L(r, Ωˆ, t) =
1
4π
φ˜00(r, t) +
√
3
4π
(
φ˜1−1(r, t)Y1−1(Ωˆ) + φ˜10(r, t)Y10(Ωˆ) + φ˜11(r, t)Y11(Ωˆ)
)
(2.26)
From combining Equations 2.23, 2.25, and 2.26, we see that the P1 approximation of the light
radiance is a linear combination of the photon fluence rate and flux, i.e.,
L(r, Ωˆ, t) =
1
4π
Φ(r, t) +
3
4π
J(r, t) · Ωˆ. (2.27)
A necessary condition for diffusive light transport is the validity of Equation 2.27. For nearly
isotropic light, i.e.,
assumption 3: Φ(r, t)≫ |J(r, t)|, (2.28)
the dominance of the isotropic fluence rate term in the PN expansion ensures the accuracy of the
P1 approximation.
Substituting Equation 2.27 into the radiative transport equation (Equation 2.9), we have9
1
v
∂Φ
∂t
+
3
v
∂
∂t
(J · Ωˆ) = −Ωˆ · ∇Φ− 3Ωˆ · ∇
(
J · Ωˆ
)
− (µt − µs)Φ− 3µtJ · Ωˆ+
4πQ(Ωˆ) + 3µs
∫
4π
f(Ωˆ · Ωˆ′)J · Ωˆ′dΩ′. (2.29)
9For simplicity, the r and t dependence is implicit for Φ, J, µt, µs, f , and Q.
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The last term on the right-hand side in Equation 2.29 is further simplified by evaluating the
integral in a spherical coordinate system defined such that Ωˆ is pointing in the zˆ direction:∫
4π
f(Ωˆ · Ωˆ′)J · Ωˆ′dΩ′ =
∫
4π
f(cos θ′)
[
sin θ′ cosφ′xˆ+ cos θ′ cosφ′yˆ + cos θ′zˆ
]
dΩ′ · J
=
∫
4π
f(cos θ′) cos θ′dΩ′zˆ · J
=
∫
4π
f(Ωˆ · Ωˆ′)Ωˆ · Ωˆ′dΩ′Ωˆ · J
= gΩˆ · J. (2.30)
Equation 2.30 introduces the scattering anisotropy factor, g, which is the ensemble average of
the cosine of the scattering angle θ, i.e.,
g(r, t) ≡
∫
4π
f(Ωˆ · Ωˆ′, r, t)Ωˆ · Ωˆ′dΩ′ = 〈cos θ〉. (2.31)
The closer g is to unity, the more probable it is for a photon to be scattered in the forward
direction, i.e., θ = 0. Reported near-infrared tissue measurements of g from the literature vary a
lot, but in general, g is high (> 0.7) [144].
Substituting Equation 2.30 into Equation 2.29, we obtain
1
v
∂Φ
∂t
+
3
v
∂
∂t
(J·Ωˆ) = −Ωˆ·∇Φ−3Ωˆ·∇
(
J · Ωˆ
)
−(µt−µs)Φ−3(µt−µsg)J·Ωˆ+4πQ(Ωˆ). (2.32)
Multiplying Equation 2.32 by Ωˆ and integrating over all solid angles results in a simpler relation
between the fluence rate and flux:
1
v
∂Φ
∂t
∫
4π
ΩˆdΩ = −3
v
∂
∂t
∫
4π
Ωˆ
[
J · Ωˆ
]
dΩ−
∫
4π
Ωˆ
[
Ωˆ · ∇Φ
]
− 3
∫
4π
Ωˆ
[
Ωˆ · ∇(J · Ωˆ)
]
dΩ−
(µt − µs)Φ
∫
4π
ΩˆdΩ− 3(µt − µsg)
∫
4π
Ωˆ
[
J · Ωˆ
]
+ 4π
∫
4π
Q(Ωˆ)ΩˆdΩ (2.33)
Equation 2.33 is further simplified through noting that for any vector A,∫
4π
Ωˆ
(
Ωˆ ·A
)
dΩ =
4π
3
A (2.34)
∫
4π
Ωˆ
[
Ωˆ · ∇
(
A · Ωˆ
)]
dΩ = 0. (2.35)
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Equation 2.34 is derived through evaluating the integral in a spherical coordinate system defined
such that A is pointing in the zˆ direction,∫
4π
Ωˆ
(
Ωˆ ·A
)
dΩ = |A|
∫
4π
Ωˆ cos θdΩ
= 2π|A|zˆ
∫ π
0
cos2 θ sin θdθ
=
4π
3
A, (2.36)
To derive Equation 2.35, note that10 [116, Section 1.2.6]
Ωˆ · ∇(Ωˆ ·A) = Ωˆ ·
(
Ωˆ× (∇×A) +A× (∇× Ωˆ) + (Ωˆ · ∇)A+ (A · ∇)Ωˆ
)
= Ωˆ · (Ωˆ · ∇)A = ∂Ar
∂r
, (2.37)
where the last line uses spherical coordinates; A = Ar rˆ + Aθθˆ + Aφφˆ and Ωˆ = rˆ. From
Equation 2.37, ∫
4π
Ωˆ
[
Ωˆ · ∇
(
A · Ωˆ
)]
dΩ =
∂Ar
∂r
∫
4π
ΩˆdΩ = 0. (2.38)
Substituting Equations 2.34 and 2.35 into 2.33, as well as noting that
∫
4π ΩˆdΩ = 0, we have
∇Φ = −3
v
∂J
∂t
− 3(µt − µsg)J+ 3
∫
4π
Q(Ωˆ)ΩˆdΩ. (2.39)
For diffusive light transport, two additional assumptions are now made:
assumption 4: Light sources are isotropic, i.e., Q(Ωˆ) = Q (2.40)
assumption 5: Slow temporal photon flux variations, i.e., (2.41)
3
v
∂J
∂t
+ 3(µt − µsg)J = 3(µt − µsg)J. (2.42)
Applying these two assumptions to Equation 2.39 results in the well known diffusive relation
between the fluence rate and flux, i.e., Fick’s first law of diffusion [17, Chapter 2]:
J(r, t) = − 1
3(µ′s(r, t) + µa(r, t))
∇Φ(r, t)
= −D(r, t)
v
∇Φ(r, t) = −D(r, t)∇Γ(r, t) (2.43)
10Since Ωˆ is a constant unit vector, (A ·∇)Ωˆ = 0 and A× (∇× Ωˆ) = 0. Further, by the nature of cross products,
Ωˆ and Ωˆ× (∇×A) are perpendicular vectors; thus their dot product is zero.
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Table 2.2: Relevant optical parameters in diffusion model of light transport
Quantity Symbol Units
Speed of light in tissue v = c/n cm/s
Photon fluence rate (Equation 2.14) Φ W cm−2
Photon energy concentration (Equation 2.13) Γ = Φ/v J cm−3
Absorption coefficient (Figure 2.4) µa = 1/ℓa 1/cm
Scattering coefficient (Equation 2.2) µs = 1/ℓs 1/cm
Scattering anisotropy factor (Equation 2.31) g dimensionless
Reduced scattering coefficient µ′s ≡ µs(1− g) 1/cm
Photon transport mean-free path (random walk step) ℓtr ≡ 1/(µ′s + µa) cm
Photon diffusion coefficient D ≡ vℓtr/3 cm2/s
Photon flux (Equation 2.21) J = −D∇Γ W cm−2
Concentration of radiant source power (Equation 2.18) S W cm−3
Here, Γ(r, t) is the photon energy concentration, which is given in Equation 2.13, µ′s(r, t) [1/cm]
is the reduced scattering coefficient, i.e.,
µ′s(r, t) ≡ µs(r, t) [1− g(r, t)] , (2.44)
and D(r, t) [cm2s−1] is the photon diffusion coefficient, i.e.,
D(r, t) ≡ v
3(µ′s(r, t) + µa(r, t))
=
1
3
vℓtr. (2.45)
The photon diffusion coefficient is directly proportional to the photon transport mean-free path,
ℓtr ≡ 1/(µ′s + µa) [cm], which is the random walk step of diffusing photons [17, Chapter 1].
2.3.3 Photon diffusion model
Substituting the diffusive relation between the fluence rate and flux (Equation 2.43) into the
continuity relation (Equation 2.20) results in the photon diffusion equation for the photon fluence
rate [123, 210]:
∇ · [D(r, t)∇Φ(r, t)]− vµa(r, t)Φ(r, t) − ∂Φ(r, t)
∂t
= −vS(r, t). (2.46)
Microscopically, the photon diffusion equation (Equation 2.46) is a consequence of many in-
dividual photons executing random walks through tissue [17, 49]. In this random walk visu-
alization, photons move in straight-line segments with sudden interruptions wherein either the
propagation direction is randomly changed or the photon is absorbed. The average length of the
24
Figure 2.5: Schematic of a photon taking two random walk steps through tissue. Each random
walk step involves many photon scattering events. This figure is adopted from Figure 2.2 in
David Busch’s thesis [39].
straight-line segments is the transport mean-free path, ℓtr . For near-infrared light propagating
through tissue, the scattering anisotropy factor g (2.31) is typically close to unity, which means
that µ′s ≪ µs (Equation 2.44), which in turn means that the transport mean-free path, ℓtr, is
much greater than the scattering length, ℓs ≡ 1/µs. Thus, photons scatter many times over the
length scale of ℓtr, and each scattering event produces a “kink” in their paths through tissue
(Figure 2.5). However, because of the high bias for forward scattering in tissue, the direction of
travel of photons is not fully randomized until they have moved over a length scale of ℓtr. Thus,
over large length scales, individual photon dynamics resemble random walks with step size ℓtr
(Figure 2.5).
To summarize, the validity of the photon diffusion model (Equation 2.46) rests on the validity
of several assumptions about the nature of light transport:
Light radiance is nearly isotropic (Equation 2.28): Nearly isotropic light radiance (i.e., Φ≫
|J|) is well modeled by the P1 approximation (Equation 2.27). If µ′s ≫ µa (i.e., a typical
photon takes many random walk steps of length ℓtr ≈ 1/µ′s before it is absorbed), and
the photon propagation distances within the medium are large relative to ℓtr , then the light
radiance will be nearly isotropic.
Rotational symmetry (Equations 2.16, 2.19)): The photon diffusion model assumes that the
tissue optical properties µa, µs, and f are independent of the direction of light travel.
Physically, this means that tissue should be rotationally symmetric on the absorption and
scattering length scales of ℓa ≡ 1/µa and ℓs ≡ 1/µs, respectively.
25
Radiative Transport Equation (Equation 2.9) is valid: As discussed at the end of Section 2.2,
the RTE is valid for unpolarized light propagating in media wherein ℓs and ℓa are much
greater than the light wavelength λ.
Slow temporal variations in photon flux (Equation 2.42): The implication of this assumption
is that the variation in photon flux occurs on a time scale much larger than the time it takes
photons to move one transport length, i.e., ttr ≡ ℓtr/v. The left-hand side of Equation 2.42
can be rewritten as
3
v
∂J
∂t
+ 3(µt − µsg)J = 3(µ′s + µa)
[
ℓtr
v
∂J
∂t
+ J
]
≈ 3(µ′s + µa)
[
ttr
∆J
(∆t)J
+ J
]
= 3(µ′s + µa)J, if ttr ≪ (∆t)J . (2.47)
Here, (∆t)J is the time scale over which the change in flux, ∆J, becomes significant
relative to J. Equation 2.47 is valid provided that ttr ≪ (∆t)J . For frequency space, i.e.,
J = J˜eiωt,
3
v
∂J
∂t
+ 3(µt − µsg)J = 3(µ′s + µa)(ttriω + 1)J
= 3(µ′s + µa)
√
1 + (ωttr)2e
i arctan(ωttr)J
= 3(µ′s + µa)J, if ωttr ≪ 1. (2.48)
For typical tissue properties of µa = 0.1 1/cm, µ′s = 10 1/cm, and n = 1.4, ttr ≈ 5
ps. Thus, from Equation 2.48, the slowly varying flux condition is satisfied if the linear
frequencies in the signal (i.e., f = 2πω), satisfy the condition f ≪ 32 GHz.
Homogeneous refractive index: More precisely, this means that photons travel with constant
velocity, v, between scattering events. If v depends on position and time, then this assump-
tion is relaxed by replacing v with v(r, t) in the photon diffusion equation (Equation 2.46).
In complex media where v also depends on the direction of light travel, Ωˆ, the diffusion
model is no longer valid.
Light sources are isotropic (Equation 2.40).
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These assumptions are valid in the near-infrared spectral window (∼ 650 − 950 nm) for many
tissues, wherein light transport is dominated by scattering (µ′s ≫ µa)11. For example, in brain
and breast tissue, µ′s is roughly two orders of magnitude greater than µa (see Table 2.3). Muscle,
skin, fat, and a variety of other tissues are also highly scattering, low absorbing media in the
near-infrared [144]. Many researchers have shown experimentally that the diffusion model is a
good approximation of light transport in these tissues, e.g. [55, 80, 96, 201, 266].
The photon diffusion model (Equation 2.46) is a major simplification of the radiative trans-
port model (Equation 2.9), and in several relevant tissue geometries, the diffusion model can
be solved analytically. With analytical solutions in hand, it is much easier to gain physical
insight and intuition on tissue light transport. The analytical solutions further facilitate the im-
plementation of data fitting algorithms to extract tissue hemoglobin concentrations from fluence
rate measurements. Even when numerical solutions are required, the photon diffusion model is
considerably more tractable than the full radiative transport model.
Keep in mind, though, that the diffusion model also has limitations in tissue measurements.
In anisotropic tissues such as axon fiber bundles, the rotational symmetry assumption may no
longer be reasonable. To account for anisotropy, Heino et al proposed an anisotropic diffusion
model that relaxes the isotropic assumption for the scattering phase function (Equation 2.19),
but keeps the isotropic assumption for the scattering coefficient (Equation 2.16) [126]. Although
this model is an improvement over the isotropic diffusion model (Equation 2.46), it is likely that
in tissue where the phase function is anisotropic, the scattering coefficient will be anisotropic as
well.
In tissues that contain very high concentrations of blood (i.e., high µa ), as in the liver,
or in applications wherein the photon propagation distances are comparable to ℓtr (e.g., finger
joint measurements), the photon propagation directions do not fully randomize to create a nearly
isotropic radiance. Further, some heterogenous tissues have both “diffusing regions” such as
brain tissue, where the diffusion model assumptions hold, and “non-diffusing regions” such as
cerebrospinal fluid, where the diffusion model assumptions break down [63,196]. In all of these
cases, approximations beyond the P1 (Equation 2.27) are needed for optimal data analysis. One
11Recall that µ′s ≈ 1/ℓtr (in diffusion regime) and µa are probability densities for isotropic light scattering and
light absorption, respectively (see Figure 2.4, Equation 2.2, and Equation 2.45)
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Table 2.3: Optical properties (mean ± SD) of brain and breast tissue at λ = 780 nm compiled
from Tables 2 and 3 in Jacques’ review of tissue optical properties [144].
Tissue Brain Breast Number of samples (n)
µa (cm−1) 0.15± 0.04 0.05± 0.02 5
µ′s (cm−1) 12± 8 11± 6 8
approach is to use the higher order P3 approximation (Equation 2.22 with N = 3) of the light
radiance in the radiative transport equation (Equation 2.9) to model the photon fluence rate [21,
135]. Another approach is to solve the radiative transport equation directly using numerical
methods such as Monte Carlo simulations or finite element techniques [9, 79, 124, 162, 254].
Compared to the diffusion model, these more complex approaches are computationally time
consuming.
The rest of this chapter mostly follows the tutorial approach taken in Durduran et al to
present how the diffusion model is used in practice to probe tissue absorption and scattering
with near-infrared light [79]. Section 2.13 then discusses how to convert measurements of µa at
multiple wavelengths into measurements of oxygenated and de-oxygenated tissue hemoglobin
concentrations.
2.4 Source Types
To apply the diffusion model for measuring tissue absorption and scattering, one typically detects
light at known distances from point sources. Figure 2.6 shows two source-detector pairs; one in
the reflection geometry and the other in the transmission geometry. In the reflection geometry
(also see Figure 2.2), light injected into the tissue by a source fiber (usually coupled to a laser)
is detected a distance ρ away with another fiber (usually coupled to a photomultiplier tube or
avalanche photodiode). In the transmission geometry, light detection is facilitated using either a
fiber or a lens/CCD camera system. At first glance, the directional light from a fiber violates the
isotropic source assumption for the diffusion model (Equation 2.40). This light source, however,
can be very well approximated by an isotropic light source at depth ℓtr inside the tissue [96].
In practice, the source-detector separations should exceed 3ℓtr to apply the diffusion model and
expect accurate (∼ 5%) results [154].
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Figure 2.6: Three common types of sources are employed. On the far left are schematic “banana
patterns” showing the sampled volumes in the reflection and transmission geometries. As a
rough rule of thumb, the mean light penetration depth in the reflection geometry is ρ/3 (for a
more precise relation, see [200]). For continuous wave (CW) sources (panel (1)), the input light
intensity, I0, remains constant, and slow (0.1 − 1 s) variations in the detected light intensity
(I(ρ)) induced by changes in tissue absorption and tissue scattering are measured. For intensity
modulated (FD) and time-resolved (TR) sources, the source (input) and detected (output) light
intensities resemble panels (2) and (3), respectively. In the FD measurement, the amplitude and
phase (θ) of the detected signal are related to the absolute tissue optical properties.
Three types of light sources commonly used in diffuse optics are (see Figure 2.6): continuous
wave (CW), intensity modulated (FD), and time resolved (TR). The simplest source type is
CW light, where the intensity remains constant over time [48, 61, 98, 228]. CW sources enable
fast data acquisition and the use of simple detectors and detection electronics, but as I will
discuss further, µa and µ′s cannot be determined simultaneously from a single CW measurement
(Sections 2.5).
Intensity modulated sources (the frequency-domain technique, FD) are more complex but
also give more information about the medium [10, 47, 80, 113, 133, 253]. Here, the light inten-
sity of the source is sinusoidally modulated with angular frequency ω (of order 100 MHz or
larger, up to ∼ 1 GHz), producing a diffusive wave in the medium oscillating at the same fre-
quency (Section 2.5). At a given source-detector separation, both the amplitude and phase of the
diffusing wave are measured. The additional information from the phase, in principle, permits
simultaneous determination of µa and µ′s.
Time resolved light sources (the time-domain technique, TR) deliver short light pulses (<
100 ps) to the medium, which will temporally broaden as they propagate through the medium.
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At the detector, the temporal pulse shape contains the necessary information to determine µa and
D from a single source-detector pair. Time resolved light is related to intensity modulated light
via a Fourier transform (Section 2.7), and it contains the same information content as intensity
modulated sources scanned over the wide range of modulation frequencies present in the source
light pulse [10, 16, 143, 201, 203].
2.5 Diffuse photon density waves
In the frequency-domain, the source is radio frequency modulated light delivered to the medium
at position rs such that S(r, t) in the diffusion model (2.46) is12
S(r, t) = S0
(
1 +Meiωt
)
δ(r − rs), (2.49)
where S0 [W] is the time averaged power emitted by the source, M [dimensionless] is the depth
of modulation of the source, 0 ≤ M ≤ 1, ω is the angular frequency of modulation, i.e., ω =
2πf where f is the frequency of modulation in [Hz], and δ(r) [cm−3] is the three-dimensional
Dirac delta function. This light source produces a photon fluence rate with a continuous wave
(CW) component and an oscillating ac component at the same angular frequency ω:
Φ(r, t) = Φcw(r) + Φac(r, t)
= Φcw(r) + U(r)e
iωt. (2.50)
Here, U(r)eiωt is the complex representation of the frequency-domain photon fluence rate. Both
Φcw and U are described by diffusion equations obtained from substituting Equations 2.50 and
2.49 into Equation 2.46:
∇ · (D(r)∇Φcw(r)) − vµa(r)Φcw(r) = −vS0δ(r− rs) (2.51)
∇ · (D(r)∇U(r)) − (vµa(r) + iω)U(r) = −vMS0δ(r − rs). (2.52)
For homogeneous media, these equations simplify to
(∇2 − k20)Φcw(r) = −vS0D δ(r − rs) (2.53)(∇2 − k2)U(r) = −vMS0
D
δ(r − rs), (2.54)
12For simplicity, I am employing the complex representation (eiωt) for sinuosoidal oscillations in the source and
fluence rate. The actual source and fluence rate will be the real parts of their complex representations.
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where k20 ≡ vµa/D and k2 ≡ (vµa + iω)/D.13
The general solution to Equation 2.54 is a damped wave-like fluence rate “disturbance” in
the turbid medium, which is called a diffuse photon density wave.
2.5.1 Solutions in infinite, homogeneous turbid media
2.5.1.1 Frequency domain solution
Conceptually, diffuse photon density waves are easiest to understand in the infinite, homoge-
neous medium with a single intensity modulated point source at the origin (i.e., rs = 0 in
Equation 2.49). In this geometry, the solution to Equation 2.54 given the boundary condition
that the fluence rate falls to zero at infinity is well known [10, 45]. It has the form of a simple
damped spherical wave with complex wave vector k = kr + iki, i.e.,
U(r) =
vMS0
4πDr
exp(−kr), (2.55)
where r = |r|. To determine kr and ki, note that
k2 ≡ vµa + iω
D
=
(
v2µ2a + ω
2
D2
)1/2
exp
[
i arctan
(
ω
vµa
)]
, (2.56)
and therefore
kr =
(
v2µ2a + ω
2
D2
)1/4
cos
[
1
2
arctan
(
ω
vµa
)]
= a cos[b/2], (2.57)
ki =
(
v2µ2a + ω
2
D2
)1/4
sin
[
1
2
arctan
(
ω
vµa
)]
= a sin[b/2], (2.58)
where a ≡ ((v2µ2a + ω2)/D2)1/4, and b ≡ arctan(ω/(vµa)). Equivalent expressions to Equa-
tions 2.57 and 2.58 are
kr =
(vµa
2D
)1/2 
(
1 +
[
ω
vµa
]2)1/2
+ 1


1/2
(2.59)
ki =
(vµa
2D
)1/2 
(
1 +
[
ω
vµa
]2)1/2
− 1


1/2
. (2.60)
13Some authors use slightly different definitions for k2 and U , e.g., k2 = (vµa − iω)/D with Φac = Ue−iωt;
k2 = (−vµa + iω)/D with Φac = Ue−iωt; k2 = −(vµa + iω)/D with Φac = Ueiωt. The latter two definitions
enable us to write Equation 2.54 in Helmholtz form, which has the advantage of more obvious analogies with waves.
I chose the definitions used by Arridge et al in their classic paper deriving solutions to Equation 2.54 for several
useful geometries [10], i.e., k2 = (vµa + iω)/D with Φac = Ueiωt. Of course, regardless of the way terms are
defined, the solutions are the same.
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The complete diffuse photon density wave is given by
Φac(r, t) = A(r) exp [i(ωt− θ(r))] , (2.61)
where A(r) and θ(r) are the amplitude and phase of the diffuse photon density wave, respec-
tively:
A(r) =
vMS0
4πDr
exp(−krr) (2.62)
θ(r) = kir. (2.63)
From measurements of A and θ at one source-detector separation r, Equations 2.62 and 2.63 can
be solved for the optical properties µa and µ′s only if v and the product MS0 are known. We
typically do assume a tissue index of refraction of n = 1.4 for calculating v = c/n in the near-
infrared spectral range [29,144]. However, the product MS0 is unknown in practice. Even if the
modulation depth and power of the source laser are carefully measured initially, small changes
in any elements of the fluence rate measurement (e.g., detector sensitivity, fiber coupling with
tissue) will effectively change MS0 [96]. I will discuss these fluence rate measurement effects
in detail in Section 2.11.
The determination of optical properties with diffuse photon density waves, then, requires
measurements of their amplitude and phase at multiple distances from the source. Figure 2.7
outlines the procedure for extracting µa and µ′s from measured changes in wave amplitude and
wave phase with distance from the source. Briefly, the slopes of log(Ar) vs. r and θ vs. r
are −kr and ki, respectively, from which µa and µ′s can be calculated using Equations 2.57 and
2.58 [93].
Specifically, from using trigonometry relations,
kr
ki
− ki
kr
=
1 + cos b− 1 + cos b
sin b
=
2
tan b
=
2vµa
ω
, (2.64)
and
k2r − k2i = a2 cos b = a2
vµa√
ω2 + (vµa)2
=
vµa
D
. (2.65)
Rearranging Equations 2.64 and 2.65, we obtain
µa =
ω
2v
(
kr
ki
− ki
kr
)
, (2.66)
µ′s =
2v
3ω
krki − µa ≈ 2v
3ω
krki. (2.67)
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Figure 2.7: A radio-frequency modulated light source at rs = 0 induces a diffuse photon density
wave, Φac(r, t) (Equation 2.61), which is characterized by its amplitude, A, and its phase shift
from the source, θ (a). Some researchers use θ˜ = −θ (also depicted in panel (a)) to characterize
the phase shift of the diffuse photon density wave instead, i.e., Φac = A exp[i(ωt + θ˜)]. In
the homogeneous infinite geometry, Φac is a simple spherical wave. Panel (b) shows constant
phase contours (θ in degrees) as a function of position for a typical set of parameters in tissue
measurements: µa = 0.1 1/cm, µ′s = 10 1/cm, ω = 2π × (70 MHz) and an index of refraction
n = 1.4. Note that the wavelength (2π/ki ∼ 19 cm) is roughly a factor of 20 greater than the
attenuation length (1/kr ∼ 1 cm). For this same set of parameters, panel (c) plots log(Ar) (blue
solid line) and θ (green dashed line) as a function of the radial distance from the source, r. The
slopes reveal −kr and ki (see Equations 2.62 and 2.63), from which µa and µ′s can be calculated
using Equations 2.66 and 2.67 (v is assumed). Note that the slope of θ˜ vs. r is −ki instead of ki.
Therefore, phase measurements from instruments that report θ˜ will show decreasing phase with
increasing r.
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The approximation in Equation 2.67 is equivalent to making the approximation D ≈ v/(3µ′s).
Equations 2.59 and 2.60 reveal why frequency domain sources are radio-frequency modu-
lated. If ω ≪ vµa, then ki is very close to zero, resulting in unmeasurable phase changes with
increasing r. As ω increases, the instrument will have an improved sensitivity to phase changes
with increasing r at the cost of higher attenuation in the amplitude. The modulation frequency
should be chosen to balance the trade off between having a high sensitivity to phase with in-
creasing r and having a large range of separations r over which the amplitude signal is above
the noise floor of the detector. Thus, radio frequencies of order ∼ 100 MHz up to 1GHz are
used for modulating light sources in frequency domain measurements of tissue. Note that instru-
ment measurements cannot differentiate between phase shifts of 0, 2π, 4π, etc. Source-detector
separations in multiple distance measurements, then, should be chosen such that the phase does
not change by more than 2π between adjacent separations. In practice this is not an issue for
frequencies less than 1 GHz because the wavelength of the diffuse photon density wave (2π/ki)
is much greater than the attenuation length of the wave (1/kr), as is evident from Figure 2.7.
Therefore, at separations wherein the phase has changed by over a wavelength, the amplitude is
essentially zero.
2.5.1.2 Continuous wave solution
The CW fluence rate is the solution to Equation 2.53 in the homogeneous infinite geometry,
which is the special case of the ac solution (Equation 2.55)at ω = 0:
Φcw(r) =
vS0
4πDr
exp(− [vµa/D]1/2 r). (2.68)
The optical properties µa and µ′s cannot be uniquely determined from measurements of Φcw(r)
alone, regardless of the number of distances r that are measured. In a classic paper, Arridge and
Lionheart theoretically proved that it is impossible to uniquely separate absorption from scatter-
ing with CW light [8]. Consequentially, in order to obtain µa from CW light measurements, D
must be assumed, which is a major drawback. Errors in the assumed tissue scattering coefficient
will result in systematic errors in the measured absorption coefficient.
Some frequency domain instruments, such as the ISS Imagent (ISS Medical, Urbana-Champaign,
IL), measure both the ac and dc fluence rates. In the same manner as described in Figure 2.7,
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µa and D can be determined from measurements of dc amplitude and phase at multiple source-
detector separations. The dc amplitude (Equation 2.68) is less attenuated than the ac amplitude
(Equation 2.62) at a given separation r, which in principle means the signal to noise ratio of the
dc amplitude is higher than the ac amplitude. However, the ac amplitude and phase combination
for determining optical properties is less sensitive to stray ambient light. In typical measure-
ments, the phase is substantially noisier than the ac or dc amplitudes. This suggests that it may
be best to bypass the phase measurements by using the ac and dc amplitudes to obtain the tis-
sue optical properties. However, although the ac and dc signals are less noisy than the phase,
the extracted optical properties from ac and dc amplitude measurements are very susceptible to
instrument noise because of the similarity in changes of the ac and dc amplitudes with increas-
ing r [93, Section 2D]. In practice, Equations 2.68 and 2.62 are not independent, meaning they
cannot be uniquely solved for µa and µ′s.
2.5.1.3 Time domain solution
The time-domain and frequency-domain solutions to Equation 2.46 are Fourier transform pairs
(Section 2.7). Therefore, the inverse Fourier transform of Equation 2.55 gives the homogeneous
infinite medium fluence rate solution to Equation 2.46 in the presence of a pulsed point source of
the form S(r, t) = S0δ(r)δ(t), where S0 [J] is the total energy of the light pulse. The resulting
fluence rate is
Φ(r, t) =
vS0
(4πDt)3/2
exp
[
− r
2
4Dt
− µavt
]
. (2.69)
Here, instead of using fluence rate measurements at multiple distances to derive optical prop-
erties, one measures the fluence rate at multiple times for a single source-detector separation.
Equation 2.69 (convolved with an “instrument response function”) is then fit to this measured
time-domain data to extract D and µa [39, 191]. Alternatively, if it is only necessary to deter-
mine µa, the full nonlinear fit can be avoided by noting that ∂ log Φ(r, t)/∂t→ −µav as t→∞.
Thus, µa is given by the slope of the natural log of the fluence rate at long times (i.e., typically
only a few nanoseconds) [201].
The major advantage of using time-resolved pulsed sources compared to intensity modulated
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sources is that only one source-detector separation is needed to measure absolute optical prop-
erties. Also, by employing time-gating and moments analysis at the detection end, it is possible
to pathlength resolve the detected light in order to reject contributions from superficial tissue
layers [172, 222]. However, time-resolved instrumentation is considerably more complex and
expensive than frequency-domain instrumentation.
2.6 Boundary Conditions
While conceptually useful, the infinite homogeneous medium is not a good appoximation for
practical tissue geometries. Most realistic geometries have interfaces between different media.
For example, in the DOS measurement depicted in Figure 2.2, there is the interface between the
scalp and the probe. A particularly useful geometry is the planar interface wherein a semi-infinite
turbid tissue is bounded in the other half-space by air (Figure 2.8). Another commonly used
geometry is the slab geometry wherein tissue is bounded by two planar interfaces (Figure 2.8).
The diffusion model can still be applied near these interfaces provided appropriate boundary
conditions on the fluence rate are used. In this section, I will derive the partial-flux boundary
condition (also known as the Robin boundary condition) and the extrapolated-zero boundary
condition on the photon fluence rate at the interface between a highly scattering medium (e.g.,
tissue) and a non-scattering medium (e.g., air) [7,123]. These boundary conditions are applicable
at a given point ri on any turbid-nonscattering interface. In this derivation, it is necessary to
consider the light radiance (see Table 2.1) again.
2.6.1 Partial-Flux Boundary Condition
Photons escaping from the tissue into air will almost never re-enter the tissue medium because
non-scattering media do not alter the direction of light travel. Therefore, if all light sources are
inside the tissue, the incoming irradiance (i.e., total light power per area traveling into the diffuse
medium at the boundary) at position ri on the interface, i.e., Jin(r, t), is due to Fresnel reflections
of the radiance in the diffuse medium that travels out toward the interface (see Figure 2.8):
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Figure 2.8: Common geometry used to model tissue with refractive index n that is bounded by
a non-scattering medium with refractive index nout. In the semi-infinite geometry, w, h, and d
all go to infinity, while in the infinite slab geometry, w and h are infinite but d is finite. Both
geometries have azimuthal symmetry about the z-axis, meaning the photon fluence rate only
depends on the radial and axial cylindrical coordinates ρ and z. On the left, a single source-
detector pair (with separation ρ) in the remission geometry is shown. Note that for the slab
geometry, detectors can also be used for transmission measurements by being placed on the
z = d plane. On the right is a cross-section showing that the radiance moving into the turbid
medium at a point ri on the boundary is due to the Fresnel reflection of the radiance incident on
the boundary.
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Jin(ri, t) ≡
∫
Ωˆ·zˆ>0
L(ri, Ωˆ, t)ΩˆdΩ · zˆ (2.70)
=
∫
Ωˆ·zˆ<0
RFresnel(Ωˆ)L(ri, Ωˆ, t)ΩˆdΩ · (−zˆ). (2.71)
RFresnel(Ωˆ) is the familiar Fresnel reflection coefficient for light incident upon the boundary in
a direction Ωˆ from within the tissue [116, Chapter 9], and ri denotes a point on the boundary.
Note that Jin is also called the partial flux because the integration in Equation 2.70 is over 2π
steradians in the z > 0 hemisphere, whereas the integration in the full photon flux, J (Equa-
tion 2.21), is over all 4π steradians of space14. All of the light power crossing the boundary into
the tissue is from Fresnel reflections, and consequentially the partial flux is the total reflected
power into the tissue from light traveling inside the tissue towards the boundary (Equation 2.71).
To convert Equations 2.70 and 2.71 into a boundary condition on the fluence rate, we use
the P1 approximation of the radiance (Equation 2.27), which we also used to derive the photon
diffusion equation. Substituting Equation 2.27 into Equation 2.70 and evaluating the integral in
spherical coordinates results in
Jin(ri, t) =
∫ π/2
0
∫ 2π
0
(
1
4π
Φ+
3
4π
J · [sin θ cosφxˆ+ sin θ sinφyˆ + cos θzˆ]
)
cos θ sin θdφdθ
=
1
2
Φ(ri, t)
∫ π/2
0
cos θ sin θdθ +
3
2
Jz(ri, t)
∫ π/2
0
cos2 θ sin θdθ
=
Φ(ri, t)
4
+
Jz(ri, t)
2
, (2.72)
where Jz(ri, t) is the z−component of the photon flux.
14
J(ri, t) · zˆ is the net light power per area crossing the boundary. The Fresnel reflections in Equation 2.71
determine the total light power per area crossing the boundary into the tissue, which is the partial flux.
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Similarly, substituting Equation 2.27 into Equation 2.71 results in
Jin(ri, t) =
∫ π/2
0
∫ 2π
0
RFresnel(θ)L(ri, π − θ, φ, t)[− cos(π − θ)] sin(π − θ)dφdθ
=
∫ π/2
0
∫ 2π
0
RFresnel(θ)
(
1
4π
Φ+
3
4π
J · [sin(π − θ) cosφxˆ+
sin(π − θ) sinφyˆ + cos(π − θ)zˆ]) cos θ sin θdφdθ
=
∫ π/2
0
∫ 2π
0
RFresnel(θ)
(
1
4π
Φ− 3
4π
Jz cos θ
)
cos θ sin θdφdθ
= RΦ
Φ(ri, t)
4
−RJ Jz(ri, t)
2
(2.73)
where
RΦ ≡
∫ π/2
0
2 sin θ cos θRFresnel(θ)dθ (2.74)
RJ ≡
∫ π/2
0
3 sin θ cos2 θRFresnel(θ)dθ. (2.75)
In arriving at Equation 2.73, we used the fact that RFresnel(Ωˆ) depends on the polar angle θ
(Figure 2.8) but not the azimuthal angle φ. For the case of unpolarized light with n > nout, the
reflection coefficient for light incident on the boundary from the tissue is [116, 123]
RFresnel(θ) =


1
2
(
n cos θ′−nout cos θ
n cos θ′+nout cos θ
)2
+ 12
(
n cos θ−nout cos θ′
n cos θ+nout cos θ′
)2
if 0 ≤ θ ≤ θc,
1 if θc ≤ θ ≤ π/2,
(2.76)
where the angle of incidence θ and the refracted angle θ′ satisfy Snell’s law, i.e., n sin θ =
nout sin θ
′
, and the critical angle θc for total internal reflection is given by n sin θc = nout.
Combining Equations 2.72 and 2.73, we obtain
Φ(ri, t) =
1 +RJ
1−RΦ (−2Jz(ri, t)). (2.77)
Equation 2.77 is commonly rearranged in terms of an effective reflection coefficient, Reff , to
account for the refractive index mismatch between tissue and the non-scattering medium:
Φ(ri, t) =
1 +Reff
1−Reff (−2Jz(ri, t)) (2.78)
with
Reff ≡ RΦ +RJ
2−RΦ +RJ . (2.79)
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n nout RΦ RJ Reff |Φ/Jz|
1.40 1.40 0 0 0 2.0
1.33 1.00 0.472 0.328 0.431 5.1
1.40 1.00 0.529 0.389 0.493 6.0
Table 2.4: Ratios of the fluence rate to the flux at the surface boundary, as given by Equation 2.77,
for some typical index refraction
Given refractive indices n and nout, Reff ≈ −1.440 (n/nout)−2+0.701 (n/nout)−1+0.668+
0.0636 (n/nout) [88, 118]. However, it is best to solve the integrals for RΦ (Equation 2.74)
and RJ (Equation 2.75) numerically using Equation 2.76 for the Fresnel reflection coefficient.
Table 2.4 lists the exact Reff and ratio |Φ/Jz | for some typical index of refraction mismatches.
The partial flux boundary condition is obtained from substituting Fick’s law of diffusion
(Equation 2.43) in for Jz in Equation 2.78:
Φ(ri, t) = zb
∂Φ(ri, t)
∂z
, (2.80)
where
zb ≡ 2
3
ℓtr
1 +Reff
1−Reff . (2.81)
2.6.2 Extrapolated-Zero Boundary Condition
The partial-flux boundary condition is exact, but it is difficult to use in practice, especially if
analytical solutions to the diffusion equation with interfaces are desired. The extrapolated-zero
boundary condition is an approximation of the partial-flux boundary condition that makes solv-
ing the diffusion equation more tractable. It is derived by Taylor expanding the fluence rate to
first order around the boundary (at z = 0, with the first derivative term taken from the partial-flux
boundary condition (Equation 2.80), i.e.,
Φ(z) = Φ(0) +
∂Φ
∂z
z = Φ(0) +
Φ(0)
zb
z. (2.82)
As shown in Figure 2.9, if we use this line to approximate the fluence rate outside of the turbid
medium (z < 0), then
Φ(z = −zb) = 0, (2.83)
which is the extrapolated-zero boundary condition.
40
Figure 2.9: The fluence rate curve is approximated by its tangent line at z = 0, where the Φ = 0
intercept of this curve is z = −zb. This figure is adapted from Li [170, Fig. 1.6].
2.7 Green’s function solutions
An age old strategy [6, 15] employed to solve the time-domain and frequency-domain diffusion
equations (Equation 2.46 and Equation 2.52) is to first find their respective Green’s functions,
and then to use these Green’s functions to construct more general solutions. We will first focus on
the special case of homogeneous media. In the time-domain, the homogeneous photon diffusion
equation is (
∇2 − vµa
D
− 1
D
∂
∂t
)
Φ(r, t) = − v
D
S(r, t). (2.84)
The homogeneous time-domain Green’s function (g(r, rs, t, ts) [cm−2s−1]) is defined as the
solution of Equation 2.84 for a normalized infinitesimally narrow light pulse emitted at position
rs and time ts, i.e.,
(
∇2 − vµa
D
− 1
D
∂
∂t
)
g(r, rs, t, ts) = − v
D
δ(r − rs)δ(t − ts), (2.85)
that satisfies the boundary condition (e.g., Equation 2.83) for the geometry of interest. For an
arbitrary source distribution, S(r, t), the photon fluence rate solution to Equation 2.84 is the
convolution of the Green’s function with S(r+ rs, t+ ts), i.e.,
Φ(r, t) =
∫
g(r′, rs, t′, ts)S(r+ rs − r′, t+ ts − t′)d3r′dt′, (2.86)
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where the spatial integration is done over the entire volume of tissue, and the temporal integration
is from −∞ to ∞. Notice that the photon fluence rate from a point source, i.e., S(r, t) =
S0δ(r− rs, t− ts), is Φ(r, t) = S0g(r, rs, t, ts).
Similarly, the frequency-domain homogeneous Green’s function (G(r, rs) [cm−2]) is the
solution of Equation 2.54 for a normalized oscillating point source at position rs, i.e.,
(∇2 − k2)G(r, rs) = − v
D
δ(r − rs), (2.87)
that satisfies the boundary condition for the geometry of interest. The solution to the homoge-
neous frequency-domain photon diffusion equation (Equation 2.54) for an arbitrary distribution
of oscillating point sources (i.e., Sac(r, t) = S(r)eiωt) is
U(r) =
∫
G(r′, rs)S(r+ rs − r′)d3r′, (2.88)
where the spatial integration again is over the entire volume of tissue. As with the time-domain,
the frequency-domain fluence rate for a point source, S(r) = S0δ(r−rs), is U(r) = S0G(r, rs).
Notice that Equation 2.86 can also be used to find the photon fluence rate, Φac(r, t) (Equa-
tion 2.50), for the same arbitrary distribution of oscillating sources. Substituting Sac into Equa-
tion 2.86, we obtain
Φac(r, t) = e
iωt
∫ (∫ ∞
−∞
g(r′, rs, t′, ts)e−iω(t
′−ts)dt′
)
S(r+ rs − r′)d3r′. (2.89)
Recalling that Φac(r, t) = U(r)eiωt (Equation 2.50), Equation 2.89 is equivalent to
U(r) =
∫ (∫ ∞
−∞
g(r′, rs, t′, ts)e−iω(t
′−ts)dt′
)
S(r+ rs − r′)d3r′. (2.90)
Comparing Equation 2.90 with Equation 2.88, it is evident that the frequency-domain Green’s
function, G(r, rs), is the Fourier transform of the time-domain Green’s function, i.e.,
G(r, rs) =
∫ ∞
−∞
g(r, rs, t, ts)e
−iω(t−ts)dt. (2.91)
Correspondingly, the time-domain Green’s function is the inverse Fourier transform of G(r, rs):
g(r, rs, t, ts) =
1
2π
∫ ∞
−∞
G(r, rs)e
iω(t−ts)dω. (2.92)
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Importantly, Equations 2.91 and 2.92 can be utilized to convert a time-domain Green’s function
to its corresponding frequency-domain Green’s function, and vice versa. The time-domain and
frequency-domain fluence rates are then given by Equations 2.86 and 2.88, respectively.
Finally, the Green’s function for a continuous-wave light source (i.e., Gcw(r, rs)) is the
special case of the frequency-domain Green’s function for ω = 0. The CW analogue of Equa-
tion 2.88 for the CW fluence rate is
Φcw(r) =
∫
Gcw(r
′, rs)S(r+ rs − r′)d3r′. (2.93)
Exactly the same approach can be used for heterogeneous geometries as well. The key
difference is that the definition of time-domain and frequency-domain Green’s functions are the
heterogeneous analogues of Equation 2.85 and Equation 2.87.
2.8 Semi-infinite Frequency-Domain Green’s Function for Partial-
Flux Boundary Condition
I will now utilize the method of images [35] to derive the frequency-domain Green’s function
of the photon diffusion equation for the semi-infinite geometry (Figure 2.8) and the partial-flux
boundary condition (Equation 2.80). The method of images consists of adding infinite medium
Green’s functions (e.g., arising from a light source and “image sources”) together in a way that
satisfies the appropriate boundary condition.
First, recall from Section 2.4 that light from the incident beam in Figure 2.8 is well approx-
imated as an isotropic point source at position (in cylindrical coordinates) rs = (ρs = 0, zs =
ℓtr). The frequency-domain Green’s function for this point source in the infinite geometry is
(see Equation 2.55)
GI([ρ, z], [ρs = 0, zs = ℓtr]) =
v
4πDr1
exp(−kr1), (2.94)
where r1 ≡
√
(z − ℓtr)2 + ρ2. The partial-flux Green’s function for the semi-infinite geometry
(i.e., GpfS ) is the sum of the infinite geometry Green’s function and a correction term Gc that
arises from the presence of the boundary:
GpfS = GI([ρ, z], [ρs = 0, zs = ℓtr]) +Gc([ρ, z], [ρs = 0, zs = ℓtr]). (2.95)
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The partial-flux boundary condition (Equation 2.80) for Equation 2.95 is
(GI +Gc)z=0 = zb
[
∂GI
∂z
+
∂Gc
∂z
]
z=0
. (2.96)
Substituting Equation 2.94 into Equation 2.96, we obtain
(
∂Gc
∂z
− 1
zb
Gc
)
z=0
= −
(
∂GI
∂z
− 1
zb
GI
)
z=0
=
(
v
4πDr21
e−kr1
[
k(z − ℓtr) + z − ℓtr
r1
]
+
v
4πDzbr1
e−kr1
)
z=0
=
v exp
[
−k
√
ℓ2tr + ρ
2
]
4πD(ℓ2tr + ρ
2)
(
−kℓtr − ℓtr√
ℓ2tr + ρ
2
+
1
zb
)
, (2.97)
where zb is given by Equation 2.81.
The next step is to consider the infinite Green’s function for an image point source (Fig-
ure 2.10) at (ρs = 0, zs = −ℓtr), i.e.,
G
image
I =
v
4πDr2
exp[−kr2], (2.98)
where r2 ≡
√
(z + ℓtr)2 + ρ2.
Notice at the interface, z = 0, that
[(
∂
∂z
+
1
zb
)
G
image
I
]
z=0
=
(
− v
4πDr22
e−kr2
[
k(z + ℓtr) +
z + ℓtr
r2
]
+
v
4πDzbr2
e−kr2
)
z=0
=
v exp
[
−k
√
ℓ2tr + ρ
2
]
4πD(ℓ2tr + ρ
2)
(
−kℓtr − ℓtr√
ℓ2tr + ρ
2
+
1
zb
)
. (2.99)
The right hand sides of Equations 2.97 and 2.99 are identical, which means that a solution for
Gc that satisfies
∂Gc
∂z
− 1
zb
Gc =
(
∂
∂z
+
1
zb
)
GimageI (2.100)
will also satisfy the partial-flux boundary condition.
To solve Equation 2.100, multiply both sides by exp[−z/zb] and then integrate the resulting
44
equation, i.e.,
∫ ∞
z
∂
∂z′
(
e−z
′/LsGc
)
dz′ =
∫ ∞
z
∂
∂z′
(
v
4πDr2
e−(kr2+z
′/zb)
)
dz′+
2
zb
∫ ∞
z
v
4πDr2
e−(kr2+z
′/zb)dz′,
⇒ −Gc = − v
4πDr2
e−kr2 − 2
zb
∫ ∞
z
v
4πDr2
e−(k0r2+[z
′−z]/Ls)dz′,
⇒ Gc = v
4πDr2
− 2
zb
∫ ∞
0
v
4πDr2(u)
e−(k0r2(u)+u/zb)du, (2.101)
where a change of variables u = z′ − z was made between lines 2 and 3.
Substituting Equation 2.101 into Equation 2.95 results in the Green’s function that satis-
fies the diffusion equation inside the semi-infinite medium (z > 0) as well as the partial-flux
boundary condition:
GpfS =
v
4πD
[
e−kr1
r1
+
e−kr2
r2
−
2
zb
∫ ∞
0
e−u/zb
exp
[
−k
√
(z + ℓtr + u)2 + ρ2
]
√
(z + ℓtr + u)2 + ρ2
du

 . (2.102)
We know that Equation 2.102 satisfies the photon diffusion equation (Equation 2.54) in ad-
dition to the partial-flux boundary condition because it is a linear sum of infinite media Green’s
functions (Equation 2.94). Each infinite Green’s function satisfies the photon diffusion equation,
and therefore their sum will also satisfy the photon diffusion equation.
As illustrated in the left panel of Figure 2.10, the first two terms in Equation 2.102 are the
infinite medium Green’s functions from a point source at (ρs = 0, zs = ℓtr) and an image source
at (ρs = 0, zs = −ℓtr). The integral in Equation 2.102 represents a continuous line of infinite
Green’s functions from image sinks (i.e., image sinks contribute negatively to GS) that starts
at (ρs = 0, z = −ℓtr) and extends to (ρs = 0,z = −∞). The magnitudes of the sinks are
exponentially damped as z → −∞ with a characteristic decay length of zb (Figure 2.10).
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Figure 2.10: Analytical Green’s functions in homogeneous semi-infinite media for both the
partial-flux (Equation 2.80) and extrapolated-zero (Equation 2.83) boundary conditions can be
derived using the method of images. The method of images finds the superposition of infinite
media Green’s functions (Equation 2.94) that satisfies the appropriate boundary condition. One
term in the superposition is the infinite Green’s function from the “real light source”. The other
terms arise from image sources (e.g., positive terms) and image sinks (e.g., negative terms). The
image source and sink distributions for the partial-flux (left panel) and extrapolated-zero (right
panel) boundary conditions are shown. For the partial-flux case, the infinite line of sinks is ex-
ponentially damped as z → −∞ with a characteristic decay length of zb. This figure is adapted
from Haskell [123, Fig. 4].
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2.9 Semi-infinite Frequency-Domain Green’s Function for Extrapolated-
Zero Boundary Condition
In the semi-infinite geometry, the extrapolated-zero boundary condition (Equation 2.83) is satis-
fied by a superposition of only two infinite medium Green’s functions (Equation 2.94), i.e.,
GS([ρ, z], [ρs = 0, zs = ℓtr]) =
v
4πD
[
exp(−kr1)
r1
− exp(−krb)
rb
]
, (2.103)
where
r1 =
√
(z − ℓtr)2 + ρ2 (2.104)
rb =
√
(z + 2zb + ℓtr)2 + ρ2.. (2.105)
The first term is from the source at (ρs = 0, zs = ℓtr) and the second term is from an image
sink at (ρs = 0, zs = −(ℓtr + 2zb)) (Figure 2.10). Obviously, the extrapolated-zero solution
(Equation 2.103) is more tractable than the partial-flux solution (Equation 2.102) because there
is no integral to evaluate.
2.9.1 Extrapolated-zero and partial-flux multipole expansion
The extrapolated-zero image configuration (Figure 2.10) is the best single-point image repre-
sentation of the partial-flux configuration, differing only in octupole and higher multipole mo-
ments [123]. Thus, far away from the image configurations, the partial-flux and extrapolated-
zero solutions are virtually the same. The semi-infinite Green’s functions Equation 2.102 and
Equation 2.103 have the same 1/|r−rs| dependence as the electrostatics Coulomb potential [116,
Section 3.4].
Therefore, a multipole expansion on the semi-infinite photon fluence rate solutions can be
done, and it’s useful to compare the “image configuration dipole moments” for the partial-flux
and extrapolated-zero fluence rates. Recall from electrostatics that two charge distributions with
the same dipole moment have virtually the same electrostatic potential at distances far from the
the distribution [116]. Similarly, two image configurations with the same dipole moment have
virtually the same fluence rate at distances far from the image distribution.
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Figure 2.11: Simulated amplitude and phase data as a function of source-detector separation, ρ,
was generated using the exact semi-infinite Green’s function (Equation 2.103) with µa = 0.1
cm−1, µ′s = 10 cm−1, n = 1.4, nout = 1, and f = ω/2π = 70 MHz. Equations 2.110 and
2.111 were employed to calculate µa (left) and µ′s (right) from linear fits to five equally spaced
source-detector separations spaced over the ranges specified on the horizontal axis, i.e., [1, 1.5,
2, 2.5, 3] cm, [1.5, 2, 2.5, 3, 3.5] cm, . . ., [6, 6.5, 7, 7.5, 8] cm.
I will first compute the dipole moment of the partial-flux image configuration in Figure 2.10:
p ≈
(
2ℓtr +
2
zb
∫ ∞
0
ze−z/zb
)
e−kρzˆ = 2(zb + ℓtr)e−kρzˆ. (2.106)
Here, I made the approximation that exp[−k|r − rs|] ≈ exp[−kρ], which is the case on the
planar interface for large ρ. Also, I used the image source position as the origin for the dipole
calculation.
The dipole moment of the extrapolated-zero image configuration in Figure 2.10 is
p ≈ 2(ℓtr + zb)e−kρzˆ, (2.107)
which is the same as Equation 2.106. It also turns out that the two image configurations have the
same quadrupole moments for the origin on the planar interface [123].
The main point to remember is that for measurements with long source-detector separations
compared to ℓtr , the extrapolated-zero fluence rate is an excellent approximation of the partial-
flux fluence rate [123].
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2.9.2 Extrapolated-zero Green’s function at the boundary (large ρ limit)
In diffuse optical measurements, the fluence rate is typically detected at the tissue-air interface,
i.e., z = 0. Equation 2.83 can be fit exactly, but in the limit ρ≫ (ℓtr+2zb), the extrapolated-zero
Green’s function simplifies considerably. Following Li’s discussion [170, Sec. 1.6], at z = 0
and ρ≫ (ℓtr + 2zb) (see Equations 2.104 and 2.105),
r1 ≈ ρ
[
1 +
1
2
(
ℓtr
ρ
)2]
,
rb ≈ ρ
[
1 +
1
2
(
ℓtr + 2zb
ρ
)2]
,
1
r1
≈ 1
ρ
[
1− 1
2
(
ℓtr
ρ
)2]
,
1
rb
≈ 1
ρ
[
1− 1
2
(
ℓtr + 2zb
ρ
)2]
.
Applying these approximations to Equation 2.83 and dropping all terms of order higher than
1/ρ2, we obtain
G([ρ, z = 0], [ρs = 0, zs = ℓtr]) ≈ v
4πD
e−kρ
ρ
[
exp
(
−kℓ
2
tr
2ρ
)(
1− 1
2
[
ℓtr
ρ
]2)
−
exp
(
−k (ℓtr + 2zb)
2
2ρ
)(
1− 1
2
[
ℓtr + 2zb
ρ
]2)]
,
≈ v
4πD
e−kρ
ρ
[(
1− kℓ
2
tr
2ρ
)(
1− 1
2
[
ℓtr
ρ
]2)
−
(
1− k0(ℓtr + 2zb)
2
2ρ
)(
1− 1
2
[
ℓtr + 2zb
ρ
]2)]
,
≈ v
4πD
e−kρ
ρ
[
1− kℓ
2
tr
2ρ
− 1 + k(ℓtr + 2zb)
2
2ρ
]
,
=
v
4πD
e−kρ
ρ2
[2k(zbℓtr + z
2
b )]. (2.108)
For an oscillating point source S(r) = MS0eiωtδ(z−ℓtr)δ(ρ), the frequency-domain photon
fluence rate is obtained from substituting Equation 2.108 into 2.88, i.e.,
U(ρ, z = 0) ≈ MS0v
4πD
e−kρ
ρ2
[
2k(zbℓtr + z
2
b
]
. (2.109)
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Figure 2.12: Two orthogonal cross-sections of the cylindrical geometry (A, B) and one cross
section of the spherical geometry (C). For the infinite cylindrical geometry, h→∞.
The amplitude and phase of this diffuse photon density wave (i.e., U(ρ, z = 0) = A(ρ)e−iθ(ρ);
see Equation 2.61) satisfy
log(ρ2A(ρ)) = −krρ+ log(A0), (2.110)
θ = θ0 − kiρ, (2.111)
where kr and ki are given by Equations 2.59 and 2.60, respectively. Therefore, in the large ρ
limit of the semi-infinite geometry, kr and ki are determined from linear fits to measurements of
log(ρ2A(ρ) and θ(ρ) at multiple source-detector separations. Then, µa and µ′s are determined
from kr and ki via Equations 2.66 and 2.67.
Equations 2.110 and 2.111 are an approximation of the semi-infinite fluence rate, which can
lead to a systematic error of up to 10% in the calculated absorption coefficient (Figure 2.11). This
systematic effect approximately divides out when computing fractional changes in hemoglobin
concentration or the tissue oxygen saturation with multispectral measurements.
2.10 Extrapolated-zero Green’s Functions in Spherical, Cylindri-
cal, Slab, and Two-layer Geometries
Tables 2.5 and 2.6 show the frequency-domain and time-domain Green’s functions subject to the
extrapolated-zero boundary condition for cylindrical (Figure 2.12), spherical (Figure 2.12), and
slab (Figure 2.8 homogeneous geometries [10]. Again, the photon fluence rates are calculated
from the Green’s functions using Equations 2.88 and 2.86.
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Case Green’s function (frequency-domain)
Infinite G(r, rs) = v4πD|r−rs| exp(−k|r− rs|)
Semi-infinite G([ρ, z], [ρs = 0, zs = ℓtr]) = v4πD
[
exp(−kr1)
r1
− exp(−krb)rb
]
Infinite Slab G([ρ, z], [ρs = 0, zs = ℓtr]) = v4πD
∞∑
m=−∞
(
exp[−kr+,m]
r+.m
− exp[−kr−.m]r−,m
)
Infinite Cylindrical G([ρ, φ, z], [ρs, zs]) = v2πDa2b
∞∑
m=−∞
cosmφ
∑
βm
e−|z−zs|/
√
k2+β2m√
k2+β2m
Jm(βmρ)Jm(βmρs)
[J ′m(βmab)]
2
Finite Cylindrical G([ρ, φ, z], [ρs, zs]) = vπD(h+2zb)
∞∑
m=1
sin mπzh+2zb sin
mπzs
h+2zb
×∑∞
n=−∞
In(ρkm)[In(abkm)Kn(ρskm)−In(ρskm)Kn(abkm)]
In(abkm)
cosnφ
Spherical (rs < r < a) G([r, φ], rs) = v4πD√rrs
∞∑
n=0
Kn+1/2(kr)In+1/2(kab)−In+1/2(kr)Kn+1/2(kab)
In+1/2(kab)
×
(2n + 1)In+1/2(krs)Pn(cos φ)
k ≡
√
(µav + iω)/D Jm(z)m
th order Bessel function, 1st kind
r1 ≡
√
(z − ℓtr)2 + ρ2 Im(z)mth order modified Bessel function, 1st kind
rb ≡
√
(z + 2zb + ℓtr)2 + ρ2 Km(z)m
th order modified Bessel function, 2nd kind
zb = 2ℓtr
1+Reff
3(1−Reff ) Reff ≈ −1.440
(
n
nout
)−2
+ 0.701
(
n
nout
)−1
+ 0.668 + 0.0636
(
n
nout
)
m, an integer Pm(z)mth order Legendre polynomial
r±,m ≡
√
ρ2 + (z − z±,m)2 a, cylinder/sphere radius (Fig. 2.12)
z+,m ≡ 2m(d+ 2zb) + ℓtr ab = a+ zb, i.e., extrapolated-zero boundary (cylinder/sphere)
z−,m ≡ 2m(d+ 2zb)− 2zb − ℓtr βm, a positive root of Jm(βmab) = 0
d, slab thickness (Fig. 2.8) φ, angle between input/output light beams (cylinder/sphere, Fig. 2.12)
km ≡
√
k2 +m2π2/(h+ 2zb)2 ρ, radial cylindrical coordinate
r, radial spherical coordinate h, finite cylinder axial length (Fig. 2.12)
Table 2.5: Frequency-domain Green’s functions (Equation 2.87) in several homogeneous geome-
tries subject to the extrapolated-zero boundary condition (Equation 2.83). Notation is defined in
the lower part of the Table, and for more details about the geometries, refer to Figures 2.8 and
2.12. The sum over βm for the infinite cylindrical Green’s function explicitly means to sum
over all positive roots of the mth order Bessel function, Jm(z), and J ′m(z) is the derivative of
Jm(z). In practice, the infinite sums are truncated after a desired accuracy has been reached.
Further, note that the special case ω = 0 corresponds to the continuous-wave Green’s functions
(Equation 2.93).
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Case Green’s function (time-domain)
Infinite g(r, rs, t, ts) = v(4πD(t−ts))3/2 exp
[
− |r−rs|24D(t−ts) − µav(t− ts)
]
Semi-infinite g([ρ, z], [ρs = 0, zs = ℓtr], t, ts) = v exp[−µav(t−ts)](4πD(t−ts))3/2
(
exp
[
− r214D(t−ts)
]
− exp
[
− r2b4D(t−ts)
])
Infinite Slab g([ρ, z], [ρs = 0, zs = ℓtr], t, ts) = v exp[−µav(t−ts)](4πD(t−ts))3/2
∞∑
m=−∞
(
exp
[
− r
2
+,m
4D(t−ts)
]
− exp
[
− r
2
−,m
4D(t−ts)
])
Infinite Cylindrical g([ρ, φ, z], [ρs, zs], t, ts) =
v exp
[
−
(
µav(t−ts)+ (z−zs)
2
4D(t−ts)
)]
2πa2b
√
πD(t−ts)
×
∞∑
m=−∞
cosmφ
∑
βm
exp[−Dβ2m(t− ts)]Jm(βmρ)Jm(βmρs)[J ′m(βmab)]2
Finite Cylindrical g([ρ, φ, z], [ρs, zs], t, ts) = 2ve
−µav(t−ts)
πa2b(h+2zb)
∞∑
m=1
exp
[−Dm2π2(t−ts)
(h+2zb)2
]
sin mπzh+2zb sin
mπzs
h+2zb
×
∞∑
n=−∞
cosnφ×∑
βn
e−Dβ2n(t−ts) Jn(βnρ)Jn(βnρs)
[J ′n(βnab)]
2
Spherical (rs < r < a) g([r, φ], rs, t, ts) = −v exp[−µav(t−ts)]2πa2b√rrs
∞∑
m=0
∑
βm+1/2
Jm+1/2(βm+1/2r)Jm+1/2(βm+1/2rs)
[Jm+3/2(βm+1/2ab)]
2 ×
(2m+ 1)Pm(cosφ)e
−Dβm+1/22(t−ts)
Table 2.6: Time-domain Green’s functions (Equation 2.85) in several homogeneous geometries
subject to the extrapolated-zero boundary condition (Equation 2.83). Notation is defined in
Table 2.5. As with the frequency-domain Green’s functions, in practice, the infinite sums are
truncated after a desired accuracy has been reached.
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Analytical Green’s functions also exist for heterogeneities such as spherical [22] and cylin-
drical inclusions [252] in homogeneous media as well as for multi-layer media [129, 157, 212].
I have used the Green’s function for the two-layer geometry extensively to distinguish be-
tween cerebral and superficial tissue layers (Figure 2.13). The two-layer geometry is comprised
of a semi-infinite bottom layer (e.g., corresponding to the cortical regions of the brain) with a
distinct absorption coefficient and scattering coefficient of µa,c and µ′s,c, respectively, and a su-
perficial top layer (e.g., corresponding to extra-cerebral scalp and skull tissue) with thickness
ℓ, and distinct tissue properties denoted by µa,ec, and µ′s,ec. The frequency-domain Green’s
function for this geometry at the z = 0 plane is [157]
G([ρ, z = 0], [ρs = 0, zs = z0]) =
1
2π
∫ ∞
0
G˜(s)sJ0(sρ)ds, (2.112)
G˜(s) =
v sinh[kec(zb + z0)]
Deckec
Deckec cosh[kecℓ] +Dckc sinh[kecℓ]
Deckec cosh[kec(ℓ+ zb)] +Dckc sinh[kec(ℓ+ zb)]
−
v sinh[kecz0]
Deckec
,
where Dj = v/[3(µ′s,j + µa,j)], k2j = (Djs2 + vµa,j + iω)/Dj (with subscript j denoting c
(cerebral) or ec (extra-cerebral)), zb = 2(Dec/v)(1 + Reff )/(1 − Reff ), z0 = 3Dec/v, and
Reff is defined by Equation 2.79 (this solution assumes the top and bottom layers have the same
optical index of refraction).
Although an analytical solution for the time-domain two-layer Green’s function does not
exist, it can be determined numerically from substituting Equation 2.112 into Equation 2.91 and
evaluating the resulting expression with a fast Fourier transform technique [108, 157].
2.11 Relationship Between the Fluence Rate and the Detected Sig-
nal
From the previous sections, I presented the photon diffusion model and its solutions in several
geometries for the photon fluence rate. I will now discuss the relationship between the photon
fluence rate and the detected light intensity [52, 123]. Two common methods for light detection
are depicted in 2.14.
Let’s first consider the case of optical fiber based detection at position r on the boundary. The
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Figure 2.13: (A) Two-layer tissue model of the head and (B) parallel plane two-layer tissue
geometry.
Figure 2.14: Diffusing light can be detected with both contact and non-contact probes. Contact
probes typically use an optical fiber (with numerical aperture NAF ) to transport light emerging
from a point r to a light detector (e.g., photomultiplier tube). Non-contact probes typically
utilize a lens (with numerical aperture NAL) to image the light emerging from a point rd onto
its corresponding point on the detector plane, i.e., rd,CCD. As in Figure 2.8, n is the tissue index
of refraction and nout is the refractive index of the non-scattering medium bounding the tissue.
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detected light intensity, I(r, t), is the light radiance integrated over the collection solid angle and
detection area (σfiber) of the fiber, i.e.,
I(r, t) =
∫
σfiber
d2r
∫
NAF
dΩT (r, Ωˆ, t)L(r, Ωˆ, t). (2.113)
Here, T (r, Ωˆ, t)dΩ is the probability that a photon at position r and time t traveling in the Ωˆ
direction is detected. To relate the detected signal to the fluence rate, the P1 approximation of
the light radiance (Equation 2.27) is employed in Equation 2.113, i.e.,
I(r, t) =
∫
σfiber
d2r
∫ ϑc
0
dϑ sinϑ
∫ 2π
0
dφT (r, Ωˆ, t)
1
4π
[
Φ(r, t) + 3J(r) · Ωˆ
]
, (2.114)
where the half-angle of the maximum cone of light that can propagate through the fiber, ϑc, is
determined from the fiber’s numerical aperture via ϑc = arcsin(NAF /n). With the additional
assumptions that T is spatially homogeneous across the fiber detection area and is symmetric
about the central optical axis of the fiber, i.e., T = T (ϑ, t) (see Figure 2.14), Equation 2.114
simplifies to
I(r, t) =
∫
σfiber
d2r
∫ ϑc
0
dϑ sinϑT (ϑ, t)
∫ 2π
0
dφ
1
4π
[Φ(r, t)+
3J(r, t) · (sin(ϑ) cos(φ)xˆ + sin(ϑ) sin(φ)yˆ − cos(ϑ)zˆ]]
=
∫
σfiber
d2r
∫ ϑc
0
dϑT (ϑ, t)
1
2
[Φ(r, t)− 3Jz(r, t) cos(ϑ)] sin(ϑ). (2.115)
Since the fluence rate is proportional to the flux at the boundary, i.e., the partial-flux boundary
condition (Equation 2.78), Equation 2.115 is equivalent to
I(r, t) =
[∫ ϑc
0
T (ϑ, t)
1
2
(
1 +
3
2
1−Reff
1 +Reff
)
dϑ
] ∫
σfiber
Φ(r, t)d2r. (2.116)
If the fluence rate is approximately constant over the area σfiber, then the detected signal is di-
rectly proportional to Φ(r, t), i.e.,
I(r, t) =
[
σfiber
∫ ϑc
0
T (ϑ, t)
1
2
(
1 +
3
2
1−Reff
1 +Reff
]
dϑ
]
Φ(r, t) = C(t)Φ(r, t). (2.117)
Here, the multiplicative factor in brackets is the so-called light coupling coefficient, C , which
is the proportionality constant between the detected signal intensity and the photon fluence rate.
55
It depends on many factors, such as the Fresnel transmission coefficient from the tissue to the
fiber, the light sensitivity of the detector, “fiber-detector coupling”, and physical properties of
the tissue surface (e.g., hair follicles, melanin content in the skin, thin layers of dust and/or water
droplets, etc.). If any of these aspects of the measurement changes with time, then C will also
change with time. It is very difficult to predict C theoretically, so in practical measurements, C
is regarded as an unknown.
Equation 2.117 applies to the non-contact detection arrangement in Figure 2.14 as well, i.e.,
I(rd,CCD, t) = CLΦ(rd, t). Non-contact detection has a different light coupling coefficient
wherein the critical angle ϑc in Equation 2.117 is given by the numerical aperture of the lens,
i.e., ϑc = arcsin(NAL/nout), and the fiber detection area σfiber is replaced by σL, which is
the area of the “resolution cell” just resolved by the lens imaging the surface. Further, the
probability density function for light detection, i.e., T (ϑ), for the lens/CCD scheme is different
from the fiber/PMT scheme. Note that the lens detection scheme works best if the detection
point of interest, rd, is not too far from the central optical axis of the lens. At points far from the
axis, larger aberrations could induce significant contamination at rd,CCD from light emerging at
neighboring positions to rd on the tissue surface. Effectively, aberrations increase the resolution
cell area and affect ϑc, thus altering the light coupling coefficient CL. Finally, beam vignetting
decreases the light coupling coefficient, CL, at detection points on the tissue surface far from the
lens axis [52].
2.11.1 Strategies for Estimating Light Coupling Coefficients
For a frequency-domain measurement with a single source-detector optical fiber pair (e.g., Fig-
ure 2.8), there are two equations, i.e., one for the measured amplitude (Equation 2.110) and one
for the measured phase (Equation 2.111), but four unknowns. In addition to tissue absorption
and scattering, there are also two light coupling coefficient unknowns for amplitude and phase,
i.e., Ca and Cp, where C = Ca exp(−iCp) (see Equation 2.117). Thus, for accurate estimates of
µa and µ′s, frequency-domain measurements at multiple source-detector separations is preferred.
If the source fiber is physically translated across the medium using a translation stage [121], then
to a decent approximation, Ca and Cp will be the same at every separation. In this case, Equa-
tions 2.110 and 2.111 can be directly applied to linearly fit the measured amplitude and phase
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Figure 2.15: (A) Multiple source-detector separations are highly preferred for accurate measure-
ments of tissue absorption and scattering with intensity modulated light sources. (B) Top view of
an exemplar self-calibrating probe. Both the self-calibrating probe and the linear probe in panel
(A) have four source-detector separations. A self-calibrating probe requires at least two sources
and two detectors (see text).
data for −kr and ki, which are then used to calculate µa and µ′s via Equations 2.66 and 2.67.
However, physically translating a single fiber places a severe limit on time resolution, and
the measurement is also prone to motion artifacts and light leakage since the moving fiber is not
fixed to the tissue. Another, more practical approach utilizes multiple fibers secured to the tissue
of interest (Figure 2.15A). The drawback here, though, is that since each fiber has its own light
coupling coefficient, there will be two additional unknowns for each additional fiber used. Two
methods are commonly employed to address this problem. One approach uses calibration phan-
toms with known optical properties to determine the coupling coefficients before and after each
experiment [36, 133, 253]. A second approach employs self-calibrating probes [268]. The first
method assumes the coupling coefficients will be the same for tissue and phantom; the second
method assumes axially symmetric tissue. The subsequent discussions of these approaches are
for optical fibers, but the results are also applicable for non-contact detection.
2.11.1.1 Phantom Calibration
The phantom calibration technique estimates the fiber light coupling coefficients from measure-
ments on a homogeneous semi-infinite phantom with known optical properties (µPa , µ′Ps ). For
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an arbitrary source-detector pair (i.e., source fiber i, coupling coefficient Cs,i; detector fiber j,
coupling coefficient Cd,j) with source-detector separation ρij , the measured signal intensity is
given by (Equation 2.117)
IPij = |IPij | exp[−ipPij] = Cs,aiCd,aj exp [−i(Cs,pi + Cd,pj)]AP (ρij) exp[−iθP (ρij ]. (2.118)
Here, AP (ρij) and the θP (ρij are the calculated amplitude and phase obtained from substituting
the known phantom optical properties into the frequency-domain semi-infinite diffusion Green’s
function (e.g., Equation 2.103); pPij is the measured phase difference between the intensities
detected by fiber j and delivered by fiber i on the phantom, and the measured amplitude is
|IPij | ≡
√
IP∗ij I
P
ij . Equation 2.118 is a system of two equations, i.e.,
Cs,aiCd,aj = |IPij |/AP (ρij), (2.119)
Cs,pi + Cd,pj = p
P
ij − θP (ρij). (2.120)
After the phantom calibration, the probe is attached to the tissue of interest, and the measured
amplitude and phase on the tissue are
|Iij | = Cs,aiCd,ajA(ρij), (2.121)
pij = Cs,pi + Cd,pj + θ(ρij), (2.122)
where A(ρij) and θ(ρij) are the amplitude and phase predicted by the photon diffusion model
(Equation 2.52). To correct the measured amplitude and phase for the light coupling coefficients,
substitute Equations 2.119 and 2.120 into Equations 2.121 and 2.122, i.e.,
A(ρij) =
AP (ρij)
|IPij |
|Iij |, (2.123)
θ(ρij) = pij −
(
pPij − θP (ρij)
)
. (2.124)
The tissue optical properties can then be extracted from fitting these corrected amplitude and
phase measurements at all source-detector separations to the photon diffusion model.
A big advantage of the phantom calibration technique is its flexibility. It can be utilized for
any arrangement of source and detector fibers. With phantom calibration, it is even possible
to estimate absolute absorption and scattering with only a single source-detector separation.
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Equations 2.123 and 2.124 form a system of two equations, wherein the two unknowns are µa
and µ′s. However, the single separation frequency-domain measurement is not recommended
because it is highly prone to cross talk induced by measurement noise.
The phantom calibration technique also has drawbacks. Its underlying assumption is that the
fiber coupling coefficients calculated on the phantom remain the same when the probe is moved
to tissue. This assumption is not always valid. Hair follicles strongly effect the coupling coeffi-
cients, and can easily have a heterogeneous effect across different fibers. If this is the case, the
phantom calibration technique will not work. Another extreme case is if there is any liquid un-
derneath the fibers. The light coupling coefficients on a solid phantom are different than they are
on a liquid (e.g., intralipid), which is why the phantom calibration approach usually fails when
using a probe calibrated on a solid phantom to measure optical properties of a liquid. Finally, the
phantom calibration technique assumes temporally constant light coupling coefficients. In prin-
ciple, the coupling coefficients will change with time if any of the factors they depend on changes
with time (see Equation 2.117). Although it is feasible to reset the calibration with additional
phantom measurements, it is not possible to monitor the coupling coefficients continuously.
2.11.1.2 Self Calibrating Probes
Self-calibrating probes rely on tissue symmetry to estimate the light coupling coefficients with-
out phantom calibration. Specifically, the underlying assumption is that the tissue is appro-
priately symmetric such that the fluence rate predicted by the photon diffusion model (i.e.,
A exp(−iθ)) is the same for equidistant source-detector pairs. Semi-infinite/slab (Figure 2.8),
spherical (Figure 2.12, and two-layer geometries (Figure 2.13) have this symmetry on the tissue-
air boundaries. This assumption also applies in the cylindrical geometry (Figure 2.12) if the
equidistant source-detector pairs on the boundary also have the same z-component separations.
More generally, the self-calibrating technique is appropriate for N-layered planar, spherical, and
cylindrical geometries (N is an integer). They are best understood by example (Figure 2.15B).
Light coupling coefficients are estimated from ratios of the signals from equidistant source-
detector pairs. Using the same notation defined in Equation 2.118 for the probe in Figure 2.15B,
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these ratios are
r1 ≡ I11
I12
=
Cs,a1Cd,a1
Cs,a1Cd,a2
exp[−i(Cs,p1 + Cd,p1]
exp[−i(Cs,p1 + Cd,p2]
A(ρ)e−iθ(ρ)
A(ρ)e−iθ(ρ)
,
r2 ≡ I11
I41
=
Cs,a1Cd,a1
Cs,a4Cd,a1
exp[−i(Cs,p1 + Cd,p1]
exp[−i(Cs,p4 + Cd,p1]
A(ρ)e−iθ(ρ)
A(ρ)e−iθ(ρ)
,
r3 ≡ I12
I22
=
Cs,a1Cd,a2
Cs,a2Cd,a2
exp[−i(Cs,p1 + Cd,p2]
exp[−i(Cs,p2 + Cd,p2]
A(ρ)e−iθ(ρ)
A(ρ)e−iθ(ρ)
,
r4 ≡ I12
I32
=
Cs,a1Cd,a2
Cs,a3Cd,a2
exp[−i(Cs,p1 + Cd,p2]
exp[−i(Cs,p3 + Cd,p2]
A(ρ)e−iθ(ρ)
A(ρ)e−iθ(ρ)
, (2.125)
where ρ = 3cm. Separating these ratios into their amplitude and phase components (e.g., r1 =
r1,a exp(−ir1,p)), we obtain
r1,a = Cd,a1/Cd,a2, r1,p = Cd,p1 − Cd,p2,
r2,a = Cs,a1/Cs,a4, r2,p = Cs,p1 − Cs,p4,
r3,a = Cs,a1/Cs,a2, r3,p = Cs,p1 − Cs,p2,
r4,a = Cs,a1/Cs,a3, r4,p = Cs,p1 − Cs,p3. (2.126)
The self-calibrating probe in Figure 2.15B has four distinct separations. The measured sig-
nals at these separations are
|I42| = Cs,a4Cd,a2A(ρ42), p42 = Cs,p4 + Cd,p2 + θ(ρ42),
|I11| = Cs,a1Cd,a1A(ρ11), p11 = Cs,p1 + Cd,p1 + θ(ρ11),
|I21| = Cs,a2Cd,a1A(ρ21), p21 = Cs,p2 + Cd,p1 + θ(ρ21),
|I31| = Cs,a3Cd,a1A(ρ31), p31 = Cs,p3 + Cd,p1 + θ(ρ31). (2.127)
The signal measurements given by Equation 2.127 are corrected for light coupling using Equa-
tion 2.126, i.e.,
A(ρ42) =
r2,ar1,a
Cs,a1Cd,a1
|I42|, θ(ρ42) = p42 − (Cs,p1 + Cd,p1) + r2,p + r1,p,
A(ρ11) =
1
Cs,a1Cd,a1
|I11|, θ(ρ11) = p11 − (Cs,p1 + Cd,p1),
A(ρ21) =
r3,a
Cs,a1Cd,a1
|I21|, θ(ρ21) = p21 − (Cs,p1 + Cd,p1) + r3,p,
A(ρ31) =
r4,a
Cs,a1Cd,a1
|I31|, θ(ρ31) = p31 − (Cs,p1 + Cd,p1) + r4,p. (2.128)
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Notice that there are only two unknowns from light coupling in the system of equations given by
Equation 2.127, which are Cs,a1Cd,a1 and Cs,p1+Cd,p1. Thus, Equation 2.128 is readily solved
for the tissue optical properties.
In addition to the self-calibration technique not requiring phantom calibration, its other big
advantage is that it can be applied for every measurement time point. Thus, unlike the phantom
calibration technique, the self-calibration technique accurately handles time-varying light cou-
pling coefficients. However, self-calibrating probes are larger in size than corresponding probes
using phantom calibration (compare Figure 2.15A with Figure 2.15B). Self-calibrating probes
also require very accurate source-detector separations to ensure equidistant source-detector pairs.
A difference in separation of ∼ 1 mm between two pairs that are supposed to be equidistant is
enough to induce significant errors. For this reason, self-calibrating probes work best for rigid
probes.
2.11.2 Validity of P1 Approximation at Tissue Boundary
The key step in relating the detected signal to the photon fluence rate is using the P1 approxi-
mation for the light radiance (i.e., Equation 2.114). The P1 approximation is accurate for nearly
isotropic light wherein Φ ≫ |J| (Equation 2.28). On examination of Table 2.4, though, the
fluence rate is not a lot greater than the photon flux at the boundary, especially for the index-
matched case wherein n = nout. This consequentially raises questions about the accuracy of
the P1 approximation at the boundary. Specifically, does the boundary perturb incident diffusive
light enough to induce light anisotropy beyond the P1 approximation?
To answer this, I used the MCML Monte Carlo software package [255] to solve the linear
transport equation (Equation 2.9) directly at a semi-infinite index-matched tissue boundary. This
Monte Carlo solution is compared to the continuous-wave semi-infinite photon diffusion fluence
rate solution (i.e., Equation 2.103 with ω = 0) in Figure 2.16A. Recall that the photon diffu-
sion equation is the P1 approximation to the linear transport equation. Therefore, since there
is excellent agreement between the Monte Carlo and photon diffusion solutions, the P1 approx-
imation is accurate at the boundary. Intuitively, this result makes sense because the detected
signal is sensitive only to light propagating in directions within the fiber’s numerical aperture.
The light radiance in these “incident directions” is much less affected by the boundary than the
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Figure 2.16: (A) Comparison of Monte Carlo and continuous-wave photon diffusion solutions
as a function of source-detector separation, ρ, for the detected light signal at the boundary of
an index-matched semi-infinite medium (µa = 0.1, µ′s = 10 cm−1, n = nout = 1.4; see
Figure 2.8). The Monte Carlo simulation utilized 10 million photons to numerically solve the
linear transport equation (Equation 2.9), while the photon diffusion model is the P1 approxi-
mation of the linear transport equation. In the photon diffusion model, I(ρ)/I(ρ = 2.5 cm) =
Φ(ρ)/Φ(ρ = 2.5 cm) (Equation 2.117), where the fluence rate Φ(ρ) is given by the continuous-
wave semi-infinite Green’s function (i.e., Equation 2.103 with ω = 0). (B) Simulated “normal-
ized” detected signals, I(ρ)/I(ρ = 2.5 cm), for detection fiber core diameters of d = 1 mm
and d = 3 mm, plotted against ρ. The simulated detected signals were computed by spatially
integrating Φ(ρ) (i.e., continuous-wave semi-infinite Green’s function) over the detection fiber
areas (see Equation 2.116). The normalization by I(ρ = 2.5 cm) was done to divide out the
light coupling coefficient in Equation 2.116.
light radiance traveling in opposite directions back into the tissue. Therefore, even though the
light radiance at the boundary is not nearly isotropic over all directions, it is nearly isotropic over
the incident directions that are detected, provided that the incident light is diffusive. Thus, the
photon diffusion model is valid at the boundary for the detected signal if the incident light on
the boundary is diffusive. At short separations, the incident light is not diffusive, and there is
deviation between the Monte Carlo and photon diffusion models (Figure 2.16A).
2.11.3 Signal Detection with “Large-diameter” Optical Fibers
In the derivation of Equation 2.117, I assumed that the fluence rate is approximately constant over
the detection area of the fiber. In practical measurements, though, large-diameter optical fibers
with diameters of 1 mm or 3 mm are often used. These fibers are big enough for the fluence rate
to change significantly over their area. However, the spatial integral of the fluence rate across the
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fiber detection area for these two diameters is still proportional to Φ(ρ) (Figure 2.16B). Thus,
Equation 2.117 is still valid for large-diameter optical fiber detection. The spatial integration
over the fiber area is another factor perturbing the light coupling coefficient (C(t)) from its
theoretical value, which is corrected for by the calibration schemes discussed above.
2.12 Penetration Depth of Diffusing Light
As illustrated in Figure 2.6, for a basic DOS measurement comprised of a point source and a
point detector, the detected light interacts with a “banana shaped” volume of tissue. In this sec-
tion, I quantitatively characterize this “banana shaped” volume of tissue sampled by a single
source-detector pair in homogeneous media. The key to understanding the sampled tissue vol-
ume is knowledge of the probability that a detected photon visits (i.e., passes through) a point r
inside the tissue [200]. I will first focus on the simpler case of continuous-wave light.
Let’s consider a point source at position rs with source power S0, i.e., S(r) = S0δ(r − rs).
The fluence rate at point r inside the tissue is given by (Equation 2.93)
Φcw(r) = S0Gcw(r, rs), (2.129)
where Gcw(r, rs) is the continuous-wave Green’s function for the geometry of interest. Since
diffusive light is nearly isotropic, Φcw(r) can be regarded as another point source with a light
power of S0Gcw(r, rs) [146]. The photon fluence rate at the detector position, rd, from this
“point source” at r is then given by S0Gcw(r, rs)Gcw(rd, r), which is the contribution to the
total fluence rate at the detector from photons that have visited the tissue point r.
Consequentially, the probability that a detected photon at position rd has visited the infinites-
imal tissue volume d3r centered at r is
P (rd, r, rs)d
3r =
Gcw(r, rs)Gcw(rd, r)d
3r∫
V
Gcw(r, rs)Gcw(rd, r)d3r
, (2.130)
where the spatial integration is over the entire tissue volume, V . Note that because P (rd, r, rs)
is a “photon visitation” probability density function, the probability that a detected photon has
visited a volume of tissue V˜ within the total volume of tissue is
Prob(rs → V˜ → rd) =
∫
V˜
P (rd, r, rs)d
3r. (2.131)
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Figure 2.17: (A) Cross-section of the photon visitation probability density function (Equa-
tion 2.130) for a semi-infinite medium (µa = 0.1, µ′s = 10 cm−1, n = 1.4, nout = 1.0)
probed with a source-detector separation of ρ = 2.5 cm. Only 15% of the detected light has vis-
ited tissue depths greater than z = 1 cm (black horizontal line). (B) Photon probability density
function isosurface at the P = 0.2 level for the same semi-infinite geometry.
In the semi-infinite geometry, P (rd, r, rs) has a “banana shaped profile” (Figure 2.17) 15 that
is weighted towards superficial tissue depths. The mean depth of photon visitation (or penetra-
tion depth), 〈z〉, given by
〈z〉 =
∫
V
zP (rd, r, rs)d
3r, (2.132)
is substantially less than the source-detector separation (Figure 2.18A). However, the width of
the banana shaped profile (e.g., σz = (〈z2〉−〈z〉2)1/2) encompasses greater tissue depths. Since
a typical scalp/skull thickness in adult humans is ∼ 1 cm, the fraction of detected photons that
have visited tissue deeper than a depth of z = 1 cm, i.e.,
Prob(z > 1 cm) =
∫ ∞
−∞
dx′
∫ ∞
−∞
dy′
∫ ∞
z
dz′P (rd, r, rs), (2.133)
is informative. Although this fraction is significant, the majority of the detected light has only
visited tissue at depths shallower than 1 cm (Figure 2.18B). For example, at ρ = 2.5 cm, only
15% of the detected light samples tissue below depths of 1 cm. The influence of optical prop-
erties on the fraction of detected light sampling depths greater than 1 cm is investigated in Fig-
ure 2.18C. Both µa and µ′s influence this fraction, though the absorption influence is stronger.
Since the detected light is heavily weighted towards superficial tissue, cerebral monitoring in
15To compute the photon visit probability density function numerically in the semi-infinite geometry, it is help-
ful to use the relation G(r, rd) = G(rd, r). Explicitly, evaluate the semi-infinite Green’s functions in Cartesian
coordinates, e.g., G(rd, r) = G([ρ, 0, 0], [x, y, z])
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Figure 2.18: For a typical semi-infinite medium (µa = 0.1, µ′s = 10 cm−1, n = 1.4, nout = 1.0),
the mean depth of detected photon visitation ((A)), the fraction of detected photons visiting tissue
depths greater than 1 cm ((B)), and the standard deviations of detected photon visitation for the
two orthogonal directions to the “source-detector line” ((C)), are plotted against the source-
detector separation, ρ. (D) Contour plot of the fraction of detected photons visiting tissue depths
greater than 1 cm as a function of tissue scattering (vertical axis) and tissue absorption (horizontal
axis).
adults is prone to superficial tissue contamination. I discuss strategies for filtering this superfi-
cial tissue contamination in Chapter 6.
Finally, notice that the banana shaped profile has a narrower width than depth, i.e., σy < σz
(Figure 2.18D).
2.12.1 Photon Visitation Probability Density Function for Frequency-Domain Light
The frequency-domain analogue of Equation 2.130 for intensity modulated light is
P (rd, r, rs)d
3r =
|G(r, rs)G(rd, r)| d3r∣∣∣∣∫
V
Gcw(r, rs)Gcw(rd, r)d3r
∣∣∣∣
, (2.134)
where G(r, rs) is the frequency-domain Green’s function for the geometry of interest (Equa-
tion 2.87). Equation 2.134 can in turn be used to compute the frequency-domain analogues
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Figure 2.19: For a typical semi-infinite medium (µa = 0.1, µ′s = 10 cm−1, n = 1.4, nout = 1.0)
probed with a source-detector separation of ρ = 2.5 cm, the signal modulation depth (i.e.,
the ratio of the detected signal amplitude divided by the CW amplitude) ((A)), the mean depth
of detected photon visitation ((B)), and the fraction of detected photons visiting tissue depths
greater than 1 cm ((C)), are plotted against intensity modulation frequency, f = ω/(2π).
of Equations 2.132 and 2.133. Interestingly, although the signal amplitude (i.e., |G(rd, rs)|) is
strongly attenuated with increasing modulation frequency (Figure 2.19A), the mean photon pen-
etration depth remains the same (Figure 2.19B). However, the standard deviation of the photon
visitation depth in the frequency-domain decreases with increasing frequency (Figure 2.19B),
and thus the fraction of detected photons visiting tissue depths greater than 1 cm also decreases
with increasing frequency (Figure 2.19C).
2.12.2 Photon Visitation Probability Density Function for Time-resolved Light
I will now briefly present the photon visitation probability density function from an infinitesi-
mally narrow light pulse emitted at position rs = 0 and time t = 0, i.e., S(r, t) = S0δ(r)δ(t).
From applying the argument presented in the previous section to time-resolved data, the proba-
bility that a detected photon at position rd and time t has visited the infinitesimal tissue volume
d3r centered at r is
Ptr(rd, r, rs, t)d
3r =
(∫ t−|rd−r|/v
|r|/v g(r, 0, t
′, 0)g(rd, r, t, t′)dt′d3r
)
∫
V d3r
∫ t−|rd−r|/v
|r|/v g(r, 0, t
′, 0)g(rd, r, t, t′)dt′
. (2.135)
The temporal integration limits in Equation 2.135 correspond to the shortest and longest possible
times for a detected photon at time t to reach the position r in the tissue. The shortest time is the
time it takes a photon to travel in a straight line from source to r, i.e., r/v. The longest time is
the detection time t subtracted by the time it takes a photon to travel in a straight line from r to
the detector, i.e., t − |rd − r|/v. One intuitive result arising from Equation 2.135 is that Ptr at
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longer detection times, t, is more sensitive to deeper tissue depths [200].
2.13 Spectroscopy for Determination of Tissue Chromophore Con-
centrations
The tissue absorption depends linearly on the concentrations of tissue chromophores. In partic-
ular, the wavelength-dependent absorption coefficient is given by
µa (λ) = log(10)
∑
i
εi (λ) ci. (2.136)
Here εi(λ) [M−1cm−1] is the wavelength-dependent extinction coefficient (usually known for
typical tissue chromophores, see Figure 2.20), ci [M] represents the concentration of the ith chro-
mophore, and log(10) is the natural logarithm of ten.16 We have seen above that the diffusion
approximation enables us to separate the scattering and absorption contributions in the detected
light signals. Thus, by measuring µa at multiple optical wavelengths, we generate a system of
coupled equations (Equation 2.136) that can be solved to yield the unknown chromophore con-
centrations. Generally, to estimate the concentrations of N chromophores, one must determine
µa at N or more wavelengths.
DOS is most typically employed to measure oxygenated and de-oxygenated hemoglobin;
thus a bare minimum of phase and amplitude measurements at two wavelengths are required.
Use of more wavelengths permits inclusion of other tissue chromophores such as water and lipid,
and also improves the accuracy of the hemoglobin measurements because measurement redun-
dancy reduces systematic errors. Of course, more wavelengths increase the cost and complexity
of the instrument and require longer data acquisition times.
For tissue spectroscopy, if the water concentration is not measured, then it should be assumed
(e.g., a 75% water volume fraction corresponds to a water concentration of 0.75 × 55 M) and
incorporated in Equation 2.136. In some tissues such as breast, fat contributes significantly
to the absorption coefficient, especially at longer wavelengths in the near-infrared around 900
16The absorption coefficient is defined such that the transmittance through a non-scattering homogeneous medium
is T ≡ I/Is = exp[−µaρ], where ρ is the distance between source and detector. Thus, − log(T ) = µaρ. Tab-
ulated extinction coefficients, though, are determined from the base 10 logarithm of the transmittance [207], i.e.,
− log10(T ) = µaρ/ log(10). This explains the presence of the factor log(10) in Equation 2.136.
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Figure 2.20: Extinction coefficient spectra in the near-infrared spectral window for oxy-
hemoglobin (HbO), deoxy-hemoglobin (HbR), and water, plotted as a function of wavelength,
λ [207]. The values plotted for water are the actual extinction coefficients multiplied by 700
thousand. I chose this scaling factor because the concentration of water in tissue is typically 700
thousand times higher than the oxy-hemoglobin concentration.
nm [52,144]. As with water, lipid content should be assumed in applications where its absorption
coefficient contribution is significant [52]. Equation 2.136 is equivalent to [144]
µa(λ) =
∑
i
fv,iµ
pure
a,i (λ), (2.137)
where fv,i is the tissue volume fraction of the ith chromophore, and µpurea,i is the absorption
coefficient of that pure chromophore. For some chromophores, µpurea,i is tabulated as a function
of wavelength rather than the extinction coefficient [207].
Finally, melanin content in the skin affects the detected signal (e.g., a higher melanin content
corresponds to a lower signal). Assuming that melanin is only in the skin, its effect is similar
to hair follicles in that it influences the light coupling coefficient for the detected signal (2.117).
As with hair, the phantom calibration technique for estimating light coupling coefficients (Sec-
tion 2.11.1.1) does not take into account melanin content. However, it is typically reasonable to
assume uniform melanin content in the skin across the area of the optical probe. For this case,
the component in the coupling coefficient from melanin is the same for every source-detector
separation, and melanin will not affect the slopes in amplitude and phase given by Equations
2.110 and 2.111.
DOS provides quick estimates of bulk chromophore concentrations in large tissue volumes.
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These estimates are often accurate enough to be useful in many monitoring applications. Imag-
ing schemes employ Equation 2.136 on a volume-element-by-volume-element basis to assign
chromophore concentrations to particular voxels in the tissue sample. The oxy- and deoxy-
hemoglobin concentrations measured by DOS (i.e., HbO and HbR) are per volume of tissue, not
per volume of blood. Normal hemoglobin concentration in blood is around 2300 µM . How-
ever, blood typically occupies only a 5% volume fraction of tissue, meaning that the hemoglobin
concentration in tissue is around 100 µM . Typically, the total hemoglobin concentration in
blood remains constant, i.e., the hematocrit remains constant. Consequentially, changes in the
measured total hemoglobin concentration with DOS, i.e., HbT = HbO + HbR, correspond
to changes in tissue blood volume. If the hematocrit is constant, the tissue total hemoglobin
concentration is proportional to tissue blood volume, i.e.,
HbT ≡ HbO +HbT ∝ Tissue Blood Volume [mL Blood / mL Tissue]. (2.138)
Further, the tissue oxygen saturation,
StO2 =
HbO
HbT
, (2.139)
is equivalent to the blood oxygen saturation.
The DOS measurements of tissue blood volume and tissue oxygen saturation are bulk av-
erages weighted towards the microvasculature (e.g., capillaries, small venules, arterioles). The
reason DOS is most sensitive to the microvasculature is that photon absorption in larger vessels is
much higher than it is in smaller vessels. Since the total hemoglobin in blood is∼ 2300 µM , the
photon absorption length when it is actually traveling inside a blood vessel is about 2.5 mm. For
small vessels, the photon exits the vessel well before this length scale. In large vessels, though,
it is more likely for photons to travel this length scale before exiting. Thus, photons passing
through large vessels are preferentially absorbed, which means that detected photons have pref-
erentially visited smaller vessels, making the DOS measurement predominantly sensitive to the
tissue microvasculature.
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2.13.1 Optimal Wavelengths for Diffuse Optical Spectroscopy
Determination of tissue chromophore concentrations requires the separation of tissue absorp-
tion from tissue scattering at more than one optical wavelength. The optimal choice of wave-
lengths for chromophore concentration determination is an important topic in its own right, with
an interesting history that involved careful consideration of measurement type, i.e. frequency-
domain, time-domain, CW, and measurement signal-to-noise. For simple, two-wavelength time-
and frequency-domain instruments, early experimenters wondered about which wavelengths to
choose to minimize cross-talk between chromophores when inverting Equation 2.136. Superfi-
cially, one might expect that at least one wavelength within the NIR window should be below
the isosbestic point of hemoglobin and one should be above this isosbestic point. The isosbestic
point is the wavelength wherein the extinction coefficients of oxygenated and de-oxygenated
hemoglobin are the same (∼800 nm, see Figure 2.20); wavelengths below the isosbestic point are
thus more sensitive to deoxy-hemoglobin, while wavelengths above are more sensitive to oxy-
hemoglobin. However, such wavelength selection processes are limited. Yamashita et al [263],
Strangman et al [235], and Boas et al [26] have shown theoretically and experimentally that
when using only two wavelengths, a pair at 660 − 760 nm and 830 nm provides superior oxy-
and deoxy- hemoglobin separation by comparison to what was the more commonly used choice
of 780 nm and 830 nm.
A formal evaluation of the optimum wavelength selection for an arbitrary number of wave-
lengths was carried out by Corlu et al [58, 60]; they introduced a general procedure for find-
ing those wavelengths which best differentiate tissue chromophores using CW and frequency-
domain light. These results built on a theoretical approach developed in a classic paper by
Lionheart and Arridge [8]. That paper [8] theoretically proved that it is impossible to uniquely
separate scattering from absorption in a diffuse optical imaging experiment employing CW light.
In an attempt to circumvent this uniqueness problem for CW imaging, Corlu et al demonstrated
that a multi-spectral approach can be employed to uniquely reconstruct the chromophore con-
centrations, ci. In a key advance, Corlu et al [58, 60] abandoned the two-step approach of deter-
mining µa at each wavelength first and then inverting Equation 2.136. Instead, they introduced
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a multi-spectral approach that exploits known spectral properties of the medium a priori to di-
rectly reconstruct chromophore concentrations with better fidelity than the traditional two-step
method. Specifically, a priori assumptions about the form of the scattering (e.g., µ′s(λ) = aλ−b)
and wavelength-dependent absorption extinction factors (i.e., Equation 2.136) are used, and the
wavelength independent variables ci, a, and b are reconstructed directly from all of the data si-
multaneously. Because the data from all wavelengths are simulataneously used, the inverse prob-
lem is better-constrained than the traditional approach (see [58] for details). The multi-spectral
technique is now commonly used, and has been extended for frequency domain sources [232],
for including uncertainties in the hemoglobin extinction coefficients [34], and for spectral win-
dow optimization when using broadband sources [87].
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Chapter 3
Diffuse Optical Spectroscopy (DOS):
Modified Beer-Lambert Law Approach
3.1 Introduction
In Chapter 2, I presented the photon diffusion approach for analysis of DOS signals to separate
tissue absorption from tissue scattering. Multi-spectral measurements of tissue absorption then
enable estimation of blood volume and blood oxygen saturation in the tissue microvasculature.
In this chapter, I discuss an alternative approach for DOS analysis, which is the Modified Beer-
Lambert law [10, 67, 130]. The Modified Beer-Lambert law is arguably the most widely used
approach for analysis of DOS signals [99,122,166,175,219,248], in large part because of its sim-
plicity. With this approach, researchers have monitored temporal changes in blood oxygenation
and blood volume with CW light, using only one source-detector separation.
The Modified Beer-Lambert law scheme relates differential light transmission changes (in
any geometry) to differential changes in tissue absorption1 . In essence, this scheme accounts for
tissue scattering by using the mean pathlength traveled by photons through the highly scattering
sample as a best estimate for the actual photon pathlengths. The mean pathlength provides a
natural constant of proportionality between the measured differential intensity and the sample’s
differential absorption.
1The term differential refers to a comparison between a baseline state and a perturbed state.
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The Modified Beer-Lambert law is well suited for monitoring temporal variations in blood
oxygenation and blood volume with respect to some perturbation, as in brain mapping. Im-
portantly, it is also valid in tissues/geometries wherein light transport is not diffusive, which
facilitates accurate absorption monitoring for small source-detector separations typical of endo-
scopic probes, for visible light wherein tissue absorption is very high, and for tissue that contain
very high concentrations of blood, as in the liver. A drawback of this approach, though, is that
it cannot determine absolute tissue hemoglobin concentrations. Most of this chapter (Sections
3.3 - 3.3.7) focuses on utilizing the Modified Beer-Lambert law in homogeneous media for both
diffusive and non-diffusive light transport. The heterogeneous media Modified Beer-Lambert
law is discussed briefly in Section 3.4.
3.2 Beer-Lambert Law for Optically Thin Homogeneous Media
In optically thin (i.e., non-scattering) homogeneous media, light travels in a straight line between
source and detector, and is exponentially attenuated by absorption, i.e.,
I = Is exp[−µaρ], (3.1)
where Is is the source intensity delivered to the sample, I is the detected intensity emerging
from the sample, and ρ is the straight line distance between source and detector (Figure 3.1).
Thus, the sample optical density (OD), which is defined as the negative logarithm of the ratio of
transmitted to incident light intensity, is proportional to the absorption coefficient:
OD ≡ − log[I/Is] = µaρ. (3.2)
Equation 3.2 is the Beer-Lambert law, which utilizes multi-spectral measurements of the op-
tical density to measure absolute chromophore concentrations (ci) in optically thin homogeneous
media via the system of equations
OD(λ) = ρ log(10)
∑
i
εi(λ)ci, (3.3)
where εi(λ) is the wavelength-dependent extinction coefficient for chromophore i. Chromophore
extinction coefficients can be calculated from multi-spectral light transmission measurements
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Figure 3.1: Schematics of an optically thin homogeneous medium (left) and an optically thick
turbid homogeneous medium (right).
through pure solutions with a known chromophore concentration, ci, i.e.,
εi(λ) =
−1
ciρ
log10
(
I(λ)
Is(λ)
)
=
OD(λ)
ciρ log(10)
. (3.4)
3.3 Modified Beer-Lambert Law for Turbid Homogeneous Media
When light scattering within the sample is significant, then light attenuation is affected by both
absorption and scattering, and the Beer-Lambert law (Equation 3.2) is no longer applicable.
As discussed in Chapter 2, photon trajectories through turbid tissues are well approximated as
random walks, and photons therefore travel over a distribution of pathlengths from source to
detector (Figure 3.1), wherein the average length of a photon path is much greater than the
straight-line distance between source and detector, ρ.
In turbid media, the effects of scattering are tangled with those of absorption. Although the
photon diffusion model can be employed to separate scattering from absorption (Chapter 2), an
alternative paradigm is the Modified Beer-Lambert law [10, 67], which is readily derived from
the first order Taylor expansion of the optical density:
OD ≈ OD0 + ∂OD
0
∂µa
∆µa +
∂OD0
∂µ′s
∆µ′s, (3.5)
where the optical densities OD ≡ − log(I/Is) and OD0 ≡ − log(I0/Is) correspond to a
“perturbed” tissue state (e.g., at time t) with optical properties of (µa, µ′s) and a “baseline”
tissue state (e.g., at time t0) with optical properties of (µ0a, µ′0s ), respectively. Further, ∆µa ≡
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µa − µ0a and ∆µ′s ≡ µ′s − µ′0s are the differential changes in absorption and scattering between
the perturbed and baseline tissue states. The Modified Beer-Lambert law is a rearrangement of
Equation 3.5 wherein the source intensity Is is assumed to remain constant, i.e.,
∆OD = − log
(
I(ρ)
I0(ρ)
)
≈ L(ρ)∆µa +
(
µ0a
µ′0s
)
L(ρ)∆µ′s ≈ L(ρ)∆µa. (3.6)
Here, L(ρ) ≡ ∂OD0/∂µa [cm] is the so-called differential pathlength, which is approximately
the mean pathlength that diffusing photons travel through the medium from a point source to
a point detector with separation ρ [10], and ∂OD0/∂µ′s ≈ (µ0a/µ′0s )L(ρ) (Section 3.3.1). It is
often reasonable to neglect the scattering term in Equation 3.6 because (1), the multiplicative
factor µ0a/µ′0s for many tissues is much less than one, and (2), tissue scattering changes that
accompany hemodynamic variations are often negligible [12].
Notice that whereas the Beer-Lambert law (Equation 3.2) relates absolute optical densities to
absolute absorption coefficients, the Modified Beer-Lambert law (Equation 3.6) relates differen-
tial changes in the optical density to differential changes in the absorption coefficient. Implemen-
tation of Equation 3.6 requires knowledge of the differential pathlength, L(ρ), which not only
depends on the source-detector separation, ρ, but also the tissue geometry and the wavelength-
dependent baseline tissue absorption and scattering properties, µ0a and µ′0s . The differential path-
length can be measured with time-resolved [67] or frequency-domain techniques [10, 75]; or
computed with a diffusion model [94] or radiative transport models [162, 255]. Direct mea-
surements of L(ρ) do not require a priori knowledge of the baseline optical properties or tissue
geometry, but light transport must be diffusive, and the instrumentation is considerably more
complex and expensive than CW measurements. Conversely, the computation of L(ρ) from
light transport models permits accurate tissue absorption monitoring with the Modified Beer-
Lambert law for non-diffusive light transport and for spatially extended light sources (e.g., plane
waves), but utilization of the light transport models requires a priori knowledge of the baseline
optical properties and tissue geometry.
3.3.1 Time-resolved Measurement of Differential Pathlength
For continuous-wave, diffusive light traveling through the medium from a point source to a
point detector, the differential pathlength is the speed of light through tissue multiplied by the
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mean time of flight of photons in tissue, i.e., L(ρ) = v〈t − ts〉. Here, ts is the time that an
infinitesimally narrow source pulse of light is emitted at position rs, t is the photon detection time
at position rd, and v is the speed of light through tissue. Thus, the differential pathlength can be
measured via direct measurement of the mean time of flight with a time-resolved instrument [67].
I will now explicitly derive this relationship between L(ρ) and 〈t− ts〉. The probability that
a photon emitted at (rs, ts) reaches the detector at rd in a time interval dt around the detection
time t is proportional to the time-domain photon diffusion Green’s function (see Section 2.12
and Equation 2.85), i.e.,
P ([t, rd], [ts, rs]) =
g(rd, rs, t, ts)dt∫∞
−∞ g(rd, rs, t, ts)dt
. (3.7)
Therefore, the mean time of flight is
〈t− ts〉 =
∫ ∞
−∞
(t− ts)P ([t, rd], [ts, rs])dt =
∫∞
−∞(t− ts)g(rd, rs, t, ts)dt∫∞
−∞ g(rd, rs, t, ts)dt
. (3.8)
From Equation 2.91, the mean time of flight is alternatively given by
〈t− ts〉 =
i ∂∂ω
∫∞
−∞ g(rd, rs, t, ts)e
−iω(t−ts)dt
Gcw(rd, rs)
=
i ∂G(rd, rs)/∂ω|ω=0
Gcw(rd, rs)
. (3.9)
Here, Gcw(rd, rs) and G(rd, rs) are the continuous-wave (Equation 2.93) and frequency-domain
(Equation 2.87) photon diffusion Green’s functions, respectively, evaluated at the baseline tissue
optical properties µ0a and µ′0s . The frequency derivative, ∂G/∂ω, is additionally evaluated at the
modulation frequency ω = 0.
For continuous-wave diffusive light transport, the detected light intensity is proportional to
Gcw(rd, rs) (Section 2.11). Consequentially, the differential pathlength is
L(ρ) ≡ ∂OD
0
∂µa
= − ∂
∂µa
log[Gcw(rd, rs)] =
−1
Gcw(rd, rs)
∂Gcw(rd, rs)
∂µa
, (3.10)
where again, Gcw(rd, rs) is evaluated at the baseline tissue optical properties. Combining Equa-
tions 3.9 and 3.10, we obtain
〈t− ts〉 =
−iL(ρ) ∂∂ωG(rd, rs)
∣∣
ω=0
∂
∂µa
Gcw(rd, rs)
. (3.11)
From examining the homogeneous frequency-domain photon diffusion equation (Equation 2.54),
the modulation frequency dependence of G(rd, rs) is contained in the variable k2 ≡ (vµa +
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iω)/D, while the absorption dependence of Gcw(rd, rs) is contained in the variable k20 ≡
vµa/D. Thus2,
∂
∂ω
G(rd, rs)
∣∣∣∣
ω=0
=
∂Gcw(rd, rs)
∂k20
× ∂k
2
∂ω
, (3.12)
∂
∂µa
Gcw(rd, rs) =
∂Gcw(rd, rs)
∂k20
× ∂k
2
0
∂µa
. (3.13)
Substituting Equations 3.12 and 3.13 into 3.11 reveals that the differential pathlength is approx-
imately the mean photon pathlength traveled from source to detector, i.e.,
L(ρ) =
〈t− ts〉∂k20/∂µa
−i∂k2/∂ω =
[
1 +
µ0a
µ0a + µ
′0
s
]
v〈t− ts〉 ≈ v〈t− ts〉. (3.14)
The latter approximation in Equation 3.14 is equivalent to the approximation D ≈ v/(3µ′s).
An advantage of measuring L(ρ) directly with a time-resolved technique is that no a priori
knowledge of baseline optical properties for the homogeneous medium is required. Compared to
continuous-wave measurements, though, time-resolved instrumentation is complex and expen-
sive.
3.3.2 Frequency-Domain Measurement of Differential Pathlength
If the time-domain Green’s function for homogeneous media, i.e., g(rd, rs, t−ts), is symmetrical
about the mean time of flight, 〈t − ts〉, then the phase of the corresponding frequency-domain
Green’s function is θ = ω〈t − ts〉 [10]. To derive this, consider an infinitesimal pulse of light
emitted at ts = 0. If g is symmetrical about the mean time of flight, i.e., g(rd, rs, t + 〈t〉) =
g(rd, rs, 〈t〉 − t), then the frequency-domain Green’s function is determined from substituting
g(rd, rs, t+ 〈t〉) into Equation 2.91:
G(rd, rs) =
∫ ∞
−∞
g(rd, rs, t+ 〈t〉)e−iω(t+〈t〉)dt
= e−iω〈t〉
(∫ ∞
−∞
g(rd, rs, t+ 〈t〉) cos(ωt)dt− i
∫ ∞
−∞
g(rd, rs, t+ 〈t〉) sin(ωt)dt
)
= e−iω〈t〉
∫ ∞
−∞
g(rd, rs, t+ 〈t〉) cos(ωt)dt,
= A(rd, rs)e
−iω〈t〉. (3.15)
2Note that ∂G(rd, rs)/∂k2|ω=0 = ∂Gcw(rd, rs)/∂k20 .
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Figure 3.2: For a semi-infinite medium with µa = 0.1, µ′s = 10 cm−1, Reff = 0.493, n = 1.4,
and ρ = 2.5 cm, the mean photon time of flight (see Equation 3.23) and the frequency-domain
phase shift, θ (as a function of ω), were calculated using the semi-infinite frequency-domain
Green’s function (Equation 2.103). Both θ and ω〈t〉 are plotted against the oscillation frequency.
Thus, from Equation 3.15, the phase shift acquired by intensity modulated light propagating from
a point source to a point detector is θ = ω〈t〉, provided that g(rd, rs, t) is symmetrical about the
mean time of flight, 〈t〉. The second term in line two of Equation 3.15 is zero because the
integral is over the product of an even function (i.e., g(rd, rs, t+ 〈t〉)) and an odd function (i.e.,
sin(ωt)). Further, since g is real, the integral in the third line is the frequency-domain amplitude,
A(rd, rs). Although g is not truly symmetrical, it is nearly symmetrical, and θ = ω〈t〉 is a good
approximation for modulation frequencies less than 200 MHz (Figure 3.2). The differential
pathlength is then (Equation 3.14)
L(ρ) ≈ vθ(ρ)/ω. (3.16)
The drawback of using Equation 3.16 to measure the differential pathlength is its sensitivity
to the assumption that the phase light coupling coefficient obtained from phantom calibration
(Section 2.11.1.1) remains the same on tissue. Nonetheless, reasonable measurements of L(ρ)
have been made using this approach in a variety of tissues [75]. If multi-separation frequency-
domain measurements are not practical, the phase information from a single separation can be
used to measure the differential pathlength, enabling tissue absorption monitoring with the Mod-
ified Beer-Lambert law (Equation 3.6).
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3.3.3 Scattering Weighting Factor in Modified Beer-Lambert Law
For diffusive light, the scattering factor weighting factor in the Modified Beer-Lambert Law, i.e.,
Ls(ρ) ≡ ∂OD0/∂µ′s, is determined from evaluating
Ls(ρ) = − 1
Gcw(rd, rs)
∂Gcw(rd, rs)
∂µ′s
, (3.17)
at the baseline tissue optical properties. Combining Equation 3.17 with Equation 3.9, we obtain
Ls(ρ) =
〈t− ts〉(∂k20/∂µ′s)
−i∂k2/∂ω =
µ0a
µ0a + µ
′0
s
v〈t− ts〉, (3.18)
which in the limit µ′s ≫ µa is
Ls(ρ) ≈ µ
0
a
µ′0s
L(ρ). (3.19)
In tissue, the ratio µ0a/µ′0s is typically small, and consequentially, L(ρ)≫ Ls(ρ).
3.3.4 Computing Differential Pathlength from Tissue Optical Properties
The differential pathlength can also be computed for any homogeneous geometry through eval-
uating the absorption derivative of the optical density at the baseline tissue optical properties,
i.e.,
L(ρ) ≡ − ∂
∂µa
log[I(ρ, µ0a, µ
′0
s )] ≈
1
∆µa
log
[
I(ρ, µ0a −∆µa/2, µ′0s )
I(ρ, µ0a +∆µa/2, µ
′0
s
]
, (3.20)
where ∆µa/µ0a = 10−5. For continuous-wave (CW) diffusive light, I is proportional to the
continuous-wave photon diffusion Green’s function, Gcw(ρ, µa, µ′s), for the appropriate geome-
try, i.e.,
L(ρ) = − ∂
∂µa
log[Gcw(ρ, µ
0
a, µ
′0
s )] ≈
1
∆µa
log
[
Gcw(ρ, µ
0
a −∆µa/2, µ′0s )
Gcw(ρ, µ0a +∆µa/2, µ
′0
s
]
. (3.21)
Substitution of the semi-infinite continuous-wave Green’s function (Equation 2.103 at ω =
0) into Equation 3.21 and taking the analytical absorption derivative results in a simple expres-
sion for the differential pathlength in terms of the baseline optical properties:
L(ρ) =
3r1rbµ
′0
s
2k0
[
ek0r1 − ek0rb
r1ek0r1 − rbek0rb
]
, (3.22)
where k0 =
√
3µ0a(µ
0
a + µ
′0
s ), r1 =
√
(µ′0s + µ0a)−2 + ρ2, rb =
√
((µ′0s + µ0a)−1 + 2zb)2 + ρ2,
zb = 2(1+Reff )/[3(µ
′0
s +µ
0
a)(1−Reff )], and Reff is an effective Fresnel reflection coefficient
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defined by Equation 2.79. The corresponding mean time of photon flight in the semi-infinite
geometry is given by (Equation 3.9)
〈t〉 = 3(µ
0
a + µ
′0
s )
(
e−k0r1 − e−k0rb)
2vk0
[
e−k0r1
r1
− e−k0rbrb
] (3.23)
For more complex geometries, it is usually easier to compute L(ρ) by evaluating the derivative
in Equation 3.21 numerically.
Importantly, the Modified Beer-Lambert law is applicable for non-diffusive light transport.
In this regime, the differential pathlength is determined from evaluating Equation 3.20, where I
is modeled with solutions of the radiative transport equation (Equation 2.9) for the tissue optical
properties and tissue geometry of interest. The radiative transport equation can be solved with a
Monte Carlo method [25, 145, 255] or with finite difference or finite volume methods [162].
Additionally, the Modified Beer-Lambert law can be utilized for applications with spatially
extended light sources. For example, the so-called optical imaging of intrinsic signals (OIS) tech-
nique uses the Modified Beer-Lambert law to obtain 2-dimensional maps of hemoglobin con-
centration changes from intensity images of a surface illuminated with planar light [77,78,163].
Although the source-detector separation no longer has meaning in this context, the differential
pathlength is still evaluated via
L ≈ 1
∆µa
log
[
I(µ0a −∆µa/2, µ′0s )
I(µ0a +∆µa/2, µ
′0
s
]
, (3.24)
where I(µa, µ′s) is the detected signal from the spatially extended source when the tissue optical
properties are (µa, µ′s). I(µa, µ′s) is obtained from solving the photon diffusion equation for
the appropriate source and geometry (e.g., Equation 2.93), or solving the radiative transport
equation. I discuss OIS further in Chapter 7.
3.3.5 Differential Pathlength Factor
In the large source-detector limit (i.e., ρ ≫ 2zb + (µ0a + µ′0s )−1), the semi-infinite differential
pathlength (Equation 3.22) simplifies to [94]
L(ρ) ≈ 3µ
′0
s ρ
2
2
(
ρ
√
3µ0aµ
′0
s + 1
) . (3.25)
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Figure 3.3: Comparison of the exact semi-infinite differential pathlength (Equation 3.22) plot-
ted against source-detector separation, ρ, with (A), the “large ρ dpf” approximation (Equa-
tion 3.26), and with (B), the “empirical dpf” approximation, L(ρ) ≈ 7.3278ρ, i.e., dpf =
L(ρ = 3 cm)/(3 cm) = 7.3278. (C) Ratio of the exact semi-infinite differential pathlength
divided by the source-detector separation, plotted against ρ. In all three panels, the semi-infinite
medium properties are µa = 0.1, µ′s = 10 cm−1, n = 1.4, and Reff = 0.493. The empirical dpf
approximation is in good agreement with the exact differential pathlength for separations close
to the “calibration separation”, i.e., 3 cm. Further, the ratio L(ρ)/ρ slowly approaches a constant
value (i.e., dpf = 8.66 from Equation 3.26) as ρ increases.
A more severe approximation than Equation 3.25 is
L(ρ) ≈ 3µ
′0
s
2
√
3µ0aµ
′0
s
ρ = dpf × ρ. (3.26)
Here, the differential pathlength is proportional to the source-detector separation, and the propor-
tionality coefficient is the so-called differential pathlength factor, i.e., dpf . The ρ−independence
of dpf makes it more convenient to tabulate in the literature as a function of wavelength for a
given tissue type, and it is in large part for this reason that the dpf is commonly used. Typically,
the differential pathlength is measured using a time-resolved technique (Equation 3.14) at mul-
tiple wavelengths and then divided by the source-detector separation, ρ, to empirically compute
the differential pathlength factor. In addition to depending on wavelength, the dpf depends on
age and tissue type, since the tissue optical properties vary with age and tissue type. Scholkmann
and Wolf have recently reviewed the wavelength and age dependence of the dpf for the frontal
human head [220]. Differential pathlength values have also been published for other regions of
the adult human head [272], and in muscle [243].
However, even when accounting for age and tissue type, there is still considerable variability
across human subjects in the dpf , because the tissue optical properties are heterogeneous across
different subjects [144]. Further, Equation 3.26 only roughly approximates the true differential
pathlength (Figure 3.3), which could be a source of systematic error. When employing the dpf
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Figure 3.4: For a semi-infinite medium with µa = 0.1, µ′s = 10 cm−1, Reff = 0.493, and
n = 1.4, the differential pathlength for intensity modulated light (L(ρ), Equation 3.27) is plotted
against the source-detector separation ρ for several different intensity modulation frequencies f .
The dpf values in the legend are L(2.5 cm)/(2.5 cm).
approach for analysis, it is of course best to use published values of the dpf that were measured
in a sample of statistically similar tissue types with a similar source-detector separation and sim-
ilar wavelengths. It is even more preferable to use time-resolved or frequency-domain instru-
mentation to measure subject-specific differential pathlengths for the Modified Beer-Lambert
law.
3.3.6 Differential Pathlength with Intensity Modulated Light
The Modified Beer-Lambert law (Equation 3.6) can also be employed for intensity modulated
light. For this case, the optical density is the negative logarithm of the detected intensity modu-
lated amplitude, and the differential pathlength is
L(ρ) = − ∂
∂µa
log[|G(ρ, µ0a, µ′0s )|], (3.27)
where |G(ρ, µ0a, µ′0s )| is the amplitude of the frequency-domain Green’s function. For lower
modulation frequencies (< 100 MHz), the differential pathlength is roughly equivalent to the
CW differential pathlength (Figure 3.4). Thus, for lower modulation frequencies, it is a decent
approximation to utilize the measured CW differential pathlength given by Equation 3.14 or
Equation 3.16 in the frequency-domain Modified Beer-Lambert law.
82
3.3.7 Spectroscopy for Determination of Tissue Chromophore Concentration Changes
Recall that the absorption coefficient depends on the tissue chromophore concentrations (Equa-
tion 2.136), and therefore multi-spectral measurements of the tissue optical density enables mon-
itoring of differential changes in chromophore concentrations (∆ci) with the Modified Beer-
Lambert law, i.e.,
∆OD(λ) = − log
(
I(ρ, λ)
I0(ρ, λ)
)
≈ L(ρ, λ) log(10)
∑
i
εi(λ)∆ci. (3.28)
The Modified Beer-Lambert law is most typically employed to measure changes in oxy-hemoglobin
concentration (∆HbO) and deoxy-hemoglobin concentration (∆HbR).
Since the Modified Beer-Lambert law is the first order Taylor series expansion of the optical
density, it is expected to be accurate in the limit ∆µa/µ0a ≪ 1. However, simulations show that
Equation 3.28 remains accurate for substantial changes in HbO and HbR (Figure 3.5). Even
for ±50% changes, the Modified Beer-Lambert law still recovers the true hemoglobin changes
within ∼ 5% (Figure 3.5). Notice also that the Modified Beer-Lambert is more erroneous for
decreases in HbO and HbR than increases.
As I mentioned previously, the main drawback of Equation 3.28 is its inability to estimate
absolute “basline” hemoglobin concentrations. Further, if it’s not feasible to measure the dif-
ferential pathlengths directly, then the baseline hemoglobin concentrations along with the base-
line tissue scattering (µ′0s (λ)) are needed for calculating the differential pathelengths L(ρ, λ)
(e.g., Equation 3.22, where µ0a(λ) is obtained from the baseline chromophore concentrations
(Equation 2.136). Often, the baseline hemoglobin concentrations and tissue scattering must be
assumed, which leads to errors in the differential pathlengths used for hemoglobin monitoring.
Simulations, however, show the computed hemoglobin concentration changes with the Mod-
ified Beer-Lambert law to be fairly robust to differential pathlength errors (Figure 3.6). Recall
that wavelengths above the hemoglobin spectral isobestic point of λ = 800 nm are more sensi-
tive to HbO, while wavelengths below 800 nm are more sensitive to HbR. Thus, computation of
∆HbO is more sensitive to errors in L(830 nm) than in L(690 nm), and vice versa for compu-
tation of ∆HbR (Figure 3.6). Further, the simulations show that underestimating the differential
pathlengths induce larger errors in the computed hemoglobin concentrations than overestimating
the differential pathlengths does. For example, underestimation of the differential pathlengths by
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Figure 3.5: Contour plots of (A), the fractional error between the oxy-hemoglobin computed with
the Modified Beer-Lambert law (HbOMBL ≡ HbO0 + ∆HbOMBL; ∆HbOMBL determined
from Equation 3.28) and the actual oxy-hemoglobin (HbOactual ≡ HbO0 +∆HbOactual), i.e.,
HbOMBL/HbOactual − 1, and (B), the fractional error between the deoxy-hemoglobin com-
puted with the Modified Beer-Lambert law (HbRMBL ≡ HbR0 + ∆HbRMBL; ∆HbRMBL
determined from Equation 3.28) and the actual deoxy-hemoglobin (HbRactual ≡ HbR0 +
∆HbRactual), i.e., HbRMBL/HbRactual − 1. For both panels, the contour levels are plot-
ted as a function of the actual fractional oxy-hemoglobin change (vertical axis) and the actual
fractional deoxy-hemoglobin change (horizontal axis). These plots were generated from apply-
ing the Modified Beer-Lambert law to simulated multi-spectral data (λ = 690, 786, 830 nm)
at a source-detector separation of ρ = 2.5 cm. The simulated data was generated from vary-
ing HbO and HbR from baseline hemoglobin concentrations representative of the brain (i.e.,
HbO0 = 58 µM , HbR0 = 27 µM ) while tissue scattering remained constant (µ′s(λ) = 10
cm−1) [86]. Equation 2.136, with an assumed water volume fraction of 80%, was employed
to convert each oxy-hemoglobin and deoxy-hemoglobin concentration pair to multi-spectral ab-
sorption coefficients (µa(λ)). Then, the semi-infinite continuous-wave diffusion Green’s func-
tion (Equation 2.103 with ω = 0) was utilized to compute simulated detected intensities (I(λ))
from µa(λ) and a constant tissue scattering coefficient of µ′s = 10 cm−1. The multi-spectral
differential pathlengths were computed with Equation 3.25.
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∼ 25% induces underestimations in the computed hemoglobin concentrations of ∼ 10%, while
overestimation of the differential pathlengths by ∼ 25% induces < 5% errors in the computed
hemoglobin concentrations (Figure 3.6).
3.4 Modified Beer-Lambert Law for Turbid Heterogeneous Media
The homogeneous Modified Beer-Lambert law discussed above assumes that the absorption
change, ∆µa, is homogeneously distributed across the sampled light volume. This has the ad-
vantage of simplicity, but realistically, tissue is heterogeneous; it contains multiple compartments
with different optical properties due to vasculature, fat, and bone. Often these regions arise as
“layers” below the tissue surface such as scalp, skull, and cortex. Under these conditions, a Tay-
lor series expansion of the optical density can also be used to derive the Modified Beer-Lambert
law for heterogeneous media [130]. Assuming that the heterogeneous tissue can be divided into
N piecewise homogeneous regions, then the first-order Taylor series expansion of the optical
density is
OD ≈ OD0 +
N∑
k=1
[
∂OD0
∂µa,k
∆µa,k +
∂OD0
∂µ′s,k
∆µ′s,k
]
. (3.29)
Here, µa,k and µ′s,k are the tissue absorption and scattering for the kth homogeneous region in
the tissue, and ∆µa,k ≡ µa,k − µ0a,k and ∆µ′s,k ≡ µ′s,k − µ′0s,k denote the differential changes in
absorption and scattering from baseline. Rearranging Equation 3.29, the Modified Beer-Lambert
law for heterogeneous media is:
∆OD ≈
N∑
k=1
[
Lk(ρ)∆µa,k +
µ0a,k
µ′0s,k
Lk(ρ)∆µ
′
s,k
]
≈
N∑
k=1
Lk(ρ)∆µa,k, (3.30)
where the partial pathlengths, {Lk(ρ) ≡ ∂OD0/∂µa,k}, are the mean pathlengths that de-
tected photons travel in the kth region [130, 235]. In other words, the kth partial pathlength
is the photon mean time of flight in the kth region multiplied by the speed of light in the kth
region, i.e., Lk(ρ) = vk〈tk〉. As in Equation 3.6, the scattering term ∂OD0/∂µ′s,k∆µ′s,k ≈
Lk(µ
0
a,k/µ
′0
s,k)∆µ
′
s,k is often negligible compared to the absorption term.
In addition to the partial pathlengths depending on source-detector separation, ρ, they also
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Figure 3.6: Semi-infinite simulated data sets imitating cerebral signal changes induced by fin-
ger tapping (panels A, B) and induced by ischemic stroke (panels C, D), were utilized to make
contour plots showing the sensitivity of the computed hemoglobin concentration changes from
Equation 3.28 (λ = 690, 830 nm; ρ = 2.5 cm) to errors in the differential pathlength at λ = 830
nm (horizontal axis) and at λ = 690 nm (vertical axis). The contour levels are the fractional er-
rors in the Modified Beer-Lambert law calculations (using the erroneous differential pathlengths
specified on the horizontal and vertical axes) of (A) oxy-hemoglobin (HbOMBL/HbOactual−1;
HbOMBL defined in Figure 3.5) and (B) deoxy-hemoglobin ( HbRMBL/HbRactual − 1;
HbRMBL defined in Figure 3.5). Here, the actual oxy- and deoxy-hemoglobin concentration
changes are representative of the finger tapping task-induced changes in the motor cortex, i.e.,
∆HbOactual = 15 µM , ∆HbRactual = −5 µM [85]. Contour plots are also generated for
the fractional errors in the Modified Beer-Lambert law calculations of (C) oxy-hemoglobin
and (D) deoxy-hemoglobin for a different set of actual concentration changes that mimic the
changes induced by an ischemic stroke in the core of the lesion, i.e., ∆HbOactual = −15 µM ,
∆HbRactual = 15 µM [62]. The baseline tissue state is the same for all contour plots (i.e.,
HbO0 = 58 µM , HbR0 = 27 µM , µ
′0
s = 10 cm
−1), and the actual differential pathlengths,
L0(830 nm) = 13.2 cm and L0(690 nm = 14.1 cm, were computed with Equation 3.25. Tissue
scattering was not varied. Additional details on generating the simulated data are provided in the
caption for Figure 3.5. The reason that the zero-level contours do not intersect the point (1,1) is
because of errors in the Modified Beer-Lambert law itself (3.5). The Modified Beer-Lambert law
is a first-order Taylor series approximation, so it will not calculate the true hemoglobin changes
with perfect accuracy.
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depends on tissue geometry and the baseline tissue properties, {µ0a,k, µ′0s,k}. The partial path-
lengths cannot be directly measured, but they can be numerically computed with the hetero-
geneous analogue of Equation 3.20, which requires a priori knowledge of the baseline tissue
optical properties and tissue geometry.
The heterogeneous analogue of Equation 3.28 for spectroscopy with Equation 3.30 is
∆OD(λ) = − log
(
I(ρ, λ)
I0(ρ, λ)
)
≈ log(10)
N∑
k=1
[
Lk(ρ, λ)
∑
i
εi(λ)∆ci,k
]
, (3.31)
where ∆ci,k is the differential concentration change for the ith chromophore in the kth region.
3.4.1 Two-layer Modified Beer-Lambert Law
The simplest heterogeneous model for tissue is the two-layer geometry (Figure 3.7), which
many researchers use to model the brain as a compromise between simplicity and accuracy
[55,91,108,120,172,208,215]. The two-layer Modified Beer-Lambert law is the special case of
Equation 3.30 for N = 2 homogeneous layered regions, i.e.,
∆OD = − log
(
I(ρ)
I0(ρ)
)
≈ Lc(ρ)∆µa,c + Lec(ρ)∆µa,ec. (3.32)
Here, ∆µa,c and ∆µa,ec are the differential absorption changes in the cerebral and extra-cerebral
layers, respectively, and Lc(ρ) and Lec(ρ) are the cerebral and extra-cerebral partial pathlengths,
which depend on ρ, baseline optical properties, and the extra-cerebral layer thickness, ℓ.
I presented the two-layer photon diffusion Green’s function for the planar two-layer geom-
etry in Section 2.10 (Equation 2.112), which can be utilized to compute the two-layer partial
pathlengths:
Lc(ρ) ≡ ∂OD
0
∂µa,c
≈ 1
∆µa,c
log
[
G(ρ, µ0a,c −∆µa,c/2, µ0a,ec, µ′0s,c, µ′0s,ec, ℓ)
G(ρ, µ0a,c +∆µa,c/2, µ
0
a,ec, µ
′0
s,c, µ
′
s,ec0, ℓ)
]
, (3.33)
Lec(ρ) ≡ ∂OD
0
∂µa,ec
≈ 1
∆µa,ec
log
[
G(ρ, µ0a,c, µ
0
a,ec −∆µa,ec/2, µ′0s,c, µ′0s,ec, ℓ)
G(ρ, µ0a,c, µ
0
a,ec +∆µa,ec/2, µ
′0
s,c, µ
′
s,ec0, ℓ)
]
, (3.34)
where ∆µa,c/µ0a,c = ∆µa,ec/µ0a,ec = 10−5. Alternatively, a Monte Carlo technique [255] can
be utilized to evaluate Equations 3.33 and 3.34 for Lc(ρ) and Lec(ρ).
The two-layer partial pathlengths for representative baseline tissue optical properties of the
head are plotted as a function of source-detector separation in Figure 3.8. The extra-cerebral
87
Figure 3.7: (A) Two-layer tissue model of the head and (B) parallel plane two-layer tissue ge-
ometry.
partial pathlength is substantially greater than the cerebral partial pathlength, which confirms
that the detected light is weighted towards superficial tissue. Further, the partial pathlengths
are significanlty influenced by even small changes in the layer thickness, e.g., ∆ℓ = 2 mm
(Figure 3.8B).
The two-layer model is useful in many tissues for distinguishing between superficial tissue
(e.g., scalp/skull) and the tissue of interest (e.g., brain). However, the problem in general with
heterogeneous tissue models is that there are too many unknowns. Even with the two-layer
model, the partial pathlength computation requires 5 input parameters (i.e., µ0a,c, µ0a,ec, µ′0s,c,
µ′0s,ec, ℓ) that are potentially unknowns. Heterogeneous models also rely on the “finer features”
of the detected signal to distinguish between the different tissue regions, and are consequentially
less robust to measurement noise than the homogeneous model is.
In chapter 6, I will discuss how probe pressure modulation and multiple source-detector
separations can be utilized to add constraints to the two-layer model, making cerebral absorption
monitoring with the two-layer model more tractable.
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Figure 3.8: (A) Computed cerebral (Lc; Equation 3.33) and extra-cerebral (Lec; Equation 3.34)
partial pathlengths, plotted as function of source-detector separation, ρ, for a two-layer medium
representative of the head [55], i.e., µ0a,c = 0.16, µ0a,ec = 0.12, µ′0s,c = 6, µ′0s,ec = 10 cm−1,
ℓ = 1 cm, n = 1.4, and Reff = 0.493. (B) The ratio Lc(ρ)/Lec(ρ) is plotted as a function of ρ
for different extra-cerebral layer thicknesses, ℓ.
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Chapter 4
Diffuse Correlation Spectroscopy
(DCS): Correlation Diffusion Approach
4.1 Introduction
Diffuse optical spectroscopy (DOS) (Chapters 2, 3) is a static technique that measures slow (0.1
- 1 s) variations in the detected light intensity (I) induced by changes in tissue absorption (µa)
and tissue scattering (µ′s). Diffuse correlation spectroscopy (DCS) is a qualitatively different
dynamic light scattering technique that measures the rapid (e.g., microsecond scale fluctuations)
speckle light intensity fluctuations induced by red blood cell motion (Figure 4.1) [24, 37, 84].
DCS is a variant of the diffusing wave spectroscopy technique used in condensed matter physics
to study particle dynamics [179, 204, 257].
To probe blood flow, DCS uses the same measurement geometry as DOS, wherein NIR light
travels diffusively through tissue over a distribution of pathlengths from source to detector. At
the detector, the light electric fields from the different pathlengths interfere constructively or de-
structively to produce a bright or dark spot, or speckle. The motion of red blood cells within
the tissue slightly alters these light pathlengths, inducing speckle intensity fluctuations between
constructive and destructive interference. Higher blood flows correspond to faster speckle fluc-
tuations.
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Quantitatively, these speckle intensity fluctuations are characterized by computing the nor-
malized intensity autocorrelation function, i.e.,
g2(τ) ≡ 〈I(t)I(t+ τ)〉〈I(t)〉2 , (4.1)
at multiple delay-times, τ , where I(t) is the detected light intensity at time t, and the brackets
〈〉 represent time-averages (for experiments) or ensemble averages (for calculations) [18]. It is
straight forward to show that [18]
g2(τ) =
〈δI(t)δI(t + τ)
〈I(t)〉2 + 1, (4.2)
where the fluctuation, δI(t) ≡ I(t) − 〈I(t)〉, represents the deviation of the intensity from its
average value. At “long delay-times” wherein the intensity fluctuation at time t is not predictive
of the fluctuation at time t+ τ , 〈δI(t)δI(t + τ)〉 = 〈δI(t)〉2 = 0, and g2(τ) = 1. At τ = 0,
g2(0) =
〈[I(t)]2〉 − 〈I(t)〉2
〈I(t)〉2 + 1 = 1 + Λ
2 = 1 + β, (4.3)
where Λ ≡ σI/〈I〉 is the speckle contrast of the speckle fluctuations, and β ≡ Λ2. Thus, g2(τ)
decays from 1 + β to 1 as τ increases. Faster intensity fluctuations, which are associated with
higher blood flow, correspond to steeper decays in g2(τ) (Figure 4.1C).
For “fully developed” speckle, the speckle contrast is unity, i.e., g2(0) = 2, which indicates
that the speckle intensity fluctuations are of the same order as the average intensity (Section 4.2)
[112]. However, in practice there are a number of measurement-related factors that can reduce
speckle contrast, such as source coherence and experimental collection optics. If the width of
the pathlength distribution (i.e., the spread of different pathlengths) is comparable to or exceeds
the coherence length of the source, then the speckle contrast is substantially reduced. The phase
of the source light needs to remain constant on a length scale comparable to the spread of light
pathlengths between source and detector for the detectable interference that underlies a high
speckle contrast to exist [100, Section 32-4]. On the detection side of the measurement, the
detected signal is typically a sum over independent speckle intensities with the same statistics
[168]. For example, these independent speckle intensities can arise from orthogonal polarization
states and optical fiber modes. The effect of summing over independent speckle intensities is a
reduction in speckle contrast [112, 168] (Section 4.2).
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Figure 4.1: (A) Schematic for a homogeneous, semi-infinite model of the head with a blood flow
index, absorption coefficient, and reduced scattering coefficient of F , µa, and µ′s, respectively.
The incident continuous wave source intensity, Is, is assumed to remain constant over time.
Blood cell motion (e.g., red disks at time t and light-red disks at time t+τ ) induces fast temporal
fluctuations (i.e., speckle intensity fluctuations) in the detected light intensity on the time scale
of µs, while absorption changes modify mean light intensities (e.g., averaged on time scales of
ms or greater). (B) Schematic of detected intensity fluctuations for a baseline tissue state (red
curve) and a perturbed state from baseline with higher blood flow and absorption (blue curve).
The horizontal black lines are the mean intensities for the two states, denoted as I0 and I . (C)
The fast speckle intensity fluctuations in the two states are characterized by normalized intensity
autocorrelation functions (i.e., g02(τ), g2(τ)). The decay of the intensity autocorrelation function
curves is related to tissue blood flow.
For DCS, low speckle contrast is bad. The closer β is to zero, the more difficult it is to ascer-
tain blood flow from the decay in g2(τ). With no speckle contrast (i.e., β = 0), there is no decay
in the autocorrelation function at all, making it impossible to estimate blood flow. To maximize
speckle contrast in the DCS measurement, a high-coherence light source (e.g., coherence length
> 5 m) and single-mode fiber detection should be used (Section 4.10). However, since single
mode fibers have low numerical apertures and small core diameters, the detected light intensi-
ties are quite low at longer source-detector separations (e.g., 3 cm), and the DCS signal suffers
from low SNR. Several strategies for improving SNR in the DCS measurement are discussed in
Section 4.10.
To quantitatively relate the measurements of g2(τ) to blood flow, a correlation diffusion
approach (Section 4.5) is employed to calculate the electric field autocorrelation function, i.e.,
g1(τ) ≡ 〈E∗(t)E(t+τ)〉/〈I(t)〉 (I(t) = |E(t)|2), as a function of a blood flow index describing
the dynamics of red blood cells (F [cm2/s]) [23, 24, 79]. The blood flow index is ascertained by
fitting the calculated g1(τ) to the experimentally measured g2(τ) using the Siegert relation [168]:
g2(τ) = 1 + β|g1(τ)|2, (4.4)
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with β defined in Equation 4.3. The Siegert relation is valid if E(t) is a Gaussian variable with
zero mean. This is the case for any linear combination of “fully developed” speckle electric
fields (Section 4.2) [112]. For DCS measurements of tissue, the Siegert relation is generally a
good approximation (Section 4.10).
Although the blood flow index does not have absolute blood flow units, it is directly propor-
tional to tissue blood flow (Section 4.9), and has been successfully validated against a plethora
of gold-standard techniques [149,182]. Further, it is feasible to calibrate DCS for absolute blood
flow monitoring with an “initial” measurement of absolute blood flow from another technique
such as time-domain measurements of the contrast agent ICG [70].
Two key approximations of light transport make the calculation of g1(τ) tractable. The
first approximation is the photon diffusion model of light transport (Chapter 2), wherein each
path from source to detector involves many scattering events, and the photon directions of light
transport are completely randomized. The second approximation uses the phase change from an
average scattering event as the phase change for each individual photon scattering event.
4.2 Speckle Statistics
Speckle fluctuations, which appear in a signal that is composed of a large number of independent
phasors [112], are fundamental to the DCS measurement of blood flow. For many scattering
media, including tissue in the NIR spectral regime, the polarized light electric field at a point in
space and time, i.e., E(rd, t), is described by a random phasor sum:
E(rd, t) =
N∑
n=1
ane
iφn . (4.5)
Here, N ≫ 1 is the number of phasor components, and (an, φn) denote the amplitude and phase
of the nth phasor in the sum. For “fully developed” speckle fields, the statistics of the phasor
components satisfy the following three fundamental assumptions:
• The amplitudes and phases an and φn are statistically independent of am and φm provided
n 6= m.
• For any n, an and φn are statistically independent of each other.
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• The phases φn are uniformly distributed on the interval (−π, π), i.e., all values of phase
are equally likely.
Recall that two parameters are statistically independent if knowledge of one parameter conveys
no knowledge of the other parameter. Equation 4.5 constitutes a random walk in the complex
plane, and it is straight forward to show that E(r, t) is a Gaussian-distributed variable with zero
mean [112]. The probability density function for the amplitude of the electric field is therefore
given by the Rayleigh distribution [112], i.e.,
PE(|E|) = |E|
2πσ2
exp
[
−|E|
2
2σ2
]
, (4.6)
where σ2 = 〈a2〉/2.
Dynamic light scattering techniques generally measure the intensity, I(rd, t) = |E(rd, t)|2,
instead of the electric field. The probability density function for the intensity of a fully developed
speckle field is the negative exponential distribution [112], i.e.,
PI(I) =
∣∣∣∣d|E|dI
∣∣∣∣PE(√I) = 1〈I〉 exp
(
− I〈I〉
)
. (4.7)
Thus, a histogram of intensities measured over many time points at the spatial location rd is
characterized by an exponential distribution1 . One characteristic of the exponential distribu-
tion is that there are many more intensities below the mean (“dark spots”) than above the mean
(“bright spots”). Another property is that the standard deviation of intensities is equal to the
mean, and the speckle contrast is therefore unity. Recall that unity speckle contrast is expected
for polarized light detected at one spatial point. In practice, the detected light intensity is typi-
cally a sum over multiple independent fully developed speckle intensities, each governed by the
same statistics (Equation 4.7).
For example, consider the case of partially polarized light. Here, the detected light intensity
is the sum of two independent speckle intensities corresponding to the two orthogonal polariza-
tion states, i.e., I = I1 + I2, which reduces the speckle contrast to [112, 168]
Λ =
√
〈I1〉2 + 〈I2〉2
〈I1〉+ 〈I2〉 =
√
1 + r2
1 + r
, (4.8)
1The exponential distribution also applies for intensities sampled over many spatial locations at one time point,
i.e., an image.
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where r = 〈I2〉/〈I1〉. For completely unpolarized light, i.e., r = 1, Λ = 1/
√
2, and the intensity
autocorrelation intercept is β = g2(0)− 1 = 0.5 (see Equation 4.3).
More generally, if there are N fully developed speckles present in the detected signal, the
speckle contrast is [112, 168]
Λ =
√
β =
√∑N
n=1〈In〉2∑N
n=1〈In〉
, (4.9)
where 〈In〉 is the mean intensity of the nth speckle. For light detection with a multimode fiber
that supports M independent modes of light propagation, the number of speckles is N = M for
polarized light, and N = 2M for unpolarized light (discussed further in Section 4.10). In the
special case wherein the mean speckle light intensities are equal (i.e., 〈In〉 = I0 for all n), then
Equation 4.9 simplifies to
Λ =
√
β =
1√
N
. (4.10)
As a brief digression, for an imaging detection scheme with a lens and CCD camera (Fig-
ure 2.14), the spatial size of a speckle, b, is roughly the diffraction-limited spot size on the CCD
from the lens, i.e., b ≈ 2.44λ/NA, where λ is the wavelength of light, and NA is the numeri-
cal aperture of the lens [112]. The number of speckles detected by a pixel on the CCD is then
N ≈ Apixel/[(π/4)b2] for polarized light, and N ≈ 2Apixel/[(π/4)b2] for unpolarized light. In
this detection scheme, Equation 4.9 is still valid.
4.3 Dynamic Light Scattering in the Single-scattering Limit
Before developing the theory of DCS in the high multiple-scattering limit, it is useful to review a
simple traditional dynamic light scattering (DLS) (sometimes called quasi-elastic light scattering
(QELS)) experiment in the single-scattering limit (Figure 4.2). In the experiment, coherent,
polarized light illuminates a dilute sample of scatterers; dilute in the sense that an incident photon
is scattered once or not at all as it traverses the sample (see Figure 2.1B for the definition of a
scattering event). From the classical electromagnetic wave point of view, each scatterer develops
an induced dipole moment in the presence of the incident light given by
p = (χ˜ ·mi)Ei(t), (4.11)
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Figure 4.2: Illustration of a single scattering experiment for a dilute solution of N independent
scatterers. Light with polarization mi and wavevector ki is scattered in all directions. The com-
ponent of the scattered light with polarization ms and wavevector ks, i.e., E(rd, t), is detected
in the far field. The scattering wavevector, q ≡ ks − ki, is proportional to the momentum trans-
ferred from the incident light to the detected light. For elastic scattering, |q| = 2|ki| sin(θ/2).
where χ˜ is the polarizability tensor of the scatterer [116]. The oscillating dipole moment in the
scatterer, in turn, emits scattered light in all directions, which at the detector is given by [206,
Chapter 15]
Es(rd, t) =
µ0|Ei|
4π|rd − rj(t)|
ω2χis(t)e
−iq·rj(t)ei(ks·rd−ωt). (4.12)
Here, rd is the detector position, rj is the position of the jth scatterer, χis ≡ ms · χ˜ ·mi, and
q ≡ ks − ki (Figure 4.2). The term e−iq·rj(t) varies in time because of translation, while the
term χis(t) varies in time because of rotation or vibration.
In the single-scattering limit, only the incident light interacts with the scatterers, and there-
fore, the total light electric field at the detector is the superposition of the dipole contribution
from each scatterer (i.e., Equation 4.12). Therefore, in the far field limit,
E(rd, t) ∝
N(t)∑
j=1
χis(t) exp[−iq · rj(t)], (4.13)
where N(t) is the number of scatterers within the scattering volume at time t. Notice that if
N ≫ 1 and the scatterer positions are independent, Equation 4.13 is a random phasor sum
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that describes speckle fluctuations (Section 4.2). The electric field autocorrelation function of
Equation 4.13 is related to the scatterer displacements, ∆r(τ) = rj(t + τ) − rj(t), via [18,
Chapter 5]
g1(τ) ≡ 〈E
∗(t)E(t + τ)〉
〈I〉 = 〈exp[iq ·∆r(τ)]〉, (4.14)
provided the scatterers satisfy the following two assumptions:
1. The scatterer size is small compared to the light wavelength, λ,
2. The scatterer positions, {rj}, are statistically independent.
Assumption two is usually valid in dilute liquid solutions wherein scatterers rarely encounter
each other, but violated in solids wherein the scatterers are fixed in placed. Assumption one
ensures that the decay of g1(τ) is only due to translational motion (i.e., χis does not depend on
time). This assumption is discussed further in Section 4.3.4.
Again, recall that the 〈〉 brackets in Equation 4.14 indicate an ensemble average for the
calculation of g1(τ), i.e.,
g1(τ) =
∫
P (∆r(τ)) exp[iq ·∆r(τ)]d3(∆r), (4.15)
where the integration limits are from −∞ to ∞ in all dimensions, and P (∆r(τ)) is the proba-
bility density function for a particle to travel a distance of ∆r in time τ . Calculation of g1(τ)
thus requires knowledge of P (∆r(τ)).
4.3.1 Brownian Motion
A very important and common type of particle motion is Brownian motion. The underlying
equation describing Brownian motion is the Langevin equation [49, 50], i.e.,
du
dt
= −γu+ F(t). (4.16)
Here, u is the velocity of the particle, γ [s−1] is the frictional drag coefficient of the particle
moving through the medium divided by the particle’s mass [17], and F(t) is a stochastic term
accounting for collisions between the Brownian particle and molecules in the surrounding fluid
(e.g., water molecules). The key assumptions of Brownian motion are (1), F(t) is independent
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of u, and (2), F(t) varies extremely rapidly compared with u [49, 50]. Physically, the second
assumption means that there exist time intervals, ∆t, during which the Brownian particle velocity
changes inifinitesimally while the particle experiences a very large number of collisions with
molecules of the surrounding fluid.
On time scales t ≫ γ−1, the probability distribution for the Brownian particle’s displace-
ment, which can be derived from Equation 4.16, is Gaussian [49, 50], i.e.,
P (∆r(t)) =
1
(4πDbt)3/2
exp
[
−|∆r(t)|
2
4Dbt
]
. (4.17)
Here, the Brownian particle’s diffusion coefficient, Db, is [17, 49, 50] (see Equation 2.45)
Db =
vbℓp
3(1 − 〈cos ϑ〉) , (4.18)
where vb is the constant speed of the Brownian particle along a straight-line trajectory (or run),
ℓp is the mean run length (i.e., mean distance traveled between direction changes), and 〈cos ϑ〉
is the average of the cosine of the angle between successive runs.
Substituting Equation 4.17 into Equation 4.15, we obtain
g1(τ) = exp
[
−1
6
q2〈|∆r(τ)|2〉
]
. (4.19)
The particle mean-squared displacement is also determined from Equation 4.17:
〈|∆r(τ)|2〉 =
∫
|∆r(τ)|2P (∆r)d3∆r = 6Dbτ. (4.20)
Thus, in the single-scattering limit for Brownian motion, the electric-field autocorrelation func-
tion is
g1(τ) = exp[−q2Dbτ ]. (4.21)
Since the particle positions are independent, and the number of particles in the scattering
volume is assumed to be much greater than one, the detected electric field (Equation 4.13) is a
fully developed speckle field, and the Siegert relation (Equation 4.4) is valid. Thus, the measured
intensity auto-correlation function for Brownian motion is
g2(τ) = 1 + β exp[−2q2Dbτ ]. (4.22)
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4.3.2 Brownian Motion with Drift
If Brownian particles are exposed to a constant external force (e.g., gravity, pressure gradiant,
centrifugal), the particles still diffuse similarly to how they would in the absence of the external
force, but with a small persistent directional bias [17]. This motion is Brownian motion with
drift (or diffusion with drift). The extension of the Langevin equation (Equation 4.16) to include
an external force, Fext, is
du
dt
= −γu+ F(t) + Fext
m
, (4.23)
where m is the particle’s mass. On the same time scale t≫ γ−1, the probability distribution for
Brownian particle displacement derived from Equation 4.23 is [49]
P (∆r(t)) =
1
(4πDbt)3/2
exp
[
−|∆r(t)− vdt|
2
4Dbt
]
. (4.24)
Here, vd is the terminal drift velocity obtained from the external force, i.e., vd = Fext/(mγ).
Substituting Equation 4.24 into Equation 4.15, the electric field autocorrelation function for
diffusion with drift is
g1(τ) = exp(iq · vdτ) exp(−q2Dbτ), (4.25)
and the corresponding intensity autocorrelation function is (Equation 4.4)
g2(τ) = 1 + β exp[−2q2Dbτ ] (4.26)
Equations 4.26 and 4.22 are identical, indicating that the measured intensity autocorrelation
function cannot distinguish between isotropic Brownian motion and Brownian motion with drift.
This is also true for the high multiple-scattering limit. Importantly, the measured DCS/DLS
signal is only sensitive to the relative motions between scattering particles. Uniform motion that
is present in all of the scattering particles is not detected.
4.3.3 Random Flow
Random flow is the opposite of Brownian motion in the sense that it applies to very dilute solu-
tions (e.g., ideal gas) with scattering particles that seldom experience collisions. In this case, the
scattering particles move ballistically with velocity u between collisions. For a ballistic process,
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∆rj(t) = ujt. Ideal gases are accurately modeled with the Maxwell-Boltzmann distribution,
such that the distribution function for random flow displacement is
P (∆r) = t
[
m
2πkBT
]3/2
exp
(
−m|∆r(t)|
2
2kBT t2
)
, (4.27)
where T is the temperature, m is the particle mass, and kB is Boltzmann’s constant. Substitution
of Equation 4.27 into Equation 4.15, we obtain
g1(τ) = exp
[
−1
6
q2〈|∆r(τ)|2〉
]
= exp
[
−1
6
q2〈u2〉τ2
]
. (4.28)
Here, 〈u2〉 = 3kBT/m is the mean square velocity of the moving particles.
Of course, on small enough time scales, all motion is ballistic. DLS probes particle motion,
though, on the length scale of q−1. Looking at Equations 4.28 and 4.19, it is evident that sig-
nificant decays in g1(τ) occur on a particle displacement (∆r) length scale of q−1. Thus, if the
mean free path between collisions is long compared to q−1, then the measured particle dynamics
are ballistic. Conversely, if the mean free path between collisions is short compared to q−1, then
the measured particle dynamics are Brownian.
4.3.4 Large Particle Scattering
Equation 4.14 assumes that the scatterer size is small compared to the wavelength. However, red
blood cells, with a typical size of roughly 10 um, are substantially bigger than the wavelength.
For this regime, Equation 4.13 is [18, Chapter 8]
E(rd, t) ∝
N∑
j=1
Ψj(q, t) exp[−iq ·Rj(t)], (4.29)
where Rj(t) is the particle center of mass, and Ψj(q, t) is a particle form factor, i.e.,
Ψj(q, t) =
∫
χis(rrel, t)e
iq·rreld3rrel. (4.30)
Here, the integral is over the particle volume, and rrel ≡ r − Rk is a position in the particle
relative to the center of mass. The origin of the time-dependence in χis is particle rotation and
particle morphology changes. For rigid spheres, the rotational symmetry ensures that the form
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factor is time-independent, and the electric field autocorrelation function is determined from the
translational motion of the spheres:
g1(τ) = 〈exp[iq ·∆R(t)〉. (4.31)
However, many particles, including red blood cells, are not rigid spheres. If significant
rotational and morphologial motion occurs over the length scale of q−1, then the changes in
atomic form factor from these motions will significantly affect g1(τ). For elastic scattering,
q = 2ki sin(θ/2) (see Figure 4.2) and the length scale q−1 is approximately the light wavelength
λ. Therefore, for λ = 785 nm, q−1 ≈ 0.1 micron. If rotational and/or morphological changes
are minimal over this length scale, then Equation 4.31 is a good approximation for large particle
motions, and the results derived above for small scatterer size remain applicable.
4.4 Static and Dynamic Light Scattering in Tissue
In tissues, some scatterers are static (or very slowly moving) and some scatterers move (e.g., red
blood cells). Photon scattering from static tissue elements (Figure 4.3A) does not contribute to
the decay of g1(τ), but photon scattering from dynamically moving tissue elements (Figure 4.3B,
C) does. In tissue, red blood cells are usually the predominant dynamic light scatterers2 [30, 79,
190].
The tissue blood volume is typically a small fraction (< 4%) of the tissue volume, and red
blood cells account for only a small fraction of tissue scattering [30]. Thus, the scattering cross
section for static elements in the tissue is much greater than that for moving red blood cells,
which in turn means that the vast majority of scattering in tissue is static (type A; corresponds
to Figure 4.3A). However, on their journey from source to detector, photons will encounter
red blood cells, and these encounters are dynamic scatttering events (type B; corresponds to
Figure 4.3B).
A typical photon path through tissue consists of many static scattering steps prior to encoun-
tering a red blood cell (e.g., in a capillary), and then many more static scattering steps prior
to encountering another red blood cell (e.g., in another capillary), and so on. Mathematically,
2A notable exception is in exercising muscle, wherein the motion of muscle fibers has a big effect on the g1(τ )
decay [226].
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Figure 4.3: Photon scattering within tissue can be represented as a series of scattering steps of
types A, B, or C. ki and ks are the incident and scattered light wavevectors, and u denotes the
velocity of moving scatterers (red circles), which are assumed to be red blood cells.
this path is written as (A,A, . . . , A,B,A, . . . , A,B,A, . . .), which means that there are many
static scattering steps between each dynamic scattering event. Here, the red blood cells (RBC)
contributing to the decay of g1(τ) are independent particles.
It is also possible for photons to sequentially scatter off moving red blood cells (Figure 4.3C),
which mainly occurs within larger vessels (> 50 microns) [30]. Mathematically, this type of
scattering is (A,A, . . . , A,B,B,A, . . . ) or (A,A, . . . , A,B,B,B,A, . . .), etc. A key assump-
tion for deriving the multiply scattered light electric field autocorrelation function is scatterer
independence (Section 4.5). Moving red blood cells within the same vessel, though, may not be
independent.
Carp et. al. argued that the majority of photon-RBC interactions occur in larger vessels
wherein sequential RBC scattering is likely, because the majority of the tissue blood volume
(∼ 70%) is contained in these larger vessels [44]. However, as I discussed in Section 2.13,
light that propagates inside large vessels is preferentially absorbed because of the high light
absorption in blood. Then, the photons that are actually detected preferentially only encounter
small vessels. The contributions to the decay of g1(τ) as a function of vessel size is not well
understood, and is an interesting problem for future work.
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4.5 Dynamic Light Scattering in the High Multiple-scattering Limit
(Diffuse Correlation Spectroscopy)
I will now derive the electric field autocorrelation function in the high multiple-scattering limit
(i.e., correlation diffusion limit) [23, 24, 179, 204, 257]. The starting point is to consider a single
photon passing through tissue from source to detector that scatters N times along an arbitrary
light path p (Figure 4.4). The total pathlength of this photon is
sp =
N∑
j=0
|rj=1 − rj | =
N∑
j=0
(
kj
|kj |
)
· (rj+1 − rj), (4.32)
where kj is the wavevector of the light after j scattering events, rj is the position of scatterer j
at time t for j ≤ 1 ≤ N , r0 = rs is the light source position, and rN+1 = rd is the detector
position. The light scattering is assumed to be quasi-elastic, which means that all wavevectors
have the same magnitude (|kj | = κ◦ = 2πn/λ, for all j). Therefore, the total phase shift, φp(t),
acquired by the photon after traveling from the source to the detector along path p is
φp(t) = κ◦sp(t) =
N∑
j=0
kj(t) · [rj+1(t)− rj(t)]. (4.33)
Further, the contribution to the polarized detected electric field from this light path is Epeiφ(t),
where Ep is the amplitude of the field from path p at the detector. The field amplitude depends
primarily on the optical absorption and scattering coefficients of the medium. In tissue, these
optical properties change on a much slower time scale than the phase fluctuations. Thus, Ep is
temporally constant, and it is the phase fluctuations that induce the speckle fluctuations.
The total polarized detected electric field is the sum of Epeiφ(t) over all light paths from
source to detector, i.e.,
E(t) =
∑
p
Epe
iφp(t). (4.34)
Equation 4.34 represents a fully developed speckle field if the following assumptions are satisfied
(see Section 4.2):
• Ep and φp are statistically independent of Ep′ and φp′ for p 6= p′,
• For any light path p, Ep and φp are statistically independent of each other,
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Figure 4.4: A single light path p from source to detector in a turbid medium. The scattering is
quasi-elastic, such that the magnitudes of the wavevectors {kj} are the same. Further, kj points
in the propagation direction for light scattered from the jth particle, and rj is the position of the
jth particle.
• The phases φp are uniformly distributed on the interval (−π, π).
All three of these assumptions are valid if (1), the dynamic scatterers are independent, and
(2), the contribution to E(t) from photons that have only experienced static scattering on their
path from source to detector is negligible [14, 168]. Since g1(τ) does not decay from static
scattering, the physical meaning of point two is that the field autocorrelation function g1(τ)
fully decays to zero over a time scale much shorter than the duration of the measurement [14].
From scatterer independence, Equation 4.34 can be interpreted as a random walk in the complex
plane. If g1(τ) fully decays to zero over a shorter time scale than the measurement duration,
then many random walks will be sampled, and the distribution of E(t) over the time course of
the measurement is Gaussian with zero mean. For tissue, this means that the red blood cells
contributing to the decay of g1(τ) are independent, and that all photons in the detected signal
have interacted at least once with a red blood cell.
The electric field autocorrelation function of Equation 4.34 is
g1(τ) ≡ 〈E
∗(t)E(t+ τ)
〈I〉 =
1
〈I〉
〈(∑
p
Epe
−iφp(t)
)
∑
p′
E∗p′e
iφp′ (t+τ)


〉
, (4.35)
where 〈I〉 is the average detected intensity. From the speckle field assumptions, terms with
p 6= p′ do not contribute, i.e.,
〈E∗pEp′e−iφp(t)eiφp′ (t+τ)〉 = 〈E∗p〉〈Ep′〉〈e−iφp(t)〉〈eiφp′ (t+τ)〉 = 0. (4.36)
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Figure 4.5: Since kj(t+ τ) is in the same direction as [rj+1(t+ τ)− rj(t)], ∆kj(τ) · [rj+1(t+
τ) − rj(t)] ∝ sinϑ. To leading order, sinϑ ≈ 0, and the second term in Equation 4.38 is
negligible compared to the first term.
Thus, Equation 4.35 simplifies to
g1(τ) =
〈∑
p
|Ep|2
〈I〉 e
−i[φp(t)−φp(t+τ)]
〉
=
∑
p
〈Ip〉
〈I〉 〈e
i∆φp(τ)〉, (4.37)
where 〈Ip〉 ≡ 〈|Ep|2〉 is the average intensity from path p, and ∆φp(τ) ≡ φp(t + τ) − φp(t).
Defining qj ≡ kj(t)−kj−1(t) and ∆kj(τ) ≡ kj(t+ τ)−kj(t), we obtain from Equation 4.33
that
∆φp(τ) =
N∑
j=1
qj ·∆rj(τ) +
N∑
j=0
∆kj(τ) · [rj+1(t+ τ)− rj(t+ τ)], (4.38)
where ∆rj(τ) ≡ rj(t+ τ)− rj(t) is the scatterer displacement in time τ .
Notice that since [rj+1(t+ τ)− rj(t+ τ)] is in the same direction as kj(t+ τ) (Figure 4.4),
∆kj(τ) · [rj+1(t+ τ)− rj(t+ τ)] ∝ sinϑ, (4.39)
where ϑ is the angle between ki(t + τ) and ki(t) (Figure 4.5). For the time scales associated
with the decay of g1(τ), the angle ϑ is small, and to leading order, sinϑ ≈ 0. Thus, neglecting
the second sum in Equation 4.38, we obtain
∆φp(τ) =
N∑
j=1
qj ·∆rj(τ). (4.40)
Along a given light path in tissue, both static scattering and dynamic scattering occurs (Sec-
tion 4.4). Let Ns and Nd = N − Ns denote the number of static scattering events and number
of dynamic scattering events, respectively. Since ∆rj(τ) = 0 for static scattering events, they
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will not contribute to the sum in Equation 4.41, i.e.,
∆φp(τ) =
Nd∑
j=1
qj ·∆rj(τ). (4.41)
From the central limit theorem, ∆φp(τ) is a random Gaussian variable because it is a sum
of Nd independent random variables wherein Nd is assumed to be large (Equation 4.41). For the
special case of isotropic particle dynamics3, 〈∆φp(τ)〉 = 0, and
〈ei∆φp(τ)〉 = 1√
2π〈∆φ2p(τ)〉
∫ ∞
−∞
ei∆φp(τ) exp
[
− ∆φ
2
p(τ)
2〈∆φ2p(τ)〉
]
d(∆φp) = e
−〈∆φ2p(τ)〉/2.
(4.42)
Taking the ensemble average of the square of Equation 4.41, we obtain
〈∆φ2p(τ)〉 =
Nd∑
i=1
Nd∑
j=1
〈[qi ·∆ri(τ)][qj ·∆rj(τ)]〉 =
Nd∑
j=1
〈[qj ·∆rj(τ)]2〉, (4.43)
where again, the latter equality is true because of scatterer independence. Additionally, the
scattering vector qj and displacement vector ∆rj(τ) are assumed to be independent, and for
isotropic dynamics, 〈∆x2〉 = 〈∆y2〉 = 〈∆z2〉 = 〈∆r2〉/3, where 〈∆r2〉 is the magnitude of the
mean-square dynamic scatterer (e.g., red blood cell) displacement. Therefore,
〈∆φ2p(τ)〉 =
Nd∑
j=1
〈[qj ·∆rj(τ)]2〉
= Nd〈[qj ·∆rj(τ)]2〉
=
αN
3
〈q2〉〈∆r2(τ)〉, (4.44)
where α ≡ Nd/N is the fraction of photon scattering events that occur from moving particles in
the medium (e.g., red blood cells).
For quasi-elastic light scattering,
〈q2〉 = 〈[2κ◦ sin(ϑ/2)]2〉 = 2κ2◦(1− 〈cos ϑ〉) = 2κ2◦ℓsµ′s, (4.45)
where ϑ is the scattering angle (Figure 4.5), µ′s is the reduced scattering coefficient (Equa-
tion 2.44), ℓs is the scattering length (i.e., mean photon distance traveled between scattering
3Deterministic motion is briefly discussed in Section 4.7
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events), and κ◦ = 2πn/λ is the magnitude of the light wavevectors propagating through the
medium. Substituting Equation 4.45 into Equation 4.44 and noting that N = s/ℓs for large N ,
we obtain
〈∆φ2p(τ)〉 =
α
3
s
ℓs
2κ2◦ℓsµ
′
s〈∆r2(τ)〉 =
2α
3
κ2◦〈∆r2(τ)〉µ′ss. (4.46)
Importantly, 〈∆φ2p(τ)〉 does not depend on any other path-dependent property besides the path-
length s. Consequentially, the sum over paths in Equation 4.37 can be recast as a sum over
pathlengths. In the sum over pathlengths, 〈Ip〉/〈I〉 is replaced by the pathlength distribution
function P (s), which is the fraction of the detected scattered light intensity in paths of length s.
Recasting Equation 4.37 this way and combining it with Equations 4.46 and 4.42, we find that
the electric field autocorrelation function in the high multiple-scattering limit is
g1(τ) =
∑
s
P (s) exp
(
−α
3
κ2◦〈∆r2(τ)〉µ′ss
)
. (4.47)
In the continuum limit, Equation 4.47 becomes
g1(τ) =
∫ ∞
0
P (s) exp
(
−α
3
κ2◦〈∆r2(τ)〉µ′ss
)
ds, (4.48)
where P (s) can be calculated from the photon diffusion model of light transport (Section 4.5.1).
Equation 4.48 assumes that the decay of g1(τ) is dominated by translational motion from red
blood cells. Rotational and morphological internal motion in red blood cells can contribute to
the decay of g1(τ) (Section 4.3.4), but this type of motion is not accounted for in Equation 4.48.
The DCS autocorrelation function measured in tissue decays on the order of 100 µs (e.g.,
Figure 4.6). Therefore, in addition to assuming scatterer independence, isotropic dynamics, and
that Nd ≫ 1 for all photon paths from source to detector, Equation 4.48 assumes that blood
cell morphology remains constant and that rotation is negligible on time scales of ∼ 100 µs.
Finally, the blood cell dynamics are assumed to remain in equilibrium over the time scale of the
measurement (ms to seconds).
Importantly, the autocorrelation function decay times associated with long light paths are
relatively short, while the decay times associated with short light paths are relatively long [186,
221, 257]. This is due to the factor µ′ss in the exponent in Equation 4.48. At short delay-times,
the small particle displacement 〈∆r2(τ)〉 is obviously amplified more by µ′ss at long light paths
than short light paths, and thus the long light paths contribute more to the exponential decay at
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short τ . Consequentially, the DCS autocorrelation measurement at shorter τ in the remission
geometry (Figure 4.1A) is inherently more sensitive to deeper tissue depths [12, 221].
Since Equation 4.34 is a fully developed speckle field (i.e., a Gaussian variable with zero
mean), the Siegert relation (Equation 4.4) can be employed to convert g1(τ) (Equation 4.48) to
the intensity autocorrelation function, g2(τ) (Equation 4.1).
4.5.1 Calculation of g1(τ)
The calculation of g1(τ) given by Equation 4.48 is greatly facilitated through utilizing the photon
diffusion model. Recall that the photon diffusion equation for a point source is (Equation 2.46)
D∇2Φ(r, t)− vµaΦ(r, t)− ∂
∂t
Φ(r, t) = −vS′0δ(r)δ(t), (4.49)
and that the photon fluence rate, Φ(r, t), is proportional to the “time of flight” distribution
function ξ(t), i.e., ξ(t)dt is the probability for a photon to reach position r at time t (see Sec-
tion 2.12.2). Analogously, the pathlength distribution function P (s) is directly proportional to
the photon fluence rate as a function of light pathlength, i.e., Φ˜(r, s) = Φ(r, s/v). Explicitly,
P (s) = Φ˜(r, s)/
∫ ∞
0
Φ˜(r, s)ds, (4.50)
and the field autocorrelation function (Equation 4.48) is in turn
g1(r, τ) =
∫∞
0 Φ˜(r, s)e
−νsds∫∞
0 Φ˜(r, s)ds
, (4.51)
where ν ≡ αµ′sκ2◦〈∆r2(τ)〉/3.
Note that the diffusion equation describing Φ˜(r, s) is easily obtained from introducing the
change of variables t = s/v into Equation 4.49:
D∇2Φ˜(r, s)− vµaΦ˜(r, s)− v ∂
∂s
Φ˜(r, s) = −vS′0δ(r)δ(s/v). (4.52)
Therefore, one approach for determining g1(r, τ) is to substitute the solution of Equation 4.52
(for the appropriate geometry) into Equation 4.51. Another, more versatile approach is the cor-
relation diffusion approach described in the next section.
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4.6 Homogeneous Correlation Diffusion Equation
The correlation diffusion equation formally models G1(r, τ) ≡ 〈E∗(r, t)E(r, t+τ)〉 [W cm−2],
which is the so-called unnormalized electric field autocorrelation function. By definition, the
normalized field autocorrelation function is
g1(r, τ) ≡ G1(r, τ)/G1(r, τ = 0). (4.53)
Comparing Equation 4.53 with Equation 4.51, it is evident that
G1(r, τ) =
1
h
∫ ∞
0
φ˜(r, s)e−νsds, (4.54)
where h [cm] is a proportionality constant.
The homogeneous correlation diffusion equation is the Laplace transform of Equation 4.52,
i.e., ∫ ∞
0
(D∇2 − vµa)Φ˜(r, s)e−νsds− v
∫ ∞
0
(
∂
∂s
Φ˜(r, s)
)
e−νsds =
− v
∫ ∞
0
S′0δ(r)δ(s/v)e
−νsds, (4.55)
which is (Equation 4.54)
∇2G1(r, τ)− v
D
[
µa +
α
3
µ′sκ
2
◦〈∆r2(τ)〉
]
G1(r, τ) = − v
D
S0δ(r). (4.56)
Here, I substituted in αµ′sκ2◦〈∆r2(τ)〉/3 for ν, and S0 ≡ S′0v/h [W]. Recall that S′0 from
Equation 4.49 has units of energy, and therefore S0 has units of power. S0 can be regarded
as the power of the continuous-wave light source, which divides out in the normalization of
G1 (i.e., Equation 4.53). Further, as the correlation diffusion equation is the Laplace transform
of the photon diffusion equation, the correlation diffusion boundary conditions are the Laplace
transform of the photon diffusion boundary conditions (Equations 2.80, 2.83):
G1(r, τ) = zbzˆ∇G1(r, τ) Partial-flux. (4.57)
G1(z = −zb, τ) = 0. Extrapolated zero. (4.58)
Since Equation 4.56 with its boundary conditions has the same form as the homogeneous
photon diffusion equation (Equation 4.49) for CW sources, the Green’s function solutions of the
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correlation diffusion equation will also have the same form. For example, the continuous-wave
photon diffusion Green’s functions listed in Table 2.5 are converted to the correlation diffusion
Green’s functions by replacing k = (µav/D)1/2 with
K(τ) =
√(
µa +
α
3
µ′sκ2◦〈∆r2(τ)〉
) v
D
. (4.59)
For the important special case of the homogeneous semi-infinite geometry, the explicit solution
to Equation 4.56 subject to the extrapolated-zero boundary condition (Equation 4.58) is (see
Equation 2.103)
G1(r, τ) =
vS0
4πD
[
exp(−K(τ)r1)
r1
− exp(−K(τ)rb)
rb
]
. (4.60)
4.6.1 Heterogeneous Correlation Diffusion Equation
Equation 4.56 is only applicable for homogeneous media. For heterogeneous media, the cor-
relation diffusion equation is derived from the steady-state correlation transport equation for
continuous-wave sources and systems in equilibrium [3, 73]:
∇ ·GT1 (r, Ωˆ, τ)Ωˆ+µtGT1 (r, Ωˆ, τ) = Q(r, Ωˆ)+
µs
∫
GT1 (r, Ωˆ
′, τ)gs1(r, Ωˆ, Ωˆ
′, τ)f(r, Ωˆ, Ωˆ′)dΩ′. (4.61)
Here, GT1 (r, Ωˆ, τ) = 〈E∗(r, Ωˆ, t)E(r, Ωˆ, t + τ)〉 is the autocorrelation function of the polar-
ized electric field (with arbitrary polarization state) at position r and time t propagating in the
Ωˆ direction (see Equation 2.4), gs1(r, Ωˆ, Ωˆ′, τ) is the normalized temporal field autocorrelation
function for single scattering (Equation 4.14), f(r, Ωˆ, Ωˆ′) is the normalized differential single
scattering cross-section (see Table 2.1), Q(r, Ωˆ) is the light source distribution (see Table 2.1),
and µt = µa + µs.
Given Equation 4.61, one can implement a set of steps formally identical to the steps used to
derive the photon diffusion equation from the radiative transport equation (Section 2.3). That is,
using a P1 approximation for GT1 , the correlation transport equation reduces to the correlation
diffusion equation [23, 24]:
∇ · (D(r)∇G1(r, τ)− v
(
µa(r) +
α
3
µ′s(r)κ
2
◦〈∆r2(r, τ)〉
)
G1(r, τ) = −vS(r). (4.62)
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Here, G1(r, τ) is the “total” electric field autocorrelation function modeled in Equation 4.56,
i.e.,
G1(r, τ) =
∫
4π
GT1 (r, Ωˆ, τ)dΩ = 〈E∗(r, t)E(r, t + τ)〉, (4.63)
where E(r, t) is the total light electric field with arbitrary polarization at (r, t), and S(r) is an
isotropic CW source term (Equation 2.18). Further, D(r), µa(r), µ′s(r), and v = c/n are the
photon diffusion coefficient, absorption coefficient, reduced scattering coefficient, and speed of
light in tissue, respectively (see Table 2.2), κ◦ = (2πn/λ) is the light wavevector in tissue, α rep-
resents the fraction of photon scattering events that occur from moving particles, and 〈∆r2(r, τ)〉
is the mean-square displacement in time τ of the moving scattering particles at position r. Of
course, for the special case of homogeneous media, Equation 4.62 becomes Equation 4.56. Fi-
nally, the correlation diffusion boundary conditions given by Equations 4.57 and 4.58 remain
valid for heterogeneous media.
As with the radiative transport equation, in geometries/conditions where light transport is
non-diffusive, it is necessary to solve the correlation transport equation directly with Monte
Carlo techniques [24, 25, 186].
4.7 Diffuse Correlation Spectroscopy for Shear Laminar Flow
Brownian motion (Section 4.3.1) and random flow (Section 4.3.3) are examples of stochastic
dynamics. Here, I will very briefly discuss the DCS field autocorrelation function obtained for
deterministic laminar shear flow in the high multiple-scattering limit [260]. A special case of
laminar shear flow is planar couette flow, where the velocity of scatterers is described by
u = Γzxˆ, (4.64)
and the DCS field autocorrelation function is [260]
g1(τ) =
∫ ∞
0
P (s) exp
(
− κ
2◦s
15µ′s
Γ2τ2
)
ds. (4.65)
Note that the decay of g1(τ) for laminar shear flow depends on the gradient of the flow velocity,
i.e., ∂u/∂z = Γ, not the absolute flow velocity. For uniform flow velocity (u = u0xˆ), there
would be no decay in g1(τ). Thus, as in the single-scattering limit (4.3.2), the DCS autocorrela-
tion signal is only sensitive to the relative motions between scatterers [19, 260].
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4.8 α is proportional to tissue blood volume fraction
To derive α (Equation 4.44), let N0 be the number of incident photons on an infinitesimal volume
of tissue. The total number of these incident photons scattered within the infinitesimal volume
is N0µsd3r, where µs (not µ′s) is the tissue scattering coefficient (see Section 2.2). Of these
scattered photons, the number that have been scattered by moving red blood cells isN0µRBCs d3r,
where the scattering coefficient µRBCs is the blood cell contribution to µs. Therefore, the fraction
of photon scattering events that occur on red blood cells is
α =
µRBCs
µs
=
σRBC̺RBC
µs
, (4.66)
where σRBC [cm2] is the scattering cross-section of a red blood cell (RBC), and ̺RBC is the
number density of red blood cells in the tissue sample. Note that
̺RBC =
(Hct)(BV )
VRBCVtissue
, (4.67)
where Hct is the hematocrit (i.e., volume fraction of red blood cells in blood), BV [mL] is the
blood volume, VRBC [mL] is the volume of a red blood cell, and Vtissue [mL] is the total tissue
volume. Substituting Equation 4.67 into Equation 4.66, we obtain
α =
(
σRBC
µs
)(
Hct
VRBC
)(
BV
Vtissue
)
. (4.68)
Thus, unsurprisingly, α is proportional to the tissue blood volume fraction BV/Vtissue. If there
is more blood, then there are more scattering interactions with blood, and α increases.
4.9 Tissue Blood Flow Index
DCS is most sensitive to the motion of blood cells in the microvasculature (i.e., capillaries,
arterioles, venules), since the diffusing light is mostly absorbed when traversing large arteries
and veins (Section 2.13). Since the microvasculature is convoluted, the correlation diffusion
model (Equation 4.56) assumption of isotropic RBC directions is reasonable. The red blood cell
dynamics are incorporated into the correlation diffusion equation via their mean-square displace-
ment, 〈∆r2(τ)〉. For the case of Brownian motion (Section 4.3.1), 〈∆r2(τ)〉 = 6Dbτ , where
Db is the particle diffusion coefficient. For the case of random ballistic flow (Section 4.3.3),
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Figure 4.6: Exemplar autocorrelation measurements from a mouse tumor, a piglet brain, an
adult human calf muscle, and an adult human brain. The dashed lines denote the fits to the semi-
infinite correlation diffusion solution (Equation 4.60) with 〈∆r2〉 ∼ τ2 (random flow), and the
solid lines denote the fits with 〈∆r2〉 ∼ τ (Brownian). This figure is reprinted from [79].
〈∆r2(τ)〉 = 〈u2〉τ2, where 〈u2〉 is the second moment of the particle speed distribution. Exten-
sive DCS autocorrelation measurements collected over a wide range of tissue types and length
scales all fit the correlation diffusion solution with Brownian dynamics better than the correlation
diffusion solution with ballistic dynamics (Figure 4.6). Equation 4.59 for the Brownian model is
K(τ) =
√
(µa + 2µ′sκ2◦F )
v
D
, (4.69)
where
F ≡ αDb (4.70)
is the tissue blood flow index [cm2/s].
A standard approach for blood flow monitoring with DCS is to derive g1(τ) (Equation 4.53)
from measurements of g2(τ) (Equation 4.1) via the Siegert relation (Equation 4.4). Then, the
correlation diffusion solution for the geometry of interest (e.g., Equation 4.60 for semi-infinite
geometry) is fit to g1(τ) using a nonlinear minimization algorithm, and an estimate of the blood
flow index (F ) is obtained from the fit. We (and others) have found that the blood flow index
correlates well with other blood flow measurement modalities [149, 182]. Additionally, Dur-
duran et al [79] and Ninck et al [190] directly demonstrated that the observed decay in g1(τ)
measurements on tissue arise from red blood cell motion. As a result, it is natural to identify F
as a flow index that is directly proportional to blood flow.
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4.9.1 Brownian Motion of Red Blood Cells
Recall from Section 4.3.2 that particles with velocities well-modeled by Equation 4.23 exhibit
Brownian motion on time scales of t≫ γ−1, where γ is the linear drag coefficient of the particle
divided by the particle’s mass, m. Equation 4.23 assumes that the drag force on the particle
depends linearly on particle velocity, which is valid for fluids at low Reynolds number [240,
Chapter 2]. The Reynolds number of a fluid is [17, Chapter 6]
R =
ubς
η
, (4.71)
where u is the particle’s speed moving through the fluid, b is the size of the particle, ς is the
mass density of the fluid, and η is the viscosity of the fluid. For blood in the microvasculature,
η ≈ 2 × 10−2 g/(cm s) [32], u ≈ 0.05 cm/s (in capillaries) [249], b ≈ 10 microns, and ς ≈ 1
g/mL, which results in a Reynolds number of R = 0.003. In arterioles, the blood cell speed is
considerably faster than capillaries, but even for a blood cell speed of u = 1 cm/s, the Reynolds
number is still only R = 0.05. Since R≪ 1 for blood in the microvasculature, the drag force on
red blood cells is linear, i.e., f = γmu.
An important time scale for assessing blood cell dynamics is γ−1 for blood cells. If we
approximate the blood cell as a sphere of radius a, then from Stoke’s law, the linear drag on the
blood cell is
f = 6πηa,
and
γ−1 =
m
f
=
2ςRBCa
2
9η
≈ 3 µs. (4.72)
The estimate of 3 µs was obtained from using a = 5 µm, a blood cell mass density of ςRBC = 1
g/cm3, and a blood viscosity of η = 2× 10−2 g/(cm s). The time scale on which the autocorre-
lation function decays is on the order of 50-100 µs, so the red blood cells in the microvasculature
plausibly undergo a biased random walk, wherein the diffusion coefficient is (Equation 4.18)
Db =
vbℓRBC
3(1 − 〈cos ϑ〉) =
1
3
vbℓ
∗
RBC . (4.73)
Here, vb is the average speed of the red blood cells, ℓRBC is the mean run length of red blood
cells (i.e., mean straight-line distance traveled between direction changes), 〈cos ϑ〉 is the average
of the cosine of the angle between successive runs, and ℓ∗RBC ≡ ℓRBC/(1 − 〈cos ϑ〉).
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Figure 4.7: An arbitrary tissue volume Vtissue is comprised of a vascular compartment (with blood
volume BV ) and a tissue compartment. The blood flow (BF ) in the vascular compartment is
the total blood flow supplying Vtissue.
Note that the motion of blood cells is highly biased in the forward direction, i.e., ϑ is very
small. Further, tissue blood flow is not in thermal equilibrium, and the diffusion coefficient given
by Equation 4.73 is a few orders of magnitude higher than the diffusion coefficient given by the
Einstein-Smoluchowski relation, i.e., Db = kbT/f [79]. This is analogous to bacteria swimming
in water (via flagellar propulsion), which have a diffusion coefficient three orders of magnitude
higher than dead bacteria in water [17, 209].
4.9.2 Relation Between Blood Flow Index and Blood Flow
A compartment model of tissue (Figure 4.7) is commonly employed to obtain bulk estimates of
average tissue blood flow and oxygen consumption [42, 62, 132, 242, 246, 273]. In this model,
the tissue is comprised of a vascular compartment and a tissue compartment, and red blood cells
with number density ψRBC (i.e., # RBC per blood volume (BV )) move with speed vb through
the vascular compartment. The compartment model is obviously an unrealistic geometry for the
actual vasculature, but it still provides a reasonable estimate of bulk blood flow in the tissue
volume Vtissue (discussed further in Section 7.6).
From Equations 4.73 and 4.66, the blood flow index (Equation 4.70) is
F ≡ αDb =
(
σRBCℓ
∗
RBC
3µs
)
(̺RBCvb). (4.74)
Note that the RBC number density per volume of tissue, ̺RBC , is related to the RBC number
density per volume of blood, ψRBC , via
ψRBC =
Vtissue
BV
̺RBC . (4.75)
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Multiplying both sides of Equation 4.74 by Vtissue/BV and utilizing Equation 4.75, we find that
F =
(
BV
Vtissue
)(
σRBCℓ
∗
RBC
3µs
)
(ψRBCvb). (4.76)
Here, ψRBCvb [# RBC / (s cm2)] is the flow of red blood cells per vascular cross-sectional area
per time. The blood volume (BV ) is related to the number of red blood cells (# RBC) via
BV =
VRBC(#RBC)
Hct
, (4.77)
where VRBC is the volume of a red blood cell, and Hct is the hematocrit. From multiplying both
sides of Equation 4.76 by VRBC/Hct, we see that F is proportional to tissue blood flow, i.e.,
F =
(
BV
Vtissue
)(
Hct
VRBC
)(
σRBCℓ
∗
RBC
3µs
)
BF. (4.78)
Here, BF = (ψRBCVRBC/Hct)vb [(mL blood) / (s (cm2 tissue)] is the tissue blood flow in
units of blood volume per time per cross-sectional area of the vascular compartment. Thus, the
blood flow index, F , is proportional to tissue blood flow. The proportionality coefficient depends
directly on the tissue blood volume fraction (BV/Vtissue), hematocrit (Hct), RBC scattering
cross-section (σRBC ), and RBC transport mean free path (ℓ∗RBC ), and inversely on the RBC
volume (VRBC ) and the tissue scattering coefficient (µs, not µ′s).
Clinically, absolute blood flow is reported in confusing units of blood volume per time per
tissue volume, e.g., [(mL blood) / (min (100 mL tissue))]. These units are understood through the
compartment model of tissue (Figure 4.7). The “clinical blood flow”, BFc, is the total volume
of blood flowing into Vtissue per time, divided by Vtissue. BFc and BF (Equation 4.78) are related
by the expression
BFc = BF
(
Atissue
Vtissue
)
, (4.79)
where Atissue is the total cross-sectional area of the tissue volume of the vascular compartment
supplying Vtissue.
4.10 DCS Signal Measurement
4.10.1 Validity of the Siegert Relation
DCS estimates the tissue blood flow index F from a nonlinear fit of the measured intensity
autocorrelation function signal, g2(τ), to the electric field autocorrelation function correlation
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diffusion solution, g1(τ). A key step in this fit is using the Siegert relation (Equation 4.4) to
derive g1(τ) from the g2(τ) measurement. The Siegert relation is valid if the detected electric
field is a Gaussian distributed variable with zero mean. This is the case if the detected electric
field is a sum of fully developed speckle fields (see Section 4.2).
For tissue measurements, it is feasible for a component of the detected signal to arise from
light paths that have only experienced static scattering (Section 4.4). In this scenario, the detected
electric field can be written as
E(r, t) = Ec(r) + Ef (r, t), (4.80)
where Ef (r, t) is the fully developed speckle electric field arising from light paths that have
encountered at least one moving scatterer, and Ec(r) is a constant term arising from light paths
that have encountered no moving scatterers. Ec(r) is cleary not a speckle field, and therefore
the Siegert relation is not valid for Equation 4.80. The relation between g2(τ) and g1(τ) for
Equation 4.80 is [168]
g2(τ) = 1 +
βf
(If + Is)2
[
I2f |g1(τ)|2 + 2If Is|g1(τ)|
]
. (4.81)
Here, If ≡ 〈E∗fEf 〉, Is ≡ E∗sEs, and βf is the speckle contrast arising from the fluctating
component of the electric field (i.e., Equation 4.9). The intercept of Equation 4.81 is
g2(0) = 1 + βf
I2f + If Is
(If + Is)2
, (4.82)
so the effect of the static scattering field component is to reduce the speckle contrast. For single
mode fiber detection of unpolarized light, if β = 0.5, then the static scattering component is
negligible. However, if the speckle contrast is lower than expected, one potential explanation for
it is that Ec in the detected signal is significant. The expectation is that this problem is more of
a risk for short separations than long separations. In most practical tissue measurements with
single mode detection, we have found that the β coefficient is about 0.5, even at short separations
around 0.7 cm. This suggests that Ec is typically small in practice.
However, recall from Section 4.5 that one of the assumptions used in the derivation of the
correlation diffusion equation is that the detected light paths from source to detector encounter
a large number of red blood cells. Therefore, even if the Siegert relation is valid, the correlation
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diffusion model may still break down if a significant fraction of the photon paths involve only a
few RBC scattering interactions. This will not be an issue for long separations, but it could be a
problem for short separations.
4.10.2 Fiber Detection with DCS
I mentioned in Section 4.2 that for detection with optical fibers, each mode propagating through
the fiber is a fully developed speckle field. The electric fields from all of the modes have iden-
tical statistics (i.e., Gaussian-distributed with zero mean), but they are independent fields that
add incoherently. The incoherent sum of independent speckle fields results in reduced speckle
contrast (i.e., Equation 4.9). From a geometrical optics point of view, various rays propagate
down a multimode fiber at different angles to the axis of the fiber (Figure 4.8). Each angle of
propagation is a fiber optic mode, and the fiber optic modes are independent because the quasi
plane wave electric fields incident on the fiber from different angles are independent (see Equa-
tion 2.4). The numerical aperture (NA) of the fiber specifies the acceptance cone of incident
light angles allowed into the fiber, i.e., θ < ϑc = arcsin(NA/n) (n is the refractive index of
the medium in contact with the fiber). However, not every ray that enters an optical fiber within
its acceptance cone can propagate successfully through the fiber. Only certain ray directions
(modes) are allowed that satisfy a “resonance condition” (see [202, Section 10-5]). The number
of modes supported by a multimode step-index fiber is M ≈ (2πn/λ)(NA)a, where λ is the
light wavelength in air and a is the radius of the fiber core [112]. For a 62.5 micron fiber with a
NA = 0.22, n = 1.4, and λ = 785 nm, M ≈ 80 modes. . Further, for unpolarized light, there
are two independent speckle fields for each mode that correspond to the two orthogonal polar-
ization states. Thus, the detected intensity from the 62.5 micron fiber for unpolarized light is a
sum of 2M = 160 speckle fields. This corresponds to a β coefficient of 0.006, i.e., essentially
no speckle contrast.
Single mode fibers have very low numerical apertures such that only the θ = 0 mode can
propagate through the fiber (Figure 4.8). With only one mode (2 speckle fields for unpolar-
ized light), single mode fibers maximize the contrast of the detected signal, but they also have
drawbacks. Because of their very small size and numerical aperture (5 micron core diameter,
0.13 NA), single mode fibers do not collect much light, and low signal-to-noise is a commonly
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Figure 4.8: Schematics of a multimode and single mode fiber. Multimode fibers have high
numerical apertures, enabling light propagation at multiple angles (i.e., modes) to the axis of the
fiber. Single mode fibers have very low numerical apertures, and therefore light only propagates
in the θ = 0 mode. This figure is adapted from [1].
encountered problem in the DCS measurement at longer source-detector separations (e.g., 3
cm) [37]. The “hair problem” is also a bigger issue for DCS than it is for DOS, because it is
easier for single mode fibers to be completely blocked by a light absorbing hair follicle than the
multimode fibers used for DOS detection [37, 84].
There are several strategies for ameliorating the DCS signal-to-noise problem. First is to use
high quantum efficiency single-photon detectors, such as the SPCM-AQ4C (Excelitas, Canada)
APD detector array. Second is to incorporate multiple detection channels in the DCS instrument.
For example, with 8 detection channels, DCS signals can be collected in parallel from 8 single
mode fibers bundled together at nearly the same position on tissue. Averaging across these 8
channels to derive a single autocorrelation curve will improve SNR by ∼ √8. For N detection
channels, the improvement in SNR is ∼ √N . However, the single photon detectors used for
DCS detection are currently expensive, placing a practical limit on the total number of detection
channels. In the future, DCS would benefit greatly from the lower costs permitted by economies
of scale in the production of single-photon counting detectors [84].
A third strategy is to increase the light source power delivered to tissue, but the maximum
power is limited by ANSI standards for maximum permissible skin exposure. For continuous
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exposure (i.e., laser is always on), the maximum permissible power delivered to a point on the
skin for λ = 785 nm is P = 28 mW, though higher powers are permissible if the laser is pulsed
(Section 4.10.4).
A fourth strategy some researchers have pursued is the use of few-mode fibers for DCS
detection [69, 125, 169]. The light intensity itself is of course greater with few-mode detection.
If N modes can propagate through the fiber, then the detected intensity is
〈Id〉 = 〈
N∑
j=1
Ij〉 = N〈Ij〉, (4.83)
which is a factor of N higher than the single mode intensity. However, as discussed above, the
summation over N independent modes reduces the β coefficient by a factor of N (4.10). If the
DCS signal decays exponentially (i.e., g2(τ) − 1 = β exp[−2Γτ ]), then the SNR of the signal
measurement is [274, 276]
SNR =
g2(τ)− 1
σg2−1(τ)
≈ 〈Id〉β
√
T tavg
exp[−2Γτ ]√
1 + β exp[−Γτ ] , (4.84)
where tavg is the DCS signal averaging time, and T is the correlator delay-time bin width. The
DCS signal typically is well approximated by an exponential decay, and therefore 4.84 is a
reasonable model for the SNR [274, 276]. For few-mode fiber detection then, the gain from
increased signal intensity is canceled by the reduction in β, and the SNR is about the same as
single-mode fiber detection. However, few-mode fibers are also prone to modal noise (e.g., from
fiber bending) [112], which is an additional source of noise not accounted for in Equation 4.84.
For these reasons, single-mode fibers are usually optimal for DCS detection, though perhaps
few-mode fibers can obtain better SNR through hair. Finally, the SNR will increase with the
square root of the averaging time (tavg in Equation 4.84) at the cost of a lower time resolution.
4.10.3 Source Coherence
As I already discussed, the coherence length of the source should be substantially greater than
the spread of light pathlengths through tissue to ensure detected speckle fluctuations with high
speckle contrast. The width of the pathlength distribution depends on the separation and optical
properties, but for practical measurements, it is less than 1 meter [201]. The source itself, though,
has to have a greater coherence length than this (roughly > 5 m) if a mulitmode fiber is utilized
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for light delivery. This is because light propagation through a multimode source fiber effectively
reduces the coherence length of the light source. The time delays introduced by the differences in
pathlength between the different light modes propagating in the fiber induce speckle fluctuations
at the end of the fiber that interrupt the constant phase of a monochromatic source.
An alternative way to understand coherence effects is in terms of the power spectrum of
the light, I(ω). The power spectrum is defined as the Fourier transform of the electric field
autocorrelation function [18]:
I(ω) ≡ 1
2π
∫ ∞
−∞
dτe−iωτ 〈E∗(t)E(t+ τ)〉. (4.85)
Consequentially, the field autocorrelation function is the inverse Fourier transform of I(ω):
〈E∗(t)E(t + τ)〉 =
∫ ∞
−∞
dωeiωτ I(ω). (4.86)
Note that
〈|E|2〉 = 〈I〉 =
∫ ∞
−∞
dωI(ω), (4.87)
so I(ω)dω is the “amount” of the light intensity in the frequency interval (ω, ω + dω). The
decay of the field autocorrelation function (G1(τ)) is related to the width of the power spectrum.
If G1(τ) decays exponentially with decay time τc, the half-width at half maximum of I(ω) is
∆ωc = τ
−1
c . In fact, blood cell motions could be estimated from the measurements of the power
spectrum as an alternative to measurements of the intensity autocorrelation function. However,
the autocorrelation function measurement is preferable to its Fourier counterpart in the low signal
limit, because the photon correlation instrumentation is a single photon counting device [81].
The power spectrum of the light source is close to monochromatic, and thus very sharply
peaked at ω = 2πc/λ. As light travels through tissue from source to detector, the time delays
from the different light paths increases the spectral linewidth of the power spectrum, ∆ωc. The
longer the source-detector separation, the greater the time delays between the different path-
lengths become. These greater time delays in turn increase the width of the power spectrum and
decrease the decay time of the autocorrelation function. This is why the DCS autocorrelation
signals decay substantially faster at longer source-detector separations than they do at shorter
separations.
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Analogously, the time delays from the different light paths in a multimode fiber broaden the
power spectrum. The longer the optical fiber is, the greater these time delays are, and corre-
spondingly, the broader the power spectrum is. Thus, the coherence of the source light delivered
to the tissue will depend on the fiber length. For optimal sensitivity to blood flow, the broadening
of the light power spectrum from this loss of coherence needs to be much less than the broaden-
ing of the light power spectrum from the blood cell motion. If the broadening from coherence
loss is comparable to the broadening from blood cell motion, then coherence effects “wash out”
the speckle fluctuation effects from blood cell motion, and the signal is not sensitive to blood
cell motion.
The speckle contrast is clearly sensitive to the coherence of the source. Thus, if the speckle
contrast is fluctuating (i.e., the g2(τ) intercept is unstable during the measurement integration
time), this could indicate that the coherence of the source is unstable. This source instability
could arise from Fresnel reflections back into the laser from improper probe contact with the
tissue (e.g., air gaps often lead to big Fresnel reflections). An unstable contrast could also arise
from light leakage into the probe from room light, since multispectral light affects the power
spectrum of the detected signal. Finally, if the probe is not well-secured to tissue, any sort
of movement could lead to sampling of different tissue locations (i.e., different speckle fields)
during the integration time of the measurement, which is another source of instability.
4.10.4 ANSI standards for Maximum Permissible Light Powers
For the DCS measurement, the total light power delivered to the tissue must be below the ANSI
standards for maximum permissible skin exposure to light [5]. According to Table 7 of the ANSI
regulation [5], the long term maximum permissible skin exposure is
Elt = 0.2CA [W / cm2], (4.88)
where the constant CA = 1 W / cm2 for λ < 700 nm and 102(λ/1000−0.7) W / cm2 for λ > 700
nm. The ANSI standard clearly states the limiting aperture diameter for skin exposure to account
for scattering once it penetrates the skin. This value can be found in Table 8a of the ANSI
standard [5], and it is 3.5 mm for exposures ranging from 1 ms to 30,000 s and for wavelengths
lying between 400 nm and 1400 nm. For a fiber-coupled laser that delivers a light power P [W]
122
continuously to a point on the skin, the experimental skin exposure is
Elt,exp = P/(π(0.35/2)
2 [W / cm2]. (4.89)
Comparing Equations 4.89 to 4.88, the maximum permissible power that can be delivered con-
tinuously (i.e., laser is always on) to a point on the skin at λ = 785 nm is P = 28.4 mW.
However, the permissible power can be higher for non-continuous light power delivery, e.g.,
the laser is on for time ton, off for time toff , on for time ton, off for time toff , and so on.
From Table 7 of the ANSI regulation [5], for exposures ton between 10−7 and 10 seconds, the
maximum permissible skin exposure is given by
E = 1.1CAt
0.25
on [J / cm2], (4.90)
where CA is defined below Equation 4.88. The experimental skin exposure from a single laser
pulse with power P and duration ton is
Eexp = Pton/(π(0.35/2)
2 [J / cm2], (4.91)
and the average long-term experimental skin exposure from a train of these laser pulses is
Elt,avg = Eexp/(ton + toff ) [W / cm2], (4.92)
where again, toff is the time interval between laser pulses. The ANSI regulations are satisfied
when Eexp (Equation 4.91) is less than E (Equation 4.90) and Elt,avg (Equation 4.92) is less
than Elt (Equation 4.88). Thus, the duty cycle of the laser needs to be chosen appropriately to
ensure these two conditions are not violated.
As a concrete example, let’s suppose that ton = 2.5 s. Setting Equation 4.91 equal to
Equation 4.90, the maximum permissible power for a pulse with duration 2.5 s is P = 79 mW.
For Elt,avg to be less than Elt for a train of pulses with ton = 2.5 s and P = 79 mW, toff has to
be greater than 4.5 s.
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Chapter 5
Diffuse Correlation Spectroscopy
(DCS): Modified Beer-Lambert Law
Approach
5.1 Introduction
Here, I present an alternative approach to the correlation diffusion approach for analysis of DCS
signals, which is a Modified Beer-Lambert law for flow. This method linearly relates measured
changes of a newly-defined “DCS optical density” to the variation of tissue blood flow, tissue
scattering, and tissue absorption. The novel algorithm parallels the DOS/NIRS Modified Beer-
Lambert law, but it has interesting differences that should be useful for applications that require
continuous monitoring of blood flow. It also has similar advantages to the DOS Modified Beer-
Lambert law. The rest of this chapter is essentially a verbatim reprint of my biomedical optics
express paper on the Modified Beer-Lambert law for flow [12]. Although some of the introduc-
tion material here has been covered in previous chapters, I kept the introduction material in to
keep this chapter self-contained.
Traditional optical spectroscopy measures the attenuation of light traveling through a sam-
ple as a function of wavelength. In cases where scattering is negligible, i.e., in which the re-
duced scattering coefficient (µ′s) is zero, light attenuation is dominated by absorption, and the
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transmitted intensity (I(t)) at time t is related to the sample absorption coefficient (µa) via the
Beer-Lambert law: I(t) = Is exp[−µaρ]. Here, Is is the incident light intensity, and ρ is the
sample length. The sample optical density (OD) is defined as the negative logarithm of the ra-
tio of transmitted to incident light intensity; it is proportional to the absorption coefficient, i.e.,
OD ≡ − log[I(t)/Is] = µaρ. When scattering within the sample is significant, however, then
light attenuation is affected by both absorption and scattering. In these situations, the effects
of scattering become tangled with those of absorption [79]. Typically, the photon trajectories
through tissue samples with significant scattering are well approximated as random walks, and
the average length of a photon path through tissue is much greater than the straight-line distance
between source and detector.
Among the most widely used approaches for analysis of such DOS/NIRS reflectance signals
is the so-called Modified Beer-Lambert law [10,67,130]. The Modified Beer-Lambert paradigm
is an algorithm that derives changes in tissue optical properties based on continuous-wave (CW)
diffuse optical intensity measurements. In its simplest form, the scheme relates differential light
transmission changes (in any geometry) to differential changes in tissue absorption. Here the
term differential refers to a comparison between a baseline state and a perturbed state. In essence,
the Modified Beer-Lambert law accounts for tissue scattering by using the mean pathlength
traveled by photons through the highly scattering sample as a best estimate for the actual photon
pathlengths. The mean pathlength provides a natural constant of proportionality between the
measured differential intensity and the sample’s differential absorption.
The Modified Beer-Lambert law is readily derived from the first order Taylor expansion of
the optical density: OD ≈ OD0 + (∂OD0/∂µa)∆µa + (∂OD0/∂µ′s)∆µ′s, wherein the partial
derivatives are evaluated in the “baseline” state (µa = µ0a, µ′s = µ′0s ), OD0 ≡ − log[I0/Is] is the
baseline optical density, and the differential changes in absorption and scattering are denoted by
∆µa ≡ µa(t)− µ0a and ∆µ′s ≡ µ′s(t)− µ′0s , respectively. Note that the superscript “0” indicates
baseline. Within this approximation, the change in optical density from baseline is
∆OD = − log
(
I(t)
I0
)
≈ 〈L〉∆µa(t) +
(
µ0a
µ′0s
)
〈L〉∆µ′s(t) ≈ 〈L〉∆µa(t). (5.1)
Here, 〈L〉 ≡ ∂OD0/∂µa is the so-called differential pathlength, which is approximately the
mean pathlength that diffusing photons travel through the medium from source to detector [10].
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Notice that whereas the traditional Beer-Lambert law relates absolute optical densities to ab-
solute absorption coefficients, the Modified Beer-Lambert law (Equation 5.1) relates differential
changes in the optical density to differential changes in the absorption coefficient. This algorithm
has proved useful for many reasons; it is simple, fast, and fairly accurate. To date the Modified
Beer-Lambert algorithms have been applied predominantly to monitor hemoglobin concentra-
tion changes in the brain; within this context, it has been extended from semi-infinite geometries
to two-layer geometries [91, 130, 215, 234, 235] characteristic of many tissues, especially the
human head.
Herein, we derive a Modified Beer-Lambert law for measurement of blood flow based on
the DCS technique in turbid tissues, and we validate the approach. The Modified Beer-Lambert
law for blood flow linearly relates changes in tissue blood flow, tissue scattering, and tissue ab-
sorption to variation of a newly-defined “DCS optical density” (ODDCS). The new algorithm
parallels the DOS/NIRS Modified Beer-Lambert law, since the transport of both the light fluence
rate and the electric field autocorrelation function through highly scattering tissues is well ap-
proximated as a diffusive process [79]. Importantly, however, the diffusion equation for the DCS
signal is sensitive to the movement of red blood cells in tissue microvasculature, and therefore
the precise form of the Modified Beer-Lambert law for blood flow is different from the tradi-
tional (DOS/NIRS) form. The weighting factors in the new law, for example, are not as easily
interpreted in terms of a mean pathlength. We derive general theoretical results for measurement
of flow changes in any geometry, and then we obtain specific expressions for two common tissue
models: homogeneous semi-infinite turbid media and two-layer turbid media. We demonstrate
the new approach with simulations and with an in-vivo pig-brain experiment. In the future, we
expect the Modified Beer-Lambert law for flow to offer increased DCS measurement speed, sim-
pler DCS instrumentation, and, importantly, access to novel measurement paradigms based on
differential blood flow signals. Ultimately, these developments should lead to improvements in
characterization of cerebral flow and metabolism, with concomitant clinical impact.
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5.2 Diffuse Correlation Spectroscopy
Diffuse correlation spectroscopy (DCS) employs NIR light to non-invasively measure tissue
blood flow. Since early work with in-vitro phantoms and in-vivo tissues [23, 24, 179, 204], it has
been used in a variety of clinical applications such as stroke [62, 86, 97, 224], brain injury [159,
160], muscle disease [183,185,225], cancer [54,83,236,270], and in functional activation studies
[85,147,169,213]. In addition, the DCS blood flow index has been successfully validated against
a plethora of gold-standard techniques [149, 182]. Several recent reviews highlight the theory,
implementation and applications of DCS [37, 79, 84, 182, 269], and therefore our background
discussion will be brief.
DCS detects tissue blood flow using speckle correlation techniques. It measures the temporal
intensity fluctuations of coherent NIR light that has scattered from moving particles (red blood
cells) in tissue (Figure 5.1(A)). These temporal fluctuations (Figure 5.1(B)) are quantified by
computing the normalized intensity temporal autocorrelation function at multiple delay-times,
τ , i.e., we compute g2(τ) ≡ 〈I(t)I(t + τ)〉/〈I(t)〉2, where I(t) is the intensity of the detected
light at time t, and the angular brackets, 〈〉, represent time-averages. An index of tissue blood
flow is then provided by the temporal decay of the detected intensity autocorrelation function
(Figure 5.1(C)).
Formally, the transport of the electric field (E(t)) autocorrelation function, G1(τ) ≡ 〈E∗(t)·
E(t + τ)〉, is well modeled by the so-called correlation diffusion equation [23, 24], which can
be solved analytically or numerically for tissue geometries of interest [24, 79]. Tissue blood
flow can be ascertained by fitting the solution for the normalized electric field autocorrelation
function, g1(τ) = G1(τ)/G1(τ = 0), to the measured (normalized) intensity autocorrelation
function via the Siegert relation [168]: g2(τ) = 1+β|g1(τ)|2, where β is a constant determined
primarily by the experimental collection optics.
As an example, for the simple case of point illumination and point detection on the surface
of semi-infinite homogeneous tissue (Figure 5.1(A)) with absorption coefficient µa, reduced
scattering coefficient µ′s, and tissue blood flow index F , the solution to the correlation diffusion
equation is [24, 79]:
G1(τ) =
3
4πℓtr
[
exp (−K(τ)r1)
r1
− exp (−K(τ)rb)
rb
]
. (5.2)
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Figure 5.1: (A) Schematic for blood flow monitoring in a homogeneous, semi-infinite turbid
tissue (see text for details). Blood cell (e.g., red disks at time t and light-red disks at time
t + τ ) motion induces temporal fluctuations in the scattered light intensity, I(t), at the light
detector (panel B). These intensity fluctuations are characterized by the normalized intensity
autocorrelation function (g2(τ)). (C) The decay of the intensity autocorrelation function curves
is related to tissue blood flow.
Here, K(τ) = [3µa(µa + µ′s)(1 + 2µ′sk20Fτ/µa)]1/2, r1 = (ℓ2tr + ρ2)1/2, rb = [(2zb + ℓtr)2 +
ρ2]1/2, ρ is the source-detector separation, and ℓtr = 1/(µa + µ′s). Further, k0 = 2πn/λ is the
magnitude of the light wave vector in the medium, and zb = 2ℓtr(1+Reff )/(3(1−Reff )), where
Reff is the effective reflection coefficient that accounts for the mismatch between the index of
refraction of tissue (n) and the index of refraction of the non-scattering medium bounding the
tissue (nout), such as air [123].
A standard approach for blood flow monitoring with DCS in this geometry is to derive g1(τ)
from measurements of g2(τ) via the Siegert relation. Then, the semi-infinite correlation diffusion
solution (Equation 5.2) is fit to g1(τ) using a nonlinear minimization algorithm, and an estimate
of the blood flow index (F ) is obtained from the fit.
5.3 Modified Beer-Lambert Law for Flow
We now develop a “Modified Beer-Lambert law” for tissue blood flow based on the DCS mea-
surement. The first step in this process is to define a “DCS optical density” (ODDCS), in analogy
with the OD for DOS/NIRS. For source-detector separation ρ and delay-time τ , we define the
DCS optical density as: ODDCS(τ, ρ) ≡ − log(g2(τ, ρ) − 1). Notice that in addition to delay
time and source-detector separation, the DCS optical density also implicitly depends on tissue
absorption, scattering, and blood flow (e.g, Equation 5.2).
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5.3.1 DCS Modified Beer-Lambert law for homogeneous tissue
We first derive a general expression for homogeneous tissue characterized by a blood flow in-
dex, F , an absorption coefficient, µa, and a reduced scattering coefficient, µ′s. The DCS Modi-
fied Beer-Lambert law is obtained by truncating the Taylor series expansion of the DCS optical
density to first order in F , µa, and µ′s, i.e.,
ODDCS(τ, ρ) ≈ OD0DCS(τ, ρ) +
∂OD0DCS
∂F
∆F +
∂OD0DCS
∂µa
∆µa +
∂OD0DCS
∂µ′s
∆µ′s. (5.3)
Here, OD0DCS(τ, ρ) ≡ − log(g02(τ, ρ) − 1) is the “baseline” DCS optical density with a base-
line blood flow index, F 0, and with baseline optical properties µ0a and µ′0s . Correspondingly,
ODDCS(τ, ρ) ≡ − log(g2(τ, ρ)− 1) is the DCS optical density for the intensity autocorrelation
function in the “perturbed” state with blood flow index F , and with optical properties µa and
µ′s. The differential changes from baseline of tissue blood flow, absorption, and scattering are
∆F ≡ F − F 0, ∆µa ≡ µa − µ0a, and ∆µ′s ≡ µ′s − µ′0s , respectively.
Comparing Equation 5.3 with Equation 5.1, the DCS analogues of the differential pathlength
are dF (τ, ρ) ≡ ∂OD0DCS/∂F , da(τ, ρ) ≡ ∂OD0DCS/∂µa, and ds(τ, ρ) ≡ ∂OD0DCS/∂µ′s,
which can be estimated analytically or numerically using the correlation diffusion model applied
to the appropriate geometry (Section 5.7). All three of these weighting factors depend on τ and
ρ, on tissue geometry, and on the baseline parameters F 0, µ0a, and µ′0s . Rearranging Equation 5.3,
we arrive at the “DCS” Modified Beer-Lambert law for homogeneous tissue:
∆ODDCS(τ, ρ) = − log
(
g2(τ, ρ)− 1
g02(τ, ρ)− 1
)
≈ dF (τ, ρ)∆F+da(τ, ρ)∆µa+ds(τ, ρ)∆µ′s. (5.4)
If the blood flow and optical properties change only slightly, then the perturbation in the DCS
optical density is small, and the first order expansion (Equation 5.3) is a good approximation.
Notice, however, that even for large tissue hemodynamic changes, ∆ODDCS can still be small at
short delay-times, because in this limit, dF , da, and ds are close to zero (Figure 5.2). Analytical
and numerical computation of these weighting factors (dF , da, ds) are described and given in
Section 5.7.
Equation 5.4 is a general result that describes the change in DCS optical density for ho-
mogeneous tissue. For a given tissue/measurement geometry, the change in blood flow can be
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computed by evaluating the weighting factors for the geometry in question, and then inserting
these resultant weighting factors into Equation 5.4.
5.3.2 DCS Modified Beer-Lambert law for homogeneous semi-infinite geometries
It is straightforward to evaluate the weighting factors in Equation 5.4 for the special case of the
homogeneous semi-infinite geometry (Figure 5.1(A)). Recall from Equation 5.2 that the normal-
ized electric field autocorrelation function is
g1(τ) =
exp(−K(τ)r1)/r1 − exp(−K(τ)rb)/rb
exp(−K0r1)/r1 − exp(−K0rb)/rb , (5.5)
where K(τ), r1, and rb are as defined in Section 5.2, and K0 = K(τ = 0) = [3µa(µa +
µ′s)]1/2. The multiplicative weighting factors in the semi-infinite geometry can be computed
from substitution of Equation 5.5 into Equations (5.11) and (5.12), e.g.,
dF (τ, ρ) =
6µ′0s
(
µ′0s + µ0a
)
k20τ
K0(τ)
[
exp
(−K0(τ)r01)− exp (−K0(τ)r0b )
exp
(−K0(τ)r01) /r01 − exp (−K0(τ)r0b ) /r0b
]
. (5.6)
In Figure 5.2, dF , da, and ds in the semi-infinite geometry are plotted as a function of τ
using typical tissue properties. Note that all three weighting factors are small in magnitude
for short delay-times. Further, the weighting factor for absorption is negative, i.e., an increase in
absorption is accompanied by a decrease in the DCS flow optical density (compared to baseline),
and the weighting factors for flow and scattering are positive.
Because the weighting factors are small at shorter delay-times (Figure 5.2), the DCS optical
density perturbation will also be small, which in turn implies higher accuracy for the DCS Mod-
ified Beer-Lambert law (Equation 5.4). Ideally, in the semi-infinite geometry, the delay-times
used for Equation 5.4 should satisfy the limits 2µ′sk20Fτ/µa ≪ 1 and 2µ′0s k20F 0τ/µ0a ≪ 1 to
obtain the most quantitatively accurate results (see Section 5.8). From our experience with simu-
lations and real data, we have found that a good “rule of thumb” for accurately using Equation 5.4
is to utilize data wherein g01(τ) > 0.5, which corresponds to g02(τ) > 1.1 for β = 0.5.
Figure 5.2(B) shows that for the same fractional changes (10%) in blood flow, tissue scat-
tering, and tissue absorption, the change in DCS optical density is greatest due to scattering,
followed by flow; changes in absorption have the least influence on the DCS signal. In practice,
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Figure 5.2: (A) The semi-infinite multiplicative weighting factors (see Equation 5.4) for tissue
scattering (ds), for tissue absorption (da), and for tissue blood flow (dF , right vertical-axis). They
are plotted as a function of the correlation time, τ , for source-detector separation, ρ = 3 cm, and
optical wavelength, λ = 785 nm, given a typical set of cerebral tissue properties, i.e., µ0a = 0.1
cm−1, µ′0s = 8 cm−1, F 0 = 10−8 cm2/s, n = 1.4, nout = 1. (B) The semi-infinite DCS
Modified Beer-Lambert components dF (τ, ρ)∆F , ds(τ, ρ)∆µ′s, and |da(τ, ρ)∆µa|, plotted as a
function of τ for a 10% increase in blood flow, tissue scattering, and tissue absorption, respec-
tively. On the right vertical-axis is the intensity autocorrelation function, g02(τ), for β = 0.5.
Given the same fractional change in tissue properties, the DCS signal is most sensitive to scat-
tering changes, followed by flow changes, and finally absorption changes. In many applications,
however, the scattering changes associated with hemodynamic perturbations are negligible, e.g.,
such as an increase in blood flow and blood volume; in these situations the scattering component
can be neglected (see text).
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concurrent frequency-domain or time-domain DOS/NIRS can (and should) be employed to di-
rectly measure tissue absorption and scattering [79, 101, 201] and account for their effects. This
mode of operation, i.e., with concurrent optical measurements, is always desirable. Importantly,
however, the tissue scattering changes that typically accompany hemodynamic concentration
variations are often negligible; the origin of hemodynamic variation is blood, but the origin of
tissue scattering is predominantly from interfaces between cells and the extracellular space, or
between cellular cytoplasm and cellular organelles [57]. The tissue blood volume (BV ) is typi-
cally a small fraction (< 4%) of the tissue volume (Vtissue), and red blood cells account for only
a small fraction of the tissue scattering [30]. Scattering from blood (µ′s,blood) is proportional
to the blood volume, i.e., µ′s,blood = σblood(1 − g)(Hct/VRBC )(BV/Vtissue), where σblood,
g, and VRBC are the scattering cross-section, scattering anisotropy factor, and volume of a red
blood cell, and Hct is the hematocrit. Consequentially, while tissue scattering can change with
variation in blood volume, the magnitude of this change is often quite small, because the overall
volume fraction of blood in tissue is quite small.
As an example, the finger tapping functional task induces a localized increase in cerebral
blood volume of roughly 10% [85], which corresponds approximately to a 10% increase in
scattering from blood. However, the fractional increase in total scattering is much less than 10%
because blood only accounts for a small fraction of tissue scattering. If we assume that blood
accounts for less than 5% of total tissue scattering [57], then the tissue scattering change due to
increased blood volume from finger tapping is less than 0.5%.
5.3.3 DCS Modified Beer-Lambert law for heterogeneous tissue
Tissue is perhaps too often approximated to be optically homogeneous for hemodynamic mon-
itoring, an approach which has the advantage of simplicity. Realistically, however, tissue is
heterogeneous; it contains multiple compartments with different optical properties due to vas-
culature, fat, and bone. Often these regions arise as “layers” below the tissue surface such as
scalp, skull, and cortex. Under these conditions, a Taylor series expansion of the DCS optical
density can also be used to derive the DCS Modified Beer-Lambert law for heterogeneous media.
Assuming that the heterogeneous tissue can be divided into N piecewise homogeneous regions,
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then the first-order Taylor series expansion of the DCS optical density is
ODDCS(τ, ρ) ≈ OD0DCS(τ, ρ)+
N∑
k=1
[
∂OD0DCS
∂Fk
∆Fk +
∂OD0DCS
∂µa,k
∆µa,k +
∂OD0DCS
∂µ′s,k
∆µ′s,k
]
.
(5.7)
Here, Fk , µa,k, and µ′s,k denote the blood flow index, tissue absorption, and tissue scattering
for the kth homogeneous region in the tissue, respectively, and ∆Fk ≡ Fk − F 0k , ∆µa,k ≡
µa,k − µ0a,k, and ∆µ′s,k ≡ µ′s,k − µ′0s,k denote the changes in these parameters from baseline.
Rearranging Equation 5.7, the DCS Modified Beer-Lambert law for heterogeneous media is:
− log
(
g2(τ, ρ) − 1
g02(τ, ρ)− 1
)
≈
N∑
k=1
[
dF,k(τ, ρ)∆Fk + da,k(τ, ρ)∆µa,k + ds,k(τ, ρ)∆µ
′
s,k
]
, (5.8)
where {dF,k ≡ ∂OD0DCS/∂Fk , da,k ≡ ∂OD0DCS/∂µa,k, ds,k ≡ ∂OD0DCS/∂µ′s,k} are DCS
analogues of the partial pathlengths from DOS/NIRS [130]. These multiplicative weighting
factors depend on tissue geometry, on the baseline tissue properties, i.e., {F 0k , µ0a,k, µ′0s,k}, and
on τ and ρ. They account for the relative importance of the various regional hemodynamic
changes in the DCS optical density perturbation, and they can be estimated in the same manner
as described in 5.7.
5.3.4 DCS Modified Beer-Lambert law for two-layer media
The simplest heterogeneous model for tissue is the two-layer geometry, an important special
case (Figure 5.3). Researchers have used this geometry in order to distinguish cerebral tissue
from extra-cerebral tissue in optical measurements of the head [55, 85, 106, 120, 172, 208, 215],
to model tissue burns [24], to distinguish skin from fat/muscle [95, 156], to distinguish fetal
from maternal tissues [53], and in other applications. For cerebral applications, the two-layer
geometry is comprised of a semi-infinite bottom layer (i.e., corresponding to the cortical regions
of the brain) with a distinct blood flow index, absorption coefficient, and scattering coefficient of
Fc, µa,c, and µ′s,c, respectively, and a superficial top layer (i.e., corresponding to extra-cerebral
scalp and skull tissue) with thickness ℓ, and distinct tissue properties denoted by Fec, µa,ec, and
µ′s,ec.
The two-layer DCS Modified Beer-Lambert law is the special case of Equation 5.8 forN = 2
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Figure 5.3: (A) Two-layer tissue model of the head and (B) parallel plane two-layer tissue ge-
ometry.
piecewise homogeneous (layered) regions, i.e.,
∆ODDCS(τ, ρ) = − log
(
g2(τ, ρ)− 1
g02(τ, ρ) − 1
)
≈ dF,c(τ, ρ)∆Fc + dF,ec(τ, ρ)∆Fec+
da,c(τ, ρ)∆µa,c + da,ec(τ, ρ)∆µa,ec + ds,c(τ, ρ)∆µ
′
s,c + ds,ec(τ, ρ)∆µ
′
s,ec.
(5.9)
Again, the multiplicative weighting factors, dF,i ≡ ∂OD0DCS/∂Fi, da,i ≡ ∂OD0DCS/∂µa,i, and
ds,i ≡ ∂OD0DCS/∂µ′s,i (with subscript i denoting c (cerebral) or ec (extra-cerebral)), indicate
the relative sensitivity of the DCS optical density variation to cerebral versus extra-cerebral
hemodynamic changes. All six parameters depend on delay-time τ , source-detector separation
ρ, top layer thickness ℓ, and baseline tissue properties F 0c , F 0ec, µ0a,c, µ0a,ec, µ′0s,c, and µ′0s,ec. They
can be computed by numerically taking the appropriate derivatives of the two-layer solution to
the correlation diffusion equation. For the parallel plane two-layer geometry (Figure 5.3(B)), the
solution is [24, 106]:
g1(τ) = G1(τ)/G1(0),
G1(τ) =
1
2π
∫ ∞
0
G˜1(τ)sJ0(sρ)ds,
G˜1(τ) =
sinh[κec(zb + z0)]
Decκec
Decκec cosh[κecℓ] +Dcκc sinh[κecℓ]
Decκec cosh[κec(ℓ+ zb)] +Dcκc sinh[κec(ℓ+ zb)]
− sinh[κecz0]
Decκec
,
where Di = 1/[3(µ′s,i+µa,i)], κ2i = (Dis2+µa,i+2µ′s,ik20Fiτ)/Di, zb = 2Dec(1+Reff )/(1−
Reff ), z0 = 3Dec, and Reff and k0 are defined in Section 5.2 (this solution assumes the top and
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bottom layers have the same optical index of refraction).
The two-layer weighting factors for a typical set of extra-cerebral/cerebral tissue properties
are plotted in Figure 5.4. Importantly, for a source-detector separation ρ = 3 cm, the change in
the DCS optical density is more sensitive to changes in flow and absorption in the cerebral layer
than in the extra-cerebral layer (except for at very long delay-times). This sensitivity is especially
prominent at the shorter delay-times (Figs. 5.4(B), 5.4(C)). In practice the situation is helped by
differences in magnitude of cerebral versus extra-cerebral flow (e.g., cerebral flow is quite often
10 times larger than extra-cerebral flow) [250]. We note here that the sensitivity to cerebral flow
changes (Figure 5.4(C)) depends on the specific ratio of cerebral to extra-cerebral flow [221].
For example, if F 0c = 6F 0ec, the ratio of the cerebral flow component (dF,c∆Fc) to extra-cerebral
flow component (dF,ec∆Fec) is 0.7 at short delay-times for ρ = 3 cm (compared to 1.15 for
F 0c = 10F
0
ec in Figure 5.4(C)). Further, this ratio depends on the extra-cerebral layer thickness,
because the NIR light intensity is exponentially attenuated with increasing tissue depth. For
example, if the extra-cerebral layer thickness is increased to ℓ = 1.1 cm, then the ratio of the
flow components in Figure 5.4(C) at short delay-times is 0.8 for ρ = 3 cm.
The increase in the influence of the extra-cerebral layer at longer delay times (Figure 5.4(C))
can be explained from consideration of the pathlengths of light, specifically their association
with short versus long correlation decay times τ . Briefly, in the temporal autocorrelation func-
tion, long light paths contribute to rapid decays of the signal (short τ ) and short light paths
contribute to slow decays of the signal (large τ ) [186, 257]. Short source-detector separations,
e.g., ρ = 0.5 cm, mostly sample the superficial layer, and the DCS optical density perturba-
tion is predominantly sensitive to the superficial layer in this case (Figure 5.4(C)). Interestingly,
a comparison of Figs. 5.4(C) and 5.4(D) reveals that the DCS optical density is more sensi-
tive to cerebral changes than the DOS/NIRS optical density (consistent with findings of Selb
et al [221]). Again, this effect arises in part because cerebral blood flow is much greater than
extra-cerebral blood flow, and in part because DCS is effectively a time-resolved technique that
permits separation of long light paths (shorter delay-times) from short light paths (longer delay-
times) [221].
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Figure 5.4: (A) The two-layer multiplicative weighting factors (see Equation 5.9) for dF,c and
dF,ec (right vertical-axis); and for da,c, da,ec, ds,c, and ds,ec. They are plotted as a function of the
correlation time, τ , for source-detector separation, ρ = 3 cm, and optical wavelength, λ = 785
nm, given a set of typical extra-cerebral and cerebral tissue properties [55], i.e., µ0a,c = 0.16,
µ0a,ec = 0.12, µ
′0
s,c = 6, µ
′0
s,ec = 10 cm
−1; F 0c = 10−8, F 0ec = 10−9 cm2/s; ℓ = 1 cm,
n = 1.4, and nout = 1. (B) The two-layer DCS Modified Beer-Lambert components dF,c∆Fc,
dF,ec∆Fec, |da,c∆µa,c|, and |da,ec∆µa,ec|, plotted as a function of τ for a 10% increase in each
parameter. On the right vertical-axis is the intensity autocorrelation function, g02(τ), for β = 0.5.
Notice that at shorter delay-times for ρ = 3 cm, the change in DCS optical density is equally
sensitive to changes in cerebral blood flow, extra-cerebral blood flow, and cerebral absorption.
The change in DCS optical density (ODDCS) is less sensitive, however, to changes in extra-
cerebral absorption. (C) The ratio of the cerebral (c) and extra-cerebral (ec) flow components in
the DCS optical density perturbation, ∆ODDCS(τ) (Equation 5.9), for 4 separations, ρ = 0.5,
1, 2, and 3 cm. These data are plotted as a function of τ assuming a 10% increase in cerebral and
extra-cerebral blood flow. For the shorter separations of 0.5 and 1 cm, the ratio is substantially
less than one; in this case, the DCS optical density is predominantly sensitive to the extra-
cerebral layer. At the 3 cm separation, the DCS optical density is more sensitive to cerebral
blood flow than extra-cerebral blood flow at the short delay-times, i.e., the ratio is greater than
one. However, at longer delay-times, the ratio decreases. (D) The ratio of the cerebral and extra-
cerebral absorption components in the two-layer Modified Beer-Lambert law for DOS/NIRS,
plotted as a function of ρ for a 10% increase in cerebral and extra-cerebral absorption. 〈L〉c and
〈L〉ec are the cerebral and extra-cerebral partial pathlengths [91, 130]. Notice from panels (C)
and (D) that the DCS optical density is more sensitive to the cerebral layer than the NIRS optical
density is, consistent with findings in work of reference [221].
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5.4 Results
5.4.1 Validation with simulated data
We tested the semi-infinite DCS Modified Beer-Lambert law (Equation 5.4) using simulated data
(Figure 5.5), as well as real data collected from a juvenile pig (Figs. 5.7, 5.8). The simulated
DCS data was generated from semi-infinite analytical solutions of the correlation diffusion equa-
tion (Equation 5.5) with added noise [276]. Baseline tissue blood flow and optical properties in
the simulated data were chosen to be representative of the head [121], and perturbations from
baseline were induced by varying blood flow (F ) from +50% to −50%, with constant tissue
optical properties. Figure 5.5(A) shows the simulated intensity autocorrelation functions for
these baseline and perturbed conditions, plotted as a function of delay-time. The DCS Modified
Beer-Lambert law (Equation 5.4) was then applied to this simulated data set to calculate the flow
change as a function of delay-time (Figure 5.5(B)). Good agreement between the calculated and
actual flow changes is found for a wide range of delay-times.
We next quantified the range of delay-times for which the DCS Modified Beer-Lambert law
can be accurately employed. First, recall that the semi-infinite DCS Modified Beer-Lambert
law is expected to be accurate in the limit 2µ′sk20Fτ/µa ≪ 1 (5.8). The simulations show
that it will remain fairly accurate even when 2µ′sk20Fτ/µa ∼ 1. In order to appreciate the
simulation results more generally, we introduce the dimensionless delay-time, τγ0F 0, which
depends on baseline blood flow (F 0), correlation time-delay (τ ), and γ0 ≡ K00 (µ′0s /µ0a)k20r01
(see Equation 5.17). When this dimensionless delay-time is ∼ 1, then the baseline electric
field autocorrelation function has decayed by ∼ 1/e. In terms of this dimensionless delay-
time, the limit 2µ′sk20Fτ/µa ≪ 1 corresponds to the baseline condition τγ0F 0 ≪ α, where
α ≡ γ0µ0a/(2µ′0s k20). For the “typical” conditions chosen for Figure 5.5, α = 2.3.
Figure 5.5(B) plots the calculated DCS Modified Beer-Lambert flow change for each di-
mensionless delay-time. The difference (error) between the calculated flow change and the true
flow change (simulated value) is relatively small, even for dimensionless delay-times approach-
ing α = 2.3. We also see that for a 50% increase in flow, the DCS Modified Beer-Lambert
law is accurate over a narrower range of dimensionless delay-time than for a 50% decrease
(Figure 5.5(B)). The latter behavior is a consequence of the fact that when flow is increased,
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Figure 5.5: (A) Simulated semi-infinite intensity autocorrelation curves (mean± SD across N =
10k curves) plotted as a function of the delay-time τ for a−50% and +50% change in flow while
tissue optical properties were held constant. The source-detector separation, light wavelength,
and baseline tissue properties are ρ = 3 cm, λ = 785 nm, and µ0a = 0.1 cm−1, µ′0s = 8
cm−1, F 0 = 10−8 cm2/s, n = 1.4, nout = 1, respectively. The simulated DCS data were
generated from the semi-infinite solution of the correlation diffusion equation (Equation 5.5)
with added noise derived from a correlation noise model [276]. The correlation noise model
was evaluated at a baseline DCS intensity of 50k photons a second and an averaging time of 2.5
seconds. (B) Fractional blood flow changes (mean± SD) estimated by applying the semi-infinite
DCS Modified Beer-Lambert law, i.e., rbf(τ) = ∆ODDCS(τ)/(dF (τ)F 0) (Equation 5.4), to
the simulated data. To appreciate the simulated results more generally, these fractional blood
flow changes are plotted against the dimensionless delay-time τγ0F 0. Here, (γ0F 0)−1, where
γ0 ≡ K00 (µ′0s /µ0a)k20r01 (see Equation 5.17), is approximately the characteristic decay time of
the baseline electric field autocorrelation function (see Section 5.8).
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the intensity autocorrelation function decays more rapidly. When the autocorrelation curves are
close to fully decayed, then the DCS Modified Beer-Lambert law is predominantly sensitive to
correlation noise instead of flow. For a perturbed state from baseline (e.g., rbf = 50%), the limit
2µ′sk20Fτ/µa ≪ 1 corresponds to τγ0F 0 ≪ α(F 0/F ) (assuming constant optical properties).
Thus, a larger value of F reduces the value of the dimensionless delay-time upper limit.
5.4.2 Noise consideration
At very short delay-times, there is little difference between the intensity autocorrelation curves
corresponding to different blood flows (Figure 5.5(A)). In this limit, the changes to the DCS
optical density are heavily influenced by correlation noise, and flow calculations at the very
short delay-times in Figure 5.5(B) are noisy. In general, from applying error propagation rules to
Equation 5.4, the noise in the calculated flow change (δ(rbf(τ))) as a function of τ for constant
tissue optical properties is
δ(rbf(τ)) =
1
dF (τ)F 0
δ(∆ODDCS(τ)) =
1
dF (τ)F 0
δ(g2(τ)− 1)
|g2(τ)− 1| . (5.10)
A correlation noise model can be used to accurately estimate δ(g2(τ)−1) [276]. As τ increases,
the correlation noise decreases, and dF (τ)F0 increases (Figure 5.2(A)). Both trends reduce the
noise in rbf . However, when |g2(τ)−1| goes to zero as τ increases, an accompanying increase in
noise is expected. From Figure 5.5(B), the noise in rbf falls with increasing delay-time and then
levels off around τγ0F 0 ≈ 0.3; the noise then remains constant for a large range of delay-times.
As one would expect, the flow change computed with a single τ in the DCS Modified Beer-
Lambert law is more sensitive to noise than the flow change extracted from nonlinear fits to the
semi-infinite correlation diffusion solution across many delay-times. To ameliorate sensitivity
to noise, multiple delay-times can also be used for the DCS Modified Beer-Lambert law. Then
Equation 5.4 becomes a system of linear equations, i.e., one equation for each delay-time, which
can very rapidly be solved to derive flow changes.
5.4.3 In-vivo validation
Finally, we validated the semi-infinite DCS Modified Beer-Lambert law in-vivo. In this case, the
scalp of a juvenile pig was reflected and 2.5-mm burr holes were drilled through the skull down
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Figure 5.6: (A) To monitor hemodynamics in the semi-infinite geometry, a juvenile pig’s scalp
was reflected, and 2.5 mm burr holes were drilled through the skull for placement of 90-degree
optical fibers. A DOS/NIRS source-detector pair (red circles) measured cerebral tissue absorp-
tion, and a DCS source-detector pair (black circles) measured cerebral blood flow. The source-
detector separation of both pairs is ρ ≈ 1.5 cm. (B) Schematic showing the timeline of the
experiment in minutes. Venous infusion of dinitrophenol (DNP, 9 mg/kg) dramatically stim-
ulated cerebral oxygen metabolism and induced a 200% increase in cerebral blood flow. The
DCS and DOS techniques were interleaved to measure blood flow and tissue absorption every 7
seconds. (C) Anterior-posterior slice of an anatomical MRI scan of a pig with similar weight to
the juvenile pig used in this measurement. The burr holes for the two optical fibers closest to the
midline in panel (A) have been artificially overlayed on this scan.
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to the dura (Figure 5.6). Optical fibers were inserted into the holes to comprise a single DCS
source-detector pair for measurement of cerebral blood flow, and a single DOS/NIRS source-
detector pair for measurement of cerebral tissue absorption (Figure 5.6(A)). The source-detector
separations of both pairs were approximately 1.5 cm, and the baseline cerebral optical properties
of the pig were assumed to be µ0a(785 nm) = 0.2 and µ′0s (785 nm) = 8 cm−1 [140]. Impor-
tantly, in this measurement the semi-infinite geometry is a good approximation for the true tissue
geometry, because the optical fibers are very close to the brain.
Figure 5.6(B) is a schematic showing the timeline of the experiment. While monitoring
with DOS and DCS, a 200% increase in cerebral blood flow was induced in the pig via venous
infusion of 9 mg/kg of the drug dinitrophenol (DNP). DNP is a proton transporter across cell
membranes which disrupts the mitochondrial proton gradient [181]. In an effort to restore the
proton gradient, cells stimulate cerebral oxygen metabolism [181], which in turn leads to a large
increase in cerebral blood flow. Additional details about the animal preparation and measurement
are in Section 5.9.
The calculated temporal cerebral blood flow changes in the pig (due to DNP) using the DCS
Modified Beer-Lambert law are in good agreement with the calculated changes from nonlinear
fits to the semi-infinite solution of the correlation diffusion equation (Figure 5.7). Measured
cerebral absorption changes (Figure 5.8(B)) were incorporated in the blood flow calculations.
Note, when using multiple delay-times in the DCS Modified Beer-Lambert law, the noise in
temporal blood flow estimates is comparable to the nonlinear diffusion fit (Figure 5.7(A)). For
single τ blood flow monitoring, the temporal blood flow noise is larger, but the average blood
flow changes are the same (Figure 5.7(B)); this behavior demonstrates the feasibility of accu-
rate single τ blood flow monitoring with DCS. In Figure 5.7(B), the dimensionless delay-time
τγ0F 0 = 0.33 (corresponding to g02(τ) = 1.3) was used for single delay-time monitoring.
The estimated cerebral blood flow changes from the DCS Modified Beer-Lambert law are
also plotted as a function of dimensionless delay-time in Figure 5.8(A) for two quasi steady-
state temporal intervals. During these temporal flow intervals, the blood flow changes were also
determined from nonlinear fits to the semi-infinite correlation diffusion solution. The average
blood flow changes from the nonlinear fit estimates are 185% and 64% (solid black lines). The
horizontal dashed lines in Figure 5.8(A) indicate the noise in the nonlinear fit estimates of blood
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Figure 5.7: Temporal fractional cerebral blood flow changes induced by injection of the drug
dinitrophenol (DNP) in a juvenile pig. The baseline flow is F 0 = 5.34 × 10−8 cm2/s, which is
the average blood flow index over the 18 minute time interval between the vertical dashed lines.
Cerebral blood flow changes were calculated from nonlinear fits to the semi-infinite correlation
diffusion solution (Equation 5.5) and from the semi-infinite DCS Modified Beer-Lambert law
(Equation 5.4) using (A) multiple delay-times, i.e., τ < 5.5 µs, which corresponds to g02(τ) >
1.25, and (B) a single delay-time, i.e., τ = 3.8 µs, which corresponds to g02(τ) = 1.3. Measured
tissue absorption changes (Figure 5.8(B)) were incorporated in both the correlation diffusion fit
and the DCS Modified Beer-Lambert law. Tissue scattering was assumed to remain constant at
µ′s = 8 cm−1, and the red and blue shaded regions indicate quasi steady-state temporal intervals
that are analyzed further in Figure 5.8.
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Figure 5.8: (A) Mean fractional cerebral blood flow changes (averaged across indicated time
intervals in the legend) as a function of the dimensionless delay-time τγ0F 0 (see Figure 5.5
caption) in a juvenile pig. (B) The pig’s cerebral absorption over time, which was calculated
from applying the semi-infinite Modified Beer-Lambert law (Equation 5.1) to the measured
DOS/NIRS intensity changes from baseline. Note that the shaded regions in panel (B) indicate
the temporal intervals averaged over in panel (A). The cerebral blood flow changes in panel
(A) were obtained from applying the semi-infinite DCS Modified Beer-Lambert law (Equa-
tion 5.4) to the measured intensity autocorrelation curves and the measured cerebral absorption
changes. The horizontal solid and dashed black lines in panel (A) indicate the fractional blood
flow changes (Mean ± SD) obtained from fitting the intensity autocorrelation curves to the non-
linear semi-infinite correlation diffusion solution (Equation 5.5).
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flow (constant because the nonlinear correlation diffusion fit uses all delay-times). Note that
the average value of the DCS Modified Beer-Lambert law estimate of the larger flow increase
is within the noise of the nonlinear correlation diffusion fit estimate for the delay-time interval
0.16 < τγ0F 0 < 0.82, which corresponds to the baseline intensity autocorrelation function
range 1.15 < g02(τ) < 1.40. The smaller flow increase in Figure 5.8(A) is accurate for an even
wider range of delay-times, because the intensity autocorrelation function associated with this
increase requires a longer delay-time to completely decay (see Section 5.4.1).
5.5 Discussion
The Modified Beer-Lambert approach has been employed extensively in the biomedical optics
community [99, 122, 166, 175, 219, 248], in large part because of its simplicity. With this ap-
proach, researchers have monitored temporal changes in blood oxygenation and blood volume
with CW light, using only one source-detector separation. In the present paper, we have extended
the Modified Beer-Lambert approach to the DCS measurement, and we have demonstrated the
accuracy of this extension in both simulations (Figure 5.5) and in-vivo data (Figs. 5.7, 5.8).
The DCS Modified Beer-Lambert approach offers some advantages compared to the traditional
analysis scheme of fitting intensity autocorrelation data to nonlinear solutions of the correlation
diffusion equation.
5.5.1 Real-time estimates of blood flow changes
The DCS Modified Beer-Lambert law is a linear equation relating changes in blood flow to
changes in signal for any tissue geometry. Although the correlation diffusion solution in the
semi-infinite geometry is closed form, the correlation diffusion solutions in more intricate ge-
ometries (e.g., curved, layered) are vastly more complex, and consequentially quite time-consuming
when fitting data. With the DCS Modified Beer-Lambert approach, the correlation diffusion so-
lutions are needed only once to evaluate the multiplicative weighting factors at the “baseline”
tissue state, e.g., Equation 5.13. We emphasize that even for geometries where closed form solu-
tions are not available, these multiplicative weighting factors can still be evaluated numerically.
Then, blood flow changes from baseline are rapidly determined by solving a linear equation (Eq.
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(5.4) or (5.8)). Consequentially, the DCS Modified Beer-Lambert law is well suited for real-time
blood flow monitoring, especially in tissue geometries that are not semi-infinite.
5.5.2 Blood flow monitoring in tissues wherein light propagation is non-diffusive
Diffusive light transport is not required for using the DCS Modified Beer-Lambert approach. In
blood flow monitoring applications wherein the photon diffusion model is not valid, the mul-
tiplicative weighting factors can be evaluated using solutions of the correlation transport equa-
tion [3,73] instead of the correlation diffusion equation (see Section 5.7). For the tissue geometry
of interest, the correlation transport equation can be solved numerically with Monte Carlo tech-
niques [24, 186]. Thus, the DCS Modified Beer-Lambert approach facilitates accurate blood
flow monitoring for the small source-detector separations typical of endoscopic probes, for com-
plex tissues that contain “non-diffusing” domains such as (arguably) cerebral spinal fluid inside
the head [63, 148, 196], and for tissues that contain very high concentrations of blood, as in
the liver [144]. In all three of these examples, the assumptions underlying the photon diffusion
model are violated, and therefore the photon diffusion model is not expected to be accurate. An-
other potential application of the non-diffusive DCS Modified Beer-Lambert approach is blood
flow monitoring with visible light.
5.5.3 Improved depth sensitivity
The DCS Modified Beer-Lambert law permits blood flow monitoring with intensity autocor-
relation measurements at a single delay-time, in contrast to the traditional correlation diffusion
approach wherein blood flow estimates are obtained by acquiring and fitting a full, nearly contin-
uous, intensity autocorrelation curve. It is now well established that the autocorrelation function
decay times associated with long light paths are relatively short, while the decay times associated
with short light paths are relatively long [186, 221, 257]. Thus, the autocorrelation function at
shorter delay-times will be inherently more sensitive to deeper tissues in remission geometries
(Figure 5.4), which in turn means that the sensitivity of the DCS measurement to blood flow at
deeper tissue depths is improved by using short delay-times in the DCS Modified Beer-Lambert
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law. Conversely, using long delay-times improves the sensitivity of the DCS measurement to tis-
sue blood flow at shallow depths. This same effect can be achieved by fitting different parts of the
intensity autocorrelation curve to the correlation diffusion model. In practice, these correlation
diffusion fits still require several delay-times spanning a significant portion of the autocorrela-
tion curve. By using a single delay-time, the experimenter has finer control of the measurement
depth sensitivity for DCS measurements. Note that for DCS measurements in transmission ge-
ometries [40], the autocorrelation function at longer delay-times (short light paths) will be more
sensitive to tissue adjacent to the straight line between source and detector.
5.5.4 Increased temporal resolution of DCS measurements
The DCS Modified Beer-Lambert law offers new routes for increased DCS measurement speed
and for simpler instrumentation. Underlying these advantages is again blood flow monitoring
with a single delay-time. We and others have used multiple-τ hardware correlators to mea-
sure the intensity autocorrelation function [72, 218] at delay-times spanning several orders of
magnitude from ∼ 100 ns to ∼ 10 ms. Achieving sufficient SNR for deep tissue DCS mea-
surements (e.g., as in the brain) typically requires averaging many (N > 100) of these 10-ms
autocorrelation curves. The single delay-time cerebral blood flow monitoring in the pig shown
in Figure 5.7(B) was done at τ = 3.8 µs. Thus, in this example, ∼250 blood flow measurements
can be acquired in 1 ms, which can then be temporally averaged to reduce noise. In 10 ms,
which is roughly the time required to measure a single autocorrelation curve with a multiple-
τ correlator, ∼2500 blood flow measurements can be acquired and averaged. Therefore, even
though single-τ blood flow monitoring with the DCS Modified Beer-Lambert law is more sensi-
tive to correlation noise than multiple-τ monitoring (Figure 5.7), the substantial improvement in
the blood flow sampling rate with single-τ monitoring means that enough averaging can be em-
ployed to compensate for this additional noise while still maintaining high DCS measurement
speeds. Blood flow measurements at high acquisition rates are advantageous in several appli-
cations, including schemes to filter out motion artifacts in exercising muscle [226]. Single-τ
monitoring also makes it possible to use single-τ hardware correlators, which are cheaper than
multiple-τ hardware correlators. Alternatively, software correlators [72] for a single delay-time
could be implemented.
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5.5.5 Filtering contamination from superficial tissues in deep tissue flow moni-
toring
The same paradigms that have been developed with the Modified Beer-Lambert law to filter con-
tamination from superficial tissues in blood oxygenation measurements of the tissue of interest
(e.g., the brain) [91, 197, 215, 217, 235] can also be used in the DCS Modified Beer-Lambert
formulation for blood flow monitoring. In fact, these paradigms are likely to work even better
with DCS, because DCS is more sensitive to deep brain hemodynamics than continuous-wave
DOS/NIRS (Figs. 5.4C, 5.4D) [221].
Building on work done with the DOS/NIRS Modified Beer-Lambert law [91, 215], a use-
ful scheme for filtering superficial tissue contamination in the DCS signal is to employ two
source-detector separations. One source-detector separation should be long and the other short.
Detected light from the long separation travels through both superficial and deep layers of tissue,
but detected light at the short separation is predominantly confined to the superficial layer. Two
two-layer DCS Modified Beer-Lambert law equations (corresponding to the two source-detector
separations) can then be employed to better isolate the deep tissue blood flow component from
the superficial blood flow component. Ideally the experimenter would acquire “initial/baseline”
measurements wherein only superficial blood flow is changing.
In cerebral monitoring, one way to change superficial blood flow without affecting cerebral
blood flow is to vary the pressure of the optical probe against the head [184]. Initial measure-
ments acquired during probe pressure modulation can then be used to derive the patient-specific
weighting factors in the DCS Modified Beer-Lambert law. These weighting factors would sub-
sequently be used to filter superficial contamination in cerebral blood flow monitoring. We will
develop this idea further in a future paper.
5.6 Conclusion
The Modified Beer-Lambert extension to the DCS measurement is accurate enough to be useful
for blood flow monitoring. It facilitates real-time flow monitoring in complex tissue geometries,
provides a novel route for increasing DCS measurement speed, and can be used to probe tissues
wherein light transport is non-diffusive. It also can be used to filter signals from superficial
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tissues.
5.7 Appendix 1
The multiplicative weighting factors dF , da, and ds in Equation 5.4 can be estimated by taking
the appropriate derivative of the solutions to the correlation diffusion equation applied to the
appropriate geometry (e.g., semi-infinite homogeneous, etc.). First, using the Siegert relation,
we have:
dF (τ, ρ) ≡ ∂OD
0
DCS
∂F
=
∂
∂F
[− log(g02(τ, ρ)− 1)] = ∂∂F [− log(β[g01(τ, ρ)]2)]
=
∂
∂F
[− log(β)− 2 log(g01(τ, ρ))] = 2 ∂∂F [− log(g01(τ, ρ))] . (5.11)
Similarly,
da(τ, ρ) = 2
∂
∂µa
[− log(g01(τ, ρ))] ,
ds(τ, ρ) = 2
∂
∂µ′s
[− log(g01(τ, ρ))] . (5.12)
Here, g1(τ, ρ) is the solution to the correlation diffusion equation for the geometry of interest [24,
79], and the derivatives of the solution are evaluated at baseline conditions. In conditions where
an analytical solution for the correlation diffusion equation does not exist, the multiplicative
weighting factors can be computed numerically:
dF (τ, ρ) =
2
∆F
log
(
g1(τ, ρ, F
0 −∆F/2, µ0a, µ′0s )
g1(τ, ρ, F 0 +∆F/2, µ0a, µ
′0
s )
)
,
da(τ, ρ) =
2
∆µa
log
(
g1(τ, ρ, F
0, µ0a −∆µa/2, µ′0s )
g1(τ, ρ, F 0, µ0a +∆µa/2, µ
′0
s )
)
,
ds(τ, ρ) =
2
∆µ′s
log
(
g1(τ, ρ, F
0, µ0a, µ
′0
s −∆µ′s/2)
g1(τ, ρ, F 0, µ0a, µ
′0
s +∆µ
′
s/2)
)
, (5.13)
where ∆F/F 0 = ∆µa/µ0a = ∆µ′s/µ′0s = 10−5. Equations (5.11), (5.12), and (5.13) are impor-
tant intermediate results, which provide generalized expressions for the analytical and numerical
computation of the multiplicative weighting factors in the DCS Modified Beer-Lambert law for
any homogeneous geometry.
Evaluating these equations requires knowledge of the baseline tissue optical properties and
the baseline flow index. The baseline flow index can be obtained from a nonlinear fit of the
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Figure 5.9: Fractional blood flow changes (i.e., F/F 0 − 1) computed from applying the semi-
infinite DCS Modified Beer-Lambert law (Equation 5.4) with assumed baseline optical prop-
erties of µ0a (vertical axis) and µ′0s (horizontal axis) to semi-infinite simulated data with noise
(N = 1k curves). The actual blood flow and absorption changes are (A) 50% and 15%, and (B)
−50% and −15%, respectively. Tissue scattering was constant, and the actual baseline proper-
ties (including simulated noise parameters) are identical to those in Figure 5.5, e.g., µ0a = 0.1,
µ′0s = 8 cm−1 (denoted by dashed lines). To compute the absorption changes from the simulated
data, the Modified Beer-Lambert law (Equation 5.1) was employed. The differential pathlength
(〈L〉) in Equation 5.1 was calculated from the assumed baseline optical properties [94]. Finally,
the baseline flow index, F 0, was extracted from a nonlinear fit of the simulated baseline data
to the semi-infinite correlation diffusion solution (Equation 5.5) evaluated at the assumed base-
line optical properties. Errors in the assumed baseline optical properties only have small effects
on the computed fractional flow change. Note that the computed fractional blood flow changes
are not exactly 50% and −50% when the exact optical properties are assumed because of small
errors arising from truncating the tissue absorption terms in the Taylor Series expansion of the
DCS optical density (Equation 5.3) to first order.
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baseline intensity autocorrelation curve to the correlation diffusion solution (see Section 5.2).
The baseline tissue optical properties can either be assumed from the literature (e.g., [144])
or measured with time-domain or frequency-domain DOS/NIRS [101, 201]. For typical tissue
measurements wherein scattering does not change, the sensitivity in the computed fractional
blood flow change to assumed baseline optical properties is small (Figure 5.9). For the example
of flow changes shown in Figure 5.9, ±50% errors in the assumed baseline optical properties
affected the estimated fractional flow change by only ±5 percentage points (e.g., from 0.50 to
0.45). Thus, for many applications, errors in the assumed baseline optical properties have little
effect on calculated changes in blood flow. Computed fractional flow changes are a little more
sensitive to errors in baseline flow than to errors in baseline optical properties. Specifically, for
the example of flow changes in Figure 5.9, ±10% errors in baseline flow affected the estimated
fractional flow change by ±5 percentage points, and ±25% errors in baseline flow affected the
estimated fractional flow change by ±10 percentage points (results not shown).
An important assumption in this approach is that the correlation diffusion equation accurately
models the electric field autocorrelation function in tissue. This assumption is valid when using
large source-detector separations, ρ ≫ 1/(µa + µ′s), to measure highly scattering media with
isotropic dynamics [24]. The DCS Modified Beer-Lambert law, Equation 5.4, however, can also
be used for correlation transport conditions wherein the correlation diffusion equation breaks
down. In this case, the derivatives in Equations (5.11) and (5.12) will have to be applied to the
solutions of the so-called correlation transport equation [3,73], which can be solved numerically
with Monte Carlo techniques [24, 186].
5.8 Appendix 2
The semi-infinite solution to the correlation diffusion equation (Equation 5.5) is approximately
exponential in the small delay-time limit, i.e., g1(τ) ≈ exp(−γFτ), with γ ≡ K0(µ′s/µa)k20r1.
Normalizing the delay-time by the characteristic decay-time, i.e., τc = (γF )−1, is a meaningful
dimensionless way to express delay-times (Figs. 5.5, 5.8), e.g., g1 ≈ 0.4 for τγF = 1. Further,
the DCS Modified Beer-Lambert law (Equation 5.4) is a good approximation in the small delay-
time limit because − log(g2(τ) − 1) = − log(βg21) = 2γτF − log(β) is linear with respect to
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F . To derive the small delay-time limit of the semi-infinite correlation diffusion solution, first
note that if the source-detector separation, ρ, is much greater than the photon transport mean-free
path through tissue, ℓtr, then (see Equation 5.2)
rb ≈ r1(1 + x/r21),
1
rb
≈ 1
r1
(
1− x
r21
)
, (5.14)
where x ≡ 2zb(zb + ℓtr). Substituting Equation 5.14 into Equation 5.2, we see that
G1(τ) =
3
4πℓtr
exp(−K(τ)r1)
r1
[
1− exp
(−K(τ)x
r1
)(
1− x
r21
)]
. (5.15)
In the limit K(τ)x/r1 ≪ 1, which is satisfied at small delay-times, Equation 5.15 simplifies
further to
G1(τ) ≈ 3
4πℓtr
x exp(−K(τ)r1)
r21
(
K(τ) +
1
r1
)
. (5.16)
In the more stringent limit 2(µ′s/µa)k20Fτ ≪ 1, the electric field autocorrelation function in
Equation 5.16 is approximately exponential:
g1(τ) =
G1(τ)
G1(0)
≈ exp(−γFτ)
(
1 +
γFτ
r1K0 + 1
)
≈ exp(−γFτ), (5.17)
where γ = K0(µ′s/µa)k20r1 and K0 ≡ K(0) = [3µa(µa + µ′s)]1/2.
5.9 Appendix 3
All animal procedures were in accordance with guidelines established by the National Institutes
of Health and approved by the Institutional Animal Care and Use Committee of the University
of Pennsylvania. Diffuse optical measurements were performed on a male Yorkshire juvenile
pig (28 kg). The animal was anesthetized with an initial intramuscular injection of ketamine (25
mg/kg), dexmedetomidine (0.025 mg/kg), and glycopyrolate (0.02 mg/kg), intubated, and then
mechanically ventilated with a mixture of ∼ 3% isoflurane in pure oxygen gas. To prepare for
hemodynamic monitoring in the semi-infinite geometry, the pig’s scalp was reflected over the left
hemisphere of the brain, and a dental drill was used to form 2.5 mm burr holes through the skull
down to the dura for the placement of optical fibers (see Figure 5.6). One DCS source-detector
pair and one DOS/NIRS source-detector pair were used for hemodynamic monitoring. The
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positions of these fibers, denoted as (lateral distance from the center of the eye, lateral distance
from midline), are (10 mm, 5 mm), (21 mm, 15 mm), (26 mm, 15 mm), and (37 mm, 5 mm)
for the DCS source, DCS detector, DOS/NIRS source, and DOS/NIRS detector, respectively.
Thus, the source-detector separations for both the DOS/NIRS and DCS pairs are approximately
15 mm.
Upon completion of the surgical preparation, the ventilation of the pig was switched to a
mixture of oxygen and nitrogen (3:7) with no isoflurane. Anesthesia was maintained instead
with intravenous administration of ketamine (20-60 mg/kg/h). Throughout the rest of the study,
arterial oxygen saturation and end-tidal CO2 were continually monitored with blood gas samples
from the femoral artery and with a capnograph, respectively. The ventilation rate was initially
adjusted to maintain an end-tidal CO2 between 40 and 50 mm Hg.
After inserting ninety-degree bend terminated optical fibers (Fiberoptic Systems, Simi Val-
ley, CA) in the burr holes, a 5-pound sandbag weight was carefully placed on top of the fibers to
secure them in place. Two 1-mm diameter multi-mode borosilicate fibers (Fiberoptic Systems)
delivered source light to the cerebral tissue, and a third 1-mm diameter multi-mode fiber received
diffusing light from the tissue for DOS/NIRS detection. For DCS detection, a 4 × 1 bundle of
780HP single-mode fibers (Fiberoptic Systems) was used. These fibers interfaced to a portable
custom-built instrument designed for hemodynamic monitoring, which is described in detail
elsewhere [36, 158]. In the DCS measurement, a continuous wave, long coherence length 785
nm laser (CrystaLaser Inc., Reno, NV) was employed to deliver source light, and the outputs
from an array of 4 high sensitivity avalanche photodiodes (SPCM-AQ4C, Excelitas, Canada)
operating in photon counting mode were connected to a multiple-τ hardware correlator (Corre-
lator.com, Bridgewater, NJ). In the DOS/NIRS measurement, three lasers (690 nm, 785 nm, 830
nm; OZ Optics, Canada) intensity modulated at 70 MHz were coupled to an optical switch (Di-
Con Fiberoptics, Richmond, CA), which sequentially cycled the source light between the three
wavelengths. A heterodyne detection scheme using a photomultiplier tube (R928, Hamamatsu,
Bridgewater, NJ) was employed for DOS/NIRS detection. The data acquisition was interleaved
between DOS/NIRS and DCS to measure blood flow and blood oxygenation with a sampling
rate of 0.15 Hz.
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After ten minutes of baseline cerebral hemodynamic monitoring in the pig, the drug dinitro-
phenol (DNP, 9mg/kg) was injected intravenously over an hour to dramatically increase cerebral
oxygen metabolism and blood flow [181] (see Figure 5.6(B)). The oxygen content in the ven-
tilated gas was increased as needed to maintain the arterial oxygen saturation in the pig above
95%. Ketamine was also supplemented as needed with boluses of diazapam (0.1-0.2 mg/kg) to
ensure adequate sedation as the oxygen metabolism increased. After two hours of hemodynamic
monitoring, the pig was euthanized with pentobarbital.
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Chapter 6
Pressure Modulation Algorithm to
Separate Cerebral Hemodynamic
Signals from Extra-cerebral Artifacts
6.1 Introduction
Diffuse correlation spectroscopy [37,79,84,182,269] (DCS) and near-infrared or diffuse optical
spectroscopy [99,115,166,175,193,219,231,248] (DOS/NIRS) are important optical techniques
that employ near-infrared light (NIR) to measure cerebral blood flow, oxygen saturation, and
total hemoglobin concentration continuously, non-invasively, and at the bedside. Further, in
combination these measurements of blood flow and blood oxygenation provide access to the
oxygen metabolic status of the brain [28, 62, 233].
As might be anticipated, this information about cerebral blood flow, blood oxygenation and
oxygen metabolism has clinical value. All three parameters, for example, are important biomark-
ers for brain diseases such as ischemic stroke [127, 229]. Treatments for ischemic stroke (and
other diseases) aim to minimize neurological damage by maximizing perfusion to the brain le-
sion [86, 97, 259]. Numerous treatment interventions for stroke are available, but variability in
response-to-treatment has been observed [86,97,155], and an effective treatment for one patient
may be ineffective, or even harmful, for another patient. Thus, a promising clinical application
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for DCS and DOS/NIRS is rapid patient-specific assessment of treatment efficacy. Indeed, DCS
and DOS/NIRS enable detection of hemodynamic changes before new neurological symptoms
emerge [84, 192, 277].
Unfortunately, the optical techniques have limitations. A well-known drawback for opti-
cal monitoring of cerebral tissue is its significant sensitivity to blood flow and oxygenation in
the extra-cerebral tissues (scalp and skull) [26, 184, 221, 237, 238]. Traditional diffuse optics
analyses approximate the head as a homogeneous medium, e.g., no a priori anatomical knowl-
edge is used. The homogenous models ignore differences between extra-cerebral hemodynam-
ics and cerebral hemodynamics in the brain, and because extra-cerebral blood flow and blood
oxygenation are non-negligible, their responses contaminate the DCS and DOS/NIRS signals.
Specifically, extra-cerebral contributions can lead experimenters to incorrectly assign cerebral
physiological responses [64, 237, 239].
The DOS/NIRS community has, of course, developed/adapted a number of approaches to
ameliorate the extra-cerebral tissue problem. Time series analysis techniques, for example, use
filtering schemes to minimize superficial tissue contamination in functional brain mapping mea-
surements [26, 90, 109, 137, 161, 216, 237, 238, 262, 271]. An assumption that underlies these
techniques is that superficial tissue contamination arises from systemic effects (e.g., heart rate)
that do not correlate with cerebral response because systemic variations are typically damped
by cerebral autoregulation. However, for numerous brain diseases, including ischemic stroke,
cerebral autoregulation is impaired [65, 111]. In fact, many stroke treatment interventions are
based on the notion of impaired cerebral autoregulation and are designed to increase cerebral
blood flow through systemic mechanisms (e.g., increased blood pressure). Thus, it is preferable
not to filter systemic components from the measured signals. In a different vein, more complex,
computationally intensive models have been proposed to handle extra-cerebral heterogeneities
directly, including layered models [148, 171, 173, 174, 212, 223, 234, 255, 261], Monte Carlo
techniques in realistic geometries of the head [25, 92, 145, 235], and imaging [26, 89, 114, 258].
The complexity of these models, however, can make them impractical to implement for real-
time monitoring. Further, these models often require a priori anatomical information about the
patient’s head, as well as knowledge of the optical properties of different tissue types.
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In this contribution, we report on a novel implementation scheme for real-time cerebral mon-
itoring with the two-layer model. The two-layer model in cerebral monitoring offers a com-
promise between simplicity and accuracy [55, 85, 91, 106, 108, 120, 172, 208, 215]. The two-
layer model consists of a homogeneous superficial (extra-cerebral) layer above a homogeneous
cerebral layer. The key to our new approach is to acquire DCS and DOS/NIRS measurements
at multiple optical probe pressures and at multiple source-detector separations. Variations in
probe pressure against the head induce variations in extra-cerebral hemodynamics, while cere-
bral hemodynamics remain constant [184]. We will show how this information can be utilized
to derive patient-specific analysis parameters that help to separate cerebral hemodynamics from
extra-cerebral blood flow and oxygenation signals. For DCS measurements of blood flow, we
employ the pressure modulation scheme and a two-layer Modified Beer-Lambert framework for
analysis [12]. For DOS/NIRS measurements, we extend Fabbri et. al.’s two-layer Modified
Beer-Lambert formulation [91] to include a pressure calibration stage prior to monitoring.
After describing the theory, we demonstrate the ability of this new measurement paradigm/algorithm
to filter extra-cerebral contamination in simulations and in functional activation experiments in
healthy adult humans. Ultimately, these developments should lead to improved accuracy in real-
time monitoring of cerebral flow and oxygen metabolism.
6.2 DCS and DOS/NIRS Monitoring (Homogeneous Tissue Model)
Traditionally, diffuse optical monitoring utilizes homogeneous tissue models of the head, which
we review first. The basic measurement geometry for diffuse optical monitoring consists of point
illumination and point detection on the tissue surface; the distance between source and detector
is ρ (Figure 6.1A). DOS/NIRS is a static technique that measures slow ( 0.1 − 1 s) variations
in the detected light intensity induced by changes in tissue absorption (µa) and tissue scattering
(µ′s). DCS is a qualitatively different dynamic light scattering technique that measures the rapid
(e.g., microsecond scale fluctuations) speckle light intensity fluctuations induced by red blood
cell motion. DOS/NIRS measurements are most commonly analyzed with photon diffusion
models [96,266] and the Modified Beer-Lambert law [10,67]. Analogously, correlation diffusion
models [23, 24] and the so-called DCS Modified Beer-Lambert law [12] can be employed for
156
analysis of DCS measurements.
The Modified Beer-Lambert law is arguably the most widely used homogeneous tissue model
for analysis of DOS/NIRS measurements [10, 67]. The Modified Beer-Lambert law relates
changes in tissue optical properties to changes in continuous-wave diffuse optical intensity mea-
surements for light that has been multiply scattered in its trajectory through tissue (Figure 6.1).
Specifically, the measured difference in optical density between a “perturbed” state and a “base-
line” state is related to tissue scattering and tissue absorption differences of the corresponding
perturbed and baseline states, i.e.,
∆OD = − log
(
I
I0
)
≈ L∆µa + µ
0
a
µ′0s
L∆µ′s ≈ L∆µa. (6.1)
Here, the tissue optical density is defined as the negative logarithm of the ratio of the detected
and incident light intensities (time-averaged), i.e., OD ≡ − log(I/Is) for the perturbed state,
and OD0 ≡ − log(I0/Is) (Figure 6.1B) for the baseline state; the incident light intensity, Is,
is assumed to remain constant. ∆OD ≡ OD − OD0, ∆µa ≡ µa − µ0a, and ∆µ′s ≡ µ′s − µ′0s
are the differential changes in tissue optical density, tissue absorption, and tissue reduced scat-
tering, respectively, between a perturbed state (OD, µa, µ′s) and the baseline state (OD0, µ0a,
µ′0s ). The multiplicative factor, L ≡ ∂OD0/∂µa, is the so-called differential pathlength, which
is approximately the mean pathlength that diffusing photons travel through the medium from
source to detector [10]. The Modified Beer-Lambert law (Equation 6.1) is a first order Taylor
series expansion of the tissue optical density about tissue absorption and tissue scattering. It is
often reasonable to make the additional approximation that the scattering term in Equation 6.1 is
negligible compared to the absorption term, because (1), tissue scattering changes that accom-
pany hemodynamic variations are often negligible [12], and (2), the multiplicative factor µ0a/µ′0s
for many tissues is much less than one. Multispectral tissue absorption changes determined
from Equation 6.1 are then readily converted to estimates of tissue oxy-hemoglobin (HbO)
and deoxy-hemoglobin (HbR) concentration changes using the well-known spectra of these
molecules [79, 207]. The total hemoglobin concentration (HbT ) is the sum of these two chro-
mophore concentrations, and the tissue oxygen saturation (StO2) is the ratio of oxy-hemoglobin
to total hemoglobin: HbT = HbO +HbR, StO2 = HbO/HbT .
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Figure 6.1: (A) Schematic for a homogeneous, semi-infinite model of the head with a blood flow
index, absorption coefficient, and reduced scattering coefficient of F , µa, and µ′s, respectively.
The incident source intensity, Is, is assumed to remain constant over time. Blood cell motion
(e.g., red disks at time t and light-red disks at time t + τ ) induces fast temporal fluctuations
(i.e., speckle intensity fluctuations) in the detected light intensity on the time scale of µs, while
absorption changes modify mean light intensities (e.g., averaged on time scales ofms or greater).
(B) Schematic of detected intensity fluctuations for a baseline tissue state (red curve) and a
perturbed state from baseline with higher blood flow and absorption (blue curve). The horizontal
black lines are the mean intensities for the two states, denoted as I0 and I . The fast speckle
intensity fluctuations in the two states are characterized by normalized intensity autocorrelation
functions (i.e., g02(τ), g2(τ)). (C) The decay of the intensity autocorrelation function curves is
related to tissue blood flow.
Equation 6.1 is valid for any homogeneous geometry, provided the correct differential path-
length is used. The differential pathlength depends on the source-detector separation (ρ), the
tissue geometry, and the baseline tissue optical properties (µ0a, µ′0s ) [10, 79]. For the important
special case of the semi-infinite homogeneous geometry (Figure 6.1A), the differential path-
length is given by [94]
L ≈ 3µ
′0
s ρ
2
2
(
ρ
√
3µ0aµ
′0
s + 1
) . (6.2)
A drawback of the Modified Beer-Lambert law is that it only determines changes in hemoglobin
concentrations. For measurement of absolute oxy- and deoxy-hemoglobin concentrations, a pho-
ton diffusion model is commonly used. Formally, the detected light intensity is directly propor-
tional to the photon diffusion equation Green’s function for the appropriate tissue geometry [79],
i.e., Φ(ρ), which depends on the tissue optical properties (µa, µ′s). Note that the proportionality
constant between the measured light intensity , I(ρ), and the photon diffusion Green’s function,
Φ(ρ), is the so-called light coupling coefficient to tissue for the source-detector pair. For semi-
infinite homogeneous tissue, the continuous-wave photon diffusion equation Green’s function
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is [79, 123]
Φ(ρ) =
1
4π

exp
(
−r1
√
3µa/ℓtr
)
r1
−
exp
(
−rb
√
3µa/ℓtr
)
rb

 . (6.3)
Here, ℓtr = 1/(µa + µ′s), r1 = (ℓ2tr + ρ2)1/2, rb = [(2zb + ℓtr)2 + ρ2]1/2, and zb = 2ℓtr(1 +
Reff )/(3(1 − Reff )), where Reff is the effective reflection coefficient that accounts for the
mismatch between the index of refraction of tissue (n) and the index of refraction of the non-
scattering medium bounding the tissue (nout), such as air [123]. A standard approach for abso-
lute tissue absorption monitoring in this geometry is to measure I(ρ) at multiple source-detector
separations, and then obtain an estimate of µa from fitting these measured intensities to the semi-
infinite Green’s function solution (Equation 6.3). Required inputs for this fit are the light cou-
pling coefficients for each source-detector pair and the tissue scattering coefficient, µ′s. Knowl-
edge of the light coupling coefficients is typically obtained from phantom calibration [133,253],
and µ′s is assumed. The assumption of µ′s is an obvious source of error for continuous-wave
DOS/NIRS. In more complex frequency-domain [101] and time-domain [201] DOS/NIRS mea-
surements, both µa and µ′s can be uniquely determined from fitting these measurements to their
respective frequency-domain and time-domain Green’s functions [79].
To estimate blood flow, DCS quantifies the fast speckle intensity fluctuations of multiply
scattered coherent NIR light (coherence length > 5 m) induced by red blood cell motion (Fig-
ure 6.1). Specifically, the normalized intensity temporal autocorrelation function, g2(τ) ≡
〈I(t)I(t + τ)〉/〈I(t)〉2, is computed at multiple delay-times, τ , where I(t) is the detected light
intensity at time t, and the angular brackets, 〈〉, represent time-averages. A DCS blood flow
index, F , is ascertained from the decay of g2(τ) (Figure 6.1C, discussed in more detail below).
The DCS blood flow index is directly proportional to tissue blood flow, and has been successfully
validated against a plethora of gold-standard techniques [149, 182].
In analogy to DOS/NIRS, a DCS Modified Beer-Lambert law [12] relates differential changes
in a “DCS optical density,” i.e., ODDCS ≡ − log(g2(τ) − 1), to differential changes in tissue
blood flow index (F ), tissue absorption (µa), and tissue scattering (µ′s):
∆ODDCS = − log
(
g2(τ, ρ)− 1
g02(τ, ρ)− 1
)
≈ dF (τ)∆F + da(τ)∆µa + ds(τ)∆µ′s. (6.4)
The multiplicative weighting factors dF (τ) ≡ ∂OD0DCS/∂F , da(τ) ≡ ∂OD0DCS/∂µa, and
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ds(τ) ≡ ∂OD0DCS/∂µ′s, can be estimated analytically or numerically using the correlation
diffusion model applied to the appropriate geometry [12]. They are analogues of the differential
pathlength in the Modified Beer-Lambert law, but note their dependence on delay-time, τ . The
DCS optical density is about equally sensitive to blood flow and tissue scattering changes, but
less sensitive to tissue absorption changes [12]. If tissue scattering remains constant, and the
fractional absorption change is small compared to the blood flow change, then ∆ODDCS ≈
dF (τ)∆F . This is a system of equations, i.e., one equation for each τ , that can be solved for
∆F in a least squares sense. For the special case of the semi-infinite homogeneous geometry,
the multiplicative weighting factor is given by [12]
dF (τ, ρ) =
6µ′0s
(
µ′0s + µ0a
)
k20τ
K0(τ)
[
exp
(−K0(τ)r01)− exp (−K0(τ)r0b )
exp
(−K0(τ)r01) /r01 − exp (−K0(τ)r0b ) /r0b
]
, (6.5)
where K0(τ) = [3µ0a(µ0a + µ′0s )(1 + 2µ′0s k20F 0τ/µ0a)]1/2, r1 = (ℓ2tr + ρ2)1/2, k0 = 2πn/λ is
the magnitude of the light wave vector in the medium, and r1 and rb are defined in Equation 6.3.
The DCS Modified Beer-Lambert law has a similar drawback to DOS/NIRS in that it only
determines blood flow changes. To estimate the absolute blood flow index, F , a correlation dif-
fusion approach is used. Formally, the electric field (E(t)) autocorrelation function, G1(τ) ≡
〈E∗(t) ·E(t+τ)〉, is well modeled by the so-called correlation diffusion equation [23,24], which
can be solved analytically or numerically for tissue geometries of interest [24, 79]. Tissue blood
flow is ascertained by fitting the solution for the normalized electric field autocorrelation func-
tion, g1(τ) = G1(τ)/G1(τ = 0), to the measured normalized intensity autocorrelation function
using the Siegert relation [168]: g2(τ) = 1 + β|g1(τ)|2, where β is a constant determined
primarily by experimental collection optics and source coherence.
For semi-infinite homogeneous tissue, the solution to the correlation diffusion equation is
[24, 79]:
G1(τ) =
3
4πℓtr
[
exp (−K(τ)r1)
r1
− exp (−K(τ)rb)
rb
]
, (6.6)
where K(τ) is defined in Equation 6.5, and r1, rb, and ℓtr are defined in Equation 6.3.
A standard approach for blood flow monitoring with DCS in this geometry is to derive g1(τ)
from measurements of g2(τ) via the Siegert relation. Then, the semi-infinite correlation diffusion
solution (Equation 6.6) is fit to g1(τ) using a nonlinear minimization algorithm, and an estimate
of the blood flow index (F ) is obtained from the fit. As discussed above, these homogeneous
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head models do not distinguish cerebral hemodynamics from extra-cerebral hemodynamics, and
are thus prone to extra-cerebral contamination.
6.3 Probe Pressure Modulation Algorithm for Cerebral Blood Flow
Monitoring with DCS
Here we introduce our pressure modulation algorithm. The scheme employs DCS measure-
ments of the brain tissues at two probe pressures and two source-detector separations to reduce
extra-cerebral contamination in cerebral blood flow monitoring. To distinguish extra-cerebral
flow from cerebral flow, the head is modeled as a two-layer medium [24, 91, 106, 215], and the
source-detector separations are chosen such that detected light at the long separation (e.g., ρl = 3
cm) travels through both layers, but detected light at the short separation (e.g., ρs = 1 cm) is
predominantly confined to the extra-cerebral layer (Figure 6.2A). Underlying this approach is
our previous work which showed that an increased probe pressure on the head is accompa-
nied by a decrease in extra-cerebral flow; cerebral blood flow is unchanged by probe pressure
variation [184]. Thus, the pressure-induced variation in the long-separation DCS signal (e.g.,
Figure 6.2B) is due only to changes in extra-cerebral flow. This extra-cerebral flow change, in
turn, is readily determined by the pressure-induced change measured in the short DCS separation
signal (e.g., Figure 6.2C) which can be analyzed using the semi-infinite medium approximation
(Equation 6.6).
We will show that the subject-specific relative contributions of extra-cerebral and cerebral
tissues to the long separation DCS signal can be determined from the measured pressure-induced
changes in the DCS signal at the long and short separations. Importantly, this patient specific
calibration with pressure modulation permits separation of the cerebral and extra-cerebral blood
flow components in all subsequent measurements.
The results derived in Sections 6.3.1 and 6.3.2 are for the special case of constant tissue
absorption and tissue scattering. In practice tissue scattering often remains roughly constant
during hemodynamic changes. Further, for many cerebral processes, blood flow changes by
a substantially larger fraction than absorption. For example, for the finger tapping functional
response [85], Fc/F 0c ∼ 1.5, µa,c/µ0a,c ∼ 1.1 (at λ = 785 nm); in this case the flow contribution
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Figure 6.2: (A) Two-layer tissue model of the head, which is comprised of a semi-infinite bottom
layer (i.e., corresponding to the cortical regions of the brain) with a distinct blood flow index,
absorption coefficient, and scattering coefficient of Fc, µa,c, and µ′s,c, respectively, and a su-
perficial top layer (i.e., corresponding to extra-cerebral scalp and skull tissue) with thickness ℓ,
and distinct tissue properties denoted by Fec, µa,ec, and µ′s,ec. The head is probed with a long
source-detector separation, ρl (yellow shading), and a short source-detector separation, ρs (red
shading), and the probe pressure against the head is varied. Increasing the probe pressure from
P 0 (blue curves) to P (red curves) induces a change in the DCS signal (g2(τ)) at both the long
separation (panel (B)) and the short separation (panel (C)). These signal changes arise entirely
from pressure-induced changes in extra-cerebral flow [184].
dominates the DCS signal change [12]. We derive the general case wherein tissue absorption
and scattering vary in Appendix 6.10.
6.3.1 Two-layer Modified Beer-Lambert Laws for Flow at Long and Short Sepa-
rations
To filter contamination from extra-cerebral tissues in blood flow measurements of cerebral tis-
sue, we use a two-layer Modified Beer-Lambert formulation for blood flow based on the DCS
measurement [12]. In analogy with the DOS/NIRS Modified Beer-Lambert law [10, 67, 130],
a “DCS optical density” for the long and short source-detector separations at delay-time τ is
defined as ODlongDCS ≡ − log(g2(τ, ρl) − 1) and ODshortDCS ≡ − log(g2(τ, ρs) − 1), respectively.
Here, g2(τ, ρl) and g2(τ, ρs) are the measured long and short separation intensity autocorrela-
tion functions with cerebral and extra-cerebral DCS blood flow indices Fc and Fec. Assuming
constant tissue absorption and scattering, the two-layer Modified Beer-Lambert laws for the long
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and short separations are [12]:
∆OD
long
DCS ≡ − log
[
g2(τ, ρl)− 1
g02(τ, ρl)− 1
]
= dF,c(τ, ρl)∆Fc + dF,ec(τ, ρl)∆Fec, (6.7)
∆ODshortDCS ≡ − log
[
g2(τ, ρs)− 1
g02(τ, ρs)− 1
]
= dF,ec(τ, ρs)∆Fec, (6.8)
where g02(τ, ρl) and g02(τ, ρs) are the “baseline” intensity autocorrelation functions at the long
and short separations with cerebral and extra-cerebral DCS blood flow indices F 0c and F 0ec (note
that the superscript “0” indicates baseline). The differential changes from baseline of cerebral
and extra-cerebral blood flow are ∆Fc ≡ Fc−F 0c and ∆Fec ≡ Fec−F 0ec, and the multiplicative
weighting factors dF,c(τ, ρl) ≡ ∂ODlong,0DCS /∂Fc and dF,ec(τ, ρl) ≡ ∂ODlong,0DCS /∂Fec indicate the
relative sensitivity of the long separation DCS optical density variation to cerebral versus extra-
cerebral blood flow changes. For the short separation, the sensitivity of DCS optical density
variation to extra-cerebral blood flow changes is dF,ec(τ, ρl) ≡ ∂ODshort,0DCS /∂Fec, and we as-
sume that because the short separation predominantly samples the extra-cerebral layer, the short
separation signal is not sensitive to cerebral blood flow changes.
Solving the system of Eqs. (6.7) and (6.8) for ∆Fc, we obtain
∆Fc =
1
dF,c(τ, ρl)
[
∆ODlongDCS −
dF,ec(τ, ρl)
dF,ec(τ, ρs)
∆ODshortDCS
]
. (6.9)
Notice that Equation 6.9 is a linearized implementation of the two-layer head model (Figure 6.2)
that enables rapid monitoring of cerebral blood flow changes in real time. This implementa-
tion requires only one DCS delay-time τ for cerebral monitoring, but to ameliorate sensitivity
to noise, multiple delay-times can also be used. Then, Equation 6.9 becomes a system of linear
equations, i.e., one equation for each delay-time, which can be rapidly solved for ∆Fc. Utilizing
Equation 6.9 in both the single and multiple delay-time implementations requires knowledge of
dF,c(τ, ρl) and dF,ec(τ, ρl)/dF,ec(τ, ρs). A key result of this paper is that these weighting fac-
tors can be estimated from “initial/baseline” DCS measurements acquired during probe pressure
modulation against the head.
6.3.2 Probe Pressure Modulation Calibration of DCS
A simple way to calibrate DCS for cerebral flow monitoring is to acquire long and short sep-
aration DCS measurements of the brain tissues at two probe pressures (i.e., P , P 0). It is not
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necessary to know the exact magnitudes of the probe pressures against the head, and neither
probe pressure has to be high enough for there to be risk of patient discomfort. The key is
that changing the probe pressure from P 0 to P induces a large enough change in extra-cerebral
blood flow such that both the long and short separation DCS signals change measurably (e.g., as
in Figure 6.2B,C).
6.3.2.1 Determination of dF,ec(τ, ρl)/dF,ec(τ, ρs)
Recall that probe pressure modulation against the head affects extra-cerebral blood flow, but not
cerebral blood flow [184], i.e., ∆Fc = 0 from probe pressure changes. Thus, for relating DCS
measurements acquired at two different probe pressures, Eqs. (6.7) and (6.8) simplify to
∆ODlong,PDCS ≡ − log
[
gP2 (τ, ρl)− 1
g02(τ, ρl)− 1
]
= dF,ec(τ, ρl)∆F
P
ec , (6.10)
∆ODshort,PDCS ≡ − log
[
gP2 (τ, ρs)− 1
g02(τ, ρs)− 1
]
= dF,ec(τ, ρs)∆F
P
ec , (6.11)
where gP2 (τ, ρl) and gP2 (τ, ρs) are the long and short separation intensity autocorrelation func-
tions acquired at pressure P wherein the cerebral and extra-cerebral flow indices are F 0c and
FPec , and ∆FPec ≡ FPec − F 0ec is the pressure induced extra-cerebral flow change. Dividing Equa-
tion 6.10 by Equation 6.11 enables direct measurement of the ratio dF,ec(τ, ρl)/dF,ec(τ, ρs), i.e.,
dF,ec(τ, ρl)
dF,ec(τ, ρs)
=
∆ODlong,PDCS
∆ODshort,PDCS
. (6.12)
Substituting Equation 6.12 into Equation 6.9, we obtain
∆Fc =
1
dF,c(τ, ρl)
[
∆OD
long
DCS −
∆OD
long,P
DCS
∆ODshort,PDCS
∆ODshortDCS
]
. (6.13)
To the extent that the two-layer model (Figure 6.2) accurately models the head, cerebral blood
flow monitoring obtained from Equation 6.13 will not be affected by extra-cerebral blood flow
changes. The assumptions used to derive Equation 6.13 are (1), probe pressure modulation has
no effect on cerebral blood flow, and (2), tissue absorption and scattering remain constant. In
Appendix 6.10, Equation 6.13 is extended to the more general case wherein tissue absorption
and scattering are changing, i.e., Equation 6.34. For accurate measurements of the magnitude of
the cerebral blood flow change, knowledge of dF,c(τ, ρl) is also required.
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6.3.2.2 Determination of the weighting factor dF,c(τ, ρl)
As we described previously [12], the multiplicative weighting factor dF,c(τ, ρl) can be computed
by numerically taking the appropriate derivative of the two-layer correlation diffusion solution
(G1) [24, 106]:
dF,c(τ, ρl) ≡
∂ODlong,0DCS
∂Fc
= 2
∂
∂Fc
(− log [G01(τ, ρl)]) ,
≈ 2
∆Fc
log
[
G1(τ, ρl, F
0
c −∆Fc/2, F 0ec, µ0a,c, µ0a,ec, µ′0s,c, µ′0s,ec, ℓ)
G1(τ, ρl, F 0c +∆Fc/2, F
0
ec, µ
0
a,c, µ
0
a,ec, µ
′0
s,c, µ
′0
s,ec, ℓ)
]
, (6.14)
where ∆Fc/F 0c = 10−5. Evaluating Equation 6.14 requires knowledge of the extra-cerebral
layer thickness (ℓ), the baseline flow levels (F 0c , F 0ec), and baseline tissue optical properties
(µ0a,c, µ0a,ec, µ′0s,c, µ′0s,ec).
Ideally, the extra-cerebral layer thickness is known from a priori anatomical information
(e.g., MRI scan), and the baseline tissue optical properties are measured with concurrent frequency-
domain or time-domain DOS/NIRS [108, 120, 156, 157, 208]. Then, estimates of F 0c and F 0ec
are determined from simultaneously fitting the long separation intensity autocorrelation curves
measured at two pressures (g02(τ, ρl), gP2 (τ, ρl)) to the two-layer correlation diffusion solu-
tion [24, 106]. Important constraints used in this fit are that cerebral blood flow is the same for
both probe pressures, i.e., ∆FPc = 0, and that the pressure-induced fractional extra-cerebral
blood flow change, ∆FPec/F 0ec, is determined from the short separation measurements (i.e.,
g02(τ, ρs), g
P
2 (τ, ρs)) via semi-infinite methods (Section 6.2). These constraints provided by
the pressure calibration data make the nonlinear optimization in the fit more tractable and less
sensitive to noise.
Note that if it is not feasible to measure baseline tissue optical properties concurrently, then
they need to be assumed based on published cerebral/extra-cerebral measurements in the liter-
ature [55, 108, 144, 221]. For some patients, a priori anatomical information may also not be
available, in which case the extra-cerebral layer thickness, ℓ, could be a third free parameter in
the two-layer fit. Although fitting for three free parameters instead of two clearly makes the fit
more susceptible to noise and cross-talk, the fitting constraints provided by pressure calibration
still enable reasonable estimates of F 0c , F 0ec, and ℓ.
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An alternative approach for using the short separation data is to fit the semi-infinite corre-
lation diffusion solution to g02(τ, ρs) for F 0ec and to gP2 (τ, ρs) for FPec (see Section 6.2). When
using these absolute extra-cerebral flow indices as constraints in the two-layer fit to the long
separation data, there are only two free parameters (F 0c , ℓ) to fit for instead of three (F 0c , F 0ec, ℓ).
However, the absolute extra-cerebral flow indices are sensitive to errors in extra-cerebral tissue
optical properties [141], source-detector separation, head curvature, and heterogeneities within
the scalp. From our experience, the first approach that utilizes robust fractional extra-cerebral
flow change measurements is more reliable.
6.3.3 Summary
Figure 6.3 is a flow chart depicting the steps in the probe pressure modulation algorithm for
filtering superficial tissue contamination in cerebral flow monitoring with DCS. In the “calibra-
tion stage” of the algorithm, intensity autocorrelation measurements at two probe pressures and
two source-detector separations are used to compute the ratio dF,ec(τ, ρl)/dF,ec(τ, ρs) (“calibra-
tion term 1”) and the long separation weighting factor dF,c(τ, ρl) (“calibration term 2”). These
calibration terms are then employed in the “monitoring stage” to permit the rapid estimation of
cerebral flow changes (∆Fc). To obtain the fractional cerebral flow change from baseline, simply
divide ∆Fc by the baseline cerebral flow index, F 0c , obtained in the calibration stage. Although
two probe pressures is usually sufficient, acquiring DCS data at more than two probe pressures
constrains the nonlinear optimization in the two-layer fit for F 0c , F 0ec, and ℓ even further. Pro-
vided that the probe pressures remain less than the venous pressure in the scalp (i.e., Fec > 0),
then there is a distinct long separation autocorrelation curve for each probe pressure to simulta-
neously fit the two-layer model to. Thus, additional probe pressures yield additional data for the
two-layer fit in the calibration stage. To determine the ratio dF,ec(τ, ρl)/dF,ec(τ, ρs) with more
than two probe pressures (“calibration term 1”), evaluate Equation 6.12 for each probe pressure
and then take the average ratio over all pressures.
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Figure 6.3: Flow chart of probe pressure modulation algorithm for cerebral blood flow mon-
itoring (∆Fc) with DCS. In the “calibration stage”, baseline long and short separation inten-
sity autocorrelation functions measured at probe pressure P 0 (g02(τ, ρl), g02(τ, ρs)) and at probe
pressure P 6= P 0 (gP2 (τ, ρl), gP2 (τ, ρs)) are used to calculate ∆ODlong,PDCS (Equation 6.10) and
∆ODshort,PDCS (Equation 6.11). These parameters are in turn used to evaluate “calibration term 1”
(Equation 6.12). “Calibration term 2” is the numerical evaluation of dF,c(τ, ρl) (Equation 6.14),
which requires knowledge of the baseline cerebral and extra-cerebral flow indices (F 0c ,F 0ec) and
the extra-cerebral layer thickness (ℓ). F 0c , F 0ec, and ℓ are extracted from a simultaneous fit of
g02(τ, ρl) and gP2 (τ, ρl) to the two-layer correlation diffusion model given the constraints that
pressure modulation does not change cerebral flow (∆FPc = 0) and that the pressure-induced
fractional extra-cerebral flow change (∆FPec/F 0ec) is determined from the short separation mea-
surements using semi-infinite methods (Section 6.2). For cases where a priori knowledge of
the extra-cerebral layer thickness is available, this two-layer fit is even more constrained. In the
“monitoring stage”, calibration terms 1 and 2 are employed to convert subsequent measurements
of differential long and short separation DCS optical density changes, i.e., ∆ODlongDCS (Equa-
tion 6.7) and ∆ODshortDCS (Equation 6.8), to differential cerebral flow changes via Equation 6.13.
Note that the baseline used for the calibration stage and for the monitoring stage is the same.
Finally, for this paper, we utilized all of the delay times satisfying the limit g02(τ, ρl) > 1.25 to
solve Equation 6.13.
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6.3.4 Correlation noise sensitivity
The probe pressure modulation scheme depicted in Figure 6.3 is a fast, patient-specific imple-
mentation of the two-layer model for cerebral flow monitoring, but a big drawback is a high
sensitivity to correlation noise, especially at short delay-times. This sensitivity arises from the
fact that correlation noise is largest at short delay-times [276], while the DCS optical density
perturbations are typically small. Combined, these opposing trends with decreasing delay-time
imply that the measured DCS optical density perturbations can easily be dominated by correla-
tion noise instead of flow changes for non-optimal measurement conditions. Specifically, let’s
consider a key step in the algorithm wherein calibration term 1 (Equation 6.12) is computed.
Compared to longer delay-times, the perturbation ∆ODlong,PDCS at short τ is less sensitive to the
superficial blood flow changes induced by probe pressure modulation. This is because the rapid
decays of the temporal autocorrelation signal at short τ are mostly due to long light paths that
spend less time in superficial tissues than the short light paths contributing to slow decays (long
τ ) [186, 221]. Therefore, the computation of calibration term 1 at short τ is prone to correlation
noise. Substantial noise contamination can lead to a significant systematic error in subsequent
cerebral flow monitoring via Equation 6.13.
Another noise-related issue is that the autocorrelation signals at the long and short separa-
tions decay at substantially different rates. Thus, at delay-times where the long separation signal
has decayed significantly, the short separation signal has decayed much less. At these delay-
times, the differences in short separation decays induced by extra-cerebral flow changes are less
pronounced than they are at longer delay-times, which means the measurement of ∆ODshortDCS is
also prone to correlation noise.
One way to address the correlation noise issue is to evaluate Equation 6.13 for ∆Fc only
using longer delay-times where the DCS optical density perturbations are larger. However, ex-
cluding short τ is not desirable because it is the short τ that are most sensitive to cerebral flow.
Further, the noise-related improvements associated with longer τ are partially canceled from
using fewer delay-times to solve Equation 6.13.
A more robust approach for handling correlation noise is to solve Equation 6.7 directly for
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∆Fc:
∆Fc =
1
dF,c(τ, ρl)
[
∆ODlongDCS − dF,ec(τ, ρl)∆Fec
]
, (6.15)
where dF,c(τ, ρl) is given by Equation 6.14, dF,ec(τ, ρl) ≡ ∂ODshort,0DCS /∂Fec is given by the
extra-cerebral analogue of Equation 6.14, and ∆Fec is obtained from short separation measure-
ments via semi-infinite techniques (Section 6.2). Pressure variation is still used in the imple-
mentation of Equation 6.15 via the two-layer fit for F 0c , F 0ec, and ℓ (Figure 6.3). These baseline
properties are inputs in the evaluation of dF,c(τ, ρl) and dF,ec(τ, ρl). Then, to determine the
extra-cerebral flow change, use the relation ∆Fec = F 0ec × rFec, where rFec ≡ ∆Fec/F 0ec is the
fractional extra-cerebral flow change obtained from fitting the semi-infinite model to the short
separation autocorrelation curves. Equation 6.15 is less sensitive to correlation noise, but more
reliant on the accuracy of the baseline tissue properties for filtering superficial tissue contamina-
tion.
6.4 Probe Pressure Modulation Algorithm for Cerebral Blood Flow
Monitoring with DCS: Practical Example
As a practical example for using this pressure modulation algorithm in the clinic, let’s consider
cerebral blood flow monitoring during head-of-bed (HOB) position changes in stroke patients
[86, 97] (Figure 6.4). To maximize perfusion at the stroke site and the surrounding ischemic
penumbra, flat head-of-bed positioning (Figure 6.4B) is often used at the clinic. Changing the
head-of-bed angle from a baseline position of 30◦ (Figure 6.4A) to a flat position of 0◦ does
increase flow in the majority of patients. However, in a significant minority of patients ( 25%),
a paradoxical decrease in flow was observed [86, 97]. Thus, optical cerebral flow monitoring
with the probe pressure modulation algorithm has potential for optimizing head-of-bed position
in individual patients.
To determine cerebral flow changes induced by HOB position changes, the first step in the
calibration stage is to acquire long and short separation intensity autocorrelation measurements
at the 30◦ HOB position with a probe pressure P (e.g., P = 20 mm Hg) applied against the
scalp, i.e., gP2 (τ, ρl), gP2 (τ, ρs). Step 2 is to decrease the probe pressure against the scalp to
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Figure 6.4: Head-of-bed (HOB) positioning at (A) the baseline condition of 30◦ and (B) the
perturbed condition of 0◦ (flat). (C) Schematic of two-layer geometry of the head probed with
a long separation, ρl, and two short separations, ρs. The downward and upward pointing arrows
indicate DCS source and detector positions, respectively.
P 0 (e.g., P 0 = 5 mm Hg). Then, at the new probe pressure P 0 and the 30◦ HOB position,
acquire a second set of long and short separation intensity autocorrelation measurements, i.e.,
g02(τ, ρl), g
0
2(τ, ρs). Using these two sets of measurements, compute calibration terms 1 and
2 from Figure 6.3. These calibration terms are employed in the monitoring stage to determine
cerebral flow changes from baseline (Figure 6.3). Continuing with our example, change the
HOB position from 30◦ to 0◦, and acquire g2(τ, ρl) and g2(τ, ρs), which are the long and short
separation autocorrelation measurements at the 0◦ HOB position. The cerebral flow change from
the HOB change, i.e., ∆Fc ≡ Fc(0◦)− F 0c (30◦), is given by Equation 6.13.
To the extent that the two-layer model accurately models the head, the cerebral flow changes
calculated in this manner will not be contaminated by flow in superficial tissues. The two-
layer model approximates the head as a spatially uniform superficial tissue layer above a semi-
infinite cerebral layer. In practical measurements of the head, though, interference from super-
ficial tissues in cerebral monitoring is often spatially inhomogeneous across the surface of the
scalp [105, 109]. One way to reduce error from these superficial heterogeneities is to probe the
superficial tissue volume above the cerebral region of interest with multiple short separations, as
shown in Figure 6.4C. As with using more than two probe pressures (Section 6.3.3), it is straight-
forward to extend the probe pressure modulation algorithm to handle multiple short separations.
In our measurements, we followed the steps outlined in Figure 6.3 for each short separation sep-
arately to obtain an estimate of the cerebral flow change. We then averaged the two estimates of
170
∆Fc obtained from using the two short separations together.
6.5 Probe Pressure Modulation Algorithm for Oxygenation Moni-
toring with DOS/NIRS
In Section 6.3, we developed a probe pressure modulation paradigm for DCS that filters contam-
ination from superficial tissues in cerebral blood flow measurements. An analogous probe pres-
sure modulation scheme can be used to calibrate continuous wave DOS/NIRS for monitoring of
cerebral oxy-hemoglobin (HbOc) and deoxy-hemoglobin (HbRc) concentrations. This scheme
employs a two-layer Modified Beer-Lambert framework wherein tissue scattering is constant.
6.5.1 Two-layer Modified Beer-Lambert Laws for Absorption at Long and Short
Separations
Following analogous steps to those outlined for flow monitoring in Section 6.3, DOS/NIRS
measurements of light intensity are made at a long source-detector separation, I(ρl), and a short
source-detector separation, I(ρs). Using a two-layer model of the head, the DOS/NIRS two-
layer Modified Beer-Lambert law analogues of Eqs. (6.7) and (6.8) are [91, 130]:
∆ODlong ≡ − log
[
I(ρl)
I0(ρl)
]
= Lc(ρl)∆µa,c + Lec(ρl)∆µa,ec, (6.16)
∆ODshort ≡ − log
[
I(ρs)
I0(ρs)
]
= Lec(ρs)∆µa,ec. (6.17)
The cerebral and extra-cerebral tissue absorption and scattering coefficients that give rise to the
measured intensities I(ρl) and I(ρs) are µa,c, µa,ec, µ′s,c, and µ′s,ec, respectively. Similarly, at the
baseline measured intensities I0(ρl) and I0(ρs), the baseline cerebral and extra-cerebral tissue
absorption and scattering coefficients are µ0a,c, µ0a,ec, µ′0s,c, and µ′0s,ec, respectively. The differen-
tial changes of cerebral and extra-cerebral absorption from baseline are ∆µa,c ≡ µa,c − µ0a,c
and ∆µa,ec ≡ µa,ec − µ0a,ec. Finally, the partial pathlengths Lc(ρl) ≡ ∂ODlong,0/∂µa,c,
Lec(ρl) ≡ ∂ODlong,0/∂µa,ec, and Lec(ρs) ≡ ∂ODshort,0/∂µa,ec are the mean pathlengths that
the detected light travels through the cerebral (c) and extra-cerebral (ec) layers [91, 130, 215].
It is assumed that detected light from the short separation does not sample the brain, and con-
sequentially, Lc(ρs) = 0 and Lec(ρs) is approximately the semi-infinite differential pathlength
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given by Equation 6.2.
Solving Eqs. (6.16) and (6.17) for ∆µa,c, we obtain
∆µa,c =
1
Lc(ρl)
[
∆ODlong − Lec(ρl)
Lec(ρs)
∆ODshort
]
. (6.18)
The key advantage of using probe pressure modulation with DOS/NIRS is that it enables direct
measurement of the ratio Lec(ρl)/Lec(ρs).
6.5.2 Probe Pressure Calibration of DOS/NIRS for Cerebral Absorption Moni-
toring
Analogously to Section 6.3.2.1, the ratio Lec(ρl)/Lec(ρs) can be directly measured from differ-
ential short and long separation optical density changes between perturbed and baseline states
wherein only the extra-cerebral absorption is different [91]. Probe pressure modulation is a
simple way to induce controlled extra-cerebral absorption changes without affecting cerebral
absorption. For relating a perturbed state at probe pressure P to the baseline state at probe
pressure P 0, Eqs. (6.16) and (6.17) simplify to
∆ODlong,P ≡ − log
[
IP (ρl)
I0(ρl)
]
= Lec(ρl)∆µ
P
a,ec, (6.19)
∆ODshort,P ≡ − log
[
IP (ρs)
I0(ρs)
]
= Lec(ρs)∆µ
P
a,ec, (6.20)
where IP (ρl) and IP (ρs) are the measured intensities at probe pressure P , and ∆µPa,ec ≡ µPa,ec−
µ0a,ec is the pressure-induced extra-cerebral absorption change.
Dividing Equation 6.19 by Equation 6.20 and then substituting the result into Equation 6.18,
we obtain
∆µa,c =
1
Lc(ρl)
[
∆ODlong − ∆OD
long,P
∆ODshort,P
∆ODshort
]
. (6.21)
Here, intensity measurements at long and short separations along with initial calibration mea-
surements at two probe pressures determines ∆µa,c within a multiplicative proportionality con-
stant, 1/Lc(ρl). For accurately estimating the magnitude of the cerebral absorption change,
Lc(ρl) is calculated by numerically computing the derivative of the continuous wave two-layer
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photon diffusion Green’s function, Φ(ρl) [157,212], evaluated at the baseline tissue optical prop-
erties:
Lc(ρl) =
∂
∂µa,c
(− log[Φ0(ρl)]) ≈ 1
∆µa,c
log
[
Φ(ρl, µ
0
a,c −∆µa,c/2, µ0a,ec, µ′0s,c, µ′0s,ec, ℓ)
Φ(ρl, µ0a,c +∆µa,c/2, µ
0
a,ec, µ
′0
s,c, µ
′0
s,ec, ℓ)
]
,
(6.22)
where ∆µa,c/µ0a,c = 10−5. The Green’s function Φ(ρl) can be evaluated using the analytical
two-layer solution, or it can also be evaluated numerically using Monte Carlo techniques [255].
The computation of Lc(ρl) requires knowledge of µ0a,c, µ0a,ec, µ′0s,c. µ′0s,ec, and ℓ. As described
in Section 6.3.2.2, ideally the extra-cerebral layer thickness is known a priori from anatomi-
cal information, and the tissue baseline optical properties are measured (e.g., with time-domain
techniques). If a priori anatomical information and instrumentation for measuring baseline op-
tical properties is not available, then the baseline optical properties need to be assumed. The
extra-cerebral layer thickness can either also be assumed or estimated from the two-layer fit of
DCS data at multiple probe pressures (Section 6.3.2.2).
Cerebral absorption determined from Equation 6.21 will not be affected by extra-cerebral
absorption changes to the extent that the two-layer model accurately models the head. Figure 6.5
is a flow chart summarizing the DOS pressure modulation algorithm for monitoring cerebral
absorption changes. Note that this algorithm can be generalized for calibration with more than
two probe pressures and monitoring with multiple short separations in an exactly analogous
manner to that described in Sections 6.3.3 and 6.4.
6.5.3 Hemoglobin Monitoring with Multispectral DOS/NIRS
The cerebral tissue absorption coefficient depends linearly on the concentrations of tissue chro-
mophores. With NIR light, changes in cerebral absorption predominantly arise from changes
in cerebral oxygenated hemoglobin (HbOc) and de-oxygenated hemoglobin (HbRc) concentra-
tions, such that [79]
∆µa,c(ρl, λ) ≈ εHbO(λ)∆HbOc + εHbR(λ)∆HbRc. (6.23)
Here, εHbO(λ) and εHbR(λ) are wavelength-dependent extinction coefficients for oxygenated
hemoglobin and de-oxygenated hemoglobin, which are both known and tabulated as a function
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Figure 6.5: Flow chart of probe pressure modulation algorithm for cerebral tissue absorption
monitoring (∆µa,c) with DOS/NIRS. In the calibration stage, baseline long and short separa-
tion intensities measured at probe pressure P 0 (I0(ρl), I0(ρs)) and at probe pressure P 6= P 0
(IP (ρl), IP (ρs)) are used to calculate ∆ODlong,P (Equation 6.19) and ∆ODshort,P (Equa-
tion 6.20), which are then used to estimate Lec(ρl)/Lec(ρs) (“DOS Calibration term 1). “DOS
Calibration term 2” is the numerical evaluation of Lc(ρl) (Equation 6.22), which requires knowl-
edge of the baseline tissue optical properties and the extra-cerebral layer thickness (ℓ). Ide-
ally, these baseline tissue properties are measured (see Section 6.5.2). In the monitoring stage,
DOS Calibration terms 1 and 2 are employed to convert subsequent measurements of differential
long and short separation optical density changes, i.e., ∆ODlong (Equation 6.16) and ∆ODshort
(Equation 6.17), to differential cerebral absorption changes via Equation 6.21. Note that the
baseline used for the calibration stage and for the monitoring stage is the same.
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of wavelength λ [207], and ∆HbOc and ∆HbRc are differential changes in cerebral oxygenated
and de-oxygenated hemoglobin concentration from baseline. For multispectral cerebral absorp-
tion monitoring with Equation 6.21, Equation 6.23 becomes a system of equations, i.e., one
equation for each wavelength, which can then be solved for ∆HbOc and ∆HbRc. A minimum
of two wavelengths is required to solve for these two chromophores.
Finally, the baseline cerebral hemoglobin concentrations HbO0c and HbR0c can be calculated
from multispectral measurements of µ0a,c(λ), which in turn enables the computation of cerebral
tissue oxygen saturation, StO2,c [79]:
StO2,c =
HbO0c +∆HbOc
HbO0c +HbR
0
c +∆HbOc +∆HbRc
.
As many researchers have discussed, combining DOS/NIRS measurements of StO2,c with DCS
measurements of cerebral blood flow (Fc) permits monitoring of cerebral oxygen metabolism
[28, 62].
6.6 Experimental Methods
The pressure modulation algorithms described above were successfully applied to both simu-
lated data with noise and in vivo measurements in healthy adult volunteers to measure cerebral
hemodynamic changes. Each of the two adults measured provided written consent, and all pro-
tocols/procedures were approved by the Institutional Review Board at the University of Pennsyl-
vania. One adult was asked to do finger tapping, which induces a localized cerebral blood flow
increase in the motor cortex along with a more global extra-cerebral flow increase from systemic
effects [26,166,237]. The other adult sat comfortably while we acquired data at several different
probe pressures against the scalp to induce graded scalp ischemia. As discussed above, probe
pressure modulation changes extra-cerebral flow while cerebral flow remains constant [184].
The instrumentation used for the in vivo measurements are described in Appendix 6.11, and the
measurement protocols are explained in Sections 6.6.1 and 6.6.2. We then discuss the generation
of simulated data in Section 6.6.3.
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6.6.1 Finger Tapping Protocol
Throughout the finger tapping measurement, the subject lay supine on a bed. First, absolute
baseline optical properties over the subject’s motor cortex (Figure 6.6A) were measured with a
multiple-distance frequency domain technique [133,253]. Specifically, a commercial frequency-
domain ISS Imagent (ISS Medical, Champaign, IL, USA) was connected to a multiple-distance
probe (ISS Medical, ρ = 2, 2.5, 3, 3.5 cm). Prior to the motor cortex measurement, the instru-
ment was first calibrated on a solid silicon phantom (ISS Medical) with known optical prop-
erties [133, 253]. We used these measurements of the bulk average optical properties over the
sampled tissue volume for both the cerebral and extra-cerebral layers.
Then, the cerebral blood flow response to finger tapping was monitored with a DCS optical
probe (ρl = 3.0 cm, ρs = 1.0 cm) secured over the motor cortex (Figure 6.6A) with double-sided
medical tape (3M 1509, Converters Inc., Huntingdon Valley, PA, USA) and an ACE bandage
wound around the head. The subject’s heart rate was also monitored in parallel with a pulse ox
(Radical TM, Masimo, Irvine, CA, USA) attached to his left index finger.
With the probes in place, an initial “pressure calibration” (Figure 6.3) was performed by
gently pressing down on the probes with the palm of the hand, as depicted in Figure 6.6B. Then,
the subject executed five finger tapping trials consisting of 40-second intervals of finger tapping
separated by 60-second rest intervals (Figure 6.6B). During finger tapping, the subject tapped
all four fingers of the right hand against the thumb at 3 Hz, in time with an audible cuing signal
provided by a metronome.
6.6.2 Graded Scalp Ischemia Protocol
As with the finger tapping measurement (Section 6.6.1), the subject’s baseline absolute optical
properties over the left forehead were measured first. Then, as the subject sat comfortably, an
optical probe (Figure 6.4C) with one long separation (ρl = 3.0 cm) and two short separations
(ρs = 1.0 cm) was placed on the subject’s left forehead and secured with a blood pressure
arm cuff (Soma Technology, Bloomfield, CT, USA) wound around the head (Figure 6.7A). The
pressure cuff was inflated and maintained at the desired air pressure with a Zimmer ATS-1500
tourniquet system (Soma Technology). DCS measurements were acquired at five different probe
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Figure 6.6: (A) To measure the cerebral blood flow response to finger tapping, a DCS optical
probe (ρl = 3.0, ρs = 1.0 cm) was secured over the hand knob area of the motor cortex,
which is slightly anterior to the C3 position in the 10-20 EEG coordinate system [150]. The
C3 position lies 2/5 of the distance between the vertex and the preaurical point (i.e., 3-4 cm
down from vertex), and the vertex is the halfway point on the curve connecting the nasion to the
inion ( 17-18 cm from nasion). The subject’s heart rate was also monitored with a pulse ox. (B)
Schematic showing the timeline of the finger tapping (FT) measurement. The subject did five
blocks of finger tapping (i.e., tapping all four fingers of the right hand against the thumb) at 3 Hz.
Prior to finger tapping, baseline absolute optical properties were measured over the measurement
location depicted in part (A) (see main text), and the probe pressure was temporarily increased
by gently pressing down on the probes with the palm of the hand.
pressures against the scalp (i.e., five different extra-cerebral blood flow levels) ranging from 15
mm Hg to 40 mm Hg (Figure 6.7B). Here, the calculation of cerebral flow involved averaging
over the measured signals acquired at both short separations, as described in Section 6.4.
6.6.3 Simulated Data
For light wavelength λ = 785 nm, we generated simulated intensity autocorrelation func-
tions (DCS) and light intensities (DOS/NIRS) at source-detector separations of ρl = 3 cm and
ρs = 0.7 cm for two types of hemodynamic perturbations. Simulated DCS data sets were
obtained for the special cases of (1), varying cerebral flow while extra-cerebral flow remains
constant, and (2), varying extra-cerebral flow while cerebral flow remains constant. Similarly,
simulated DOS/NIRS intensity data sets were obtained for the special cases of (1), varying cere-
bral absorption while extra-cerebral absorption remains constant, and (2), varying extra-cerebral
absorption while cerebral absorption remains constant. The simulated intensity autocorrelation
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Figure 6.7: (A) A blood pressure cuff wound around the head was used to uniformly adjust the
pressure of the optical probe against the forehead. (B) DCS measurements were made at five
different probe pressures against the scalp.
functions were generated from adding correlation noise [276] to 2-layer solutions of the corre-
lation diffusion equation [24, 106], while simulated DOS/NIRS intensities were generated from
adding Gaussian noise to 2-layer solutions of the photon diffusion equation [157, 212].
Specifically, baseline tissue optical properties and tissue blood flow levels in the simulated
data were chosen to be representative of the head, i.e., µ0a,c = 0.16, µ0a,ec = 0.12, µ′0s,c = 6,
µ′0s,ec = 10 cm−1; F 0c = 1.4 × 10−8, F 0ec = 1.4 × 10−9 cm2/s ; ℓ = 1.2 cm (see Figure 6.2;
optical properties from Ref. [55], extra-cerebral flow from Ref. [184], cerebral to extra-cerebral
flow ratio from Ref. [250], and the extra-cerebral layer thickness from averaging across MRI
measurements in 9 adult volunteers (Durduran et al, unpublished)). In the DCS simulations,
tissue optical properties remained constant, and the added correlation noise was derived from a
correlation noise model [276] evaluated at DCS intensities of 50k and 100k photons a second
for the long and short separations, and an integration time of 2.5 seconds. The DCS signal for
each pair of cerebral and extra-cerebral flow levels in the data sets were obtained from averaging
across N = 100 simulated autocorrelation functions with noise. Finally, to simulate an increased
probe pressure during the calibration stage of the measurement (Figure 6.3), the extra-cerebral
blood flow was decreased by 30% from baseline.
In the DOS/NIRS simulations, tissue optical scattering remained constant, and the added
light intensity noise was derived from a Gaussian noise model (SNR ≡ µ/σ = 100). The
DOS/NIRS signal for each pair of cerebral and extra-cerebral tissue absorption coefficients in
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the data sets were obtained from averaging across N = 100 simulated intensities, and the extra-
cerebral tissue absorption was decreased by 15% from baseline to simulate the increased probe
pressure during the calibration stage (Figure 6.5).
6.7 Results
6.7.1 Validation with simulated data
We tested the pressure modulation algorithms (Figs. 6.3, 6.5) on the simulated data sets de-
scribed in Section 6.6.3. The cerebral blood flow and tissue absorption changes computed with
the pressure modulation algorithms are compared to the semi-infinite blood flow and tissue ab-
sorption changes (Section 6.2) in Figure 6.8. Since the short separation measurements predomi-
nantly sample the extra-cerebral layer, the semi-infinite hemodynamic changes obtained from the
short separation data agree well with the true extra-cerebral hemodynamic changes. The long
separation measurements, however, sample both cerebral and extra-cerebral tissues. Substan-
tial signal contamination from the extra-cerebral tissues induced substantial errors in the long
separation semi-infinite estimates of cerebral flow and absorption (Figure 6.8). The pressure
modulation algorithms, though, successfully filtered much of this extra-cerebral contamination
from the measured signals, and consequentially recovered cerebral hemodynamics with higher
accuracy (Figure 6.8). Note that in the flow pressure modulation algorithm, we utilized 42 delay-
times ranging from τ = 0.2 µs to τ = 35 µs to evaluate Equation 6.13 for ∆Fc. All of these
delay-times satisfied the limit g02(τ, ρl) > 1.25.
Interestingly, comparing panels (A) and (B) with (C) and (D) in Figure 6.8, it is evident that
the semi-infinite DOS/NIRS calculation is less sensitive to the brain than the semi-infinite DCS
calculation [12, 221].
6.7.2 Validation with graded scalp ischemia
As described in Section 6.6.2, we acquired DCS measurements on the forehead of a healthy adult
volunteer during graded scalp ischemia. The subject’s baseline cerebral flow, extra-cerebral flow,
and extra-cerebral layer thickness obtained from the calibration stage of the pressure modulation
algorithm were F 0c = 4.53 × 10−8 cm2/s, F 0ec = 2.23 × 10−9 cm2/s, and ℓ = 1.35 cm,
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Figure 6.8: The DCS and DOS/NIRS pressure modulation algorithms (Figs. 6.3, 6.5) were
utilized to calculate cerebral blood flow and tissue absorption changes from simulated measure-
ments on the head acquired at long and short separations of ρl = 3 cm and ρs = 0.7 cm. These
pressure algorithm results are then compared with the homogeneous semi-infinite model esti-
mates of blood flow and tissue absorption computed from the long separation data and from
the short separation data. The simulated data sets were generated from adding noise to two-
layer solutions of the correlation diffusion equation (DCS) and the photon diffusion equation
(DOS/NIRS) (see Section 6.6.3). (A) Calculated fractional cerebral blood flow changes plotted
against the actual cerebral blood flow change in “DCS simulated data set 1” (i.e., extra-cerebral
blood flow remains constant). (B) Calculated fractional cerebral flow changes plotted against
the actual extra-cerebral blood flow change in “DCS simulated data set 2” (i.e., cerebral blood
flow remains constant). (C) Calculated fractional cerebral absorption changes plotted against the
actual cerebral absorption change in “DOS/NIRS data set 1” (i.e., extra-cerebral absorption re-
mains constant). (D) Calculated fractional cerebral absorption changes plotted against the actual
extra-cerebral absorption change in “DOS/NIRS data set 2” (i.e., cerebral absorption remains
constant). Notice that the pressure algorithm calculations of cerebral changes are substantially
less sensitive to extra-cerebral hemodynamics than the semi-infinite calculations.
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Figure 6.9: DCS measurements were acquired on the forehead of a healthy adult volunteer at
multiple probe pressures against the head (15 − 40 mm Hg). The optical probe (Figure 6.4C)
consisted of one long source-detector separation (ρl = 3 cm) and two short source-detector
separations (ρs = 1 cm). (A) Measured intensity autocorrelation curves employed in the cali-
bration stage of the probe pressure modulation algorithm (Figure 6.3) plotted against delay-time
τ . The long separation autocorrelation curves g02(τ, ρl) and gP2 (τ, ρl) are the temporally aver-
aged signals across the shaded gray and yellow regions of panel (B), respectively. Similarly,
the curves g02(τ, ρs) and gP2 (τ, ρs) are temporally averaged over the same intervals and averaged
across both short separations. The solid red lines are the simultaneous two-layer pressure cali-
bration fit (Section 6.3.2.2) to g02(τ, ρl) and gP2 (τ, ρl) given the constraints that FPc = F 0c and
that FPec/F 0ec = 0.57. Note that the latter constraint was obtained from the short separation mea-
surements using semi-infinite methods. The extracted baseline parameters from the two-layer
fit are F 0c = 4.53 × 10−8 cm2/s, F 0ec = 2.23 × 10−9 cm2/s, and ℓ = 1.35 cm. (B) Temporal
fractional flow changes computed with the DCS pressure modulation algorithm and computed
with semi-infinite techniques. These fractional flow curves are smoothed via a moving average
window of size 3 frames ( 15 seconds). Notice that the cerebral blood flow change computed
with the two-layer DCS Modified Beer-Lambert law is not affected by the extra-cerebral changes
induced from varying probe pressure.
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respectively (Figure 6.9A). Further, the baseline DCS signal intensities for the long and short
separations were 35k and 170k photons a second, and the measured baseline optical properties
over the forehead at λ = 785 nm are µ0a = 0.12 and µ′0s = 8 cm−1. We then monitored
cerebral blood flow at several different probe pressures against the head using the DCS pressure
modulation algorithm and the semi-infinite model (Figure 6.9B). The extra-cerebral blood flow
determined from applying the semi-infinite model to the short separation data decreased steeply
with increasing probe pressure, until it was close to zero at P = 40 mm Hg. Importantly,
the long separation semi-infinite estimate of cerebral blood flow also decreased substantially
with increasing probe pressure, though not as severely as the extra-cerebral flow. This apparent
change in cerebral flow is due to extra-cerebral contamination in the long separation signal from
the pressure-induced extra-cerebral flow changes. The DCS pressure modulation algorithm,
though, successfully filtered the extra-cerebral contamination from the long separation signal,
and the computed cerebral flow was not affected by probe pressure changes.
Important notes are that the ‘robust noise” formulation of the DCS pressure modulation
algorithm was used (Section 6.3.4) to obtain the curve in Figure 6.9B. Further, pressure-induced
extra-cerebral absorption changes, determined from the short separation signal intensity changes
via Equation 6.17, were incorporated into the computation of cerebral flow (e.g., Equation 6.29).
Increasing the probe pressure from baseline to 40 mm Hg decreased µa,ec by 25%. Cerebral flow
monitoring with the DCS pressure modulation algorithm wherein constant absorption is assumed
(i.e., Equation 6.15) resulted in an erroneous calculated increase in cerebral flow of 10% at 40
mm Hg.
6.7.3 Validation with in vivo finger tapping data
As another in vivo test, we used the DCS pressure modulation algorithm (Figure 6.3) to mea-
sure the cerebral flow increase induced by the finger tapping task in a healthy volunteer (Sec-
tion 6.6.1). The measured baseline optical properties over the motor cortex at λ = 785 nm were
µ0a = 0.12 and µ′0s = 8 cm−1, the baseline DCS signal intensities for the long and short sep-
arations were 18k and 140k photons a second, and the baseline heart rate was 72 bpm. In the
calibration stage of this measurement, probe pressure was increased by manually pressing down
on the probe with the palm of the hand instead of using a blood pressure cuff wrapped around
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Figure 6.10: DCS measurements at one long source-detector separation (ρl = 3 cm) and one
short source-detector separation (ρs = 1 cm) were acquired over the motor cortex of a healthy
adult volunteer while he performed finger tapping (Figure 6.6A). (A) Measured intensity auto-
correlation curves employed in the calibration stage of the probe pressure modulation algorithm
(Figure 6.3) plotted against delay-time τ . These curves are temporally averaged signals across
the 60 second “baseline” and “increased probe pressure” intervals indicated in Figure 6.6B.
The solid red lines are the simultaneous two-layer pressure calibration fit (Section 6.3.2.2) to
g02(τ, ρl) and gP2 (τ, ρl) given the constraints that FPc = F 0c and that FPec/F 0ec = 0.44, where
the extra-cerebral constraint was obtained from g02(τ, ρs) and gP2 (τ, ρs) via semi-infinite meth-
ods. The extracted baseline parameters from the two-layer fit are F 0c = 1.95 × 10−8 cm2/s,
F 0ec = 3.08 × 10−9 cm2/s, and ℓ = 1.05 cm. (B) Measured finger tapping functional responses
(mean ± SE across N = 5 trials) for cerebral blood flow (rFc = ∆Fc/F 0c ), extra-cerebral blood
flow (rFec = ∆Fec/F 0ec), and heart rate plotted against time. The finger tapping stimulus was
between the two green vertical lines. Here, rFc was computed with the DCS pressure modu-
lation algorithm (Equation 6.15), rFec was determined from applying semi-infinite methods to
the short separation signal (Section 6.2), and the heart rate was measured with a pulse ox on the
finger. Further, the blue dashed line (rF (ρl)) is the mean flow response computed from applying
the semi-infinite model to the long-separation signal.
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the head. The subject’s baseline cerebral flow, extra-cerebral flow, and extra-cerebral layer thick-
ness obtained from the two-layer fit were F 0c = 1.95× 10−8 cm2/s, F 0ec = 3.08× 10−9 cm2/s,
and ℓ = 1.05 cm, respectively (Figure 6.10A). The average cerebral flow, extra-cerebral flow,
and heart rate responses induced by finger tapping (N = 5 trials) are plotted against time in
Figure 6.10B. For comparison, the average semi-infinite flow response for the long separation
is also plotted. Notice that the cerebral flow rapidly increases to a steady state value of 30%
within 5 seconds of the start of finger tapping. The extra-cerebral flow increase, though, is more
gradual, which roughly corresponds to the delayed heart rate increase from finger tapping. As
expected, the long separation semi-infinite flow change is between the cerebral flow change com-
puted with the DCS pressure modulation algorithm (Equation 6.15) and the extra-cerebral flow
change computed from the short separation measurements (Figure 6.10B).
6.8 Discussion
Superficial tissue contamination in optical monitoring of cerebral hemodynamics is a well known
issue in the DOS/NIRS community, and several methods have been proposed to isolate the
cerebral component in the DOS/NIRS signal. Many of these methods assume statistical in-
dependence of superficial and cerebral signals, such as adaptive filtering [271], principal compo-
nent/independent component analysis [26,137,199], state space modeling [107,109], and general
linear models [137,161,238]. The justification for this assumption in brain mapping applications
is that superficial signals in the scalp arise from systemic effects that are damped by cerebral au-
toregulation in the brain. Thus, the systemic superficial signals are independent from the local
activation signals in the brain. However, as we mentioned in Section 6.1, cerebral autoregula-
tion is impaired in brain diseases such as ischemic stroke. Alternative approaches for filtering
superficial tissue contamination include tomographic imaging [68, 89, 114], time-resolved mea-
surements [108, 172, 222, 234], and two-layer models [55, 85, 91, 106, 120, 208, 215].
In the present paper, our main result is a novel implementation of the two-layer model that
utilizes two source-detector separations and probe pressure modulation to optically monitor cere-
bral blood flow (Figure 6.3). The two-layer Modified Beer-Lambert law for flow is employed to
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linearly relate DCS signal changes to changes in cerebral and extra-cerebral blood flow (Equa-
tion 6.7). Further, a patient-specific “initial” pressure calibration of the measurement substan-
tially improves the tractability of flow monitoring with the two-layer model by reducing the
number of free parameters in the model to fit for. A priori anatomical information, though help-
ful, is not required in this pressure modulation algorithm. In our in vivo tests of graded scalp
ischemia (Figure 6.9) and finger tapping (Figure 6.10), we did not use any a priori anatomical
information. Unlike with tomographic imaging and principal component analysis, the two-layer
model approach does not require a large number of optodes, which permits small area optical
probes that are easier to integrate with other monitoring devices in clinical care applications re-
quiring long-term continuous monitoring. Our optical probe for the in vivo tests (Figure 6.11)
had four optodes. Finally, the linearity of the two-layer Modified Beer-Lambert law greatly facil-
itates long-term continuous real-time monitoring of cerebral blood flow. An analogous pressure
modulation algorithm for cerebral absorption monitoring with DOS/NIRS is depicted in Fig-
ure 6.5, which is an extension of Fabbri et. al.’s two-layer formulation [91] to include pressure
modulation.
The two-layer model is a big simplification of the true head geometry, but it is still effective
in filtering extra-cerebral contamination, as we demonstrated in our graded scalp ischemia and
finger tapping tests. Cerebral blood flow calculated with the homogeneous semi-infinite model
significantly depended on probe pressure, but the two-layer pressure modulation algorithm calcu-
lation of cerebral flow (Equation 6.15) did not (Figure 6.9). Further, in our finger tapping test, the
pressure modulation algorithm successfully separated the fast cerebral blood flow increase due
to brain activation from the more gradual flow increases due to systemic effects (Figure 6.10).
We measured a steady-state increase in cerebral blood flow from finger tapping of 30%
(Figure 6.10B). This increase is low compared to other published measurements, but not unrea-
sonable. Durduran et. al. measured a mean cerebral blood flow increase of 39±10% from finger
tapping (3 Hz) [85]. Ye et. al. measured a 54 ± 11% cerebral blood flow increase from finger
tapping (2 Hz) with arterial spin labeling MRI [265], and Kastrup et. al. measured a 101± 24%
cerebral blood flow increase from finger tapping (3 Hz) with a FAIR MRI technique [2]. We sus-
pect that our optical probe was not directly centered over the finger tapping hand knob, which is
a little less than 2 cm diameter in size [267]. The EEG 10-20 system (Figure 6.6) only roughly
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identifies the hand knob location, and we struggled a lot with finding the correct position for
probe placement. We obtained assistance with probe placement from a neurosurgeon (David
Kung), which was very valuable. If the probe is not exactly over the hand knob area, then only
part of the sampled cerebral volume will encompass the hand knob area, inducing a partial vol-
ume error in the recovered cerebral flow change not accounted for in the two-layer model. This
partial volume error results in an underestimation of the magnitude of the flow increase, which
is the likely explanation for our lower than expected measured flow increase.
Also notice that although the extra-cerebral blood flow in the scalp during finger tapping in-
creases gradually with the heart rate, the extra-cerebral blood flow and heart rate finger tapping
responses behave qualitatively differently in the post-stimulus interval (Figure 6.10B). Following
finger tapping, the heart rate remains elevated and gradually returns to baseline, while the extra-
cerebral blood flow rapidly plummets, undershooting and then gradually returning to baseline.
There are several factors that can affect superficial tissue blood flow besides the heart rate, such
as blood pressure and skin-specific regulation mechanisms [26,161]. Kirilina et. al. investigated
the origin of task-evoked hemodynamic changes in the scalp, and found that task-evoked super-
ficial artifacts are co-localized with veins draining the scalp [161]. The post-stimulus undershoot
in extra-cerebral blood flow we observed could potentially be explained by an increase in scalp
venous pressure induced by arterial vasoconstriction following cessation of finger tapping.
Another aspect of the pressure modulation algorithm is its estimation of the extra-cerebral
layer thickness and baseline cerebral and extra-cerebral flow indices (Figs. 6.9A, 6.10A). We
regrettably do not have an independent measure of the extra-cerebral layer thickness in the two
adult subjects we measured to explicitly validate the extra-cerebral layer thickness estimates.
The pressure calibration estimate of the layer thickness at the forehead for the pressure variation
measurement was ℓ = 1.35 cm, while the layer thickness estimate over the motor cortex in the
finger tapping measurement for a different subject was ℓ = 1.05 cm. Both of these estimates
are within the range of layer thicknesses measured by Durduran et. al. from anatomical MRI
scans, i.e., ℓ = 1.20 ± 0.26 cm (unpublished). Further, the pressure calibration estimate of
the ratio of cerebral to extra-cerebral baseline blood flow in the finger tapping measurement
was F 0c /F
0
ec = 6.3, which is consistent with PET measurements in healthy adults [194]. The
estimate of this ratio for the graded scalp ischemia measurement was F 0c /F 0ec = 20.3. This
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ratio is high, but is explained by the probe pressure being a non-negligible 15 mm Hg during
the baseline state (Figure 6.9B). At a probe pressure of 15 mm Hg, the extra-cerebral blood
flow is substantially lower than it would be normally, which is reflected by the higher than
normal cerebral to extra-cerebral flow ratio estimate. Importantly, we have demonstrated that
pressure calibration can be done successfully through pressing down on the probe with the palm
of the hand (Figure 6.10A), facilitating its implementation in a clinical setting. In our pressure
algorithm, it is not necessary to know the quantitative pressure being applied to the probe. All
that is required is a non-negligible pressure increase to induce an extra-cerebral flow change.
We emphasize that the formulation of the pressure algorithm utlizing Equation 6.13 (Fig-
ure 6.3) is sensitive to correlation noise (Section 6.3.4). For high signals and/or long temporal
averaging times, this formulation is effective (Figure 6.8), but these luxuries are usually not
available for cerebral measurements. In our in vivo tests, the correlation noise was too severe for
Equation 6.13. Thus, we used Eqs. 6.15 and 6.29 instead, which are more robust to correlation
noise. Further, we highly recommend using multiple delay-times in evaluating these equations
for the cerebral flow change to reduce sensitivity to noise. In our in vivo tests, we utilized all
delay-times wherein g02(τ, ρl) > 1.25 (∼ 40 delay times).
Noise is less of a problem for the DOS/NIRS pressure algorithm formulation (Figure 6.5),
though, because multimode detection fibers enable higher signals. During the pressure cali-
bration stage, it is important to ensure that the source-detector separations remain fixed when
probe pressure is increased. In our flexible probe, there was a tendency for the source-detector
separations to change slightly when pressing down on the probe, and the signal changes were
dominated by separation changes rather than extra-cerebral absorption changes. This problem is
fixed if a rigid probe is used, but then making good contact with the scalp is harder. Note that
the DCS measurement is less sensitive to these small changes in separation.
We finally point out that the DCS pressure modulation algorithm (Figure 6.3) assumes that
the coherence of the source laser remains constant over time, i.e., the β coefficient in the Siegert
relation (see Section 6.2) does not change. If this is not the case, then the DCS signal will change
from varying β in addition to varying flow levels. The pressure algorithm does not account for
variations in β. If β is changing, then it is more appropriate to use a DCS Modified Beer-Lambert
law for the electric field autocorrelation function, g1(τ) ≡ 〈E∗(t) ·E(t+ τ)〉/〈I(t)〉, instead of
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the intensity autocorrelation function, g2(τ). The electric field formulation is exactly analogous
to Figure 6.3, except that the DCS optical density ODDCS ≡ − log(g2(τ)− 1) is replaced with
the “electric field DCS optical density”, ODDCS,g1 ≡ − log(g1(τ)). In this formulation, the
Siegert relation is used to convert the measured g2 signals to corresponding g1 signals, wherein
the β coefficient for each data frame can be fit for.
6.9 Conclusion
We developed a novel DCS pressure modulation algorithm that successfully isolated cerebral
blood flow during graded scalp ischemia and finger tapping without using a priori anatomical
information. This approach is accurate enough to be useful for filtering superficial tissue con-
tamination in real-time cerebral blood flow monitoring. An analogous pressure modulation al-
gorithm for DOS/NIRS will filter superficial tissue contamination in cerebral blood oxygenation
monitoring.
6.10 Cerebral Blood Flow Monitoring Pressure Modulation Algo-
rithm when Tissue Optical Properties Vary
Recall that the results derived in Sections 6.3.1 and 6.3.2 are for the special case of constant
tissue absorption and tissue scattering. In this Appendix, we relax the constant optical property
assumption and derive more general expressions for cerebral flow monitoring in the pressure
modulation algorithm framework. We first focus on the case wherein tissue absorption is chang-
ing while tissue scattering remains constant (as in Section 6.5). We then move on to the case
wherein both tissue absorption and scattering vary.
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6.10.1 Cerebral flow monitoring with varying absorption
The two-layer DCS Modified Beer-Lambert law analogues of Eqs. (6.7) and (6.8) that include
absorption components are [12]
∆OD
long
DCS = dF,c(τ, ρl)∆Fc + dF,ec(τ, ρl)∆Fec + da,c(τ, ρl)∆µa,c + da,ec(τ, ρl)∆µa,ec,
(6.24)
∆ODshortDCS = dF,ec(τ, ρs)∆Fec + da,ec(τ, ρs)∆µa,ec, (6.25)
where the tissue absorption changes ∆µa,c and ∆µa,ec can be estimated from DOS/NIRS mea-
surements via Eqs. (6.21) and (6.17), and the multiplicative weighting factors da,c(τ, ρl) ≡
∂OD
long,0
DCS /∂µa,c, da,ec(τ, ρl) ≡ ∂ODlong,0DCS /∂µa,ec, and da,ec(τ, ρs) ≡ ∂ODshort,0DCS /∂µa,ec can
be numerically determined by evaluating the appropriate derivative of the two-layer correlation
diffusion solution at the baseline flow levels, tissue optical properties, and extra-cerebral layer
thickness (e.g., Section 6.3.2.2).
For the pressure calibration stage, the analogues of Eqs. (6.10) and (6.11) are
∆OD
long,P
DCS = dF,ec(τ, ρl)∆F
P
ec + da,ec(τ, ρl)∆µ
P
a,ec, (6.26)
∆ODshort,PDCS = dF,ec(τ, ρs)∆F
P
ec + da,ec(τ, ρs)∆µ
P
a,ec, (6.27)
where ∆µPa,ec ≡ µPa,ec−µ0a,ec is the pressure induced change in extra-cerebral tissue absorption.
Solving Eqs. (6.24), (6.25), (6.26), and (6.27) for the cerebral flow change, we obtain
∆Fc =
1
dF,c(τ, ρl)
[
∆OD
long
DCS − da,ec(τ, ρl)∆µa,ec − da,c(τ, ρl)∆µa,c−
∆OD
long,P
DCS − da,ec(τ, ρl)∆µPa,ec
∆ODshort,PDCS − da,ec(τ, ρs)∆µPa,ec
(
∆ODshortDCS − da,ec(τ, ρs)∆µa,ec
)]
. (6.28)
An alternative approach more robust to correlation noise (see Section 6.3.4) is to solve Equa-
tion 6.24 directly for ∆Fc, i.e.,
∆Fc =
1
dF,c(τ, ρl)
[
∆OD
long
DCS − dF,ec(τ, ρl)∆Fec − da,c(τ, ρl)∆µa,c−
da,ec(τ, ρl)∆µa,ec] , (6.29)
where ∆Fec is determined from the short separation measurements via semi-infinite methods, as
described in Section 6.3.4. As with Equation 6.13, Eqs. (6.28) and (6.29) only require a single
τ for monitoring, but multiple delay-times should be used to ameliorate sensitivity to noise.
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6.10.2 Cerebral flow monitoring with varying absorption and scattering
If both tissue absorption and scattering vary significantly, then the differential absorption and
scattering changes should be directly measured with concurrent frequency-domain or time-
domain DOS/NIRS [79, 101, 201]. The extensions of Eqs. (6.24) and (6.25) for varying tissue
scattering are [12]
∆ODlongDCS = dF,c(τ, ρl)∆Fc + dF,ec(τ, ρl)∆Fec + da,c(τ, ρl)∆µa,c + da,ec(τ, ρl)∆µa,ec+
ds,c(τ, ρl)∆µ
′
s,c + ds,ec(τ, ρl)∆µ
′
s,ec, (6.30)
∆ODshortDCS = dF,ec(τ, ρs)∆Fec + da,ec(τ, ρs)∆µa,ec + ds,ec(τ, ρs)∆µ
′
s,ec, (6.31)
where ∆µ′s,c ≡ µ′s,c−µ′0s,c and ∆µ′s,ec ≡ µ′s,ec−µ′0s,ec are the differential changes from baseline
of cerebral and extra-cerebral tissue scattering, and the scattering weighting factors ds,c(τ, ρl) ≡
∂OD
long,0
DCS /∂µ
′
s,c, ds,ec(τ, ρl) ≡ ∂ODlong,0DCS /∂µ′s,ec, and ds,ec(τ, ρs) ≡ ∂ODshort,0DCS /∂µ′s,ec are
determined using the two-layer correlation diffusion solution as described in Section 6.3.2.2.
Pressure-induced signal changes from the extra-cerebral layer are given by
∆OD
long,P
DCS = dF,ec(τ, ρl)∆F
P
ec + da,ec(τ, ρl)∆µ
P
a,ec + ds,ec(τ, ρl)∆µ
′P
s,ec, (6.32)
∆ODshort,PDCS = dF,ec(τ, ρs)∆F
P
ec + da,ec(τ, ρs)∆µ
P
a,ec + ds,ec(τ, ρs)∆µ
′P
s,ec. (6.33)
Solving Eqs. (6.30), (6.31), (6.32), and (6.33) for the cerebral flow change, we obtain
∆Fc =
1
dF,c(τ, ρl)
[
∆OD
long
DCS − da,ec(τ, ρl)∆µa,ec − da,c(τ, ρl)∆µa,c − ds,ec(τ, ρl)∆µ′s,ec−
ds,c(τ, ρl) ∆µ
′
s,c −
dF,ec(τ, ρl)
dF,ec(τ, ρs)
(
∆ODshortDCS − da,ec(τ, ρs)∆µa,ec − ds,ec(τ, ρs)∆µ′s,ec
)]
,
(6.34)
where
dF,ec(τ, ρl)
dF,ec(τ, ρs)
=
∆OD
long,P
DCS − da,ec(τ, ρl)∆µPa,ec − ds,ec(τ, ρl)∆µ′Ps,ec
∆ODshort,PDCS − da,ec(τ, ρs)∆µPa,ec − ds,ec(τ, ρs)∆µ′Ps,ec
.
Alternatively, the variable scattering extension of Equation 6.29 derived from solving Equa-
tion 6.30 for ∆Fc is
∆Fc =
1
dF,c(τ, ρl)
[
∆OD
long
DCS − dF,ec(τ, ρl)∆Fec − da,c(τ, ρl)∆µa,c−
da,ec(τ, ρl)∆µa,ec − ds,c(τ, ρl)∆µ′s,c − ds,ec(τ, ρl)∆µ′s,ec
]
. (6.35)
Again, ∆Fc is determined from short separation measurements via semi-infinite techniques.
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6.11 Instrumentation and Optical Probe
For in vivo cerebral blood flow monitoring during finger tapping and probe pressure variation,
we used a custom built DCS instrument. Briefly, two continuous wave, long coherence length
(> 5 meters) 785 nm lasers (80 mW, DL785-100-3O, CrystaLaser Inc., Reno, NV, USA) de-
liver source light to tissue via multimode fibers. Single mode detection fibers couple diffusive
light emerging from tissue to two arrays of four high sensitivity avalanche photodiodes (SPCM-
AQ4C, Excelitas, Quebec, Canada) operating in photon counting mode. The outputs from the
detection arrays are connected to a multiple-τ hardware correlator (Correlator.com, Bridgewater,
NJ, USA) that computes intensity autocorrelation curves in real time [72].
For interfacing this instrument with the head, we used an optical probe consisting of one long
separation, ρl = 3.0 cm, and two short separations, ρs = 1.0 cm (Figure 6.11). All four fiber
bundles in the probe are terminated with 3 mm dielectric coated right-angle prisms (PS905-E02-
SP, custom, Thorlabs, Newton, NJ, USA). The high reflectivity of the prisms ( 99%) ensures high
light throughput at the skin-probe interface. Further, as illustrated in Figure 6.11, the side-firing
prism fibers lay in the same plane as the probe head, which facilitates the application of uniform
pressure to the top of the probe.
All seven single mode fibers in the “DL” bundle and one attenuated single mode fiber in
the “DS” bundle of the optical probe (Figure 6.11) were connected to the 8 detection channels
in the DCS instrument. The seven independent measurements of the intensity autocorrelation
function acquired in parallel at the DL probe position were subsequently averaged together to
improve SNR. For the single mode fiber in the DS bundle, a variable blocking pigtail style fiber
optic attenuator (OZ Optics, Ontario, Canada) was employed to avoid detector saturation. Each
“S” fiber in the probe was connected to a laser, and the “middle S position fiber” was also
attenuated (OZ Optics) to avoid detector saturation. During DCS acquisition, multiplexing of
the two S positions was achieved by sequentially switching the two DCS lasers on and off with
TTL pulses controlled with Labview software (National Instruments, Austin, TX, USA). For the
finger tapping measurement (Section 6.6.1), we only used one laser (i.e., one short separation
instead of two) to increase the time resolution.
To manufacture the probe, we utilized 3D printing to produce a mold (template) that securely
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Figure 6.11: Schematic of the optical probe used for co-localized DCS and DOS/NIRS mea-
surements (dimensions in mm). (A) For conversion of straight ferrule endtip fiber bundles to
side-firing prism-coupled fibers, EPO-TEK 353ND epoxy was utilized to glue right-angle prisms
(Thorlabs, E03 dielectric coated) to the ferrule endtips. (B) The probe consists of two fused silica
multimode source fibers (S; 400µm-core/0.22NA), one long separation detection bundle (DL) of
seven single mode fibers (780HP, Thorlabs, 5µm-MFD/0.13NA), and one short separation de-
tection bundle (DS) of three single mode fibers (780HP). The termination and bundling of these
optical fibers were done by Fiberoptic Systems, Inc. (Simi Valley, CA, USA). (C) Schematic
of the 3D printed probe mold used for embedding the prism fibers in silicon elastomer at the
positions indicated in panel B (see main text).
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holds the prism fibers at the desired probe positions (Figure 6.11C). Specifically, the mold design
was made in the Fusion 360 modeling software environment (Autodesk, CA, USA) and then
printed with VeroClear material using an Objet 500 printer (Stratasys, MN, USA and Rehovot,
Israel). Separately printed prism clamps with integrated set screws secured the prism fibers in
place along grooves in the mold (Figure 6.11C). While the fibers remained fixed in place, a
two-part silicone elastomer (VytaFlex-30, Smooth-On, PA, USA) was mixed with a black tint
(3% volume fraction; SO-Strong Color Tint, Smooth-On), vacuum degassed, and poured into
the mold. Cast as a liquid, the elastomer cures over a time period of 24 hours to form a flexible
solid probe head with the prism fibers embedded at the desired positions. Notice that this highly
flexible technique can be utilized not just for making flat probes, but also probes with “built
in” curvature that may facilitate measurements on neonates. Also, the SO black tint we used
was not highly absorbing in the near-infrared. For a more absorbing probe head in the NIR, we
recommend mixing the elastomer with india ink.
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Chapter 7
Neurovascular Coupling Varies with
Level of Global Cerebral Ischemia in a
Rat Model
This chapter is mostly a verbatim reprint of my paper published in the Journal of Cerebral Blood
Flow and Metabolism [13]. However, I have added an Appendix (Section 7.6) wherein the
compartment model for computing oxygen metabolism is explicitly derived.
7.1 Introduction
In healthy brains, localized increases in neuronal activity are strongly correlated, both spatially
and temporally, to localized increases in cerebral blood flow (CBF ) and cerebral metabolic con-
sumption of oxygen (CMRO2) [244]. Thus, quantification of hemodynamics due to increased
neuronal activity, i.e., neurovascular coupling, has long been a topic of intense interest. In addi-
tion to being critical for the interpretation of techniques such as functional magnetic resonance
imaging that use hemodynamic responses to map brain function, neurovascular coupling also
plays a role in several diseases, including Alzheimers disease [139] and cerebral ischemia [66].
In this study, the effects of global cerebral ischemia on neurovascular coupling in a rat animal
model are investigated.
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Specifically, functional CBF , CMRO2, oxy-hemoglobin concentration (HbO), deoxy-
hemoglobin concentration (HbR), and total hemoglobin concentration (HbT ) responses to forepaw
stimulation on rats were measured at several levels of global ischemia from very mild (CBF ∼
90% of normal supply) to more severe (CBF ∼ 40% of normal supply). The combined op-
tical techniques of laser speckle contrast imaging [27, 76] and optical imaging of intrinsic sig-
nals [77, 117] were employed to make these measurements. To characterize neuronal activity,
the electrical somatosensory evoked potentials (SEP) were also collected simultaneously with
the optical hemodynamic measurements. To our knowledge, this is the first study that examines
functional activation during graded ischemia.
This study is also motivated by the notion that functional stimulation can be utilized as a
treatment for stroke [38, 164]. Fox and Raichle first reported that localized CBF increases
due to functional stimulation vastly exceed the localized CMRO2 increases in healthy humans
[102]. This observation suggests that the oxygen delivery increase to the tissue from functional
stimulation exceeds the oxygen consumption increase [167]. If the mismatch between the CBF
response (surrogate for oxygen delivery) and CMRO2 response persists during ischemia, then
repeated application of functional stimulation during ischemia could increase the base level of
oxygen in the brain.
For severe ischemia (CBF supply below 40% of normal levels), no hemodynamic response
to functional stimulation was observed. For less severe ischemic tissue, though, hemodynamic
and electrical responses to stimulation were present. We will show in this paper that at these
ischemic levels, CMRO2 and SEP functional responses remained tightly coupled. Importantly,
we discovered that as the animals became ischemic, the CBF response was more strongly at-
tenuated than the CMRO2 response. This observation suggests that oxygen delivery and con-
sumption increases due to stimulation become more balanced with graded ischemia. Thus, the
mechanism for the neuroprotection of functional stimulation during ischemia observed by oth-
ers [38,164] is probably not related to CBF changes. This result also supports the notion that in
healthy tissue, oxygen delivery increases from functional stimulation exceed oxygen consump-
tion increases (Leithner et al, 2010; Vazquez et al, 2008). If the oxygen delivery and consumption
increases were in balance, then the expectation is the CBF and CMRO2 responses would be
attenuated at the same rate by ischemia, which was not observed.
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7.2 Materials and Methods
7.2.1 Surgical Preparation
All procedures were in accordance with guidelines established by the National Institutes of
Health and approved by the Institutional Animal Care and Use Committee of the University
of Pennsylvania (approval # 801100). Adult male Sprague-Dawley rats (N = 46, 327 ± 31 g;
Charles River, Wilmington, MA, USA) were anesthetized with 4% isoflurane in a bell jar, intu-
bated, and then mechanically ventilated with 1.5% isoflurane in a mixture of oxygen and nitrous
oxide (3:7). End-tidal CO2 was monitored and the ventilation rate was adjusted to maintain an
arterial CO2 pressure close to 40 mm Hg. Polyethylene catheters were placed in the femoral
artery for blood pressure monitoring and the femoral vein for drug administration. Throughout
the study, body temperature was measured with a rectal probe and maintained at 37.5 ± 0.2◦ C
with a heating pad (ATC1000, World Precision Instruments, Sarasota, FL, U.S.A.). In prepara-
tion for hemodynamic imaging, the rats were secured in a stereotaxic head holder. After reflect-
ing their scalps, their skulls were uniformly thinned to translucency over a 5 by 5 mm window
encompassing the right forepaw area of the cerebral cortex (center ∼ 3.5 mm directly lateral to
bregma) (i.e., black square in Figure 7.1A) with a dental drill. To reduce specular reflections,
ultrasound gel was applied to the translucent thinned skull and a glass coverslip placed on top.
As depicted in Figure 7.1A, two 1 mm burr holes were drilled through the skull down to the dura
(∼ 3.5 mm lateral and 3 mm anterior of bregma; ∼ 2.5 mm directly posterior to lambda) for the
placement of electrodes to measure the somatosensory evoked potentials resulting from forepaw
stimulation.
To induce global ischemia, animals were held in a supine position while a midline neck
incision was made. Both common carotid arteries (CCA) were isolated from the surrounding
connective tissue, and loose snares made from a polyethylene catheter (PE-10) were carefully
placed around them for later remote occlusion. In order to achieve more severe ischemia, a partial
sternotomy was also performed in the last 39 animals in the study. After separating sterno-hyoid
muscle, the bifurcation of the right CCA and the right subclavian artery (SCA) from the aorta
was carefully dissected and exposed. A snare was then placed around the right subclavian artery
between the first and second bifurcation of the right SCA. Finally, to even further increase the
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Figure 7.1: (A) Diagram of the rat brain showing the 5 × 5 mm thinned part of the skull over
the forepaw area of the cerebral cortex for hemodynamic imaging (black square) and the burr
hole locations for electrodes to measure somatosensory evoked potentials (SEP) (filled and open
circles). (B) Schematic of instrument used for optical imaging of hemodynamics.
degree of ischemia, the lower bodies of the last 17 animals in the study were placed inside a
custom-made pressure chamber after the snares were in position. The pressure chamber applied
negative pressure to the rats, causing blood to pool in the lower part of the body [71]. The
snares were tightened and negative pressure was applied sequentially to create different levels of
cerebral ischemia from mild to severe.
For functional stimulation, two needle electrodes were inserted subdermally in the left forepaw
of each rat, contra-lateral to the translucent imaging window. Following the surgical preparation,
α-chloralose (60 mg/kg) was administered intravenously and the isoflurane was discontinued.
Nitrous oxide was also discontinued and replaced with nitrogen gas. Anesthesia was maintained
with an intravenous infusion of α-chloralose (30 mg/kg/hr). Upon completion of the study, ani-
mals were euthanized with an overdose of barbiturate.
A control group (N = 5) was prepared in the same manner as described above with loose
snares placed around both carotid arteries and the right subclavian artery. However, these snares
were not tightened to cause ischemia.
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7.2.2 Experiment Protocol
Figure 7.2 is a timeline of the study. As described above, the aim of the experiment was to create
different levels of global ischemia and measure the hemodynamic and electrical responses to
forepaw stimulation. We generated different levels of ischemia by right common carotid artery
occlusion (RCCAO), bi-lateral common carotid artery occlusion (RCCAO+LCCAO), bi-lateral
common carotid artery occlusion with right subclavian artery occlusion (RCCAO+LCCAO+RSCAO),
and three vessel occlusion with lower body negative pressure applied in a pressure chamber. Af-
ter inducing each condition of ischemia, we waited five minutes to allow flow to stabilize before
starting functional stimulation. The control group of animals shared the same timeline except
that we did not occlude any arteries or apply lower body negative pressure. After euthanizing the
animals, laser speckle images were collected for 5 minutes to obtain a biological zero correction
to the CBF measurements [275].
The forepaw stimulation paradigm, which was executed during the time windows marked
DA (i.e., data acquisition) in Figure 7.2, consisted of a train of constant current rectangular
pulses (amplitude 1.5 mA, duration 300 µs) delivered to the forepaw at 3 Hz for 4 seconds by
a commercial high voltage stimulus isolator (A360, World Precision Instruments). The stimula-
tion train was repeated every 30 seconds for a total time period of 8 minutes. After letting the
animal rest for four minutes with no stimulation, the stimulation trains were resumed every 30
seconds for another 8 minutes. During these 8 minute periods, laser speckle and spectral images
were collected sequentially for hemodynamic imaging, and electrical somatosensory evoked po-
tentials due to the stimulation were recorded. This stimulation paradigm was repeated for every
level of ischemia, as indicated in Figure 7.2. Five minutes prior to the first data acquisition,
blood was withdrawn from the femoral artery for blood gas analysis.
7.2.3 Optical Instrument
To obtain images of changes in blood flow and oxygenation, the techniques of laser speckle
contrast imaging and optical imaging of intrinsic signals were combined [77]. As depicted in
Figure 7.1B, a 60-mm lens (Apo-Componon 2.8/40, Schneider-Kreuznach, Bad Kreuznach, Ger-
many) was used to form an image of the 5 by 5 mm forepaw region of the cerebral cortex on a
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Figure 7.2: Schematic showing the timeline of the study in minutes (time axis not to scale). DA
stands for data acquisition, where we collected laser speckle and spectral images and applied
forepaw stimulation trains (1.5 mA, 0.3 ms rectangular pulses delivered at 3 Hz for 4 seconds)
every 30 seconds as described in the text. The top row of boxes indicate the CBF conditions,
which are baseline (i.e., pre-ischemic), right common carotid artery occlusion (RCCAO), right
and left common carotid artery occlusion (RCCAO+LCCAO), right and left common carotid
artery occlusion with right subclavian artery occlusion (RCCAO+LCCAO+RSCAO), and the
occlusion of the previous three arteries with the application of negative lower body pressure.
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12-bit TEC cooled CCD camera (UP-680CL-12B, Uniq Vision Inc., Santa Clara, CA, U.S.A.)
with unity magnification. Interleaved images (exposure time T = 4 ms) under different illumina-
tion sources were then captured and recorded using a frame grabber (Grablink Avenue, Euresys
Inc., San Juan Capistrano, CA, U.S.A.) and imaging software (StreamPix, NorPix, Montreal,
Quebec, Canada).
The illumination source used for laser speckle contrast imaging of CBF was a collimated 785
nm laser diode (Sanyo, DL7140-201S, 785nm, 70 mW, Thorlabs, Newton, NJ, U.S.A.) mounted
on a temperature-controlled heat sink (LDM21 Laser Diode Temperature Controlled Mount,
Thorlabs) and driven by a commercial driver (LDC 500 Laser Diode Controller, Thorlabs). The
illumination sources used for optical imaging of intrinsic signals to measure changes in oxy-
hemoglobin (HbO) and deoxy-hemoglobin (HbR) concentrations were three collimated light
emitting diodes (LEDs) mounted on heat sinks with central wavelengths of 530, 590, and 660
nm (M530L2-C1, M590L2-C1, M660L2-C1, Thorlabs) driven by commercial drivers (LEDD1B
T-Cube LED Driver, Thorlabs).
Commercial software (SciWorks, DataWave Technologies, Boulder, CO, U.S.A.) was em-
ployed to program pulse sequences of digital outputs from an A/D board (DataWave Technolo-
gies) to control the timing for the interleaved imaging. With this instrument, we acquired 3
spectral images and 4 speckle images/second.
7.2.4 Somatosensory Evoked Potential (SEP) recordings
To measure the SEP response to stimulation, a 1 mm diameter silver/sliver chloride ball electrode
and a reference silver screw electrode were placed on the dura in the burr holes indicated by
the filled and open black circles in Figure 7.1A, respectively. The recording electrodes were
connected to a low-impedance HS4 headstage (World Precision Instruments), which amplified
and digitized the voltage difference between the two electrodes before sending the signal to a
Digital BioAmp (DB4, World Precision Instruments), where the signal was further amplified
and filtered between 5 Hz and 500 Hz. SciWorks software was used to record the SEP signal
from the BioAmp for 200 ms after each stimulation pulse was delivered to the animal.
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7.2.5 Optical Image Analysis
Laser speckle contrast imaging of CBF has been discussed extensively in previous publications
[27], and the specific analysis used in this study to calculate CBF from speckle contrast images
is described by Zhou et al [275]. It was assumed that the static scattering contribution to the
speckle contrast signal from the thinned skull [198] was negligible, since we saw very similar
flow responses to studies where the skull was completely removed [82]. Since we were interested
in functional CBF responses to stimulation, the CBF images were averaged across stimulation
trials for each level of ischemia. A stimulation trial was defined as the 20-second time period
that begins 5-seconds before the start of a stimulation pulse train.
Optical imaging of intrinsic signals (or spectral imaging) to determine HbO and HbR is
also a well-established technique [78, 163]. As with CBF , the intensity images of each LED
were averaged across stimulation trials at each level of ischemia. The averaged spectral intensity
images of the three LEDs were converted to images of HbO and HbR via a modified Beer-
Lambert law (see Section 7.5).
As many other investigators have done, we employed a compartmental model (Section 7.6)
to calculate CMRO2 images from our measurements of CBF , HbO, and HbR [62, 78, 273]:
CMRO2 =
(SaO2 −HbO/HbT )
γSaO2
×CBF × Ca. (7.1)
Here, HbT is the measured total hemoglobin concentration (i.e., HbT = HbO +HbR), SaO2
is the oxygen saturation in the cerebral arterioles (taken to be 1), γ is the blood volume fraction
contained in the venous compartment of the vascular system, and Ca is the blood arteriolar
oxygen concentration. There is mounting evidence that oxygen extraction takes place in arteries
and arterioles, and as a result, the arterioles directly feeding the cerebral capillary beds may
have a lower saturation than the systemic arterial saturation [251, 264]. In the present study,
all animals breathed 30% enriched oxygen resulting in high systemic arterial oxygen tensions
(∼ 120 mm Hg). Thus, even with oxygen extraction in the arteries, the arteriolar saturation will
still be close to one throughout the study.
Equation 7.1 is a steady-state model for CMRO2. To estimate the errors in this model when
applying it to the dynamic situation of functional stimulation, we followed Vazquezs et al [247]
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approach of applying a dynamic compartment model to solve for CMRO2 using input mea-
surements from our previous study of cerebral tissue oxygen tension and blood flow in healthy
rats during functional stimulation [4]. The increases in CMRO2 during functional activation
computed with this dynamic model were then compared to the increases computed with the
steady-state model (Equation 7.1). This comparison showed that the calculated peak increases
in CMRO2 due to stimulation for the dynamic and steady-state models were within 2% of each
other (see Section 7.6). Consequently, and as discussed below, in the present study we use the
peak increase from functional stimulation to characterize the response.
Under the assumptions that SaO2, Ca, and γ remain constant over time, substituting mea-
surements of HbO, HbR, and CBF into Equation 7.1 results in an index that is proportional
to CMRO2. Although it is feasible that these assumptions may be violated during ischemia,
our group and others have shown the calculated metabolic changes from Equation 7.1 to be
relatively insensitive (i.e., < 5%) to most of the likely physiological cases that violate these
assumptions [62, 151].
7.2.6 Quantifying Hemodynamic and SEP Responses to Stimulation
Figures 7.3A and 7.3B contain montages of fractional CBF and CMRO2 responses to stim-
ulation for an exemplar animal averaged across all trials during the CBF baseline period of
Figure 7.2. To quantify the hemodynamic responses of CBF and CMRO2, as well as the
hemoglobin concentrations HbO, HbR, and HbT (image montages not shown), we followed
the same approach as Durduran et al [82] to select a region of interest (ROI). A priori informa-
tion about the stimulus paradigm was used by computing a temporal correlation coefficient at
every image pixel between CBF and the forepaw stimulus [82] during the pre-ischemic baseline
period denoted in Figure 7.2.
In order to apply a consistent threshold across all animals for ROI selection, the resulting im-
age of correlation coefficients was normalized by the maximum pixel, resulting in an image of
normalized correlation coefficients scaled from 0 to 1 (Figure 7.3C). A ROI to consist of all pix-
els with normalized correlation coefficients above 0.8 was arbitrarily chosen, and hemodynamic
temporal response curves at each level of ischemia were obtained by averaging over all pixels
within the ROI. We note here that we did not observe significant changes in our results when
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we tried using different correlation coefficient thresholds of 0.9 or 0.7 for the ROI, indicating
robustness to the particular ROI threshold.
At ischemic condition i in an animal (e.g., i = RCCAO, RCCAO+LCCAO; see Figure 7.2),
the hemodynamic responses were quantitatively characterized by their average peak increases
from baseline because of stimulation, i.e., 〈∆x〉i ≡ 〈xpeak − x0〉i, where x refers to the CBF
index, CMRO2 index, HbO, HbR, or HbT . The SEP response, in turn, was characterized at
condition i by the average difference between the p1 and n1 peaks of the signal (Figure 7.3D),
which is denoted as 〈∆SEP 〉i. To make the quantified responses unitless, which will facilitate
comparison between the different response parameters at different ischemic levels, the hemo-
dynamic and SEP responses at each ischemic condition i were normalized by their preischemic
baseline responses, 〈∆x〉BL and 〈∆SEP 〉BL:
Normalized hemodynamic response = 〈∆x〉i/〈∆x〉BL, (7.2)
Normalized SEP response = 〈∆SEP 〉i/〈∆SEP 〉BL. (7.3)
The level of ischemia, or fraction of the normal CBF supply to the brain, reached due to the
ith ischemic condition in an animal was determined quantitatively by averaging the prestimulus
speckle CBF index during condition i, 〈CBF0〉i, and dividing this by the same average of
CBF during the baseline condition, 〈CBF0〉BL:
CBF level = 〈CBF0〉i〈CBF0〉BL . (7.4)
Also of interest is the affect of cerebral ischemia on SEP latency, which we define as the
time after stimulus onset of the p1 peak in the SEP signal.
7.2.7 Statistical Analysis
Across animals, the degree of ischemia attained following each of the manipulations was quite
heterogeneous. Thus, although blood flow was lowered only through three artery occlusions
and negative lower body pressure, many different CBF levels ranging from very mild ischemia
(i.e., 0.94) to severe ischemia (i.e., 0.36) were achieved in the animals. A major goal of this
study was to determine whether there were differences in the mean CBF , CMRO2, and SEP
normalized functional responses (Equations 7.2, 7.3) as a function of CBF level (Equation 7.4).
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Figure 7.3: Image montages of fractional changes in CBF (A) and CMRO2 (B) averaged
across stimulation trials during the baseline, or pre-ischemic, CBF condition for an exemplar
animal. The fractional changes are relative to the mean of the parameters over the 5-second
pre-stimulus time windows. Each image in the montages is spaced one second apart when read
from left to right and top to bottom. The dashed double arrows indicate the 4-second forepaw
stimulus, and the letters L and A within the first image of the CBF montage stand for lateral and
anterior, respectively, to indicate image orientation. For ROI selection, a temporal correlation
coefficient was computed at every pixel between CBF and the forepaw stimulus during pre-
ischemic stimulation, and the resulting correlation coefficient image was then normalized to the
maximum pixel [82]. The ROI for the animal in this figure consists of all pixels in the animals
normalized correlation coefficient image (C) with values greater than 0.8 (see text). The thick
black lines in panels (A) through (C) are 1 mm scale bars. (D) The SEP signal averaged across
stimulation trials during the pre-ischemic baseline condition from the same animal as shown
in panels A-C. The difference between the p1 and n1 peaks in the SEP signal was used to
characterize the electrical response to stimulation.
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To address this, a mixed effects model was used [205]. This procedure is conceptually similar
to repeated measures ANOVA but allows the CBF level to be treated as a continuous variable.
Initial graphical procedures suggested that in many cases the association between CBF level
and the normalized functional responses was non-linear. Thus, a natural cubic spline was used
to model the meanCBF , CMRO2, and SEP normalized functional responses separately at each
CBF level.
We additionally fit two natural cubic spline models to these three types of normalized re-
sponses (i.e., CBF , CMRO2, and SEP) simultaneously to determine the statistical significance
of the differences in patterns over CBF level that we observed between these different types of
responses. In one model, these differences were allowed to follow a parallel, albeit non-linear
pattern over CBF level. In the second model, the response types were allowed to change dif-
ferently over CBF level. We applied a likelihood ratio test to these two models to test the null
hypothesis that the three functional response types are all affected the same by CBF level. We
also determined the significance of the differences between the SEP response and the other two
response types by considering the Wald statistics for each of the terms in the spline of the second
model. We then repeated this analysis to compare SEP responses with the HbO, HbR, and HbT
responses as a function of CBF level.
The analysis described above addresses the global question of whether there were differences
in the meanCBF ,CMRO2, HbO, HbR, HbT , and SEP responses as a function ofCBF level.
Another important question is if there are differences in the hemodynamic responses with the
SEP response over CBF level, then what are the ranges of CBF levels where these responses
are different. To address this, we used individual mixed effects models with a natural cubic spline
to model the mean logarithms of the ratios of SEP response with the hemodynamic responses that
differed globally from SEP (i.e., log(SEP/CBF ), log(SEP/HbO), and log(SEP/HbR)) as
a function of CBF level. The hemodynamic responses were significantly different from SEP at
CBF levels where the 95% CIs from these models did not overlap zero.
Lastly, we used a mixed effects model to test the hypothesis that SEP latency increased with
CBF level. As with the normalized responses, a natural cubic spline was employed to model
the mean SEP latency as a function of CBF level, and the overall significance was assessed
using a likelihood ratio test.
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These mixed effects models were implemented with library (nlme) and library (splines) in
R 2.13 [241]. A Type I error rate of 0.05 and 95% confidence intervals on the population mean
(95% CI) were used.
7.3 Results
Prior to ischemia, the population means and standard deviations of pH , PaO2, and PaCO2
determined from blood gas analysis were 7.44 ± 0.09, 124 ± 21 mm Hg, and 37 ± 8 mm Hg,
respectively, and the arterial blood pressure was 106 ± 6 mm Hg. To aid the visualization of
the effects of graded cerebral ischemia in this animal model on blood pressure, hemodynamic
responses, and electrical responses, we discretized ischemic CBF levels into bins of width 10
percentage points (i.e., 0.85-0.95, 0.75-0.85, . . ., 0.35-0.45) and determined parameter averages
across animals at CBF levels within these bins. The arterial blood pressures (mean ± SD) at
these binned CBF levels were 115 ± 9, 122 ± 12, 112 ± 7, 118 ± 12, 117 ± 15, and 95 ± 19
mm Hg for the CBF levels of 0.85− 0.95, 0.75− 0.85, 0.65− 0.75, 0.55− 0.65, 0.45− 0.55,
and 0.35 − 0.45, respectively.
Figure 7.4 shows average fractional hemodynamic temporal response curves across animals
at each binned CBF level of ischemia. Prior to ischemia (CBF Level 1 panel in Figure 7.4),
CBF has the largest response of the hemodynamic parameters, with an average peak increase
of 21%, while CMRO2 peaked at 12%. HbO and HbR peaked at 8% and −8%, respectively,
while a small 2% peak increase in HbT was observed. All the hemodynamic functional re-
sponses were attenuated as the animals became more ischemic, and once the CBF level reached
0.4, the responses essentially disappeared. Also, notice in Figure 7.4 that the peaks of the CBF
and CMRO2 responses approach each other as the level of ischemia increases, indicating that
global ischemia more strongly attenuates the CBF response.
Corresponding to the average hemodynamic responses in Figure 7.4 are the average electrical
SEP responses presented in Figure 7.5. As with the hemodynamic responses, the SEP response
is attenuated as the level of ischemia increases. However, the SEP response has not vanished at
the CBF level of 0.4, whereas the blood flow response is very much attenuated. Additionally,
Figure 7.5 contains the mean SEP latency at each binned CBF level. The observed increase in
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Figure 7.4: The average fractional responses of cerebral blood flow (CBF ), cerebral
metabolic consumption of oxygen (CMRO2), cerebral oxy-hemoglobin (HbO), cerebral deoxy-
hemoglobin (HbR), and cerebral total hemoglobin (HbT ) measured at various CBF levels (see
Equation 7.4) within the specified bins. The CBF bins are labeled by their central numbers
(e.g., CBF level 0.8 spans the range of CBF levels from 0.75 to 0.85), and the CBF level 1
indicates the pre-ischemic responses. Here, the CBF bin 0.9 is omitted since the temporal plots
look very similar to the pre-ischemic responses. The error bars indicate the standard errors of
these averages, and the 4-second forepaw stimulus is indicated in the panels by a thick black line
(omitted from CBF Level 1 panel for readability).
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SEP latency with ischemia relative to the pre-ischemic latency is highly significant (p < 0.0001).
Interestingly, the CBF response is attenuated more strongly at milder levels of global is-
chemia than the CMRO2 and SEP responses (Figures 7.6, 7.7). Figure 7.6 is a bar plot showing
the mean normalized hemodynamic and SEP responses, as defined by Equations 7.2 and 7.3, at
each CBF level bin. Figure 7.6A suggests that the CMRO2 response is tightly coupled to SEP
as the animals become more ischemic, whereas the CBF response exhibits a greater attenuation
than does SEP. This behavior is confirmed in Figure 7.7, where instead of discretizing the data
into bins, a mixed effects model was used to model averages of CBF , CMRO2, and SEP re-
sponses at each CBF level. This analysis demonstrates strong evidence of differences among
these three response types over the CBF level (p < 0.0001) as well as evidence that CBF re-
sponse differs from SEP (p < 0.0001) and from CMRO2 (p < 0.0001). However, there was no
significant difference between SEP and CMRO2 (p > 0.1). The mixed effects model analysis
comparing SEP to the hemoglobin concentrations HbO, HbR, and HbT also provides strong
evidence of differences among these four response types over CBF level (p < 0.0001). As with
CMRO2, there was no significant difference between HbT and SEP, but the SEP response did
significantly differ from HbO (p < 0.0001) and HbR (p < 0.02).
We took the logarithms of the ratios of the SEP response with the three hemodynamic re-
sponses (CBF , HbO, HbR) that differed from SEP over CBF level, and applied individual
mixed effects models to them to determine the range of CBF levels where their means are dif-
ferent from zero (p < 0.05). These models predict the mean CBF , HbO, and HbR responses
first become different from SEP at CBF levels of 0.86, 0.83, and 0.84, respectively. The mean
CBF and HbO responses remain different from SEP at all lower CBF levels in the data set,
while the mean HbR response is different from SEP until the CBF level of 0.42. We also note
here that in the control group of animals, where no occlusions were made or negative pressure
applied, the average normalized hemodynamic and SEP responses across animals did not signif-
icantly change (i.e., fluctuations less than 5%) over the two hour time course of data collection
(data not shown).
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Figure 7.5: The average somatosensory evoked potential (SEP) across animals at each CBF
level bin. As with Figure 7.4, the CBF level bins are specified by their central numbers. The
error bars indicate the standard errors of these averages, and the time zero here corresponds to
the arrival of a stimulation pulse. The boxes in each panel contain the SEP latencies (mean ±
standard error) in milliseconds at each CBF level. The latency is the time from stimulus to the
p1 peak. SEP latencies are significantly associated with CBF level (p < 0.0001).
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Figure 7.6: Average normalized hemodynamic and SEP responses (Equations 7.2, 7.3) across
animals at the binned CBF levels of ischemia (Equation 7.4) specified on the horizontal axis.
As with Figures 7.4 and 7.5, the levels of ischemia are discretized into bins with widths of 10
percentage points, such that a CBF level of 0.9 corresponds to the range of CBF levels between
0.85 and 0.95, a CBF level of 0.8 corresponds to the range of CBF levels between 0.75 and
0.85, etc. (A) From left to right, the average normalized cerebral metabolic consumption of
oxygen (CMRO2), somatosensory evoked potential (SEP), and cerebral blood flow (CBF )
responses. (B) From left to right, the average normalized cerebral total hemoglobin (HbT ),
somatosensory evoked potential (SEP), cerebral oxy-hemoglobin (HbO), and cerebral deoxy-
hemoglobin (HbR) responses. The top row of numbers in panel (A) indicates the number of
animals contributing to the averages for each CBF level. In both panels, the red lines are standard
errors to the averages, and the asterisks (*) denote statistically significant differences (p < 0.05)
with SEP at a given bin, as determined from a mixed effects model of the mean logarithm of the
ratio of SEP with the respective hemodynamic parameter (see statistical methods). Recall that
by definition, the pre-ischemic response at CBF level 1 is 1, which is why there are no error
bars in the first bins of both panels.
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Figure 7.7: Mean normalized response (Equations 7.2, 7.3) across animals (thick lines) of SEP,
CBF , and CMRO2 as a function of CBF level (Equation 7.4). Mean values shown are based
on individual mixed effects models (see statistical methods) along with their 95% confidence
intervals (shaded regions). CBF differed from SEP (p < 0.0001) and CMRO2 (p < 0.0001),
but SEP and CMRO2 were not significantly different (p > 0.1).
7.4 Discussion
Fox and Raichle [102] first reported that for healthy humans, the localized CBF increases due to
functional stimulation vastly exceed the localized CMRO2 increases, although they were compa-
rable to the increases in localized cerebral glucose metabolism [103]. The compartmental model
of Buxton and Frank [41] explained this observation by noting that a large CBF increase could
be necessary to support a small CMRO2 increase due to oxygen diffusion limitations. A key
assumption of their model is that all of the oxygen leaving the vasculature is metabolized, which
results in a tight coupling between CBF and CMRO2. However, the direct measurements of
tissue oxygen pressure and CBF in rats by Ances et al [4] during functional stimulation provide
evidence of an uncoupling between CBF and CMRO2 in that after 1 minute of stimulation,
there was a sustained post-stimulus undershoot in tissue oxygen pressure that was not present
in CBF. This is similar to the resetting of blood flow and metabolism seen following a more
generalized activation (sheltering a rat previously exposed to the environment) [178]. Leithner
et al [167] also recently presented data in rats showing that the large CBF response from func-
tional stimulation is not necessary to support small changes in CMRO2. Their interpretation of
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these results is that there exists a safety factor wherein the blood flow increase from functional
stimulation can deliver more oxygen than is necessary to sustain the increase in neuronal activity.
Our results show an uncoupling between CBF and CMRO2 during functional stimulation
at different levels of ischemia that supports the notion of the safety factor described by Leithner
et al [167]. As seen from Figures 7.6 and 7.7, the attenuation in functional CBF increases at
milder levels of ischemia is stronger than the attenuation in the neuronal activity as measured
by SEPs. However, the CMRO2 response does not follow the CBF response at the milder
levels of ischemia, but instead remains coupled to SEP. In other words, the effect of global
ischemia is to make the safety factor between the increases in oxygen supply and consumption
during functional stimulation smaller. Thus, especially for severe ischemia, it is likely that the
mechanism for the neuroprotection of functional stimulation during ischemia observed by others
[38, 164] is probably not related to CBF changes from stimulation.
As withCBF , oxy-hemoglobin and deoxy-hemoglobin concentrations are also more severely
attenuated with moderate ischemia than the electrical SEP response. However, ischemia does not
affect the total hemoglobin response significantly differently from the SEP response. The un-
coupling between blood flow and total hemoglobin responses with ischemia demonstrates that
with functional activation, using total hemoglobin as a surrogate for blood flow via Grubbs rela-
tion [119] could lead to inaccurate results for blood flow.
Recall that to characterize the functional hemodynamic responses, we looked at peak in-
creases in the hemodynamic parameters (Equation 7.2). An alternative approach would be to in-
tegrate the temporal responses due to functional stimulation (i.e., take the area under the response
curves) instead, especially since Figure 7.4 suggests that ischemia broadens the hemodynamic
responses in addition to attenuating them. Characterizing the hemodynamic responses this way,
we find the same behavior as depicted in Figures 7.6 and 7.7, demonstrating the robustness of
our main conclusion on the uncoupling between flow and metabolism increases resulting from
ischemia.
Though we are not aware of previously published data on functional hemodynamic responses
to an identical stimulation protocol, the pre-ischemic responses we measure are reasonable. For
4 Hz, 4-second, 1.6 mA forepaw stimulation in healthy rats, Royl et al [214] observed an average
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peak CBF increase of roughly 17% with laser speckle imaging, while Durduran et al [82] ob-
served average peak CBF increases with laser speckle imaging of 13.4±2.5% and 20.0±3.0%
for 5 Hz, 4-second stimulations with amplitudes of 1 mA and 2 mA, respectively. Furthermore,
the ratios between the average peak CBF response and the average peak CMRO2, HbO, HbR,
and HbT responses in our pre-ischemic data are comparable to functional responses due to a 10-
second, 3 Hz, 1 mA forepaw stimulus reported by Dunn et al [78]. The small post-stimulus
undershoot in CMRO2 present in Figure 7.4, as well as the simultaneous rise of CBF and
CMRO2, is likely an artifact of the steady-state model, Equation 7.1 [245].
In regards to somatosensory evoked potentials, experimental work involving a focal ischemia
model in baboons showed a sharp CBF threshold for electrical activity in the brain, with com-
plete electrical failure when CBF is approximately 35% of control [33]. A similar CBF thresh-
old was observed for auditory evoked potentials in a global ischemia model in cats [227]. In our
study, we did observe severe attenuation in SEPs at a CBF level around 40% (Figures 7.5, 7.6,
7.7), although we did not observe the same sharp CBF threshold for electrical activity seen in
these non-rodent ischemia models (Figure 7.7). There is a scarcity of data examining SEPs at
milder levels of ischemia. One paper examining SEPs in a hemorrhage ischemia rat model ob-
served SEP amplitudes between 50− 60% of control when CBF was lowered to approximately
65% of control [230], which is reasonably close to the results in Figure 7.7. In another paper ex-
amining the effects of bi-lateral common carotid artery occlusion on SEPs in rats, a steady-state
decrease in the SEP p1 amplitude to 90% of control is observed, although this decrease was not
statistically significant [20]. In the present study, bi-lateral common carotid artery occlusion de-
creased CBF to 70±15% (mean± SD) of control. Since in the control group, the SEP amplitude
remains stable, it is likely that the observed decreases in SEP amplitude during mild ischemia
are in fact due to the reduced blood flow levels in the brain. The effect of an increased SEP
latency with ischemia (Figure 7.5) has been observed in rodent models of ischemia by others as
well [128, 256].
The mechanisms that couple changes in neuronal activity to changes in cerebral blood flow
have been under investigation for several decades and involve not only the neurons but also
vascular cells and astrocytes encompassing the so-called neurovascular unit [165]. The main
mediators for the hemodynamic response to neuronal activation include nitric oxide, adenosine,
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glutamate, arachidonic acid metabolites, and epoxyeicosatrienoic acids [139]. During and fol-
lowing cerebral ischemia, the elements that comprise the neurovascular unit may be altered and
vascular reactivity depressed [56], with the degree of depression dependent on the degree of is-
chemia [153]. However, data is lacking on changes to these mediators during graded ischemia.
Although a specific mechanism accounting for the decrease in blood flow response as baseline
blood flow is decreased cannot be identified, reduction of cerebral blood flow resulting from
upstream vascular clamping or hypotension causes the local vasculature to dilate with potential
negative implications for further dilation in response to neuronal activation.
To summarize, we have collected a large data set of hemodynamic and electrical functional
responses in rats at many different levels of global cerebral ischemia. All of the electrical and
hemodynamic responses are attenuated as the global ischemia becomes more severe, but the
blood flow, oxy-hemoglobin, and deoxy-hemoglobin responses are more strongly attenuated
at milder levels of global ischemia than the electrical or metabolic responses. The observed
uncoupling between flow and metabolism at ischemic levels is evidence supporting the notion
that during healthy conditions, functional stimulation increases oxygen delivery to brain tissue
more than oxygen consumption. During functional stimulation in global ischemia, though, a
higher fraction of the oxygen delivered from the vasculature will be consumed.
7.5 Appendix: OIS Modified Beer-Lambert Law with Light Emit-
ting Diodes
A Modified Beer Lambert law for OIS was employed to compute hemoglobin concentration
changes from intensity measurements under light emitting diode illumination:
− log
(
Ijk(t)
I0,jk
)
=
∑
i
wi [εHbO(λi)∆HbOk(t) + εHbR(λi)∆HbRk(t)]L(λi). (7.5)
Here, Ijk(t) is the measured intensity at time t and I0,jk is the averaged measured pre-stimulus
baseline intensity at a given ischemic condition for LED j and pixel k in the CCD camera,
εHbO(λ) and εHbR(λ) are molar extinction coefficients [207] for HbO and HbR at wavelength
λ, respectively, ∆HbOk(t) and ∆HbR(k) are the concentration changes in HbO and HbR
from baseline at pixel k and time t, respectively, L(λ) is a differential pathlength, wi are weights
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indicating the contribution of wavelength λi in the spectra of LED j, and the sum is over all i
wavelengths present in the LED spectra. Equation 7.5 assumes that light absorption from tissue
chromophores other than HbO andHbR is negligible, and that tissue scattering remains constant
over time. The LEDs had a broad spectra (width > 20 nm), which is why it was necessary to
measure the emission spectra of the three LEDs used with a spectrophotometer.
The weight wi in Equation 7.5 is the power of wavelength i emitted by a given LED divided
by the total power emitted by the LED over all wavelengths. Using Monte Carlo simulations,
the differential pathlengths at each wavelength in the LED spectra were calculated with the
procedure described by Kohl et al [163] (also see Chapter 3). The mean differential pathlengths
for the 530, 590, and 660 nm LEDS we used were 0.063, 0.087, and 0.474 cm, respectively.
Equation 7.5 forms a system of 3 equations for each of the 3 LEDs, which was solved for
∆HbOk(t) and ∆HbRk(t) using a least squares approach.
In addition to using Equation 7.5 to calculate changes in HbO and HbR due to stimulation at a
given ischemic condition, Equation 7.5 was also employed to calculate changes in HbO and HbR
between adjacent steps of graded ischemia. For example, to measure the changes in HbO and
HbR due to unilateral carotid artery occlusion, Ijk and I0,jk in the left-hand side of Equation 7.5
are the average pre-stimulus intensities during the uni-lateral carotid artery occlusion and the pre-
ischemic baseline periods, respectively, for LED j and pixel k (Fig. 2). HbO and HbR changes
between unilateral carotid artery occlusion and bilateral carotid artery occlusion, bilateral carotid
artery occlusion and three vessel occlusion, and three vessel occlusion and negative lower-body
pressure were calculated the same way. The changes in HbO and HbR between adjacent steps
of graded ischemia are small enough that the modified Beer Lambert Law (7.5) is still accurate
[152].
It was assumed during the pre-ischemic baseline period for every animal that the cortical
tissue under the imaging window is spatially homogeneous with HbO0 = 60 µM, HbR0 =
40 µM, and a reduced scattering coefficient of 10 cm−1 for all wavelengths emitted by the
LEDs. From this starting point, images ofHbO andHbR were then calculated for all subsequent
conditions of ischemia.
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Table 7.1: Parameters utilized in compartment model (see Equation 7.28 and Figure 7.8).
Quantity Symbol Units
Vascular [O2] (Eq. 7.22) C(x, t) µmol O2 / (L blood)
Plasmatic [O2] (Eq. 7.12) Cp(x, t) µmol O2 / (L blood)
Tissue [O2] Ct(t) µmol O2 / L
Arteriole [O2] (C(x = 0, t), Eq. 7.20) Ca(t) µmol O2 / (L blood)
Venule [O2] (C(x = L, t), Eq. 7.16) Cv(t) µmol O2 / (L blood)
Vascular cross-section area (Eq. 7.21) Ac(x, t) cm2
Arteriole cross-section area (Eq. 7.19) Aa(t) cm2
Venule cross-section area (Eq. 7.15) Av(t) cm2
Tissue compartment volume Vt mL
Total tissue volume Vtissue mL
O2 Permeability (Eq. 7.8) P cm / min
surface area O2 exchange (Eq. 7.11) s(x)dx cm2
Arteriole blood flow (Eq. 7.18) CBFa(t) (mL blood) / (min cm2)
CBFa, clinical units (Eq. 7.27) CBFa,c(t) (mL blood) / (min (100 mL tissue))
Venule blood flow (Eq. 7.14) CBFv(t) (mL blood) / (min cm2)
CBFv, clinical units (Eq. 7.27) CBFv,c(t) (mL blood) / (min (100 mL tissue))
Tissue [O2] Metabolism (Eq. 7.26) CMRO2(t) µmol O2 / min
CMRO2, clinical units (Eq. 7.28) CMRO2,c(t) µmol O2 / (min (100 mL tissue))
7.6 Appendix: Tissue Compartment Model for CMRO2
The tissue compartment model is essentially a mass balance relation for oxygen that is commonly
used to estimate oxygen metabolism (also known as oxygen consumption) from measurements
of tissue blood flow and tissue oxygen saturation [41–43,62,104,131,132,136,138,180,187,195,
242,246,273]. The so-called single compartment model approximates the tortuous vasculature in
tissue as a single tube embedded in a well-mixed (i.e., spatially homogeneous O2 concentration)
tissue compartment (Figure 7.8) [242]. The parameters used in the compartment model are
tabulated in Table 7.1.
7.6.1 Relation of Compartment Model Parameters to Tissue Vasculature
The first step in deriving the compartment model is to calculate the oxygen diffusing from a sin-
gle blood vessel to the tissue volume at an arbitrary point x along the blood vessel (see dashed
box in Figure 7.9). Let w denote the width of the vessel membrane and c(y) denote the concen-
tration of oxygen at a point y within the membrane (Figure 7.9). The oxygen concentration c(y)
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Figure 7.8: An arbitrary tissue volume Vtissue is comprised of a vascular compartment of length
L and a well-mixed tissue compartment. The total amount of oxygen flowing into the vascular
compartment is (AaCa) × CBFa (Equation 7.17), where Ca is the average arteriole oxygen
concentration, Aa is the cross-sectional area of the vascular compartment at x = 0, and CBFa
is the blood flow supplying Vtissue. Oxygen leaves the vascular compartment via venous drainage
((AvCv)×CBFv (Equation 7.13); Cv is average venule oxygen concentration, Av is the cross-
sectional area of the vascular compartment at x = L, CBFv is the blood flow draining Vtissue)
and via oxygen exchange with the tissue compartment (see main text). C(x) is the total concen-
tration of oxygen at position x in the vascular compartment, Cp(x) is the contribution to C(x)
from oxygen dissolved in the plasma, P is the oxygen permeability of the vascular compartment
(Equation 7.8), s(x)dx is the infinitesimal surface area of oxygen exchange between the vascu-
lar and tissue compartments at x, and Ct is the concentration of oxygen in the well-mixed tissue
compartment. The tissue compartment is supplyed by oxygen from the vascular compartment,
and “drained” by the consumption of oxygen in Vtissue (i.e., CMRO2).
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Figure 7.9: Schematic of three vessels spanning the tissue volume Vtissue with draining blood
flows of CBFv,1, CBFv,2, and CBFv,3. For each vessel, the variable x is understood to be the
length along the vessel from its point of entry into the tissue volume. At the “exit points” where
the vessels leave Vtissue, the oxygen concentrations in the blood are Cv,1, Cv,2, and Cv,3, and
the cross-sectional areas of the vessels are Ac,1, Ac,2, and Ac,3. The dashed purple box is a
zoomed-in view of a vessel membrane.
is described by the diffusion equation
∂c
∂t
= DO2
∂2c
∂y2
, (7.6)
with the boundary conditions c(y = 0) = Cp(x) and c(y = w) = Ct. DO2 is the diffusion
coefficient of oxygen in the vessel membrane, Cp(x) is the oxygen concentration dissolved in
the blood plasma at x, and Ct is the oxygen concentration in the tissue compartment. Assuming
steady-state, i.e., ∂c/∂t = 0, the solution to Equation 7.6 is
c(y) = Cp(x) + [Ct − Cp(x)] y
w
. (7.7)
From Fick’s law, the flux of oxygen from the vessel into the tissue at position x, is
JO2(x) = −DO2 ∂c
∂y
=
D
w
(Cp(x)− Ct) = P (Cp(x)− Ct), (7.8)
where P = DO2/w [cm / min] is the oxygen permeability of the vessel membrane.
Now, let’s consider three vessels flowing through Vtissue (Figure 7.9). For a single vessel j,
the transport rate of oxygen from vessel to tissue at length x along the vessel is the oxygen flux
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given by Equation 7.8 multiplied by the vessel’s infinitesimal surface area of oxygen exchange,
sj(x)dx, i.e., TO2(x) = P sj(x)dx[Cp,j(x)−Ct] [µmol / min]. The total oxygen transport rate is
the sum over the rates for each blood vessel, e.g.,
TO2(x) = (P s1(x)[Cp,1(x)− Ct] + P s2(x)[Cp,2(x)− Ct] + P s3(x)[Cp,3(x)− Ct])dx
= Ps(x)dx[Cp(x)− Ct], (7.9)
where s(x)dx = (s1(x) + s2(x) + s3(x))dx is the total surface area of oxygen exchange, and
Cp(x) = [s1(x)Cp,1(x)+ s2(x)Cp,2(x)+ s3(x)Cp,3(x)]/s(x) is a weighted average of the vessel
plasmatic oxygen concentrations.
More generally, the total rate of oxygen transport to tissue from N vessels is
TO2(x) =
N∑
j=1
P sj(x)dx[Cp,j(x)− Ct]
= Ps(x)[Cp(x)− Ct], (7.10)
where
s(x) =
N∑
j=1
sj(x), (7.11)
Cp(x) =
1
s(x)
N∑
j=1
sj(x)Cp,j(x). (7.12)
Also of interest is the “drainage rate” of oxygen from blood flow exiting Vtissue, i.e., T dO2
[µmol / min]. The oxygen transport rate out of the tissue from blood flow in an arbitrary vessel
j is CBFv,j(Cv,jAv,j), where CBFv,j, Cv,j, and Av,j are the vessel’s blood flow, oxygen concentra-
tion, and cross-sectional area, respectively, at the vessel’s exit point from Vtissue. Therefore, the
total drainage rate from N vessels is
T dO2 =
N∑
j=1
CBFv,j(Cv,jAv,j)
= CBFv(AvCv). (7.13)
Here,
CBFv =
N∑
j=1
CBFv,j (7.14)
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is the total blood flow exiting Vtissue,
Av =
N∑
j=1
Av,j (7.15)
is the total cross-sectional area of the blood vessels at the exit points of Vtissue, and
Cv =
1
CBFvAv
∑
j=1
CBFv,jAv,jCv,j (7.16)
is a weighted average of the vessel oxygen concentrations at their tissue exit points.
Analogously, the “supply rate” of oxygen from blood flow entering Vtissue is
T sO2 =
N∑
j=1
CBFa,j(Ca,jAa,j)
= CBFa(AaCa), (7.17)
where CBFa,j, Ca,j, and Aa,j are the jth vessel’s blood flow, oxygen concentration, and cross-
sectional area, respectively, at the vessel’s entry point into Vtissue. Further,
CBFa =
N∑
j=1
CBFa,j (7.18)
is the total blood flow supplying Vtissue,
Aa =
N∑
j=1
Aa,j (7.19)
is the total cross-sectional area of the blood vessels at the entry points of Vtissue, and
Ca =
1
CBFaAa
∑
j=1
CBFa,jAa,jCa,j (7.20)
is a weighted average of the vessel oxygen concentrations at their tissue entry points.
Finally, analogously to Equations 7.19 and 7.20, the vascular compartment cross-sectional
area (Ac(x)) and oxygen concentration (C(x)) at length x in the vascular compartment are
Ac(x) =
N∑
j=1
Ac,j(x), (7.21)
C(x) =
1
CBF (x)Ac
∑
j=1
CBFj(x)Ac,j(x), (7.22)
where CBF (x) =
N∑
j=1
CBFj(x) is the total blood flow at length x.
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7.6.2 Oxygen Transport Equations in Vascular and Tissue Compartments
The conservation law [176, Section 1.2] of oxygen in the vascular compartment (see Figure 7.8)
is
d
dt
∫ L
0
Ac(x, t)C(x, t)dx = T
s
O2 − T dO2 −
∫ L
0
TO2(x)dx, (7.23)
where the left hand side is the temporal rate of change of oxygen in the vascular compartment,
T sO2 is the oxygen supply rate to the vascular compartment, T dO2 is the oxygen drainage rate from
vessels exiting the vascular compartment, and the integral on the right-hand side is the diffusive
rate of oxygen transport between the vascular and tissue compartments. Substituting Equations
7.10, 7.13, and 7.17 into Equation 7.23, we obtain the vascular compartment oxygen transport
equation, i.e.,
d
dt
∫ L
0
Ac(x, t)C(x, t)dx = CBFa(t)Aa(t)Ca(t)− CBFv(t))Av(t)Cv(t)−∫ L
0
Ps(x, t)[Cp(x, t)− Ct(t)]dx. (7.24)
For the tissue compartment, the oxygen transport equation is
d
dt
(Vt(t)Ct(t)) =
∫ L
0
Ps(x)[Cp(x, t)− Ct(t)]dx− CMRO2(t), (7.25)
where Vt(t) is the volume of the tissue compartment at time t (not to be confused with Vtissue,
which is the total tissue volume), and CMRO2(t) [µmol / min] is the tissue oxygen metabolism.
In words, Equation 7.25 states that the rate of change in oxygen [µmol/min] in the tissue com-
partment is the oxygen supply rate diffusing from the vasculature minus the oxygen consumption
rate.
Combining Equations 7.24 and 7.25, we find that the compartment model expression for
CMRO2 is
CMRO2(t) = CBFa(t)[Aa(t)Ca(t)]− CBFv(t) [Av(t)Cv(t)]−
d
dt
[Vt(t)Ct(t)]− d
dt
[∫ L
0
Ac(x, t)C(x, t)dx
]
. (7.26)
As I discussed in Section 4.9.2, absolute blood flow is reported clinically in units of blood
volume per time per tissue volume, e.g., [(mL blood) / (min (100 mL tissue))]. The “clinical”
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arterial and venous blood flows, i.e., CBFa,c and CBFv,c, relate to CBFa and CBFv via
CBFa,c = CBFa
(
Aa
Vtissue
)
, CBFv,c = CBFv
(
Av
Vtissue
)
. (7.27)
Dividing Equation 7.26 by Vtissue, we find that the compartment model for CMRO2 in terms of
CBFa,c and CBFv,c is
CMRO2,c(t) ≡ CMRO2(t)
Vtissue
= CBFa,c(t)Ca(t)− CBFv,c(t)Cv(t)−
1
Vtissue
(
d
dt
[Vt(t)Ct(t)] +
d
dt
[∫ L
0
Ac(x, t)C(x, t)
])
.
(7.28)
Here, CMRO2,c(t) [µmol / (min (100 mL tissue))] is the tissue oxygen metabolism normalized
by the tissue volume.
7.6.3 Steady State Compartment Model
For steady-state conditions wherein the time derivatives are zero and the arterial and venous
blood flows are equal, i.e., CBFa,c = CBFv,c = CBFc, Equation 7.28 simplifies substantially
to
CMRO2,c = CBFc [Ca − Cv] . (7.29)
Recall that CBFc is proportional to the DCS blood flow index (i.e., Equation 4.79). Further, if
the oxygen dissolved in the plasma is negligible compared to the oxygen bound to hemoglobin,
which is usually the case (Figure 7.10), then
Ca = 4SaO2[HbT ]a,blood = 4υSaO2Hcta, (7.30)
Cv = 4SvO2[HbT ]v,blood = 4υSvO2Hctv. (7.31)
Here, SaO2 and SvO2 are weighted averages of the oxygen saturation in vessels supplying Vtissue
(e.g., arterioles) and in vessels draining Vtissue (e.g., venules), respectively. Further, [HbT ]a,blood
[µmol HbT / L blood] and [HbT ]v,blood are the total hemoglobin concentrations in the blood as-
sociated with SaO2 and SvO2. Finally, Hcta and Hctv are the corresponding hematocrit levels,
and υ [µmol HbT / (RBC volume)] is the average amount of total hemoglobin per red blood
cell volume. The factor of 4 in Equations 7.30 and 7.31 is present because the concentration of
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Figure 7.10: Ratio of the dissolved oxygen in plasma over the oxygen bound to hemoglobin
(Cp/Cbound), plotted as a function of the hemoglobin oxygen saturation (SO2 = HbO/HbT ).
Cp was calculated from the empirical hemoglobin dissociation curve relating oxygen concen-
tration dissolved in the plasma to oxygen saturation, i.e., Cp = Cp,50(1/SO2 − 1)−1/h, with
Cp,50 = 36.1 µM and h = 2.73 [242]. The bound oxygen is Cbound = 4SO2[HbT ]blood, with
[HbT ]blood ≈ 2300 µM.
bound oxygen is roughly four times that of oxy-hemoglobin (i.e., 4 oxygen molecules are bound
to each oxygenated hemoglobin protein).
For constant hematocrit (Hcta = Hctv = Hct), the steady-state oxygen metabolism ob-
tained from substituting Equations 7.30 and 7.31 into 7.29 is
CMRO2,c = (4υHct)CBFc (SaO2 − SvO2) . (7.32)
Optical techniques sensitive to CBFc include DCS and laser speckle contrast imaging. We know
from Chapter 2 that DOS is sensitive to tissue oxygen saturation (StO2, see Equation 2.139).
Thus, to determine CMRO2,c from Equation 7.32, the goal is to estimate the oxygen extraction
SaO2 − SvO2 (or changes in oxygen extraction) from StO2 measurements. This is a difficult
task, though, because the DOS measurement samples a mixture of arteriole, capillary and venule
blood oxygen saturation and does not separate venous from arterial saturations.
To proceed, StO2 is assumed to be a weighted average of arteriole and venule oxygen satu-
rations [62]:
StO2 = (1− γ)SaO2 + γSvO2, (7.33)
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where γ is a weighting factor. Substituting Equation 7.33 into Equation 7.32, we obtain
CMRO2,c = (4υHct)CBFc
(
SaO2 − StO2
γ
)
. (7.34)
Fractional oxygen metabolism changes relative to a baseline state are in turn given by
CMRO2,c
CMRO02,c
=
(
CBFc
CBF 0c
)(
SaO2 − StO2
SaO02 − StO02
)(
γ0
γ
)
, (7.35)
where the superscript “0” denotes baseline. The fractional blood flow change can be directly
measured with DCS, and DOS can measure the tissue oxygen saturations. The arteriole oxygen
saturations are often assumed to be unity, or else estimated from other techniques such as a pulse
ox. Although one could estimate γ from knowledge of the venous blood volume fraction, this
estimate is complicated by the non-trivial distribution of detected photon paths in tissue. For
example, photons traversing larger vessels have a strong tendency to be absorbed, and therefore
even large veins with a high blood volume fraction may contribute little to the DOS signal.
However, if the arteriole, capillary, and venule blood volume fractions remain constant between
a baseline and perturbed tissue state, then it is reasonable to assume that γ0/γ = 1.
Alternatively, it is feasible to monitor SvO2 directly with DOS by looking at hemoglobin
changes in sync with the respiration rate [177]. This is a promising approach that can be used to
estimate γ. It works best if the respiration rate is regular.
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Chapter 8
Conclusions/Future Work
Diffuse correlation spectroscopy (DCS) and diffuse optical spectroscopy (DOS) are noninva-
sive optical techniques capable of cerebral blood flow (CBF ), cerebral blood volume (CBV ),
and cerebral blood oxygenation (StO2) monitoring. Further, a tissue compartment model (Sec-
tion 7.6) can be utilized to estimate cerebral oxygen metabolism (CMRO2) from the optical
data. In many applications, such as assessing stroke treatment efficacy and detecting secondary
stroke in brain-injured patients, this information provides clinical value.
DOS signals are commonly analyzed either with a photon diffusion approach (Chapter 2)
or a Modified Beer-Lambert approach (Chapter 3). Analogously to the DOS photon diffusion
approach, DCS signals are analyzed with a correlation diffusion approach (Chapter 4) to extract
blood flow. I extended the Modified Beer-Lambert approach for DOS to the DCS measurement,
and validated it with both simulated and in vivo data (Chapter 5).
The novel DCS Modified Beer-Lambert approach has some useful advantages compared to
the correlation diffusion approach. It facilitates real-time flow monitoring in complex tissue
geometries, provides a novel route for increasing DCS measurement speed, and can be used to
probe tissues wherein light transport is non-diffusive. It also can be used to filter signals from
superficial tissues. The latter advantage is especially important, because a well-known drawback
of optical cerebral monitoring is its significant sensitivity to superficial tissues above the brain
(e.g., scalp and skull). This sensitivity makes the optical techniques prone to extra-cerebral
artifacts.
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Combining the DCS Modified Beer-Lambert framework with probe pressure modulation
is a novel technique that I successfully used to remove extra-cerebral artifacts in in vivo cere-
bral blood flow monitoring during graded scalp ischemia and finger tapping (Chapter 6). This
pressure modulation algorithm does not require a priori anatomical information, and it can be
implemented for real time monitoring. The technique can further be extended to the DOS mea-
surement utilizing the DOS Modified Beer-Lambert framework (Chapter 6).
In another major part of my thesis, I used optical techniques to obtain surface images of
CBF and CMRO2 functional responses to forepaw stimulation in rats at many different levels
of cerebral ischemia (i.e., conditions of lower than normal CBF ) (Chapter 7). Electrical func-
tional responses to the forepaw stimulation were also measured in order to assess neurovascular
coupling (Chapter 7) during graded cerebral ischemia. All of the electrical and hemodynamic
responses are attenuated as the global ischemia becomes more severe, but the blood flow, oxy-
hemoglobin, and deoxy-hemoglobin responses are more strongly attenuated at milder levels of
global ischemia than the electrical or metabolic responses. The observed uncoupling between
flow and metabolism at ischemic levels is evidence supporting the notion that during healthy
conditions, functional stimulation increases oxygen delivery to brain tissue more than oxygen
consumption. During functional stimulation in global ischemia, though, a higher fraction of the
oxygen delivered from the vasculature is consumed. Another finding is that CBF and CBV
were affected differently by ischemia, which demonstrates the importance of using DCS or a re-
lated technique to measure CBF directly rather than relying on CBV as a surrogate for CBF .
Future work will include testing the pressure algorithm approach further in clinical settings.
Specifically, the non-invasive approach with DCS for monitoring CBF will be compared in
traumatic brain-injured patients against the current clinical standard of CBF monitoring with
an invasive thermodilution technique. It is further worth exploring the extension of the pressure
algorithm to more complex geometries than the two-layer approach, such as geometries that
contain non-diffusing domains from cerebral spinal fluid. The interactions of detected light with
the vasculature is also not well understood. Monte Carlo simulations with a realistic vascula-
ture would provide useful insights on estimating the γ coefficient in the CMRO2 compartment
model calculation (Section 7.6) as well as on relating the DCS blood flow index to absolute
blood flow.
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